{
  "schemaVersion": "deck-intelligence.v1",
  "id": "019dd923-622c-750b-8b9a-2a2468219173",
  "slug": "ce565b841c40",
  "title": "Nevro Corp. (NVRO)",
  "subtitle": "Kir Kahlon · 2021-01",
  "author": "Kir Kahlon",
  "date": "2021-01-07 00:00:00",
  "pageCount": 239,
  "kind": "activist-deck",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "targetCompany": "Nevro Corp.",
  "targetTicker": "NVRO",
  "document": {
    "id": "019dd923-622c-750b-8b9a-2a2468219173",
    "slug": "ce565b841c40",
    "title": "Nevro Corp. (NVRO)",
    "rawTitle": "NVRO",
    "authorId": "58_Scorpion_Capital",
    "authorName": "Kir Kahlon",
    "authorDisplay": "Kir Kahlon",
    "kind": {
      "slug": "activist-deck",
      "label": "Activist deck"
    },
    "sourceType": {
      "slug": "short_seller",
      "label": "Short seller"
    },
    "fileName": "NVRO.pdf",
    "sourceUrl": "http://www.scorpioncapital.com",
    "sourceDate": "2021-01-07 00:00:00",
    "presentationDate": "2021-01-07 00:00:00",
    "ingestedAt": "2026-04-22 22:27:50+00",
    "status": "ready",
    "pageCount": 239,
    "orientation": "landscape",
    "aspectRatio": 1.3333334,
    "targetCompany": "Nevro Corp.",
    "targetTicker": "NVRO",
    "metadata": {
      "local_root": "/tmp/legacy-images/ce565b841c40",
      "activist_firm": "Scorpion Capital",
      "origin_corpus": "contrarian",
      "extraction_seconds": 191.97015810012817
    }
  },
  "coverage": {
    "pageCount": 239,
    "pagesIndexed": 239,
    "pagesWithImages": 239,
    "pagesWithMetadata": 239,
    "imageCoveragePct": 100,
    "metadataCoveragePct": 100,
    "componentCount": 2145,
    "chartCount": 12,
    "metricSlides": 0,
    "toolMatches": 38,
    "documentToolMatches": 4,
    "frameworkMatches": 176,
    "arcMatches": 1,
    "beatMatches": 3,
    "loopMatches": 2,
    "patternMatches": 0,
    "storymakersMatch": false,
    "scoreAvailable": false,
    "reviewAvailable": false,
    "activistThesisAvailable": true,
    "pitchdeckMetadataAvailable": false,
    "pitchdeckProfileAvailable": false
  },
  "blocks": [],
  "matches": {
    "arcs": [
      {
        "arc": {
          "name": "Overcoming the Monster",
          "slug": "overcoming-monster",
          "status": "active",
          "bestFor": "Competitive positioning, rallying teams",
          "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
          "description": null,
          "familyLabel": null,
          "categoryName": "Booker's 7 Plots",
          "categorySlug": "booker-s-7-plots"
        },
        "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
        "evidence": "The deck's structure and content follow a narrative of exposing Nevro's flaws",
        "isPrimary": true,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:01:16.713365+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "beats": [
      {
        "to": 20,
        "arc": {
          "name": "Overcoming the Monster",
          "slug": "overcoming-monster",
          "status": "active",
          "bestFor": "Competitive positioning, rallying teams",
          "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
          "description": null,
          "familyLabel": null,
          "categoryName": "Booker's 7 Plots",
          "categorySlug": "booker-s-7-plots"
        },
        "from": 9,
        "name": "The Monster",
        "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
        "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
        "beatType": {
          "name": "The Monster",
          "slug": "overcoming-monster-the-monster",
          "status": "active",
          "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
          "version": 1,
          "description": null
        },
        "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
        "position": 0,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Hook",
          "slug": "hook",
          "status": "active",
          "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
          "version": 1,
          "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 50,
        "arc": {
          "name": "Overcoming the Monster",
          "slug": "overcoming-monster",
          "status": "active",
          "bestFor": "Competitive positioning, rallying teams",
          "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
          "description": null,
          "familyLabel": null,
          "categoryName": "Booker's 7 Plots",
          "categorySlug": "booker-s-7-plots"
        },
        "from": 21,
        "name": "The Struggle",
        "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
        "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
        "beatType": {
          "name": "The Struggle",
          "slug": "overcoming-monster-the-struggle",
          "status": "active",
          "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
          "version": 1,
          "description": null
        },
        "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
        "position": 1,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Development",
          "slug": "development",
          "status": "active",
          "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
          "version": 1,
          "description": "The middle stretch in arcs that have one. Often where length problems creep in."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      },
      {
        "to": 150,
        "arc": {
          "name": "Overcoming the Monster",
          "slug": "overcoming-monster",
          "status": "active",
          "bestFor": "Competitive positioning, rallying teams",
          "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
          "version": 1,
          "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
          "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
          "description": null,
          "familyLabel": null,
          "categoryName": "Booker's 7 Plots",
          "categorySlug": "booker-s-7-plots"
        },
        "from": 51,
        "name": "The Victory",
        "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
        "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
        "beatType": {
          "name": "The Victory",
          "slug": "overcoming-monster-the-victory",
          "status": "active",
          "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
          "version": 1,
          "description": null
        },
        "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
        "position": 2,
        "isPrimaryArc": true,
        "parentBeatType": {
          "name": "Turn",
          "slug": "turn",
          "status": "active",
          "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
          "version": 1,
          "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
        },
        "alignedBlockIds": null,
        "matchConfidence": 0.8
      }
    ],
    "loops": [
      {
        "to": 20,
        "from": 10,
        "loop": {
          "name": "05_the_reveal",
          "slug": "05-the-reveal",
          "status": "active",
          "bestFor": "Product launches, strategic pivots, unexpected findings",
          "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
          "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
          "familyLabel": null,
          "categoryName": "Narrative",
          "categorySlug": "narrative"
        },
        "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
        "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
        "position": 0,
        "objective": "Reveal Nevro's flaws",
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-16 22:01:16.880515+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      },
      {
        "to": 60,
        "from": 50,
        "loop": {
          "name": "27_cost_of_inaction",
          "slug": "27-cost-of-inaction",
          "status": "active",
          "bestFor": "Urgent budget requests, compliance, risk mitigation",
          "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
          "version": 1,
          "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
          "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
          "description": "Quantify what happens if the audience does nothing",
          "familyLabel": null,
          "categoryName": "Urgency",
          "categorySlug": "urgency"
        },
        "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
        "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
        "position": 1,
        "objective": "Highlight the cost of inaction",
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 22:01:16.92243+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": "doc-narrative-v1"
        }
      }
    ],
    "tools": [
      {
        "tool": {
          "name": "CEO quote contradiction",
          "slug": "ceo-quote-contradiction",
          "status": "active",
          "bestFor": "When management credibility is the lever",
          "canonId": "019dd9e1-52e9-717f-8454-93e627563ed6",
          "version": 1,
          "bodyDocId": "019dd9a1-8296-720d-8f51-da76937f9415",
          "description": "You reproduce management's own words — verbatim, with source and date — and\nthen place them next to the outcome that contradicts them. The CEO built\nthe rope; you put it around their own neck.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "document",
        "agents": null,
        "matchId": "f1940128-0bc4-4835-bb9b-3989746a4814",
        "evidence": null,
        "pageRefs": null,
        "priority": null,
        "whenToUse": "When management credibility is the lever",
        "confidence": null,
        "extraction": {
          "at": "2026-04-29 12:07:50.209813+00",
          "model": "unknown-legacy",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": null,
        "whyItWorks": "- **Maximum credibility**: no adjective you could write is as damning as the\n  target's own prior statement.\n- **No rebuttal path**: management can't argue they didn't say it.\n- **It forces accountability onto a person**, not an institution — even if\n  you aren't explicitly naming a villain elsewhere.\n- **Reporters amplify it**. A CEO-quote-contradiction slide is quotable,\n  which means it lands in WSJ/FT/Bloomberg coverage.",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Peer gap chart",
          "slug": "peer-gap",
          "status": "active",
          "bestFor": "When relative underperformance is the core argument",
          "canonId": "019dd9e1-54f1-775a-94a1-d5cf3bb75abf",
          "version": 1,
          "bodyDocId": "019dd9a1-8653-7748-9050-807f067196c3",
          "description": "A single visual that benchmarks the target against its best-in-class peers on\na single quantitative KPI — and shows the target losing. The gap is the\npunchline.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "document",
        "agents": null,
        "matchId": "d5d0cab0-4b3c-4c62-8c47-00c4ed199768",
        "evidence": null,
        "pageRefs": null,
        "priority": null,
        "whenToUse": "When relative underperformance is the core argument",
        "confidence": null,
        "extraction": {
          "at": "2026-04-29 12:07:50.209813+00",
          "model": "unknown-legacy",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": null,
        "whyItWorks": "- It's the **most credible claim in the deck** because it's arithmetic, not\n  opinion.\n- It's immediately **actionable** — close this gap and value accrues.\n- It **pre-empts the \"context is different\" defence** by pitting the target\n  against direct peers in the same category.",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain naming",
          "slug": "villain-naming",
          "status": "active",
          "bestFor": "When governance or specific decisions are the core thesis",
          "canonId": "019dd9e1-55a4-74db-9314-0ced4cd46cd2",
          "version": 1,
          "bodyDocId": "019dd9a1-88f1-72ad-8f4e-56ec29d7b369",
          "description": "You identify a **specific person** responsible for the target's underperformance\nor the behaviour you want changed — and name them. Not \"management\" or \"the\nboard\". A named executive or director with a specific failure attributable to\nthem.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "document",
        "agents": null,
        "matchId": "8e87bdda-a006-47f4-802a-a54ba7c725bb",
        "evidence": "Keith Grossman (CEO); Carolinas Pain Institute investigators; top-paid KOL implanters (Amirdelfan, Kapural, Li, Galvan, Sayed)",
        "pageRefs": null,
        "priority": null,
        "whenToUse": "When governance or specific decisions are the core thesis",
        "confidence": null,
        "extraction": {
          "at": "2026-04-29 12:07:50.209813+00",
          "model": "unknown-legacy",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": null,
        "whyItWorks": "- **Accountability needs a face.** Voters (shareholders, regulators,\n  journalists) act faster against people than institutions.\n- **Credibility rises with specificity.** \"The CFO has repeatedly missed\n  guidance\" > \"Management has missed guidance\".\n- It **pre-empts evasion**. An individual can be removed; an abstraction\n  cannot.\n- It **forces the target to respond personally** — and their defensive\n  response usually generates more attention for your thesis.",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain slide",
          "slug": "villain-slide",
          "status": "active",
          "bestFor": "In activist decks where the personality matters",
          "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
          "version": 1,
          "bodyDocId": null,
          "description": "A dedicated slide presenting the named villain visually",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "document",
        "agents": null,
        "matchId": "5256984d-75cd-40e5-9b8a-51ed2f0de585",
        "evidence": null,
        "pageRefs": null,
        "priority": null,
        "whenToUse": "In activist decks where the personality matters",
        "confidence": null,
        "extraction": {
          "at": "2026-04-29 12:07:50.209813+00",
          "model": "unknown-legacy",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": null,
        "whyItWorks": "Makes the antagonist concrete",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Audience Definition",
          "slug": "audience-definition",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
          "version": 1,
          "bodyDocId": null,
          "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "bc4ef4ad-28ba-41d1-9840-9f2c616db5ab",
        "evidence": "The slide provides information about Nevro, including its market cap, stock price, and short interest, indicating that the audience is likely investors or financial analysts.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:28.98442+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Call to action",
          "slug": "call-to-action",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c",
          "version": 1,
          "bodyDocId": null,
          "description": "Explicit prescription of what the audience should do next.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "0c88baf8-f7ca-4e5d-ae6d-2c5fbcb89e5f",
        "evidence": "The title/action-title 'A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall' could be seen as a call to action, although it's more of a provocative statement.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-16 23:09:29.022821+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Credibility Transfer",
          "slug": "credibility-transfer",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-bd34-759a-8e3b-2f14b571a2a1",
          "version": 1,
          "bodyDocId": null,
          "description": "Borrowing authority from trusted sources or vivid details",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "5f1f8fc5-a320-4a0e-a728-833d9dd20c24",
        "evidence": "The quotes from physicians lend credibility to the claims made about Nevro.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:29.099046+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Evidence Matrix",
          "slug": "evidence-matrix",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
          "version": 1,
          "bodyDocId": null,
          "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "82bb15e4-7a77-4705-b27a-9d7218dbc8f0",
        "evidence": "The quotes provide evidence to support the claims made about Nevro's business practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:29.172827+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Anadiplosis",
          "slug": "anadiplosis",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
          "version": 1,
          "bodyDocId": null,
          "description": "Ending one clause with a word that begins the next",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "26da1bc5-e8e1-4f5e-aa99-24b9f63aaaa5",
        "evidence": "The use of repetition in the quote and callout sections emphasizes the risks associated with Nevro.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.103459+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain slide",
          "slug": "villain-slide",
          "status": "active",
          "bestFor": "In activist decks where the personality matters",
          "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
          "version": 1,
          "bodyDocId": null,
          "description": "A dedicated slide presenting the named villain visually",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "c3da92f2-44e5-4a06-bfdd-10b7d8fc8235",
        "evidence": "The slide presents Nevro as a company with significant risks, including a toxic combination of leverage and cash burn, and compares it to Nuvectra, which filed for liquidation.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": "In activist decks where the personality matters",
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-16 23:09:31.071068+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "whyItWorks": "Makes the antagonist concrete",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "2x2 matrix",
          "slug": "matrix-2x2",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
          "version": 1,
          "bodyDocId": null,
          "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "43dd0c69-40e3-42bc-84be-136962e7d05e",
        "evidence": "Although not explicitly a 2x2 matrix, the table could be interpreted as a simple comparison framework.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-16 23:09:31.167518+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 14,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "0fd5153e-d544-4918-9d29-2fc753ba3f12",
        "evidence": "The use of a bar chart to show Nevro's revenue and growth rate helps to visualize the problem.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-16 23:09:31.266555+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 15,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Problem Statement Canvas",
          "slug": "problem-statement-canvas",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
          "version": 1,
          "bodyDocId": null,
          "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Architect",
        "layer": "slide",
        "agents": [
          "Architect"
        ],
        "matchId": "8547d444-dada-45ff-8492-5e9037213378",
        "evidence": "The slide presents a problem statement about Nevro's growth stalling, and provides context about the company's history and product launch.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.232975+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 15,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "b13c8fb6-3076-4592-8133-a1c13676f116",
        "evidence": "The use of a bullet list to present execution issues helps to clearly outline the problems.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.335287+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Logical chain",
          "slug": "logical-chain",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-5104-702f-8953-85757af6553d",
          "version": 1,
          "bodyDocId": null,
          "description": "If-then, premise-conclusion, deductive chain.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "c23c6590-432f-4aaf-8f57-75d3f2173c6f",
        "evidence": "The use of a logical sequence of quotes and testimonials helps to build a narrative.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.400841+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Anaphora",
          "slug": "anaphora",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-9fee-74aa-a920-078aa44132c0",
          "version": 1,
          "bodyDocId": null,
          "description": "Repeating words at the beginning of successive clauses for rhythm",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "0d2c9751-c11d-4440-82b0-c1c1163ef6f2",
        "evidence": "The repetition of 'No matter what we did in the field, it didn't work' emphasizes the device's lack of efficacy.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.466805+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 18,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chiasmus",
          "slug": "chiasmus",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-9f90-77d2-92d7-9a9780d23677",
          "version": 1,
          "bodyDocId": null,
          "description": "Reversing structure in successive phrases for emphasis (A-B then B-A)",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "74200bec-f8aa-4bf8-b3ce-a3556f054a2d",
        "evidence": "The use of contrasting ideas, such as 'the device stops working' and 'doctors sour on the device', helps to emphasize the problems.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.532266+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 19,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Rhetorical figure",
          "slug": "rhetorical-figure",
          "status": "active",
          "bestFor": null,
          "canonId": "d03b1504-fbd5-42a0-b1fe-e82c055d18d8",
          "version": 1,
          "bodyDocId": null,
          "description": "Classical rhetorical patterns (chiasmus, anaphora, antithesis, etc.) used for memorability.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "21a8d7d7-17cc-4fa5-8737-70cf2f4b4332",
        "evidence": "The use of rhetorical devices, such as metaphors or analogies, helps to emphasize the problems.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.596731+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 20,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "optional",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Authority Bias",
          "slug": "authority-bias",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-c38d-70b9-a284-b2b479763356",
          "version": 1,
          "bodyDocId": null,
          "description": "Expert opinions are weighted more heavily - cite credible sources",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Architect",
          "Storyteller"
        ],
        "matchId": "bb44e6f4-6da2-4dec-bc5e-41d7d1fff75d",
        "evidence": "The use of a quote from a former executive or KOL helps to establish credibility.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.659811+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 22,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Call-and-Response",
          "slug": "call-and-response",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
          "version": 1,
          "bodyDocId": null,
          "description": "Engaging audience by creating pattern they complete mentally",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "bf3f5a60-671c-44e9-8daa-4d55ad5f1a5b",
        "evidence": "The use of a call-and-response pattern helps to emphasize the problems.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.723433+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chart Selection Guide",
          "slug": "chart-selection-guide",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
          "version": 1,
          "bodyDocId": null,
          "description": "Choosing the right chart type for your data and message",
          "familyLabel": null,
          "categoryName": "Slide",
          "categorySlug": "slide"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "04ea72d8-1ba4-4376-8784-5b066d16fc77",
        "evidence": "The use of bar charts to show quarterly revenue helps to visualize the trend.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-16 23:09:31.788735+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 24,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Evidence Matrix",
          "slug": "evidence-matrix",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
          "version": 1,
          "bodyDocId": null,
          "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Designer",
        "layer": "slide",
        "agents": [
          "Designer"
        ],
        "matchId": "48d02690-38d2-4ca4-af23-294a74490d69",
        "evidence": "The use of a list to present evidence helps to build a case.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:31.856099+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 25,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "AIDA Model",
          "slug": "aida-model",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-86fc-773c-813f-d416714b8413",
          "version": 1,
          "bodyDocId": null,
          "description": "Attention, Interest, Desire, Action - classic persuasion sequence",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "b2d9a3f9-18d2-4b43-afc4-5766bc892f5c",
        "evidence": "The launch of Saluda Medical’s “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:32.537774+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 51,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Call to action",
          "slug": "call-to-action",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c",
          "version": 1,
          "bodyDocId": null,
          "description": "Explicit prescription of what the audience should do next.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "fab8ba74-81f5-49fb-94cf-0cef45c03065",
        "evidence": "The launch of Saluda Medical’s “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:32.569937+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 51,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Executive summary",
          "slug": "executive-summary",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
          "version": 1,
          "bodyDocId": null,
          "description": "A condensed view of the entire argument on a single slide / block.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "436ea900-b7a1-44f5-b8b3-95a8ea4bf6d4",
        "evidence": "Summary of key findings",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-16 23:09:32.635205+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 52,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Anadiplosis",
          "slug": "anadiplosis",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
          "version": 1,
          "bodyDocId": null,
          "description": "Ending one clause with a word that begins the next",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "cbdb1c7c-b7fe-4644-84ac-c8ea458ecae6",
        "evidence": "Multiple quotes from different KOLs and experts corroborating similar concerns about Nevro's practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:45.883422+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 68,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Call-and-Response",
          "slug": "call-and-response",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
          "version": 1,
          "bodyDocId": null,
          "description": "Engaging audience by creating pattern they complete mentally",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "fcc7269a-5cdc-464d-8365-40c985307873",
        "evidence": "The use of quotes from KOLs and experts in response to allegations about Nevro's practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:45.926246+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 68,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Call-and-Response",
          "slug": "call-and-response",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
          "version": 1,
          "bodyDocId": null,
          "description": "Engaging audience by creating pattern they complete mentally",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "3ee1c2f8-bf8e-4791-bb0b-db44b5142adf",
        "evidence": "The slide includes multiple quotes from KOLs and experts, creating a call-and-response structure to build a narrative.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:33.192531+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 77,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Anadiplosis",
          "slug": "anadiplosis",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
          "version": 1,
          "bodyDocId": null,
          "description": "Ending one clause with a word that begins the next",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "f0c11bd8-0b0f-4882-bb7d-241cc6d99f74",
        "evidence": "The use of repeated phrases and ideas, such as the concept of 'beating on the spinal cord' and 'refractory response,' demonstrates anadiplosis.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-16 23:09:34.393631+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 101,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain slide",
          "slug": "villain-slide",
          "status": "active",
          "bestFor": "In activist decks where the personality matters",
          "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
          "version": 1,
          "bodyDocId": null,
          "description": "A dedicated slide presenting the named villain visually",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "cbd71043-0948-48b0-a12c-505a4195f79a",
        "evidence": "The slide presents a critical view of Nevro, highlighting concerns about its product's effectiveness and safety, which aligns with the villain slide technique.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": "In activist decks where the personality matters",
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-16 23:09:34.3603+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 101,
        "whyItWorks": "Makes the antagonist concrete",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Authority citation",
          "slug": "authority-citation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
          "version": 1,
          "bodyDocId": null,
          "description": "Quoting an authority figure, study, or precedent to lend weight.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "f2e9224f-5907-443b-ad97-bf3cee9c882f",
        "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:46.052872+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 107,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain slide",
          "slug": "villain-slide",
          "status": "active",
          "bestFor": "In activist decks where the personality matters",
          "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
          "version": 1,
          "bodyDocId": null,
          "description": "A dedicated slide presenting the named villain visually",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "64b51001-1d86-40a8-8073-924666f9a732",
        "evidence": "The slide is explicitly titled 'villain_critique' and presents critical information about Nevro's response to its explants crisis.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": "In activist decks where the personality matters",
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:55:46.010804+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 107,
        "whyItWorks": "Makes the antagonist concrete",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Chiasmus",
          "slug": "chiasmus",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-9f90-77d2-92d7-9a9780d23677",
          "version": 1,
          "bodyDocId": null,
          "description": "Reversing structure in successive phrases for emphasis (A-B then B-A)",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "c6e1a903-de8e-4968-b0fd-2ec80ef3d7c1",
        "evidence": "The use of contrasting ideas and quotes to highlight the contradictions in Nevro's practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:55:46.137154+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 118,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "List presentation",
          "slug": "list-presentation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
          "version": 1,
          "bodyDocId": null,
          "description": "Bulleted, numbered, or checklist enumerations.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "81979259-12c2-496d-8a76-9d4a302a80a5",
        "evidence": "The use of bullet points to present multiple quotes and testimonials from experts.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:46.221862+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 140,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Audience Definition",
          "slug": "audience-definition",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
          "version": 1,
          "bodyDocId": null,
          "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
          "familyLabel": null,
          "categoryName": "Block",
          "categorySlug": "block"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "b331783e-b247-40e6-8307-813d90602ebd",
        "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices and target audience.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.5,
        "extraction": {
          "at": "2026-07-17 03:55:46.306279+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 142,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Data Story Arc",
          "slug": "data-story-arc",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd956-9c30-728e-b974-d3fb123dcf5a",
          "version": 1,
          "bodyDocId": null,
          "description": "Context → Conflict → Insight → Implication structure for data narratives",
          "familyLabel": null,
          "categoryName": "Loop",
          "categorySlug": "loop"
        },
        "agent": "Storyteller",
        "layer": "slide",
        "agents": [
          "Storyteller"
        ],
        "matchId": "fe3796a0-af79-4fa3-ad13-84d8fd5ee29d",
        "evidence": "The use of data and literature to support the allegations about Nevro's practices.",
        "pageRefs": null,
        "priority": "Core",
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:46.392709+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 156,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Authority citation",
          "slug": "authority-citation",
          "status": "active",
          "bestFor": null,
          "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
          "version": 1,
          "bodyDocId": null,
          "description": "Quoting an authority figure, study, or precedent to lend weight.",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "feacb666-db5d-4860-a5b5-69bd2e20ddd6",
        "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-07-17 03:55:46.478324+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 174,
        "whyItWorks": null,
        "antipattern": null,
        "cardinality": "common",
        "narrativePurpose": null
      },
      {
        "tool": {
          "name": "Villain slide",
          "slug": "villain-slide",
          "status": "active",
          "bestFor": "In activist decks where the personality matters",
          "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
          "version": 1,
          "bodyDocId": null,
          "description": "A dedicated slide presenting the named villain visually",
          "familyLabel": null,
          "categoryName": null,
          "categorySlug": null
        },
        "agent": null,
        "layer": "slide",
        "agents": null,
        "matchId": "e849d845-778f-44fa-ada3-88e5c6a4ceb3",
        "evidence": "The slide features several quotes and testimonials that portray a negative view of Saluda and its influence on medical professionals, indicating a villain critique.",
        "pageRefs": null,
        "priority": null,
        "whenToUse": "In activist decks where the personality matters",
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-16 23:09:38.720273+00",
          "model": "or:meta-llama/llama-4-scout",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 191,
        "whyItWorks": "Makes the antagonist concrete",
        "antipattern": null,
        "cardinality": null,
        "narrativePurpose": null
      }
    ],
    "frameworks": [
      {
        "matchId": "3ace5aba-830c-40c8-9961-c870acd53807",
        "evidence": "The slide frames the company as a 'failed one-trick pony' and 'reeking of fraud'.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:31.35+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 1,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "6ac7d25f-2992-4828-b7ac-4677eaf82c67",
        "evidence": "The slide presents testimonials to allege criminal data manipulation and bribery.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:23.16+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 3,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "3e224232-d8e1-43ca-b59f-bdebf90834a7",
        "evidence": "The slide uses testimonials to expose alleged data falsification and unethical business practices.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:23.647+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 4,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "23cd50c4-bf59-4728-8703-3386e077dae0",
        "evidence": "The slide explicitly frames Nevro's KOL network as a 'cult' and 'corrupt trial factory'.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:27.911+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 11,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "b613ddee-5796-4728-b511-5e33595b911f",
        "evidence": "Comparison of Nevro to failed Nuvectra to establish a villainous narrative.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:25.894+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 13,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "52db4180-7adf-421a-80c8-c39b9f9d4908",
        "evidence": "Compares Nevro against top 50 medtech peers across market cap, growth, and margins.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:30.258+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 14,
        "frameworkName": "comparison_frame"
      },
      {
        "matchId": "b248df8d-4c55-4567-8b22-c1cd4849988c",
        "evidence": "The slide explicitly sets up a company-provided narrative ('execution issues') to contrast with the activist's critical analysis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:26.795+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 16,
        "frameworkName": "expose_contradiction"
      },
      {
        "matchId": "93e9b7ef-586f-4b89-b8a9-45ea55fa5c17",
        "evidence": "The slide systematically dismantles management's stated reasons for growth decline to imply deeper issues.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-05-02 20:15:27.822+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 17,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e43ca8f3-2ae5-46a6-8ab6-9c94cff42ad3",
        "evidence": "Contrasts company narrative with internal employee testimony",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:35.23+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 18,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "e0e27a6a-06f1-48dc-bc8a-6c6490b9392a",
        "evidence": "Contrasting KOL testimonials with public earnings call disclosures",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:27.932+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 19,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "de7b17a5-94f0-4226-ac45-c1a77b852855",
        "evidence": "The slide uses expert testimony to allege that the company is lying about product performance data.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:28.253+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 20,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "93449d00-56d5-4709-85c0-584e097bf870",
        "evidence": "The slide explicitly frames the company's actions as lying and hypocrisy to undermine investor confidence.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:28:25.314+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 21,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "aba551ad-896a-4717-af82-23c46c105c99",
        "evidence": "Uses expert testimonials to directly challenge the CEO's stated strategy and competence.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:27.544+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 22,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "70d1ee2e-a05e-49e4-8013-8bf65a970884",
        "evidence": "The slide uses quotes from former executives to contradict the CEO's public narrative.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:34.458+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 23,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "1102b13d-6ade-4ea8-928b-3ff8121e813f",
        "evidence": "The slide explicitly frames the CEO's past performance as a 'canary in the coal mine' to warn investors of potential deception or failure.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:28.145+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 24,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "3da1daeb-d56a-4202-a201-c3100e9ab4f3",
        "evidence": "Contrasts CEO's past positive quote with subsequent negative outcomes (settlements/fraud allegations).",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:15:28.828+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 25,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "6cd033be-c32c-4dc7-a9a4-c0856b276af5",
        "evidence": "Uses documentary and victim testimony to frame the CEO as a villain.",
        "framework": null,
        "confidence": 0.95,
        "extraction": {
          "at": "2026-07-17 03:28:25.851+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "254b5575-1c78-471b-9ba2-5c88509b55ac",
        "evidence": "Uses graphic descriptions of medical trauma to influence investor sentiment.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:28:25.851+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 26,
        "frameworkName": "emotional-appeal"
      },
      {
        "matchId": "d39e291f-f6b0-4e38-be9d-ed8ed65aa921",
        "evidence": "The slide systematically uses external investigative reports to expose the company's product as fraudulent or ineffective.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:29.618+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 28,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "14db52e6-0802-4fd1-878d-cab50daa9fbc",
        "evidence": "Frames the company/industry as a 'hustle' preying on patients.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:32.015+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 29,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "f6725d57-e5a3-4d0e-93ef-203a0eca0005",
        "evidence": "The slide systematically presents negative regulatory and safety data to undermine the company's market position.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:29.627+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 31,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "437f19e3-b5b8-4e9b-a2c7-306cc85dd285",
        "evidence": "The slide explicitly frames the company as a 'poster child for abuses' and alleges 'criminal' data manipulation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:29.54+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 32,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "8baf3a8f-979b-4e9b-9cdb-ceb4640d4332",
        "evidence": "The slide frames Nevro's technology as a dangerous, failing product through expert testimony.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-05-02 20:15:32.883+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 33,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "e6766511-c5ae-4c7c-9b5f-8fa4da2d7588",
        "evidence": "Uses patient testimonials to frame the company as ignoring widespread harm.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:30.692+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 34,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "51c27fc8-3404-4bdc-a47e-42d53ca53b74",
        "evidence": "Aggregating negative user testimonials to expose product failure and potential company misrepresentation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:29.193+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 36,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "16ac1ecb-c468-4e5b-afc1-94f4feae9dbb",
        "evidence": "Frames the company as causing physical harm to patients for profit.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:34.098+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 37,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "d0705c81-6cf3-4f2a-9839-86ba9a95cbf7",
        "evidence": "The slide explicitly frames the company's business model as a 'hustle' and 'billing fraud' using anecdotal evidence.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:30.624+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 38,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "702065e4-237d-498b-b38a-6af32c18c164",
        "evidence": "Uses anecdotal social media evidence to allege corporate misconduct and product failure.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:44.183+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 39,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "ac7b90a6-4fef-4068-aa5b-ff424990ac82",
        "evidence": "The slide frames Nevro as a failing entity ('disaster', 'reckoning', 'one-trick pony') to be dismantled by the activist.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:31.229+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 41,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "94dfb25e-155e-4d9b-b77f-fdd6c8982189",
        "evidence": "The slide explicitly frames the company's clinical trial as a 'fraud' and 'sham' to undermine the investment thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:32.372+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 42,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "87ed8180-aade-4de3-9b32-a6b745e35a93",
        "evidence": "The slide systematically dismantles the company's core value proposition using clinical evidence and expert testimony.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:35.083+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 43,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "08c884b9-a93c-49e8-b40f-95fb5c4d10b0",
        "evidence": "The slide systematically presents evidence of product failure and management deception to support a short thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:35.756+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 44,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "b22791fc-ca9f-4624-8c1a-53241306ed67",
        "evidence": "The slide frames Nevro as the antagonist through negative KOL testimonials.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:36.554+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 45,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "1a8d8051-cf35-43ae-a5e2-59d9c3c1c377",
        "evidence": "The slide systematically lists allegations of corporate deception, cover-ups, and falsified data to build a case for a short position.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:32.09+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 46,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "4216045a-b4fe-4b92-aab7-e2d7fffd141a",
        "evidence": "The slide uses negative testimonials and internal contradictions to argue for a structural failure in the company's business model.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-05-02 21:26:31.524+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 47,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "5fecc442-5c7e-470e-b7ec-1e70c113b903",
        "evidence": "The slide explicitly labels company claims as 'fraudulent narrative', 'a lie', and 'misleading'.",
        "framework": null,
        "confidence": 0.95,
        "extraction": {
          "at": "2026-05-02 20:15:32.39+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 48,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "bb3febbc-16ba-4173-a8fb-238365126cf9",
        "evidence": "The slide explicitly claims 'data fabrication' and 'false' market growth stories to expose the company's narrative.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:32.485+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 52,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "0274d216-94f8-4ae1-be2f-bdea23bc03d6",
        "evidence": "The slide systematically presents evidence of alleged illegal kickbacks and bribery to expose corporate fraud.",
        "framework": null,
        "confidence": 0.95,
        "extraction": {
          "at": "2026-05-02 20:15:33.366+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 53,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "b81150c2-431e-47fc-9c67-19c292a064ae",
        "evidence": "The slide systematically lists allegations of illegal/unethical conduct to build a case for regulatory or legal risk.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:35.064+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 54,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e28af46e-993b-4a32-9627-59e187bb2f78",
        "evidence": "The slide explicitly frames the business model as predicated on unauthorized practice of medicine, a common activist short thesis.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:35.881+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 55,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "f2a6409c-bc59-49c2-bb45-08313547ae1f",
        "evidence": "Contrasts company IPO claims with allegations of fraud.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:35.387+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 56,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "97a1b477-43bf-4d51-8bd3-8921eb6edc34",
        "evidence": "The slide explicitly frames the study as a 'fraud' and uses data to challenge the company's claims.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:36.654+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 57,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "469e1b07-8db6-4c19-98d9-b802f0c22cf1",
        "evidence": "The slide explicitly frames the clinical trial as a 'sham exercise' and 'fraud' to expose potential corporate misconduct.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:28:29.724+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 58,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "9e271d9f-9c93-44de-bf37-89e5352bd2ab",
        "evidence": "The slide explicitly frames the clinical trial as a 'fraud' based on subjective methodology.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:36.068+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 59,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "de06857c-bf98-4f93-aa20-6c65fda8d95c",
        "evidence": "The slide explicitly frames the clinical trial as a fraud based on expert testimony.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:37.506+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 60,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e8c2c9ce-9c62-4d87-9bbf-6061fec61e63",
        "evidence": "The slide explicitly frames the clinical trial as a fraud and the company's actions as a disinformation campaign.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:37.646+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 61,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "f42abb1e-7cc3-410f-b849-2ed82c9b1512",
        "evidence": "The slide explicitly frames the company's clinical evidence as a 'fraud' by contrasting it with the testimony of the lead investigator.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:37.085+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 62,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "2610f999-6655-4102-a60e-e7c3fe5317ba",
        "evidence": "The slide systematically presents expert testimony to allege fraudulent trial design.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:38.585+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 63,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "40deb260-b2a4-49c0-9c50-030b8ac19c01",
        "evidence": "The slide explicitly frames a specific doctor as a villain to undermine the credibility of a clinical study.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:36.616+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 65,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "bb4e4de8-c3d0-4ad9-ab9e-a9050db39007",
        "evidence": "The slide systematically presents testimonials to allege fraudulent study design.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:37.931+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 66,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "94bc5bf1-4038-437d-8663-dee0d883d998",
        "evidence": "The slide systematically presents allegations of unethical behavior and data manipulation to discredit the company's clinical trial results.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:38.342+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 67,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "6c4a18f3-e3b7-4166-a3e1-96d17aa6cf0e",
        "evidence": "Allegations of rigged studies and manipulated patient data to engineer favorable outcomes.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:50:12.515+00",
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 68,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "971f2126-5854-4159-8519-4db02d020542",
        "evidence": "The slide explicitly frames the content as exposing a fraud in a clinical trial.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:40.269+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 69,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "884adeeb-caaa-4798-bed6-09695d3e1181",
        "evidence": "Frames the company's technology as a 'phony premise' and uses expert testimony to undermine it.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:39.517+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 71,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "d101c589-9a95-4ce4-9dd5-61c145c536bf",
        "evidence": "The slide explicitly frames the company's core technology as a 'phony premise' using clinical data to contradict marketing claims.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:38.022+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 72,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "3b091dae-7d71-45de-998a-fd5bcb6dd9b3",
        "evidence": "Framing Boston Scientific and the PROCO study as the truth-tellers against Nevro's 'phony' claims.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:42.776+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 73,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "63060c41-1088-4b13-b860-6df6001b0934",
        "evidence": "The slide explicitly frames the company's core technology as a 'phony premise' and highlights investigator bias.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:39.586+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 74,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "5f70e7ec-729b-4ac9-a692-97f98173a607",
        "evidence": "The slide explicitly contrasts Nevro's claims with a double-blind study showing no efficacy.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:15:42.492+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 75,
        "frameworkName": "expose_contradiction"
      },
      {
        "matchId": "0adf7fae-fad6-43e7-8076-9f0ee56c759f",
        "evidence": "Uses quotes from industry experts to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:39.713+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 76,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "c548cbb4-6075-430b-a024-9cd11c828670",
        "evidence": "The slide frames Nevro's high-frequency technology as a 'fatal flaw' and a burden to patients.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:40.509+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 77,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "37214cad-50c4-41b9-b417-5cc887922d42",
        "evidence": "Frames the company's core technology as a 'fatal flaw' and 'disruption' that is actually a weakness.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:41.717+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 78,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "97f90da2-7d72-4aa5-900d-d615435a9883",
        "evidence": "Frames the company's core product as the source of its failure.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:40.27+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 80,
        "frameworkName": "villain_critique"
      },
      {
        "matchId": "2d6152b6-9b29-4d68-af95-3e8cfd9a2c88",
        "evidence": "The slide frames the company's product as the 'villain' causing operational chaos.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:40.574+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 81,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "549f9af1-a035-48ac-8af2-8a5b496cc4cd",
        "evidence": "The slide frames the company's technology as a 'fatal flaw' and uses expert testimony to discredit it.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:41.818+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 82,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "36c3d2cd-16ac-43e9-ab36-498d474e83ee",
        "evidence": "Frames management as the villain causing the company's failure.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:41.663+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 83,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "8ee3c7f5-5bcd-4e2f-9b37-0187bbd65211",
        "evidence": "The slide explicitly contrasts a corporate claim with research findings to expose a contradiction.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:42.388+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 84,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "ef71dff6-ecf3-4070-9d23-6706a4d0bf90",
        "evidence": "The slide explicitly frames the study as a 'marketing brochure masquerading as a legitimate paper' to expose corporate deception.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:41.85+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 85,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "7d5f6b4b-d1d9-414a-ae75-77df89b9b55f",
        "evidence": "The slide explicitly contrasts company claims with real-world data to allege a cover-up.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:42.005+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 86,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "494a77f8-080f-497b-98dc-280d64f65022",
        "evidence": "The slide explicitly frames the company's reported data as a 'lie' and 'covered-up' crisis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:34.463+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 89,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "539a6459-5c11-461c-8eeb-70f3fba80650",
        "evidence": "The slide systematically presents expert testimony to expose alleged device failures and cover-ups.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:44.353+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 91,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e0c87612-2ce2-43ab-a254-7159026176af",
        "evidence": "Uses KOL quotes to validate the claim of high explant rates.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:44.161+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 92,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "dde8c5c9-5513-4617-90e7-4cfc80aed157",
        "evidence": "The slide explicitly frames the company's reported data as a 'covered-up' crisis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:43.39+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 93,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "4573d62a-7002-4e4b-9795-0091658bbae9",
        "evidence": "Contrasts company-reported 1% explant rate with anecdotal 80% claims from competitors.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:43.917+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 94,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "34004c08-996a-4490-aec1-38e4279b966c",
        "evidence": "The slide explicitly frames the content as exposing fraudulent data manipulation in a clinical study.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:50.906+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 99,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "c597402b-63fb-4f31-804d-b556c51f677d",
        "evidence": "The slide frames the company's technology as the 'villain' causing harm to patients.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:53.218+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 101,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "a25ec51d-9623-4e6b-836b-a755ee179d43",
        "evidence": "The slide explicitly frames the KOLs' statements as 'false' and 'contradicting' disclosures to expose potential corporate malfeasance.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:47.202+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 106,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "4851a86d-55ec-4d54-851b-f75a0917ccb3",
        "evidence": "Frames Nevro management as the antagonist using KOL testimonials.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:47.947+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 109,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "06984559-c29f-43a1-9ce8-c9b47583583c",
        "evidence": "The slide contrasts the company's official stance with a KOL's experience of manipulation.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:51.889+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 110,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "c1d417c3-7c0a-4fb4-bc34-9aa44c06936a",
        "evidence": "The slide frames Nevro and its associated doctors as a 'cult' and 'unethical' to discredit them.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:48.358+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 111,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "e92bbe39-1adc-42fb-8bd0-8f40fc961e3d",
        "evidence": "The slide explicitly compares Nevro's practices to the Insys fentanyl scandal to frame them as fraudulent.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:48.7+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 113,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "377e8e32-b367-4563-94b9-e6bff09afa2b",
        "evidence": "Physicians would have an aha moment",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:15:54.494+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 114,
        "frameworkName": "aha-moment"
      },
      {
        "matchId": "f57d04ce-107a-4242-82e3-edae630ee35f",
        "evidence": "Using expert testimony to contradict the company's narrative of success",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:54.494+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 114,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "f8e1a2ba-4999-49ca-bdfa-c5f37be92c64",
        "evidence": "Uses expert testimony to contradict company narrative of device success.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:52.094+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 115,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "9ccea823-6c64-4691-96d1-fa5a79677d3f",
        "evidence": "Uses KOL testimonial to contradict company sales claims",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:50.075+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 116,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "71fd09e6-89f5-4b2f-a90d-23b8484a5a3c",
        "evidence": "The slide explicitly frames the narrative around unethical and illegal conduct to expose corporate fraud.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:54.421+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 117,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "9d884d04-adb7-4dc3-9d2d-de2958c30b47",
        "evidence": "The slide explicitly frames the content as exposing corporate misconduct and manipulation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-07-17 03:28:33.262+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 118,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "2b40eee4-20b1-4a3f-b26b-ffcc42106161",
        "evidence": "The slide frames the sales representatives as the antagonist manipulating patients.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:52.01+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 119,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "96ace6ae-db75-4b99-9e71-8daf83da2b1b",
        "evidence": "Citing KOLs and high-volume implanters to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:51.506+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 120,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "c3647620-6d7f-48bc-b642-69350f090a0b",
        "evidence": "Uses expert testimony to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:34.476+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 121,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "566b77ad-2139-45f1-a674-8ac8f6d9aee8",
        "evidence": "Framing Medtronic as the expert observer exposing Nevro's flaws.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:52.318+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 123,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "3d79026e-b850-49b9-a567-19c134991948",
        "evidence": "The slide explicitly frames the company's success as a result of 'biased' data and 'not real-world' results to expose a contradiction in their market performance.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:51.302+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 126,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "bd638ea2-dd3b-4ba8-bb10-cbbed4081a31",
        "evidence": "The slide uses expert testimony to allege a discrepancy between clinical trial results and real-world performance, framing it as a corporate deception.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-05-02 20:15:59.133+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 127,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "ff410af8-7b42-4dbf-b588-aec0cd66be3b",
        "evidence": "The slide frames the company as the antagonist by using former employees to expose unethical sales practices.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:57.133+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 129,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "3ac62f65-cceb-4135-ac06-7f2bcad64249",
        "evidence": "The slide frames the Omnia product as a 'Hail Mary' and 'colossal flop' to undermine the CEO's turnaround strategy.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:52.59+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 130,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "58a2cda2-14fd-4eb3-b305-5209cfd09ae6",
        "evidence": "Contrasts current company strategy with historical S-1 filing statements.",
        "framework": null,
        "confidence": 0.95,
        "extraction": {
          "at": "2026-05-02 20:15:54.009+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 131,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "00f41c11-dce5-434c-b783-ae2b3e133d74",
        "evidence": "The slide explicitly contrasts the CEO's stated expectations with his later admission of stagnant adoption rates.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:59.281+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 132,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "bead9769-440f-43be-9a13-14644894590a",
        "evidence": "The slide explicitly contrasts the CEO's quote with the author's interpretation of the product launch failure.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:15:55.094+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 133,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "c531a8fb-c9ec-41b8-9642-86311b3e8435",
        "evidence": "Frames the company's product as a 'colossal flop' through expert testimony.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:56.091+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 134,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "d919fe73-d2af-4469-b3ac-d02a07defd1a",
        "evidence": "Uses multiple KOL quotes to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:57.402+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 135,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "f36fabda-f1f5-4422-ba96-bbbe8ebc6eee",
        "evidence": "Frames Nevro's product as a 'colossal flop' and 'delusion' to build a case against the company.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:00.856+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 137,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "47f67e14-0c55-47c1-8f8c-118b7fd0cf09",
        "evidence": "Frames the company's product as a 'colossal flop' and 'old stuff' via expert testimony.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:55.903+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 138,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "0722a249-9fdb-4684-bf7d-b015ee933638",
        "evidence": "Uses former employees to frame the company's product as a failure.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-07-17 03:28:36.46+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 140,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "4b99c812-8697-4070-8bdc-569604c02a72",
        "evidence": "Using former employees to validate claims",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:56.236+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 141,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "70abdf40-3d9d-4365-936f-adba9ecb7f43",
        "evidence": "Citing a territory manager with 20 years of SCS experience and a longtime C-level executive to validate the short thesis.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-07-17 03:50:37.353+00",
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 142,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "e77e3001-9043-418f-bbbd-b1b7c86f8f56",
        "evidence": "The slide explicitly claims a 'fraudulent narrative' regarding product innovation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:03.456+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 146,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "41b18648-83af-41e0-9760-25c4cb33dd47",
        "evidence": "The slide contrasts the company's public clinical claims with internal reports of suppressing alternative treatment methods.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:15:58.275+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 147,
        "frameworkName": "expose_contradiction"
      },
      {
        "matchId": "44d2482d-08cb-4060-af82-8c9840c5d1c4",
        "evidence": "The slide explicitly frames the product as a 'marketing ploy' and 'stock promotion' to expose a clinical contradiction.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:36.617+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 148,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "c4146ba2-3ff6-4975-8eeb-00f62b8f7802",
        "evidence": "The slide explicitly frames the company's marketing as 'a lie' and 'disingenuous' based on expert testimony.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:00.001+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 149,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "6e4118c6-bbb8-488a-aae7-8e3ec1eee9d3",
        "evidence": "Frames Nevro's product as a 'colossal flop' and 'clinically illogical' via expert testimony.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:59.272+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 150,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "89d498dc-554a-45c1-adb0-ef676a70d5a1",
        "evidence": "Uses expert testimony to frame the company's product as a failure.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:15:59.802+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 151,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "d72fcd89-30c3-4081-b4d2-a7c587a5b5b1",
        "evidence": "The slide explicitly frames the company's claims as a 'preposterous contradiction' and 'fraudulent' based on expert testimony.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:00.755+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 152,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "1fbdd491-8893-461b-908d-70a36ba80dc7",
        "evidence": "Juxtaposition of company market sizing funnel with CEO hype quotes to suggest a mirage.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:00.984+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 153,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "c3a53a0f-aaed-48ff-8c44-d7fd4ae9e871",
        "evidence": "The slide explicitly frames the company's claims as a 'mirage' and 'stupid' based on expert testimony to expose a contradiction in the company's growth narrative.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:01.191+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 154,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "cbe47396-2a4a-4755-903f-fc897efb358b",
        "evidence": "Contrasts current company claims with historical academic literature.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-07-17 03:28:36.725+00",
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 156,
        "frameworkName": "expose_contradiction"
      },
      {
        "matchId": "865fcdb4-b794-4853-a60b-19b6e6e951c8",
        "evidence": "Exposing company claims as a 'mirage' using primary source documentation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:01.29+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 157,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "713851d1-9db9-4998-9ad1-f323d9cf9dfc",
        "evidence": "The slide uses expert testimonials to expose the company's growth narrative as deceptive.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:36.608+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 158,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "f7fce66a-1a0b-4043-9d87-d255b3f0d0fe",
        "evidence": "Uses expert testimony to contradict company growth claims",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:02.79+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 160,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "fdf25b14-36ed-4906-984e-709069cfde3d",
        "evidence": "The slide frames the company as a deceptive actor using 'smoke and mirrors' and 'tricks'.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:06.581+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 161,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "f1af12d2-dc6b-4e81-91cd-ecb3d7027775",
        "evidence": "Uses KOL quotes to validate claims",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:03.996+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 163,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "0e6a65c2-5c8e-4d34-860c-0e927b6b6436",
        "evidence": "The slide explicitly accuses the company of 'cherry-picking' and committing a 'cardinal sin' in study design to mislead investors.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:04.908+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 164,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "a51e399b-9142-48fd-96ad-4cf61d0ebe07",
        "evidence": "Uses clinical trial data to argue that the company's growth narrative is based on manipulated/cherry-picked data.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:03.59+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 165,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "9d8b2379-4bf6-44f1-8a4a-1f5646fcfeb2",
        "evidence": "Frames Nevro as the 'villain' or ineffective solution compared to Abbott's DRG.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:05.56+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 167,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "3a7a59ff-7e85-44fb-bd36-7c7b4a8f37a8",
        "evidence": "The slide explicitly labels the company's claims as 'fraudulent' and 'a mirage' based on technical contradictions.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:05.146+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 168,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "1a15ceef-1fcc-4be8-a61d-7301dcfaf4cb",
        "evidence": "The slide frames Nevro's management claims as a 'mirage' and uses expert testimony to discredit them.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:06.61+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 170,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "a4a08ea7-6c25-48af-9dc1-b8aa5686090f",
        "evidence": "Contradicting company TAM claims with expert testimony",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 21:26:37.029+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 171,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e38e3f7a-5ef4-43ad-bd19-80953daccb55",
        "evidence": "Uses expert testimony to contradict company growth claims.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:08.677+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 172,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "726ecacc-fe3a-42a9-aabb-bed22bdc9e1a",
        "evidence": "Focuses heavily on criticizing the newly appointed CEO Keith Grossman using ex-executive quotes.",
        "framework": null,
        "confidence": 0.85,
        "extraction": {
          "at": "2026-07-17 03:50:48.549+00",
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 174,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "5473a988-0fa6-4b25-ad86-ff7d54e9caf8",
        "evidence": "The slide uses a clear, thesis-driven headline to frame the argument.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:06.254+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 175,
        "frameworkName": "action-titles"
      },
      {
        "matchId": "4bfe7788-6aa4-4db7-a142-5c1725b8ae66",
        "evidence": "Uses expert quotes to directly contradict CEO earnings call narratives.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:06.319+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 176,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "ed9d1f82-6c48-4519-862a-b28f1e3c7c63",
        "evidence": "Uses former executive quotes to validate the bearish thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:06.462+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 178,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "fff6fdc9-4284-4cd6-a697-57f6304ff4d1",
        "evidence": "Frames the CEO as the antagonist whose excuses are running out.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:07.377+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 180,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "47ec7f2e-9184-44f1-8af1-5afaedba795a",
        "evidence": "Uses expert testimony to validate the thesis",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:07.211+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 181,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "7649df24-a1c2-4a28-b3ea-29129629e797",
        "evidence": "Frames Saluda and other competitors as the 'next disruptor' and 'catastrophe' for Nevro.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:07.275+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 183,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "6bc6143c-e335-4747-935a-0f138abaed57",
        "evidence": "Uses expert C-level testimony to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:08.127+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 184,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "b650ee79-85ab-4bdf-8184-f11edb4da37e",
        "evidence": "The slide frames Nevro as the 'villain' or failing entity through expert testimonials.",
        "framework": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-05-02 20:16:09.35+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 185,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "6eb97021-625f-4aa2-87c7-ee43a0a83983",
        "evidence": "Frames Nevro as a failing incumbent with a 'gimmicky' product facing a superior competitor.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:08.389+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 186,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "0b37a4d0-bc2d-46e1-b20a-99ca41e31e18",
        "evidence": "Linking financial payments to clinical trial authorship to suggest bias.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:09.199+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 187,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e13818c2-e5e1-4452-807a-9e3793d01ada",
        "evidence": "Citing industry experts and competitors to validate the thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:13.174+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 189,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "3470dd34-ee2f-49b6-87eb-639d4270dcd9",
        "evidence": "The slide frames the company's pricing strategy as a 'drug' and 'collapse' mechanism, positioning the company's actions as the villain.",
        "framework": null,
        "confidence": 0.7,
        "extraction": {
          "at": "2026-05-02 20:16:15.712+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 192,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "b1876c41-6d2b-461d-a49f-55c8ae5dc01e",
        "evidence": "Uses former executive quotes to directly contradict company growth claims.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:10.577+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 194,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "f69457da-7713-4fea-b79e-492621c02f6d",
        "evidence": "Uses former executive testimony to validate claims",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:11.091+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 195,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "d626d2d2-b8c9-41ec-8c21-3e6af58ebefb",
        "evidence": "Uses expert testimony to highlight the structural conflict between physician-owned ASCs and Nevro's pricing power.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:11.045+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 196,
        "frameworkName": "expose_contradiction"
      },
      {
        "matchId": "eb123428-7f62-4cb7-a723-2a6f2693b4f6",
        "evidence": "The slide frames the company's management and pricing strategy as the 'villain' causing its own collapse.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 21:26:43.763+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 197,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "6aa6cf75-1927-443f-b4a4-2647b2d34bc6",
        "evidence": "The slide uses a strong, thesis-driven headline that summarizes the argument.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:16:11.769+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 198,
        "frameworkName": "action-titles"
      },
      {
        "matchId": "acda4e4a-5978-4acc-90ce-36acbd53744f",
        "evidence": "Uses KOL quotes to validate the bearish thesis",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:19.942+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 201,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "59cbc03b-3bd8-4f93-a78d-857f3d816e69",
        "evidence": "Uses expert testimonials to validate claims",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:17.2+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 203,
        "frameworkName": "authority-citation"
      },
      {
        "matchId": "87267cde-ac51-44ec-9eaa-245a59b48a86",
        "evidence": "The slide explicitly frames the narrative as a 'fraudulent exercise' and uses expert testimony to expose the contradiction between public growth claims and internal reality.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:13.884+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 204,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "e7806ceb-f154-40d6-86ec-1531628f2303",
        "evidence": "Frames the company as a beneficiary of the opioid crisis and 'bad actors'.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:14.78+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 206,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "df968256-1d1f-4025-a5ef-46b1473405c8",
        "evidence": "The slide presents evidence of alleged bribery and kickbacks to support a short thesis.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:14.125+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 207,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "b7df404c-5ded-463c-862a-2096f72e6b09",
        "evidence": "The slide explicitly frames the company's business model as a kickback scheme.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:14.275+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 208,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "08183c94-15ee-4539-afb3-d72060723fdd",
        "evidence": "The slide explicitly links the company's business model to potential legal violations (FCPA) and regulatory scrutiny.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:19.101+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 209,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "a9a84657-068f-48f4-a71f-5b22fc251de1",
        "evidence": "The slide uses expert testimony to allege corporate misconduct and kickback schemes.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:15.316+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 210,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "226c8461-3a71-454c-ae9e-8d8af3398100",
        "evidence": "The slide explicitly frames financial data to expose a 'kickback scheme'.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:14.501+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 211,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "91638105-b82a-42c7-8364-6bb2bb2a7fcd",
        "evidence": "The slide frames Nevro's business practices as analogous to the criminal activities of Insys Therapeutics.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:15.641+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 212,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "5e6a5232-5096-4d6f-87b9-3eb79eef248f",
        "evidence": "Uses regulatory alert to frame company business model as illegal",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:14.263+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 213,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "064b8a17-9252-44f2-9a26-a3daefc45d8f",
        "evidence": "The slide explicitly frames the business model as violating anti-kickback laws and references OIG Fraud Alerts.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:15.942+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 214,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "44587dc2-4151-4b20-b22b-98c6e7b25a56",
        "evidence": "The slide explicitly frames the business model as relying on unethical kickbacks and uses quotes to expose alleged corruption.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:17.092+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 216,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "008c0329-83f3-4559-9e56-c9b427b1c9ea",
        "evidence": "The slide explicitly frames the business model as illegal and relies on whistleblower testimony to expose a contradiction between public claims and private practices.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:16.096+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 217,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "454424f3-688a-44ae-a8e6-57682be1977b",
        "evidence": "The slide explicitly frames the company as a villain by detailing unethical practices and patient exploitation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:16.826+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 218,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "6ac82638-7794-4c7b-abde-be7426ef9432",
        "evidence": "The slide presents CEO quotes to frame his strategy as evidence of exploitation.",
        "framework": null,
        "confidence": 1,
        "extraction": {
          "at": "2026-05-02 20:16:17.624+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 219,
        "frameworkName": "ceo-quote-contradiction"
      },
      {
        "matchId": "f9aeb620-779d-4f00-83e7-ede58602b25a",
        "evidence": "The slide frames the company's sales practices as exploitative and unethical.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:17.524+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 221,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "ff93305b-fa97-4f4e-8451-9a920955bfce",
        "evidence": "The slide systematically presents evidence of unethical and potentially fraudulent sales practices.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:18.962+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 222,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "0e8763af-f1d0-4f9d-9c3f-99a75c77c13c",
        "evidence": "The slide frames doctors and the company as the antagonist in a narrative of patient exploitation.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 21:26:43.833+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 223,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "cf1b39af-0f7d-4738-b5b9-dc8ad88166ce",
        "evidence": "Uses expert testimony to allege systemic abuse and financial exploitation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:18.318+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 224,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "17c63637-8e0b-4554-b086-96639321bac5",
        "evidence": "The slide explicitly frames sales representatives as unethical manipulators to build a case against the company.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 21:26:45.32+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 225,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "c848cfb2-893b-4976-9283-4ca801e04894",
        "evidence": "The slide explicitly frames Nevro's management and sales practices as the 'villain' causing patient harm.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:23.489+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 226,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "7aed3e31-159c-4969-9828-e470acffadc2",
        "evidence": "The slide explicitly frames the business model as a mechanism for financial abuse and over-utilization.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:19.664+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 227,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "66cd8ac5-c092-4a46-93df-1f657b9d2a9d",
        "evidence": "Frames doctors and sales reps as the antagonists exploiting patients for profit.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:19.169+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 228,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "37d9b4a0-d974-4467-a30e-6ba0bf5e38c7",
        "evidence": "The slide frames the company and its associated doctors as the 'villain' exploiting patients for profit.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:21.19+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 231,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "06bb6b28-2f45-4be6-ae07-8d3ee76ca684",
        "evidence": "The slide uses expert testimony to allege systemic unethical behavior and patient exploitation.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:21.167+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 232,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "01f61783-abf7-434e-b85e-81afc89c9697",
        "evidence": "The slide uses expert testimony to expose alleged unethical and fraudulent business practices.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:21.712+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 233,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "68bb9f51-989e-4ceb-a2d8-f0303c970735",
        "evidence": "The slide explicitly frames the company's business model as a criminal liability to expose potential fraud or regulatory risk.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:21.215+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 234,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "09bdd715-ad2d-48cf-ba08-65c5d323d713",
        "evidence": "The slide explicitly frames the business model as an illegal practice of medicine, a common tactic in activist short-selling reports to expose regulatory/legal risk.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:21.788+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 235,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "c34ef42c-2ff2-47ca-96d8-2ce8c21fd276",
        "evidence": "The slide attempts to expose potential illegal activity (unauthorized practice of medicine) to undermine the company's business model.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:24.517+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 237,
        "frameworkName": "fraud-exposure"
      },
      {
        "matchId": "71f09ef7-70ee-4b27-9edb-59dfea340718",
        "evidence": "Frames the company's business model as inherently unethical/illegal through executive testimony.",
        "framework": null,
        "confidence": 0.8,
        "extraction": {
          "at": "2026-05-02 20:16:22.795+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 238,
        "frameworkName": "antagonist-introduction"
      },
      {
        "matchId": "83e1afb7-083a-4045-8f91-4601143c383b",
        "evidence": "Uses a KOL quote to contradict the company's business model legitimacy.",
        "framework": null,
        "confidence": 0.9,
        "extraction": {
          "at": "2026-05-02 20:16:25.245+00",
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "seconds": null,
          "promptVersion": null
        },
        "pageNumber": 239,
        "frameworkName": "ceo-quote-contradiction"
      }
    ],
    "patterns": []
  },
  "storymakers": null,
  "score": null,
  "review": null,
  "activistThesis": {
    "tone": "adversarial",
    "notes": "Classic Scorpion Capital long-form short report (239 pages) with 19 thesis chapters, 35+ research interviews, and extensive use of highlighted KOL quotes. Not a short-squeeze hit piece — it's an encyclopedic fraud case covering trial integrity, device efficacy, kickbacks (domestic AKS + European FCPA), competitive threat from Saluda, and unauthorized practice of medicine by reps. Stake not quantified (Scorpion only discloses it is short); no explicit price target. Tone is heavily adversarial with litigious undercurrent (explicit AKS/FCPA/FDA-recall framing). Strong use of CEO-quote contradictions (Grossman on Omnia still running 85-90% at 10kHz). Not a sum-of-parts or peer-gap visual story; the core 'before/after' frame is Nevro's claimed 1.2-3.7% explant rate versus the NANS 22-33% real-world data.",
    "kpisCited": [
      {
        "detail": "15x sales at $168/share — vs a collapsing growth profile",
        "metric": "Price/sales multiple"
      },
      {
        "detail": "$5.8B against a single product with no durable franchise",
        "metric": "Market cap"
      },
      {
        "detail": "22% within 1-2 years and 33% within 2-3 years, vs Nevro's 1.2-3.7% claim",
        "metric": "Explant rate (NANS 2020 paper)"
      },
      {
        "detail": "Actual rates 50-70%+, with some reaching ~100% in individual practices",
        "metric": "Explant rate (KOL interviews)"
      },
      {
        "detail": "Still programmed at 10kHz 85-90% of the time per CEO, belying multi-frequency positioning",
        "metric": "Omnia high-frequency use"
      },
      {
        "detail": "CHF 10,000 (~$10,181) per implant paid to Swiss doctors under the 'Nevro Partnership Program' since 2017",
        "metric": "European kickbacks"
      },
      {
        "detail": "~$3.5MM/year via CMS OpenPayments, mostly speakers-program spend",
        "metric": "General payments to doctors"
      },
      {
        "detail": "Could eradicate 18-33% of Nevro's business within 6-12 months",
        "metric": "Saluda competitive threat"
      },
      {
        "detail": "Prices dropping up to $5,000/device/year — roughly -20%",
        "metric": "Discounting"
      },
      {
        "detail": "8% of float as of 1/06/21 (Bloomberg)",
        "metric": "Short interest"
      }
    ],
    "closingAsk": "Short NVRO: the SENZA trial is a sham, explant rates are catastrophic, and the business hinges on illegal kickbacks and unauthorized practice of medicine — warranting an FDA recall of HF10.",
    "extraction": {
      "at": "2026-04-22 22:27:50+00",
      "model": "unknown-legacy",
      "runId": null,
      "seconds": 191.97015,
      "promptVersion": null
    },
    "scqaReward": "At 15x sales for a collapsing one-trick pony with explant rates 10-30x Nevro's claims, a failed Omnia relaunch, and a 6-12-month competitive existential threat, shares face catastrophic downside toward a Nuvectra-like crescendo.",
    "thesisTypes": [
      "fraud_exposure",
      "operational_turnaround",
      "management_change"
    ],
    "top3Reasons": [
      "SENZA-RCT pivotal trial described as 'essentially a fraud' by KOLs and ex-employees",
      "Real-world explant rates of 22-33% vs Nevro's claimed 1.2-3.7% (10-30x gap)",
      "Sales propped up by anti-kickback violations including ~$10K/implant in Switzerland"
    ],
    "scqaSituation": "Nevro is a $5.8B one-product medical-device company whose Senza and Omnia spinal cord stimulators dominate the high-frequency SCS niche built on its HF10 technology launched in the US in 2015.",
    "thesisSummary": "Scorpion Capital argues Nevro (NVRO), a $5.8B single-product medical-device company, rests on a fraudulent foundation and faces existential collapse. Their 20+ physician interviews indicate that the pivotal SENZA-RCT trial behind HF10 high-frequency spinal cord stimulation was described by KOLs and ex-employees as 'essentially a fraud' run at a 'corrupt' Carolinas Pain Institute 'factory' — the same pattern as the Insys fentanyl trial. Real-world explant rates are 22% within 1-2 years and 33% within 2-3 years per a 2020 NANS paper, versus Nevro's marketed 1.2-3.7%. The Omnia stimulator launched in November 2019 is 'a colossal flop,' painful diabetic neuropathy is a 'mirage,' Saluda Medical's closed-loop device threatens 18-33% of sales in 6-12 months, and the business hinges on anti-kickback and FCPA-violating payments — including ~$10,000 per implant in Switzerland — that doom any turnaround.",
    "primaryDemands": [
      "Short NVRO equity",
      "FDA recall of HF10 spinal cord stimulator",
      "Investigation of anti-kickback and FCPA violations tied to Nevro's speaker/partnership programs",
      "Disclosure of true real-world explant rates"
    ],
    "scqaResolution": "Short NVRO and call for an FDA recall of HF10; exit before Saluda Medical's imminent launch, further explant-rate papers, and a likely DOJ/FCPA reckoning expose the fraud embedded in the study, the device, and the business model.",
    "thesisOneLiner": "Nevro is a failed one-trick pony at 15x sales: the pivotal SENZA trial was rigged, HF10 is a phony premise, explant rates run 22-33%, and kickbacks prop up what remains of sales.",
    "precedentsCited": [
      "Insys Therapeutics (fentanyl kickbacks, executive convictions)",
      "Nuvectra (SCS company bankruptcy — 'fatal Nuvectra-like crescendo')",
      "DOJ OIG Special Fraud Alert on speaker programs (Nov 16, 2020)"
    ],
    "scqaComplication": "KOLs, ex-employees, and a 2020 NANS paper describe the pivotal SENZA-RCT trial as a sham, real-world explant rates at 22-33% versus Nevro's 1.2-3.7% claim, and sales sustained only by anti-kickback-violating payments to implanters.",
    "narrativeInterest": 5,
    "notableSlidePages": [
      1,
      3,
      11,
      84,
      86
    ],
    "peerCompaniesCited": [
      "Medtronic",
      "Boston Scientific",
      "Abbott",
      "St. Jude Medical",
      "Saluda Medical",
      "Nuvectra",
      "Stryker",
      "Johnson & Johnson",
      "Biotronik",
      "Insys Therapeutics"
    ],
    "valuationFrameworks": [
      "multiple_comparison"
    ],
    "visualCraftInterest": 2
  },
  "pitchdeck": {
    "metadata": null,
    "profile": null
  },
  "slides": [
    {
      "page": 1,
      "type": "setup",
      "title": "Includes a YouTube link referencing the film 'Spinal Tap' as a metaphor for the company's technology.",
      "function": "front_matter",
      "imagePath": "https://imgproxy.kitesheet.com/7dXsNe68Vhvy79-YCgI8aKhcK5dUbuEny_srKRZwB_k/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5wbmc",
      "rawType": "cover",
      "block": null,
      "metadata": {
        "slideType": "cover",
        "slideTypeCanon": {
          "name": "Cover",
          "slug": "cover",
          "status": "active",
          "canonId": "019de52d-05f2-729d-9f93-e0504f0a2410",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 63,
        "componentCount": 8,
        "textChars": 725,
        "nDataPoints": 6,
        "notes": "Includes a YouTube link referencing the film 'Spinal Tap' as a metaphor for the company's technology.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:31.35+00",
          "seconds": 3.83,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/1",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-1",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-60c6d60dfdf2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.66,
            "x": 0.17,
            "y": 0.525
          },
          "kind": "image",
          "text": "Spinal Tap, the fictitious 1980's rock band and Nevro parable, explains the science behind the company's “high frequency“ spinal cord stimulator.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "862b65fd-41d4-4809-9fad-dad11c2a7e88",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "market cap: $5.8B",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-68e10babe77a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.78,
            "x": 0.11,
            "y": 0.475
          },
          "kind": "paragraph",
          "text": "$5.8B market cap | $168/share | $65/$188 52wk hi/low | $51M ADV, 30d avg | Short interest 8% of float",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "60e01451-c8cc-4105-aa00-7acc33f61af1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Spinal Tap, the fictitious 1980’s rock band and Nevro parable, explains the science behind the company’s “high frequency“ spinal cord stimulator.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-64456a0d2915",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.07,
            "y": 0.26
          },
          "kind": "title",
          "text": "A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b6f4469-a40f-4997-abaa-a5a20ad96a44",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.5,
            "x": 0.25,
            "y": 0.175
          },
          "kind": "title",
          "text": "NEVRO (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02aa708e-9597-4cb6-a634-1c3259cfe976",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54522dc3-5464-43ca-a814-20c7945b33a6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Audience Definition",
            "slug": "audience-definition",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
            "version": 1,
            "bodyDocId": null,
            "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "bc4ef4ad-28ba-41d1-9840-9f2c616db5ab",
          "evidence": "The slide provides information about Nevro, including its market cap, stock price, and short interest, indicating that the audience is likely investors or financial analysts.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:28.98442+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Call to action",
            "slug": "call-to-action",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c",
            "version": 1,
            "bodyDocId": null,
            "description": "Explicit prescription of what the audience should do next.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "0c88baf8-f7ca-4e5d-ae6d-2c5fbcb89e5f",
          "evidence": "The title/action-title 'A Failed One-Trick Pony At 15X Sales, Reeking of Study Fraud, Kickbacks, And A Covered-Up Explants Crisis That Merits An FDA Recall' could be seen as a call to action, although it's more of a provocative statement.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-16 23:09:29.022821+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "3ace5aba-830c-40c8-9961-c870acd53807",
          "evidence": "The slide frames the company as a 'failed one-trick pony' and 'reeking of fraud'.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:31.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 1,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "thumbSrc": "https://imgproxy.kitesheet.com/11lFtRukJfA8csh2hzU8U_KRV0RWLauHyaHiO5Abq9c/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5wbmc",
      "imagePathAlt": "https://imgproxy.kitesheet.com/RC3JM2aUc62nkklJrAln2fgUPEcsBKcXNX9CDPqkWS0/rs:fit:1200:1200:0/q:82/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5qcGc",
      "thumbSrcAlt": "https://imgproxy.kitesheet.com/BhxUolGWlle-8ScycKQLXTCIH5naDH2megG4KnxPxgA/rs:fit:480:480:0/q:78/f:webp/czM6Ly9raXRlc2hlZXQvY29ycHVzL3NsaWRlcy9jZTU2NWI4NDFjNDAvcDAwMS5qcGc"
    },
    {
      "page": 2,
      "type": "setup",
      "function": "other",
      "rawType": "appendix_disclosure",
      "block": null,
      "metadata": {
        "slideType": "appendix_disclosure",
        "slideTypeCanon": {
          "name": "Appendix disclosure",
          "slug": "appendix_disclosure",
          "status": "active",
          "canonId": "019de52d-07b2-7549-8e8b-932a19f6e616",
          "version": 1,
          "description": null
        },
        "function": "other",
        "functionCanon": {
          "name": "Other (fallback)",
          "slug": "other",
          "status": "active",
          "canonId": "019de52d-15e1-75bc-99dc-07732380e2ce",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 9,
        "componentCount": 3,
        "textChars": 248,
        "nDataPoints": 0,
        "notes": null,
        "elementsJson": [
          "paragraph"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:22.08+00",
          "seconds": 1.887,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/2",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-2",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "THIS REPORT REPRESENTS THE CURRENT OPINIONS OF SCORPION CAPITAL LLC CONCERNING NEVRO, INC. (NVRO).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-347d00bbc858",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.88,
            "x": 0.06,
            "y": 0.16
          },
          "kind": "disclaimer",
          "text": "DISCLOSURES: THIS REPORT REPRESENTS THE CURRENT OPINIONS OF SCORPION CAPITAL LLC CONCERNING NEVRO, INC. (NVRO)...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:22.08+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da4a93de-9b6c-4ba9-93a7-3f125a9c98f9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:22.08+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d4689ab-94c7-4851-ab7c-1c2fd6aa1134",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 3,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize the most damaging claims within the quotes.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 8,
        "textChars": 1673,
        "nDataPoints": 0,
        "notes": "The slide uses yellow highlighting to emphasize the most damaging claims within the quotes.",
        "elementsJson": [
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:23.16+00",
          "seconds": 2.938,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/3",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-3",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "So, it was a big scam. The way that they manipulated the data was criminal.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-8d7d3865142d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "quote",
          "text": "We subsequently found out...that the manipulation in statements from the patients was crazy...So, it was a big scam. The way that they manipulated the data was criminal.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f732792-d4ba-4725-99c0-eb08885c6c9d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "quote",
          "text": "I got excited by Nevro. I thought it was the Tesla of spinal cord stimulators...I became increasingly frustrated as I began to see a lot of failures with the device...Nevro is a one trick pony.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "509ae837-9bca-4545-a0f3-5e8fefd43f57",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.79
          },
          "kind": "quote",
          "text": "There were definitely practices at Nevro that pushed patients into implants. They will invariably be audited by Medicare. They're doing other things that are not on the up and up.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e21188f0-fb0d-404f-acc5-36612b1a63c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "quote",
          "text": "Doctors that implanted a lot of devices, they hated Nevro...The only way I know to change that doctor's practice paradigm is bribing...Doctors are whores.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e967445c-1415-4e95-ae8d-945e043a7a78",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I got excited by Nevro. I thought it was the Tesla of spinal cord stimulators...I became increasingly frustrated as I began to see a lot of failures with the device...Nevro is a one trick pony.” —Physician #1, a former high volume Nevro implanter; “Doctors that implanted a lot of devices, they hated Nevro...The only way I know to change that doctor’s practice paradigm is bribing. It works...Doctors are whores.” —Physician #2, a key opinion leader (KOL) in the spinal cord stimulation space; “So, it was a big scam. The way that they manipulated the data was criminal.” —Physician #3, a KOL and high volume implanter; “There were definitely practices at Nevro that pushed patients into implants. They will invariably be audited by Medicare. They’re doing other things that are not on the up and up.” —Former Nevro sales rep",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-9289c7d28ce5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "06216d9f-5236-419e-8db2-8629fd5f0ff2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "62c3a100-98fc-4703-89a4-c94877051f37",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Credibility Transfer",
            "slug": "credibility-transfer",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-bd34-759a-8e3b-2f14b571a2a1",
            "version": 1,
            "bodyDocId": null,
            "description": "Borrowing authority from trusted sources or vivid details",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "5f1f8fc5-a320-4a0e-a728-833d9dd20c24",
          "evidence": "The quotes from physicians lend credibility to the claims made about Nevro.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:29.099046+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "6ac7d25f-2992-4828-b7ac-4677eaf82c67",
          "evidence": "The slide presents testimonials to allege criminal data manipulation and bribery.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:23.16+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 3,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 4,
      "type": "tension",
      "title": "The slide uses a series of quotes to build a narrative of corporate malfeasance and product failure.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 9,
        "textChars": 2482,
        "nDataPoints": 1,
        "notes": "The slide uses a series of quotes to build a narrative of corporate malfeasance and product failure.",
        "elementsJson": [
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:23.647+00",
          "seconds": 3.285,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/4",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-4",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro is a failed one-trick pony at 15x sales: the pivotal SENZA trial was rigged, HF10 is a phony premise, explant rates run 22-33%, and kickbacks prop up what remains of sales.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-3a46588c9111",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.76
          },
          "kind": "quote",
          "text": "We went to Nevro's headquarters to discuss the explants... I realized this shit doesn't work... His take on Nevro is slimy people, falsification of data.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5333356d-7981-4188-9093-1229fafd093e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "quote",
          "text": "A lot of doctors in Germany are saying that Nevro's device only works for 2 to 2 1/2 years... People have become nervous and become afraid to use Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ba5fffa-1dbd-464e-b7aa-3d34433399ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "quote",
          "text": "Nevro keeps explant rates very well hidden... The explant rate was a hell of a lot higher than [the stated] 2%.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "772ce2b3-7af8-4098-8cb5-8d059174ac52",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "quote",
          "text": "According to a 2019 contract... Nevro...offered Swiss doctors CHF10,000... for each Nevro spinal cord stimulator implanted",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b62194be-3efb-4c7e-b71b-afcb0f163e75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "If you put doctors into boxes, Money Mike couldn't care less if there's a high explant rate... Yes, there are unethical, corrupt doctors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f859ae4e-3d35-4d6f-b689-6baf43da1cef",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"According to a 2019 contract obtained by the German language paper, California-based Nevro...offered Swiss doctors CHF10,000 ($10,181) for each Nevro spinal cord stimulator implanted in a patient...The kickback scheme, which has now been terminated, has been running since 2017 under the auspices of the “Nevro Partnership Program.”\" — Swiss Broadcasting Corporation; \"Nevro keeps explant rates very well hidden from the field reps...The explant rate was a hell of a lot higher than [the stated] 2%. I don't know that people asked for it, because ignorance is bliss. I didn't want to know. Don't ask questions you don't want to know the answer to. My peers in the field felt the same way.\" — Former Nevro regional sales director; \"If you put doctors into boxes, Money Mike couldn't care less if there's a high explant rate. It's just about the price you give him for the device. He could care less about whether it works or not. Yes, there are unethical, corrupt doctors. In that population, Nevro is the best thing since sliced bread.\" — Physician #4; \"A lot of doctors in Germany are saying that Nevro's device only works for 2 to 2 ½ years and then the patient comes back with more pain...People have become nervous and become afraid to use Nevro.\" — Physician #5; \"We went to Nevro's headquarters to discuss the explants...I realized this shit doesn't work...His take on Nevro is slimy people, falsification of data...I don't understand how Nevro can continue to keep the smoke and mirrors going, I really don't. I mean, it's crazy.\" — Physician #3",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-3f86038274ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cc1e273c-a5fd-4f02-a060-85e84f470aca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac280e80-167b-404d-8154-85db01a9a82b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Evidence Matrix",
            "slug": "evidence-matrix",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
            "version": 1,
            "bodyDocId": null,
            "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "82bb15e4-7a77-4705-b27a-9d7218dbc8f0",
          "evidence": "The quotes provide evidence to support the claims made about Nevro's business practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:29.172827+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "3e224232-d8e1-43ca-b59f-bdebf90834a7",
          "evidence": "The slide uses testimonials to expose alleged data falsification and unethical business practices.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:23.647+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 4,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 5,
      "type": "setup",
      "title": "The TOC includes aggressive, thesis-driven descriptions for each section, typical of activist short reports.",
      "function": "front_matter",
      "rawType": "table_of_contents",
      "block": null,
      "metadata": {
        "slideType": "table_of_contents",
        "slideTypeCanon": {
          "name": "Table of contents",
          "slug": "table_of_contents",
          "status": "active",
          "canonId": "019de52d-0643-721b-9b85-69676bb85cf8",
          "version": 1,
          "description": null
        },
        "function": "front_matter",
        "functionCanon": {
          "name": "Front matter",
          "slug": "front_matter",
          "status": "active",
          "canonId": "019de52d-133d-73f0-9e26-201eda96b098",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 14,
        "componentCount": 3,
        "textChars": 429,
        "nDataPoints": 0,
        "notes": "The TOC includes aggressive, thesis-driven descriptions for each section, typical of activist short reports.",
        "elementsJson": [
          "headline_text",
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:23.72+00",
          "seconds": 3.1,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/5",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-5",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.75,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "list",
          "text": "1. Introduction to Nevro (9-41)\n2. Summary of key findings (42-55)\n3. The SENZA-RCT pivotal trial (56-69)\n4. HF10 is a phony premise and mechanism of action (70-76)\n5. High frequency is Nevro’s fatal flaw and dooms any turnaround (77-83)\n6. A covered-up device failure and explants crisis (84-94)\n7. Nevro’s explants crisis is pervasive yet unknown to most investors (95-105)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Numbered list",
              "slug": "numbered",
              "status": "active",
              "canonId": "019de52c-fcc0-7718-a284-a4250c805df2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "numbered",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.72+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "62ad952b-9f53-4de9-8adc-7f4388a5d88a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.72+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd6ca52d-86fd-4e1c-9c65-b2495f1ff32b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "Table of contents",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.72+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4fcf42c3-9abb-46c4-87c4-883729857fa8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 6,
      "type": "setup",
      "title": "The slide uses aggressive, highly critical language to frame the upcoming sections of the report.",
      "function": "summarize",
      "rawType": "table_of_contents",
      "block": null,
      "metadata": {
        "slideType": "table_of_contents",
        "slideTypeCanon": {
          "name": "Table of contents",
          "slug": "table_of_contents",
          "status": "active",
          "canonId": "019de52d-0643-721b-9b85-69676bb85cf8",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 12,
        "componentCount": 3,
        "textChars": 334,
        "nDataPoints": 0,
        "notes": "The slide uses aggressive, highly critical language to frame the upcoming sections of the report.",
        "elementsJson": [
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:23.065+00",
          "seconds": 2.394,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/6",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-6",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "quote",
          "text": "Omnia is “a joke to most doctors” — KOL feedback. Nevro’s claims are so dubious and promotional that KOL’s labeled them “smoke and mirrors,” “so stupid,” and “just dopey.” — KOLs and former Nevro employees.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-a2ecbd0d9681",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "table",
          "text": "Table of contents listing sections 8 through 12 with page ranges and descriptive summaries.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.065+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a41bbc05-41a1-484e-ad39-2c7ce7f23b75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:23.065+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "024e1c7e-f40e-4da6-986c-2ee74fb89292",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 7,
      "type": "setup",
      "title": "This is a continuation of a larger table of contents, starting at item 13.",
      "function": "summarize",
      "rawType": "table_of_contents",
      "block": null,
      "metadata": {
        "slideType": "table_of_contents",
        "slideTypeCanon": {
          "name": "Table of contents",
          "slug": "table_of_contents",
          "status": "active",
          "canonId": "019de52d-0643-721b-9b85-69676bb85cf8",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 21,
        "componentCount": 4,
        "textChars": 528,
        "nDataPoints": 0,
        "notes": "This is a continuation of a larger table of contents, starting at item 13.",
        "elementsJson": [
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:25.923+00",
          "seconds": 5.07,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/7",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-7",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "quote",
          "text": "I don’t blame them. — KOL speaking of insurers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-7fafb1a15554",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.88,
            "x": 0.06,
            "y": 0.16
          },
          "kind": "table",
          "text": "13. Investor hopes of a Nevro acquisition are delusional and misinformed... 182-185\n14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat... 186-191\n15. Pricing pressure and discounting are a key driver of Nevro's collapse... 192-197\n16. The SCS market growth story fueled by Wall Street is false... 198-206\n17. We believe that Nevro's business model hinges on unsustainable kickbacks... 207-217",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.923+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "719de69b-8398-46a1-a9b0-fdc1ca054521",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.923+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "18721aac-c519-4c1c-9a40-7862f0936f8d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "Table of contents",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.923+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "17fa7d6a-91e9-49a9-b21f-f151a0cdcba4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 8,
      "type": "setup",
      "title": "This slide appears to be a continuation of a larger table of contents, starting at page 18.",
      "function": "summarize",
      "rawType": "table_of_contents",
      "block": null,
      "metadata": {
        "slideType": "table_of_contents",
        "slideTypeCanon": {
          "name": "Table of contents",
          "slug": "table_of_contents",
          "status": "active",
          "canonId": "019de52d-0643-721b-9b85-69676bb85cf8",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 14,
        "componentCount": 3,
        "textChars": 278,
        "nDataPoints": 1,
        "notes": "This slide appears to be a continuation of a larger table of contents, starting at page 18.",
        "elementsJson": [
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:26.499+00",
          "seconds": 4.708,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/8",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-8",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.16
          },
          "kind": "table",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales, 218-233; 19, Nevro’s business model is predicated on employees engaging in the unauthorized practice of medicine, 234-239",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.499+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e25fa2bb-49c1-4410-9be2-e95e57145de7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.499+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d654411-c7ed-4139-9011-a789244f8b5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "Table of contents",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.499+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a07b2e7e-3dbb-4a7d-a625-4cd6eef5b619",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 9,
      "type": "tension",
      "title": "The slide uses highly critical, emotive language ('medieval', 'crude', 'Hail Mary') to frame the company's core product negatively.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 66,
        "componentCount": 8,
        "textChars": 842,
        "nDataPoints": 3,
        "notes": "The slide uses highly critical, emotive language ('medieval', 'crude', 'Hail Mary') to frame the company's core product negatively.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "photo",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:25.909+00",
          "seconds": 3.622,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/9",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-9",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Had electricity been harnessed during the medieval age, one might characterize stimulators as medieval in their underlying simplicity, crudeness, and adverse effects, despite the field favoring fancier terms like neuromodulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-474cb15546ab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.43,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "image",
          "text": "X-ray of spinal cord stimulator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6af53701-24ab-4b9f-82e8-502ca4b7b709",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.43,
            "x": 0.51,
            "y": 0.44
          },
          "kind": "image",
          "text": "X-ray of spinal cord stimulator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbdc4089-04b8-478d-ae53-8ce63333526c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "market cap: $5.8B",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-4a81e447bb79",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro is a one-product medical device company with a $5.8B market cap. The company’s sole offering is a spinal cord stimulator (SCS) for pain relief... An SCS kit typically sells for $20-30K.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "971a14fa-2b5a-40fc-b205-36ab6c369abd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: https://en.wikipedia.org/wiki/Spinal_cord_stimulator; Image 1 https://www.painnewsnetwork.org/stories/2017/12/20/no-i-dont-want-to-get-a-spinal-cord-stimulator; image 2 https://consultqd.clevelandclinic.org/spinal-cord-stimulation-is-effective-for-chronic-neuropathic-pain/;",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "40b96c3d-6eb1-4a0a-9dc4-90e1642da8da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "342b3fcc-bc6a-411a-b8aa-b8764b43e653",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.909+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b82384c6-1cf1-4d79-9728-2ed1519ab723",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 10,
      "type": "tension",
      "title": "The slide uses a 'villain' framing by highlighting the '180 degree unwind' of the company's core messaging and patient complaints about charging.",
      "function": "frame_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "frame_problem",
        "functionCanon": {
          "name": "Frame problem",
          "slug": "frame_problem",
          "status": "active",
          "canonId": "019de52d-13db-753e-ad70-e9b2d0dab398",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 1536,
        "nDataPoints": 2,
        "notes": "The slide uses a 'villain' framing by highlighting the '180 degree unwind' of the company's core messaging and patient complaints about charging.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "photo",
          "callout_box",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:36.673+00",
          "seconds": 9.11,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/10",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-10",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.3,
            "x": 0.25,
            "y": 0.52
          },
          "kind": "callout",
          "text": "Charging paddle that must be placed next to implant location. On Facebook groups, patients report spending close to an hour or more daily to re-charge Nevro’s stimulators",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "baaa0d35-99e3-4b2e-82cb-ccc7a5e1d8a1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "On Facebook groups, patients report spending close to an hour or more daily to re-charge Nevro’s stimulators",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-f2d2bde551e0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.35,
            "x": 0.6,
            "y": 0.5
          },
          "kind": "image",
          "text": "New Omnia battery/IPG",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5881e5b8-3055-4adc-b443-3bd05205b93d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.45,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "image",
          "text": "Senza model IPG with remote control and charging unit",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6b0799b-acba-4093-a361-7d3811590eea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Spinal cord stimulation has historically been a backwater space with poor economics and little innovation. Nevro entered the US market in 2015 claiming it had found the holy grail of pain relief: a stimulator that delivered pulses at a higher frequency (10khz) versus the low frequencies (eg, 1kHz) used by traditional devices. Nevro patented its high frequency “HF10” technology, saying that “frequencies above 5kHz have a unique inhibitory effect on pain circuitry.” As the first “innovation” in SCS in perhaps decades and armed with clinical data showing superior pain relief, Nevro caught the 3 legacy players asleep and quickly took 15-17% of the market. Launching with the Senza stimulator, Nevro has now bet the company on its Omnia device, which launched in November 2019 and offers both low and high frequencies - an abrupt (and telling...) 180 degree unwind of its HF10-only message.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c845f0e0-b926-4625-a6c1-e4520bcf13ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.7,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Image 1 https://www.medgadget.com/2015/05/nevro-senza-high-frequency-spinal-cord-stimulator-gets-green-light-by-fda.html; image 2 https://s24.q4cdn.com/932612397/files/images/media_kit/Omnia_Implantable_Pulse_Generator.jpg",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "318990c1-037d-4bbb-b33e-8a43028ad43b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b788f98f-f3b4-4ed1-a529-3122ec3e527e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.673+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34ec4d37-7aa2-4b2e-9901-b6906ac8b520",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 11,
      "type": "tension",
      "title": "The slide uses a combination of narrative text, a testimonial quote, and a bar chart to link high-volume implanters to high payments.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 10,
        "textChars": 1441,
        "nDataPoints": 9,
        "notes": "The slide uses a combination of narrative text, a testimonial quote, and a bar chart to link high-volume implanters to high payments.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "bar_chart_horizontal",
          "photo",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:27.911+00",
          "seconds": 5.587,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/11",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-11",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The same cast of characters that keeps popping up as lead investigators for Nevro’s studies, and as some of its highest volume implanters, also has a knack for topping its OpenPayments leaderboard, which appears to consist mostly of…speaking payments.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-d97856fae642",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.32,
            "x": 0.06,
            "y": 0.69
          },
          "kind": "chart",
          "text": "Top Entities Receiving General Payments in All Years",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d37c409-535b-4837-8f67-d37ac8669663",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.23,
            "w": 0.55,
            "x": 0.39,
            "y": 0.7
          },
          "kind": "image",
          "text": "Photos of KOLs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c991ac5-3d67-4552-9860-b0928af8631e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "General Payments: $800K",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-e2800a2b4ec2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "paragraph",
          "text": "1. Introduction to Nevro\nNevro would have one believe that no stimulator manufacturer in the last 60 years ever bothered to crank up the frequency to see what happens...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b122777b-e351-4f45-aa96-5304faf9f0cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "When Nevro first started, if you look at the doctors in the forefront... I wouldn't say they were outcasts, but... it was like a Scientology thing. They did these retreats at some huge mansion, like crazy stuff...Nevro is not science.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b57a4b78-029b-4a87-8913-96a3252aea43",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“When Nevro first started, if you look at the doctors in the forefront, true thought leaders, key opinion leaders, the white shoe reputable people - that’s not who they got. They brought in a bunch of guys - I wouldn’t say they were outcasts, but... it was like a Scientology thing. They did these retreats at some huge mansion, like crazy stuff...Nevro is not science. It’s a cult and I am blown away because every doctor I know that does a lot of implant volume doesn’t use Nevro except for a small cult.” — KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-dce9c9700701",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: expert consultation calls; CMS OpenPayments...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "78c76958-82fa-4c5e-93e0-4572787f9860",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9743dc84-2d08-4995-b492-559aca242fa1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "title",
          "text": "Top recipients of Nevro payments per CMS OpenPayments data",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e39161cb-83c6-4f72-a239-c1a0beca1802",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "23cd50c4-bf59-4728-8703-3386e077dae0",
          "evidence": "The slide explicitly frames Nevro's KOL network as a 'cult' and 'corrupt trial factory'.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:27.911+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 11,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 12,
      "type": "analysis",
      "title": "The slide uses a strong, accusatory tone, labeling the company a 'textbook Ponzi'.",
      "function": "diagnose_problem",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "diagnose_problem",
        "functionCanon": {
          "name": "Diagnose problem",
          "slug": "diagnose_problem",
          "status": "active",
          "canonId": "019de52d-176d-761f-b608-cf52262d2ab2",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 61,
        "componentCount": 6,
        "textChars": 1224,
        "nDataPoints": 120,
        "notes": "The slide uses a strong, accusatory tone, labeling the company a 'textbook Ponzi'.",
        "elementsJson": [
          "paragraph",
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.214+00",
          "seconds": 6.654,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/12",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-12",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Having incinerated ~$360MM of cash since 2012, the debt requires new debt or equity to be repaid - in our opinion, a textbook Ponzi.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-b3b657a9681f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "Net Income: $360MM",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:20+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-b4cf2dfc4867",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "1. Introduction to Nevro\nNevro’s filings peg the global SCS market at $2.5B – making its $5.8B market cap an absurd 2.3X the size of its entire market. Three large device players - Medtronic, Abbott’s St. Jude division, and Boston Scientific, with a combined ~$400B of market cap – have long dominated the SCS space. Despite only ~15% share and flat to down sales over the last 2-3 years, Nevro is valued at several times the combined stimulator sales of MDT, ABT, and BSX – even though it’s a perpetually money-losing enterprise. Shockingly poor margins, especially for a medical device company, have collapsed even further since 2018 as its growth crashed, evidence of a fatally-flawed business model that survives only by continually raising new equity and debt. As of 9/30, the company had $328MM of long term debt. Having incinerated ~$360MM of cash since 2012, the debt requires new debt or equity to be repaid – in our opinion, a textbook Ponzi.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.214+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c530804-ea70-49d3-ad22-07cbc4496db1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.1,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Capital IQ",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.214+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbaf7d8a-7543-4645-8dd4-0b7624bfad27",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.88,
            "x": 0.06,
            "y": 0.47
          },
          "kind": "table",
          "text": "Income statement, Cash flows, and Margins table from 2012 to 2020E.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.214+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3115d666-1afe-4b58-8d11-4544c1fbe091",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.214+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02e81616-ffda-411b-ab27-0a7d7548ad0b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 13,
      "type": "tension",
      "title": "Includes a stock chart of Nuvectra and quotes from former executives/KOLs to support the thesis.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 1378,
        "nDataPoints": 8,
        "notes": "Includes a stock chart of Nuvectra and quotes from former executives/KOLs to support the thesis.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "line_chart",
          "quote_block",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:25.894+00",
          "seconds": 3.321,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/13",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-13",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.42,
            "x": 0.52,
            "y": 0.82
          },
          "kind": "callout",
          "text": "90% of implants are still done by the top 10% of doctors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "856fc36e-8781-4898-8377-fa56b3d7a98e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "With the same toxic combination of leverage and cash burn, we believe investors underestimate Nevro’s risk of becoming the next Nuvectra, especially if the FDA takes any action against its product, or if the OIG’s Nov 16th Special Fraud Alert on speakers programs is predictive of what’s coming.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-d409f53cd796",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.45,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "chart",
          "text": "Nuvectra stock chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dcc040a6-25d8-4165-a494-cfc3e3783b64",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro's atrocious economics and leverage are a feature of the space, as illustrated by the other pure play SCS stock and closest comp - Nuvectra (NVTR), which filed for chapter 7 liquidation last year and is a canary in the coal mine...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52d985b6-915b-4fd7-bfce-29e344a0827d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.42,
            "x": 0.52,
            "y": 0.62
          },
          "kind": "quote",
          "text": "There's probably 120 global physicians that represent the majority of Nevro's total revenue. If each of those guys is doing, like a mega Nevro guy doing 70 to 100 devices a year, that's like $300 million.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "78c8bd0d-8afb-4239-94b9-9a9dc528026e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“There’s probably 120 global physicians that represent the majority of Nevro’s total revenue. If each of those guys is doing, like a mega Nevro guy doing 70 to 100 devices a year, that’s like $300 million. The number of physicians doing more than 40 implants a year would surprise you. It’s a very small number.” — Former Nevro executive; “90% of implants are still done by the top 10% of doctors.” — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b336-dbd06fc2220a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Capital IQ; Capital IQ stock chart; consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "82a71b09-1e26-44fe-a6a8-a5b74c611a77",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ddb19d2-1a04-4be2-a6ca-dab64038154f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "40fb1619-06e9-4912-a8d7-def48b2d3132",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Anadiplosis",
            "slug": "anadiplosis",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
            "version": 1,
            "bodyDocId": null,
            "description": "Ending one clause with a word that begins the next",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "26da1bc5-e8e1-4f5e-aa99-24b9f63aaaa5",
          "evidence": "The use of repetition in the quote and callout sections emphasizes the risks associated with Nevro.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.103459+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Villain slide",
            "slug": "villain-slide",
            "status": "active",
            "bestFor": "In activist decks where the personality matters",
            "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
            "version": 1,
            "bodyDocId": null,
            "description": "A dedicated slide presenting the named villain visually",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "c3da92f2-44e5-4a06-bfdd-10b7d8fc8235",
          "evidence": "The slide presents Nevro as a company with significant risks, including a toxic combination of leverage and cash burn, and compares it to Nuvectra, which filed for liquidation.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": "In activist decks where the personality matters",
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-16 23:09:31.071068+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "whyItWorks": "Makes the antagonist concrete",
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "b613ddee-5796-4728-b511-5e33595b911f",
          "evidence": "Comparison of Nevro to failed Nuvectra to establish a villainous narrative.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:25.894+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 13,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 14,
      "type": "setup",
      "title": "The slide highlights Nevro's underperformance compared to its peers in the top 50 medtech companies by market cap.",
      "function": "compare_peers",
      "rawType": "peer_benchmark",
      "block": null,
      "metadata": {
        "slideType": "peer_benchmark",
        "slideTypeCanon": {
          "name": "Peer benchmark",
          "slug": "peer_benchmark",
          "status": "active",
          "canonId": "019de52d-08f0-7158-a78d-d7b5331fefaf",
          "version": 1,
          "description": null
        },
        "function": "compare_peers",
        "functionCanon": {
          "name": "Compare peers",
          "slug": "compare_peers",
          "status": "active",
          "canonId": "019de52d-1453-72ba-a367-9ba3d34c1630",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 7,
        "textChars": 588,
        "nDataPoints": 200,
        "notes": "The slide highlights Nevro's underperformance compared to its peers in the top 50 medtech companies by market cap.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "comparison_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:30.258+00",
          "seconds": 2.625,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/14",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-14",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro is a top 50 medical device company by market cap and an extreme outlier on two counts. First, it has just about the worst economics in the top 50, a stark reminder of just how atrocious a business it is.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-0be4aecb8447",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "EBIT margin: -20%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-0c981dc5639d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro is a top 50 medical device company by market cap and an extreme outlier on two counts. First, it has just about the worst economics in the top 50, a stark reminder of just how atrocious a business it is...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5cb3da02-01ff-4a00-bbfc-cd6ad1ff65c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Capital IQ, as of 1/6/2021",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "878282a5-f42b-42fc-92e0-93c567a5dcd7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "table",
          "text": "Top 50 medtech companies by market cap, descending order",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4adeef01-28d7-4858-a402-3a5fce46335b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4aa0853d-362b-4679-8ac3-2a6a1baac466",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84a8ce76-b14e-44fd-9e28-7fdf13313023",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "2x2 matrix",
            "slug": "matrix-2x2",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-50ab-72d1-8afb-3ab0a38e32a8",
            "version": 1,
            "bodyDocId": null,
            "description": "BCG matrix, importance/urgency, any axes-and-quadrants frame.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "43dd0c69-40e3-42bc-84be-136962e7d05e",
          "evidence": "Although not explicitly a 2x2 matrix, the table could be interpreted as a simple comparison framework.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-16 23:09:31.167518+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 14,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "52db4180-7adf-421a-80c8-c39b9f9d4908",
          "evidence": "Compares Nevro against top 50 medtech peers across market cap, growth, and margins.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:30.258+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 14,
          "frameworkName": "comparison_frame"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 15,
      "type": "tension",
      "title": "The slide uses a dual-axis chart to show revenue growth vs. YOY growth rate, illustrating the 'hitting a wall' narrative.",
      "function": "diagnose_problem",
      "rawType": "problem_statement",
      "block": null,
      "metadata": {
        "slideType": "problem_statement",
        "slideTypeCanon": {
          "name": "Problem statement",
          "slug": "problem_statement",
          "status": "active",
          "canonId": "019de52d-0879-768d-bba8-8da8a5a121d4",
          "version": 1,
          "description": null
        },
        "function": "diagnose_problem",
        "functionCanon": {
          "name": "Diagnose problem",
          "slug": "diagnose_problem",
          "status": "active",
          "canonId": "019de52d-176d-761f-b608-cf52262d2ab2",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 7,
        "textChars": 975,
        "nDataPoints": 18,
        "notes": "The slide uses a dual-axis chart to show revenue growth vs. YOY growth rate, illustrating the 'hitting a wall' narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bar_chart_vertical",
          "line_chart",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:26.002+00",
          "seconds": 2.714,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/15",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-15",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "By late 2017 – a mere 2 years after launch - growth mysteriously hit a wall.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-4188cfddd997",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.88,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "chart",
          "text": "Nevro revenue and growth rate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d7610d8-d5c5-46f6-89d1-e4ad02095452",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "YOY growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-46e181ba1120",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "Nevro went public in November 2014 at $18/share, and launched its high frequency device in mid-2015. Sales took off: doctors were eager try a new device, and Nevro poached longtime stim reps from Medtronic, Boston Scientific, and Abbott along with their books of business, as its stock represented the first real money-making opportunity for veterans in a sleepy space. Sales grew from $70MM in 2015 to $327MM in 2017. The sell-side gushed with excitement. The honeymoon would be short-lived, however. By late 2017 – a mere 2 years after launch - growth mysteriously hit a wall. The stock, having peaked at $104 in late 2016, began to tread water. Little explanation was provided. The then-CEO blamed an alleged deceleration of the SCS market, and the stock crashed into the $30's.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59a41720-6d94-43a1-b13f-4a794b833b0f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.1,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Capital IQ",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fca99ced-2f36-4b85-93ab-002e489e68eb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "79d71e9b-1815-4523-9c11-60e966296a93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.002+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c55920d-f84e-4fc7-946c-a6687366b7da",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "0fd5153e-d544-4918-9d29-2fc753ba3f12",
          "evidence": "The use of a bar chart to show Nevro's revenue and growth rate helps to visualize the problem.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-16 23:09:31.266555+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 15,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Problem Statement Canvas",
            "slug": "problem-statement-canvas",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-839d-744b-ad11-9bf3e3642a18",
            "version": 1,
            "bodyDocId": null,
            "description": "Structured definition of the problem: What? Who? Where? When? Scale?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Architect",
          "layer": "slide",
          "agents": [
            "Architect"
          ],
          "matchId": "8547d444-dada-45ff-8492-5e9037213378",
          "evidence": "The slide presents a problem statement about Nevro's growth stalling, and provides context about the company's history and product launch.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.232975+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 15,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 16,
      "type": "tension",
      "title": "The slide uses a red circle to highlight a specific claim from a company presentation, which the activist is likely about to debunk.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 48,
        "componentCount": 7,
        "textChars": 691,
        "nDataPoints": 0,
        "notes": "The slide uses a red circle to highlight a specific claim from a company presentation, which the activist is likely about to debunk.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "line_chart",
          "callout_box"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:26.795+00",
          "seconds": 3.485,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/16",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-16",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.08,
            "y": 0.43
          },
          "kind": "callout",
          "text": "2018: Growth Stalled by Execution Issues",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bf107474-9d48-4ae8-8c15-476fcee19d01",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.28,
            "x": 0.38,
            "y": 0.55
          },
          "kind": "chart",
          "text": "Trials vs Perm Procedures chart",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "580da1e0-e3fa-4b77-a268-e293c8dc424a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.35,
            "x": 0.11,
            "y": 0.54
          },
          "kind": "list",
          "text": "Execution Issues: Aggressively forward-built company infrastructure for growth; Large numbers of reps hired with inadequate onboarding/training; Low productivity/high attrition; Lack of focus on trial growth; Senza II pricing missteps; HF10-only bias alienated some customers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a79054af-566a-4151-a8f0-e2c7a1113631",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "With the stock stuck in the $30's, the CEO was ejected by the Board in March 2019 and replaced by Keith Grossman... The stock narrative has become a simple one: \"execution issues\" under the previous CEO led to Nevro's growth collapse...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "51322c29-a3c0-4b85-95b8-3427c999166e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.6,
            "x": 0.06,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "*Red ours for emphasis. Source: Nevro IR page...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3f7edf9-23d8-474e-8cd3-89e79245df58",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "99491b99-d213-4d09-a42a-645e1e5a42da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.18,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "396b30a5-f11f-461f-b413-06c2c12d1e49",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "b13c8fb6-3076-4592-8133-a1c13676f116",
          "evidence": "The use of a bullet list to present execution issues helps to clearly outline the problems.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.335287+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "b248df8d-4c55-4567-8b22-c1cd4849988c",
          "evidence": "The slide explicitly sets up a company-provided narrative ('execution issues') to contrast with the activist's critical analysis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:26.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 16,
          "frameworkName": "expose_contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 17,
      "type": "tension",
      "title": "The slide uses a 'villain critique' style to frame management's excuses as implausible, setting up the investigative methodology.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 46,
        "componentCount": 6,
        "textChars": 728,
        "nDataPoints": 5,
        "notes": "The slide uses a 'villain critique' style to frame management's excuses as implausible, setting up the investigative methodology.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:27.822+00",
          "seconds": 4.323,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/17",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-17",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "In order to understand what actually went wrong, we embarked on what we believe to the most intensive and thorough investigation of Nevro to date.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:21+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-203ebf40c90b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.9
          },
          "kind": "disclaimer",
          "text": "All former employees were at least six-months removed from the company, per best practice research and compliance guidelines.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Disclaimer",
              "slug": "disclaimer",
              "status": "active",
              "canonId": "91173477-d91f-4024-bbaf-d4f93e3f82dc",
              "version": 1,
              "description": "Legal/cautionary text that occupies most of the body of its slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd601c19-32a4-430f-88bc-802fbd81cd84",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "list",
          "text": "21 physicians and KOL's... 9 former Nevro executives/employees... 7 executives/territory managers/sales reps at Nevro's key competitors...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6779da89-14e2-4f1c-acbe-1e21f1eb0410",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "The purported explanation struck us as curious, however: if high frequency provides almost twice the pain relief of conventional stimulators, as claimed, why did growth collapse so abruptly, especially as its share had only hit ~15% with blue skies in front?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cafafa85-facf-408f-9fa6-fcf5837fee50",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ef8d41a-b8c4-4adf-b5ef-a59d69930e5f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f86fdb38-000e-4923-9525-02c54050a59c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Logical chain",
            "slug": "logical-chain",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-5104-702f-8953-85757af6553d",
            "version": 1,
            "bodyDocId": null,
            "description": "If-then, premise-conclusion, deductive chain.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "c23c6590-432f-4aaf-8f57-75d3f2173c6f",
          "evidence": "The use of a logical sequence of quotes and testimonials helps to build a narrative.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.400841+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "93e9b7ef-586f-4b89-b8a9-45ea55fa5c17",
          "evidence": "The slide systematically dismantles management's stated reasons for growth decline to imply deeper issues.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-05-02 20:15:27.822+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 17,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 18,
      "type": "tension",
      "title": "The slide uses a testimonial-heavy format to undermine the company's official narrative regarding sales force attrition and product performance.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 9,
        "textChars": 1349,
        "nDataPoints": 0,
        "notes": "The slide uses a testimonial-heavy format to undermine the company's official narrative regarding sales force attrition and product performance.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:35.23+00",
          "seconds": 6.987,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/18",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-18",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "No matter what we did in the field, it didn't work.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-7a65c32ee590",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "As we interviewed former Nevro sales executives, managers, and reps, an entirely different explanation emerged for the sudden collapse in growth – and why the “attrition” was actually a mass exodus.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "402088af-79c4-4e12-9723-379ce0fb4256",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.55
          },
          "kind": "quote",
          "text": "No matter what we did in the field, it didn't work. I would have a hard time selling this device when I didn't believe that it’s right. I couldn't look them in the eye and ask them for visits anymore, because I didn't believe in the therapy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "146018ef-b9f0-4d37-a1b9-72d9d600f336",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.75
          },
          "kind": "quote",
          "text": "One reason for explants is that patients get sick of recharging, which can cause heating at the site and cause infections. A second reason is that the therapy wasn't working so patients would just get fed up.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b084e20a-5012-458f-8d9b-d5e59551a4b4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "quote",
          "text": "Six months in, I started to notice that the implants were not comparing to the outcomes in the trials...and then, the company started seeing it. The device isn't working.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6b24841-71bf-4102-bab3-ea915db8b763",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Six months in, I started to notice that the implants were not comparing to the outcomes in the trials...and then, the company started seeing it. We weren't getting the results that we thought we were going to get...the company realized that at the 18 month mark and they started freaking out. Sort of every KOL was saying the device isn't working.\" — Former district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-7d1c942af192",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "87481e31-880d-43c2-974e-6bb194dd767c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56b3a92e-4e7b-423c-924a-ed0f5941aa46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94f059d6-b0eb-407c-bbd3-1c0ccfa2b9e8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Anaphora",
            "slug": "anaphora",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-9fee-74aa-a920-078aa44132c0",
            "version": 1,
            "bodyDocId": null,
            "description": "Repeating words at the beginning of successive clauses for rhythm",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "0d2c9751-c11d-4440-82b0-c1c1163ef6f2",
          "evidence": "The repetition of 'No matter what we did in the field, it didn't work' emphasizes the device's lack of efficacy.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.466805+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 18,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "e43ca8f3-2ae5-46a6-8ab6-9c94cff42ad3",
          "evidence": "Contrasts company narrative with internal employee testimony",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:35.23+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 18,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 19,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize negative performance metrics reported by former consultants and KOLs.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 3486,
        "nDataPoints": 2,
        "notes": "The slide uses highlighted text to emphasize negative performance metrics reported by former consultants and KOLs.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:27.932+00",
          "seconds": 4.124,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/19",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-19",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL’s and ex-employees were remarkably consistent, across several dozen interviews, in explaining why Nevro’s sales growth collapsed – yet we failed to see one instance of device failures, lack of efficacy, and explants being asked about or mentioned in ~5 years of earnings calls or effusive sell-side reports.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-6310d57c3794",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "KOL's and ex-employees were remarkably consistent, across several dozen interviews, in explaining why Nevro's sales growth collapsed – yet we failed to see one instance of device failures, lack of efficacy, and explants being asked about or mentioned in ~5 years of earnings calls or effusive sell-side reports. We quote 4 different high-volume KOL's below, each with an eerily similar experience, as we detail in case studies on pages 95-105.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4ef1818-db20-4345-8f88-178963e68d0d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.6
          },
          "kind": "quote",
          "text": "KOL #2, a former Nevro consultant, said the rapid drop-off in efficacy led doctors to sour on the device",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03077b08-ce28-4582-aca4-311ff6bf2571",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "quote",
          "text": "When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and was very impressed in the beginning. But then the failures just kept coming. People just kept getting explanted or the pain just kept coming back ...After three to six months it was like clockwork that patients just started shitting the bed. So I just stopped using it...It was between three to six months almost across the board...I didn't have a single patient that made it past a year ...I might have 2 back patients that still have it out of 90 I implanted with Nevro. That's not unheard of. There are a lot, a lot, of doctors who have had that experience. I know of a lot of doctors who had a 70-80% explant rate. My overall explant rate is very low. No one can say that my Nevro explants were due to my patient selection.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63c197f0-2b76-48df-b5a2-1b62d9b84eba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "I've consulted at length for Boston Scientific, Abbott, Nuvectra, and of course `Nevro over the course of my career. I have been doing implants for 20 years. I've put in probably several thousand...What I noticed is that initially almost everybody did really well and subsequently there was a big fall off. We would hold round tables where we would have 15 implanter leaders and I and two other moderators would talk about the space in general and I found that I was not alone and that other busy implanters also had the same experience, where initially things looked good and then there was a significant drop off to where many doctors were hesitant to use the product.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ae1a087-17c9-473c-bace-7e68262b5f1c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "quote",
          "text": "KOL #1 stated that the device stops working in months, with almost all of his Nevro implants explanted, and that other doctors have had 70-80% explant rates",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e04f2edb-48f1-4583-a0dc-9793af07758e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and was very impressed in the beginning. But then the failures just kept coming. People just kept getting explanted or the pain just kept coming back ...After three to six months it was like clockwork that patients just started shitting the bed. So I just stopped using it...I didn't have a single patient that made it past a year ...I might have 2 back patients that still have it out of 90 I implanted with Nevro. That's not unheard of. There are a lot, a lot, of doctors who have had that experience. I know of a lot of doctors who had a 70-80% explant rate. My overall explant rate is very low. No one can say that my Nevro explants were due to my patient selection. — KOL #1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-662ce2bf5f7c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e32c7ae-bed4-4cd9-877f-6b0ce7d277ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "726cf6da-7989-44e1-82b2-93fea8d8e081",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef5625f6-768d-4109-a8f7-4b87f9415c74",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chiasmus",
            "slug": "chiasmus",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-9f90-77d2-92d7-9a9780d23677",
            "version": 1,
            "bodyDocId": null,
            "description": "Reversing structure in successive phrases for emphasis (A-B then B-A)",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "74200bec-f8aa-4bf8-b3ce-a3556f054a2d",
          "evidence": "The use of contrasting ideas, such as 'the device stops working' and 'doctors sour on the device', helps to emphasize the problems.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.532266+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 19,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "e0e27a6a-06f1-48dc-bc8a-6c6490b9392a",
          "evidence": "Contrasting KOL testimonials with public earnings call disclosures",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:27.932+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 19,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 20,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs to build a narrative of corporate dishonesty and product failure.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 8,
        "textChars": 3035,
        "nDataPoints": 4,
        "notes": "The slide uses direct quotes from KOLs to build a narrative of corporate dishonesty and product failure.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:28.253+00",
          "seconds": 4.289,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/20",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-20",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The company just lies. They’re full of it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-48c50427fbbc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "KOL #3 confirmed Nevro's explants problem, having spoken with “hundreds of physicians” as a speaker “Some of the engineers at Boston Scientific went to Nevro. I know a couple of them very well. There was a pretty significant falloff in Nevro usage after the honeymoon...I made the decision that Nevro can't really be used, based on the problems we're seeing. So, the percentage of my implants that are Nevro is zero. None....I can tell you from talking to hundreds of physicians across the United States and internationally, because I did speaking programs internationally, it's about explants. The number of explants that you see...you can do the math. Why doesn't Nevro publish its explant data? We've asked them to do that, and they refused. You put a stimulator in, life is good for a little while. Then the honeymoon's over. Nevro doesn't talk about explant data long-term, and you need that because that's real life.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d82183e-e8ca-43e9-bf1a-ee78d5a8fff6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "paragraph",
          "text": "KOL #4 stated that the 33% explant rate in a recent paper is low, and that the actual rate could be 50-60%, “Everything was great for a few months. But then I noticed that for a lot of the patients, the device stopped working after three to six months...And then I noticed that the high frequency started hurting patients.. It went from being great to not working to irritating...The 33% explant rate for Nevro devices [in the NANS paper] is definitely low. It's significantly higher. Patients hate the Nevro device. That thing is a piece of shit. The explant rate could easily be 50-60%. It definitely doesn't work much more often than it does 6-12 months out. The high frequency is causing the nerves to become hypersensitive. The company just lies. They're full of it...I've been implanting for a long time and I rarely explant. Sure, sometimes stimulators don't work. But rarely do they stop working and irritate a patient. I mean, it's happened but not at the numbers we saw with Nevro. I would rarely explant people. I would say 1 or 2%, if that.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70fa9f3e-e4b7-4b82-9d69-3ae251575247",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's #3 and #4 repeated the same, indicating a widespread explants problem with Nevro's device and an actual rate far higher than the 33% finding in a recent NANS paper – potentially 50-60%. One indicated that the high frequency mechanism of action not only failed to provide pain relief, but was “hurting patients” – a finding we shall shortly detail – and causing “the nerves to become hypersensitive”: “The company just lies. They're full of it.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2925746-f067-4171-8fd8-a0d96aa2fef6",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I can tell you from talking to hundreds of physicians across the United States and internationally, because I did speaking programs internationally, it's about explants. — KOL #3; The device stopped working after three to six months...It went from being great to not working to irritating...The 33% explant rate for Nevro devices [in the NANS paper] is definitely low. It’s significantly higher. Patients hate the Nevro device. That thing is a piece of shit. — KOL #4",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-4ef43b3d97dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "434e4a1d-fd23-49f5-9cee-d65e35498222",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a434153d-aa7b-4290-a221-c9b2933b2669",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ce46969-a8a6-493b-96bd-3e2910cdfb5f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Rhetorical figure",
            "slug": "rhetorical-figure",
            "status": "active",
            "bestFor": null,
            "canonId": "d03b1504-fbd5-42a0-b1fe-e82c055d18d8",
            "version": 1,
            "bodyDocId": null,
            "description": "Classical rhetorical patterns (chiasmus, anaphora, antithesis, etc.) used for memorability.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "21a8d7d7-17cc-4fa5-8737-70cf2f4b4332",
          "evidence": "The use of rhetorical devices, such as metaphors or analogies, helps to emphasize the problems.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.596731+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 20,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "optional",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "de7b17a5-94f0-4226-ac45-c1a77b852855",
          "evidence": "The slide uses expert testimony to allege that the company is lying about product performance data.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:28.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 20,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 20,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 9,
          "name": "The Monster",
          "beatId": "531dd341-6a18-4138-9808-503ee7f0f77f",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Monster",
            "slug": "overcoming-monster-the-monster",
            "status": "active",
            "canonId": "019dd9b8-3ba3-70b3-85b6-6dc1928acd40",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a series of criticisms and contradictions against Nevro",
          "position": 0,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Hook",
            "slug": "hook",
            "status": "active",
            "canonId": "019dd9b8-01a6-7328-bff2-b22eb40b3ea5",
            "version": 1,
            "description": "The opener — a deliberate move to earn attention before any argument. Used by AIDA, Monroes, Pixar Pitch, Overcoming the Monster."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 20,
          "from": 10,
          "loop": {
            "name": "05_the_reveal",
            "slug": "05-the-reveal",
            "status": "active",
            "bestFor": "Product launches, strategic pivots, unexpected findings",
            "canonId": "019dd956-67e8-77bc-a867-02c2b36370bd",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "Setup the Question -> Build Suspense -> The Big Reveal",
            "description": "Build mystery and anticipation, then deliver a surprising or powerful conclusion",
            "familyLabel": null
          },
          "matchId": "c6d7ccb1-a71b-4960-8866-cbf6a13f3065",
          "evidence": "The deck presents a series of contradictions and criticisms against Nevro",
          "position": 0,
          "objective": "Reveal Nevro's flaws",
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-16 22:01:16.880515+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 21,
      "type": "tension",
      "title": "The slide uses anecdotal evidence from a 'longtime executive' to frame Nevro as deceptive.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 10,
        "textChars": 2287,
        "nDataPoints": 1,
        "notes": "The slide uses anecdotal evidence from a 'longtime executive' to frame Nevro as deceptive.",
        "elementsJson": [
          "paragraph",
          "quote_block"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:25.314+00",
          "seconds": 3.625,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/21",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-21",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "He added that Nevro’s recent Omnia launch, which essentially repudiates the high frequency message it’s pushed for a decade, renders the company as “hypocrites” and “liars.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-92bb713aa6bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "other",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9a1bec24-42e3-4d2f-b57c-f3c47565a05e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "A longtime executive in the SCS space explained a surprising dynamic: most Nevro implanters are blissfully unaware that they have an explants problem, as they outsource all patient follow-up to Nevro reps, who then lie to the doctor about how patients are faring.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "description",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "133d27e8-5e53-4963-bf03-8e8566e0629f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "paragraph",
          "text": "So, five weeks later, he called me up and he said, 'My Nevro rep is no longer allowed in my account. I called one of my patients who came to me because his Nevro system wasn't working.' The Nevro rep had called my buddy to tell him the results of six patients he said are all doing fantastic. One of those patients was the patient my buddy called who needed an explant, so the rep was lying to the doctor.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "877d8846-1326-4e7e-9ab6-f25ec9cda806",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "paragraph",
          "text": "My doctor friend went through all of his patients, almost a hundred of them, called them up personally, and 45% of his patients were not doing as well as the Nevro rep told him they were doing, and he wound up explanting a bunch of them and trying a different product that wasn't just high frequency and those products worked. The doctors that weren't on Nevro's payroll that had implanted Nevro's product, they were starting to verbalize that they were having the same problem.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "96f1c975-5271-4d94-9616-c36908eede01",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.3
          },
          "kind": "paragraph",
          "text": "A physician friend of mine had implanted almost a hundred Nevro's at the time and I said, \"How many of your Nevro-implanted patients still have pain relief?\" He said, \"All of them.\" I said, \"How do you know that?\" And he said, \"Well, my Nevro rep told me that.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d8a99738-d801-4257-b39a-63d5d16e68fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.78
          },
          "kind": "quote",
          "text": "Nevro obviously through their actions knew that their metrics were flawed... They're hypocrites. They're liars.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c7617e9e-c54d-4db1-9829-c3aaa9516504",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro obviously through their actions knew that their metrics were flawed, because they were saying, ‘We have the panacea. It’s a car with five wheels and everybody with four wheels is behind.’ What does Nevro do now? They’ve introduced a four-wheel product and they’ve shut their mouth about their five-wheel and basically stopped selling it. They now offer not only a high-frequency IPG, but they offer a low frequency. They’re hypocrites. They’re liars.” — Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-9428b63c2b6a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "21aebfe1-098e-41b3-81b0-e0a3544f9510",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eeb53183-caea-4145-b84d-d203734c3489",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "93449d00-56d5-4709-85c0-584e097bf870",
          "evidence": "The slide explicitly frames the company's actions as lying and hypocrisy to undermine investor confidence.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:28:25.314+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 21,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 22,
      "type": "tension",
      "title": "Uses heavy use of yellow highlighting for emphasis on critical quotes.",
      "function": "expose_contradiction",
      "rawType": "ceo_quote",
      "block": null,
      "metadata": {
        "slideType": "ceo_quote",
        "slideTypeCanon": {
          "name": "CEO quote",
          "slug": "ceo_quote",
          "status": "active",
          "canonId": "019de52d-09b6-71c8-93a5-f90a9772a8fa",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 73,
        "componentCount": 8,
        "textChars": 1786,
        "nDataPoints": 0,
        "notes": "Uses heavy use of yellow highlighting for emphasis on critical quotes.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:27.544+00",
          "seconds": 3.352,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/22",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-22",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We are unsure whether Keith Grossman, during his ongoing ~2 year repetition of “execution issues” as the driver of no growth in 3 years, is ignorant of high frequency’s lack of efficacy and resulting explants, or simply lying to investors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-c07a240d89ff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We are unsure whether Keith Grossman... is ignorant of high frequency's lack of efficacy... or simply lying to investors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0b1b9373-2f17-4f63-b8ed-31af95d56913",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.3
          },
          "kind": "quote",
          "text": "Grossman doesn't have a strategy. This is what concerns me. This is why I don't own a penny of Nevro... I would bet that that's about the due diligence that Keith Grossman did, and he was sold hook, line, and sinker.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b6deeeb-4c70-4b20-b449-9edc1d3ce910",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "quote",
          "text": "Grossman has a history of working with Bess Weatherman... They don't really add true value... I don't think there's a long-term plan there... I really don't see it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75daef04-33d7-4958-81bb-7d96d2707bc4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Grossman doesn't have a strategy. This is what concerns me. This is why I don't own a penny of Nevro. Keith Grossman may have wanted to flip it in six months... I would bet that that's about the due diligence that Keith Grossman did, and he was sold hook, line, and sinker. Now he's going to have to roll up his sleeves and say, ‘What do I do with this thing?’” — Longtime C-level executive in the space; “Grossman has a history of working with Bess Weatherman of Warburg Pincus who’s on the board... They move some people in, move some people out, but at the end of the day, they really control cost. They don’t really add true value and that’s kind of how I see Grossman... I’m very underwhelmed... I don’t think there’s a long-term plan there... Nevro has boxed themselves into a corner and now they’ll die of a thousand cuts...” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-c720d3a186d3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts; *CMS OpenPayments data for 2019, https://openpaymentsdata.cms.gov/company/100000136428",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "efca4f19-4477-4e34-bc18-f9b486cd3981",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5fd2889d-3940-4855-8a00-cb5739dbb5ef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86792dc6-7f54-4d1c-8a37-aa32a791ab5d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Authority Bias",
            "slug": "authority-bias",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-c38d-70b9-a284-b2b479763356",
            "version": 1,
            "bodyDocId": null,
            "description": "Expert opinions are weighted more heavily - cite credible sources",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Architect",
            "Storyteller"
          ],
          "matchId": "bb44e6f4-6da2-4dec-bc5e-41d7d1fff75d",
          "evidence": "The use of a quote from a former executive or KOL helps to establish credibility.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.659811+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 22,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "aba551ad-896a-4717-af82-23c46c105c99",
          "evidence": "Uses expert testimonials to directly challenge the CEO's stated strategy and competence.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:27.544+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 22,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 23,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize critical claims about the CEO's lack of engagement and the company's underlying performance issues.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 3687,
        "nDataPoints": 0,
        "notes": "The slide uses yellow highlighting to emphasize critical claims about the CEO's lack of engagement and the company's underlying performance issues.",
        "elementsJson": [
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:34.458+00",
          "seconds": 10.197,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/23",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-23",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Another former Nevro executive implied Grossman is already checked out and “very busy on a lot of other things” with “other people who are running the ship.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-14170f67eea8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Another former Nevro executive implied Grossman is already checked out and “very busy on a lot of other things” with “other people who are running the ship.” An industry executive stated his belief that even Grossman is confused by the stock, and suggested Nevro staff are skeptical of “the substance” of his efforts. The executive opined that Grossman lucked out with COVID, as it gave him a free pass for 2020, describing him as shifting from one excuse to another during his ~2 year tenure - adding that his moment of truth is imminent as the pandemic fades and the gravity of Nevro’s situation becomes obvious to Wall Street.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "87f5db26-2352-4715-b90d-0d323dbcacc2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“I study a leader's history to see what adversity they've dealt with. Did they pull a company out of the hole against all odds? Grossman's product sold itself at Thoratec. I don't think he has an appreciation for what motivates the spinal cord stimulator customer...I know for a fact, on the inside, Grossman has said he's scratching his head over why the stock has done what it's done. He may have bitten off more than he can chew...Internally at Nevro, I don't think they see the substance, based on what I've been told, and they're scratching their heads and saying, \"Hey, whatever. I'll take it. I hope the stock keeps going.\" There aren't fundamentals behind it.” – Longtime C-level executive in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c693cfd8-47b6-4a22-8032-c283ed56595c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "quote",
          "text": "“I also got a sense this wasn't a role that he was expecting and that he's very busy on a lot of other things he's doing. A lot of other things, and I don't know how much attention - I mean obviously he's spending a lot of time on Nevro - but I think there are other people who are running the ship largely and that's sort of the sense I got from these people on the leadership team” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ddccfc3d-0218-47d4-b8ea-c5b62b81443e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "quote",
          "text": "“On his first two quarterly calls he basically said, 'I'm too new to give you numbers. I'm not going to commit to anything.' I've said all along: eventually, this guy is going to have to perform. His timing [in getting a pass from COVID] is pretty damn good because I know the people on the street at Nevro who are selling product, and I know the roadblocks they're up against. They haven't out-performed from a revenue standpoint. They've been given a 24-month pass. Rami was the scapegoat, and then it was, \"Okay, let's give Grossman a year to get his feet under him,\" and now it's COVID. So, when does Nevro actually have to perform in Wall Street's eyes? They were the first company to say that that SCS market was shrinking and that just wasn't true. It's that they were losing market share, and they didn't know how to explain it away.” – Longtime C-level executive in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb3550d6-c5b3-4ee8-bf03-f32bd3d02513",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I also got a sense this wasn't a role that he was expecting and that he's very busy on a lot of other things he's doing. A lot of other things, and I don't know how much attention - I mean obviously he's spending a lot of time on Nevro - but I think there are other people who are running the ship largely and that's sort of the sense I got from these people on the leadership team” — Former Nevro executive; “I don't think he has an appreciation for what motivates the spinal cord stimulator customer...I know for a fact, on the inside, Grossman has said he's scratching his head over why the stock has done what it's done.” — Longtime C-level executive in the space; “It's that they were losing market share, and they didn't know how to explain it away.” — Longtime C-level executive in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-195e21e1d912",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "723cc9ea-4ef2-4c06-a3d7-60e78aa51345",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca038e7f-8543-4a1c-8667-2cee7e28c8c2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2318c662-862a-4bf6-ba56-36bb70dc7d17",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Call-and-Response",
            "slug": "call-and-response",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
            "version": 1,
            "bodyDocId": null,
            "description": "Engaging audience by creating pattern they complete mentally",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "bf3f5a60-671c-44e9-8daa-4d55ad5f1a5b",
          "evidence": "The use of a call-and-response pattern helps to emphasize the problems.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.723433+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "70d1ee2e-a05e-49e4-8013-8bf65a970884",
          "evidence": "The slide uses quotes from former executives to contradict the CEO's public narrative.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:34.458+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 23,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 24,
      "type": "tension",
      "title": "The slide uses historical revenue data from two previous companies to discredit the CEO's reputation as a turnaround specialist.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 9,
        "textChars": 1624,
        "nDataPoints": 28,
        "notes": "The slide uses historical revenue data from two previous companies to discredit the CEO's reputation as a turnaround specialist.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bar_chart_vertical",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:28.145+00",
          "seconds": 3.685,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/24",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-24",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "callout",
          "text": "Quarterly trend at Conceptus and Thoratec during Grossman's stints (in red) showed zero \"turnaround\" – canaries in the coal mine for Nevro investors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38c0d617-4143-4772-9ba2-60de6a39e2d3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "Grossman's skill is not in fixing companies, but in smearing lipstick and punting as fast as possible - in other words, a promoter.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-a764aadc9f6c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.46,
            "x": 0.48,
            "y": 0.64
          },
          "kind": "chart",
          "text": "Thoratec quarterly revenue",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81e3d34d-2fa3-4faa-a410-ba8f09be3394",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.42,
            "x": 0.06,
            "y": 0.64
          },
          "kind": "chart",
          "text": "Conceptus quarterly revenue",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fd30dd1b-14d6-4ed7-b0b2-9e93b268b60b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "quarterly revenue",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-ab48071846c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "We delved into the ex-Nevro executive's skepticism of Grossman's playbook – cutting costs and window dressing for a quick sale – by looking at the two acquisitions that are the source of his acclaim. From 1996 to 2006, Grossman was CEO of Thoratec, which sold a ventricular assist device for heart failure. By 2014, following a spate of injuries and fatalities, the stock collapsed and Grossman returned as CEO for a little over a year, flipping the company and doubling the stock. In December 2011, he joined as CEO of Conceptus, which sold a birth control device and had also hit the skids, flipping it in ~1.5 years. The quarterly trajectories at both Thoratec and Conceptus during his brief tenures show that he trimmed some costs but failed to return either company to growth. Grossman's skill is not in fixing companies, but in smearing lipstick and punting as fast as possible - in other words, a promoter. He has now been at Nevro longer than either of his last two flips, which makes us wonder: having presumably scrambled to flip Nevro since 2019 and failed, and with no skill at returning failed device companies to growth, what exactly are Nevro investors betting on after a 3-4X run?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b86b49a7-b2c4-4b8e-8a6e-eac0deaaa185",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.1,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Capital IQ",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d9a6b1ab-e535-45aa-91af-b244bfd82326",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6b40cb4a-0f71-4dbe-b6fe-bb8a5e5d3401",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9991ddf5-bece-488c-8186-522f5b3cd4fa",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chart Selection Guide",
            "slug": "chart-selection-guide",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-b1a0-700b-ba17-0e16c4d5bcae",
            "version": 1,
            "bodyDocId": null,
            "description": "Choosing the right chart type for your data and message",
            "familyLabel": null,
            "categoryName": "Slide",
            "categorySlug": "slide"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "04ea72d8-1ba4-4376-8784-5b066d16fc77",
          "evidence": "The use of bar charts to show quarterly revenue helps to visualize the trend.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-16 23:09:31.788735+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 24,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "1102b13d-6ade-4ea8-928b-3ff8121e813f",
          "evidence": "The slide explicitly frames the CEO's past performance as a 'canary in the coal mine' to warn investors of potential deception or failure.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:28.145+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 24,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 25,
      "type": "tension",
      "title": "Uses a 'villain' narrative to undermine the credibility of the current CEO by linking him to a past corporate scandal.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 9,
        "textChars": 1134,
        "nDataPoints": 4,
        "notes": "Uses a 'villain' narrative to undermine the credibility of the current CEO by linking him to a past corporate scandal.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "headline_text",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:28.828+00",
          "seconds": 4.315,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/25",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-25",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "callout",
          "text": "Bayer to pay $1.6B to settle 90% of Essure injury claims",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9c2d0f6-de8f-4add-a9f5-df6e2dfa5f35",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "For those who disagree with our assessment of Grossman as just another stock promoter, we encourage them to look past his polished delivery on earnings calls and to study his last pump, Conceptus.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b337-fdf333405456",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.5,
            "y": 0.73
          },
          "kind": "list",
          "text": "Essure PMA Was Fraudulent, Patient Group Says",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02c7d9ba-aa8b-4409-a480-c46f1c7f361f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "list",
          "text": "Sales of Essure birth control implant to be halted by Bayer; U.S. last to sell controversial device",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "782af81c-325d-4749-89a5-3ecbe781f454",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "For those who disagree with our assessment of Grossman as just another stock promoter, we encourage them to look past his polished delivery on earnings calls and to study his last pump, Conceptus...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "82a81a06-59ba-44fa-8ef9-501020640511",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "First, the safety and efficacy profile of the Essure product is uniquely compelling. I mean, it really is just a terrific product...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cff7ebba-53b6-4a39-93cb-62008d298121",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "First, the safety and efficacy profile of the Essure product is uniquely compelling. I mean, it really is just a terrific product and it continues, by the way by any medical device measure I think, and continue to be most effective option available for permanent birth control for women. — Keith Grossman, Capital IQ earnings transcript, 2/23/2012",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:22+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-013ff6f7e85c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42dcfe65-0fbd-485a-8bcd-c34c641b385f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da515273-95af-4e46-ae5a-0c0f489032e6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Evidence Matrix",
            "slug": "evidence-matrix",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7ecc-74c2-b46c-0b9c1f4c73d7",
            "version": 1,
            "bodyDocId": null,
            "description": "Planning visual assets: Claim → Evidence Needed → Data Source → Visual Type",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Designer",
          "layer": "slide",
          "agents": [
            "Designer"
          ],
          "matchId": "48d02690-38d2-4ca4-af23-294a74490d69",
          "evidence": "The use of a list to present evidence helps to build a case.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:31.856099+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 25,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "3da1daeb-d56a-4202-a201-c3100e9ab4f3",
          "evidence": "Contrasts CEO's past positive quote with subsequent negative outcomes (settlements/fraud allegations).",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:15:28.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 25,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 26,
      "type": "tension",
      "title": "Uses emotional appeal and external media (Netflix documentary, NYT review) to frame the subject as a villain.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 68,
        "componentCount": 8,
        "textChars": 1228,
        "nDataPoints": 0,
        "notes": "Uses emotional appeal and external media (Netflix documentary, NYT review) to frame the subject as a villain.",
        "elementsJson": [
          "paragraph",
          "screenshot",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:25.851+00",
          "seconds": 3.156,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/26",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-26",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "But it indicates his playbook, which we encourage investors to note, as they gauge the veracity of his claims regarding Nevro's supposed safety, efficacy, and lack of explants, particularly next week at the JP Morgan conference.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-c038493c5a33",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.27,
            "x": 0.06,
            "y": 0.47
          },
          "kind": "image",
          "text": "The Bleeding Edge documentary poster",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c505bd6-c560-4097-975a-50c835287a0e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Given the hushed reverence with which certain Wall Street analysts still speak of Grossman, notably the one who landed Nevro’s last offering. we suggest watching the 2018 Netflix documentary The Bleeding Edge...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52ecd66d-c6d6-4972-807f-cce8138d1aaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.59,
            "x": 0.35,
            "y": 0.47
          },
          "kind": "quote",
          "text": "New York Times review: \"But it’s the interviews — watching patients recount agonies they’ve suffered from poorly researched and regulated medical devices — that are hardest to sit through...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a8da187-73a7-439c-a799-3c094d29ecae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.59,
            "x": 0.35,
            "y": 0.65
          },
          "kind": "quote",
          "text": "Clips from documentary: [11:05 minutes in] \"My husband has gone with me to the hospital and we’re in a room...and just blood exploded out of me...it looked like a horror scene...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e77cf3c-d3af-471b-93bc-eb9a8450e1c7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"But it’s the interviews — watching patients recount agonies they’ve suffered from poorly researched and regulated medical devices — that are hardest to sit through…The Bleeding Edge” isn’t an anti-medical film, but a look at calamities caused when the obsession for profit overwhelms an industry.\" — New York Times review",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-c5f128da893b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.23,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "subtitle",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce",
              "version": 1,
              "description": "Header-zone supporting text near the title (= ex body.description with bbox)."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e1199f1-12d3-4ee9-9bfe-ded33330c423",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "39d3f4f2-0bc9-4017-a2b7-ddddb019cd62",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6cd033be-c32c-4dc7-a9a4-c0856b276af5",
          "evidence": "Uses documentary and victim testimony to frame the CEO as a villain.",
          "framework": null,
          "confidence": 0.95,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "frameworkName": "antagonist-introduction"
        },
        {
          "matchId": "254b5575-1c78-471b-9ba2-5c88509b55ac",
          "evidence": "Uses graphic descriptions of medical trauma to influence investor sentiment.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:28:25.851+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 26,
          "frameworkName": "emotional-appeal"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 27,
      "type": "tension",
      "title": "The slide uses a 'villain' framing by associating the company with the opioid crisis and the Insys fentanyl scandal.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 11,
        "textChars": 2847,
        "nDataPoints": 3,
        "notes": "The slide uses a 'villain' framing by associating the company with the opioid crisis and the Insys fentanyl scandal.",
        "elementsJson": [
          "paragraph",
          "callout_box",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.388+00",
          "seconds": 4.163,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/27",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-27",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.55
          },
          "kind": "callout",
          "text": "But the stimulators — devices that use electrical currents to block pain signals before they reach the brain — are more dangerous than many patients know, an Associated Press investigation found. They account for the third-highest number of medical device injury reports to the U.S. Food and Drug Administration, with more than 80,000 incidents flagged since 2008. Patients report that they have been shocked or burned or have suffered spinal-cord nerve damage ranging from muscle weakness to paraplegia, FDA data shows. Among the 4,000 types of devices tracked by the FDA, only metal hip replacements and insulin pumps have logged more injury reports. The FDA data contains more than 500 reports of people with spinal-cord stimulators who died, but details are scant...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "849aef79-0341-4a52-bcf6-433d7c6c29f4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "But the stimulators — devices that use electrical currents to block pain signals before they reach the brain — are more dangerous than many patients know, an Associated Press investigation found.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-621ef7d492ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.82
          },
          "kind": "paragraph",
          "text": "The AP reported on spinal stimulators as part of a nearly yearlong joint investigation of the global medical devices industry that included NBC, the International Consortium of Investigative Journalists and more than 50 other media partners around the world. Reporters collected and analyzed millions of medical records, recall notices and other product safety warnings, in addition to interviewing doctors, patients, researchers and company whistleblowers.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "156cbe63-207c-4c05-a707-c1399c357aaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Devices with Essure’s profile - lack of efficacy plus severe side effects - are inherently high-risk businesses that tend to gradually fade or abruptly implode. We note Penumbra’s device recall the other week following an investigative short report. While Wall Street has endowed spinal cord stimulation with institutional respectability, now that there’s a pure play stock that pays banking fees, Nevro is just another menu offering at the same sketchy pain clinics responsible for some of the worst abuses in healthcare, such as the opioid crisis and the Insys fentanyl racket. We note a number of long-form investigations of abuses in the stimulator space, which report that the devices typically fail to work and have one of the worst safety records of all medical devices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ab2510f-5616-4cd3-a3ca-01c44c9c23b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.05,
            "y": 0.51
          },
          "kind": "paragraph",
          "text": "By MITCH WEISS and HOLBROOK MOHR November 26, 2018",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9fa30e7-38c8-4f45-8e40-2a0996fe5502",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“But the stimulators — devices that use electrical currents to block pain signals before they reach the brain — are more dangerous than many patients know, an Associated Press investigation found. They account for the third-highest number of medical device injury reports to the U.S. Food and Drug Administration, with more than 80,000 incidents flagged since 2008.” — Associated Press",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-66f64627f42d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://apnews.com/article/38145385944248b5bf8d442579505258",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09a29330-c2fb-4686-9141-00c78a9aa6a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.6,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "title",
          "text": "Patients shocked, burned by device touted to treat pain",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5cc98929-5691-4950-9f51-204b4bc162d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6c5ea0db-026b-4d82-8a87-a7e86050fdb3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.05,
            "y": 0.41
          },
          "kind": "title",
          "text": "Associated Press investigation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d578c1a-d155-453f-aff4-2a83026bf4d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d868a9b-3dff-4c52-9c9f-2b88f1afd05a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 28,
      "type": "tension",
      "title": "The slide uses a 'villain critique' approach by citing external authorities to undermine the company's product efficacy and business ethics.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 12,
        "textChars": 2547,
        "nDataPoints": 4,
        "notes": "The slide uses a 'villain critique' approach by citing external authorities to undermine the company's product efficacy and business ethics.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.618+00",
          "seconds": 4.203,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/28",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-28",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "callout",
          "text": "Associated Press investigation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c4d6df2-1fe0-4755-b694-b2b8f1182922",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "callout",
          "text": "Insurance trade article commenting on stimulators",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3db5ce9-823c-4505-a594-9660abe7b4fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.05,
            "y": 0.82
          },
          "kind": "callout",
          "text": "Washington state study of SCS outcomes and side effects",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e632055b-c868-40d7-a16a-c77e4b10b2ae",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "the stimulation space is driven by rampant manipulation and exploitation of chronic pain patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-9149056b7d2d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Aside from lack of efficacy and side effects, the AP's investigation found... that the stimulation space is driven by rampant manipulation and exploitation of chronic pain patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d3653ec-bce5-41ab-ba12-c12121efe2b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.85
          },
          "kind": "quote",
          "text": "[W]eak evidence exists that SCS may provide temporary improvement of pain in some patients, but there is no evidence of mid or long term pain improvement.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4d274fab-0ab3-4bdf-9089-2f3668769cce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "Taft is one of 40 patients interviewed by the AP who said they had problems with spinal-cord stimulators... Twenty-eight of them said their spinal-cord stimulators not only failed to alleviate pain but left them worse off...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "710caeda-c143-4dc2-91f0-77ae4f199ab4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "quote",
          "text": "Spinal cord stimulators are some of the most problematic implants... The devices 'more often fail than succeed,' and he estimates that they cause complications with MEMIC comp patients 90% of the time...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e21cd5d-7298-4f79-abbe-b154d1ded71c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Taft is one of 40 patients interviewed by the AP who said they had problems with spinal-cord stimulators...Twenty-eight of them said their spinal cord stimulators not only failed to alleviate pain but left them worse off than before their surgeries...More than half the patients interviewed by the AP said they felt pressured to get stimulators because they feared their doctors would cut off their pain medications\" — Associated Press investigation. \"Spinal cord stimulators are some of the most problematic implants, according to various insurers, with a recent study showing a high removal rate...[W]e don't see a lot of success with them at all...Spinal cord stimulators are the most frequent failed medical device for workers compensation claimants at Portland...The devices 'more often fail than succeed,' and he estimates that they cause complications in MEMIC comp patients 90% of the time...\" — Insurance trade article. \"[W]eak evidence exists that SCS may provide temporary improvement of pain in some patients, but there is no evidence of mid or long term pain improvement.\" — Washington state study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-96ed8814dd78",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: https://apnews.com/article/86ba45b0a4d443fad1214622d13e6cb; https://www.nbcnews.com/health/health-care/spinal-cord-stimulators-help-some-patients-injure-others-n940131; https://www.businessinsurance.com/article/20190701/NEWS08/912329205/Comp-payers-wary-of-implanted-pain-relievers-; https://www.hca.wa.gov/assets/program/spinal-cord-stimulation-signal-update-20180807.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4bf62d6b-5ee2-4d37-8e00-ad961ebdb9fa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2674208-2638-44e5-9ca8-5b72c86148d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "528e2c88-dc57-49e0-acc7-85e5a2e5d741",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d39e291f-f6b0-4e38-be9d-ed8ed65aa921",
          "evidence": "The slide systematically uses external investigative reports to expose the company's product as fraudulent or ineffective.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:29.618+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 28,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 29,
      "type": "tension",
      "title": "Uses a pull-quote from a surgical nurse to emphasize the negative patient experience.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 6,
        "textChars": 1305,
        "nDataPoints": 3,
        "notes": "Uses a pull-quote from a surgical nurse to emphasize the negative patient experience.",
        "elementsJson": [
          "paragraph",
          "callout_box",
          "screenshot"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.015+00",
          "seconds": 6.465,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/29",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-29",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.2,
            "w": 0.43,
            "x": 0.52,
            "y": 0.495
          },
          "kind": "callout",
          "text": "I have been a surgical nurse for 40 years and have seen many patients receive SCS...and many, many fail, or return to surgery for fractured electrode wires, misplaced wires, or infected battery pockets...spinal fluid leaks...severe headaches...[they] find out in 2-8 months that they wish they never had agreed to it ...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54afa5ac-1a76-48b9-9020-d41b027eaa14",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "paragraph",
          "text": "1. Introduction to Nevro. In 2014, the Wall Street Journal investigated spinal cord stimulators, analyzing adverse-event reports submitted to the FDA and finding over 100 cases of partial or permanent paralysis after implantation...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fa6e33b-876b-4e59-82f6-2b7697ca29ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.45,
            "x": 0.05,
            "y": 0.43
          },
          "kind": "paragraph",
          "text": "When Spine Implants Cause Paralysis, Who Is to Blame? Mr. Greenwood, 66 years old, is among more than 100 patients who have experienced partial or permanent paralysis...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9547e7e7-596f-4ca6-8766-ef0f781214b7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I have been a surgical nurse for 40 years and have seen many patients receive SCS...and many, many fail, or return to surgery for fractured electrode wires, misplaced wires, or infected battery pockets...spinal fluid leaks...severe headaches...[they] find out in 2-8 months that they wish they never had agreed to it ... — Anonymous (comment on a blog discussing the WSJ article)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-adb914cf391f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://www.wsj.com/articles/SB10001424052702304512504579493843647492538; https://painsandiego.com/2014/08/06/spinal-cord-stimulators-paralysis-adverse-effects/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad9cb842-e142-4bae-99da-997b098c5ae1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "262b9940-7c3d-4633-943d-d9a519e3c469",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "14db52e6-0802-4fd1-878d-cab50daa9fbc",
          "evidence": "Frames the company/industry as a 'hustle' preying on patients.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:32.015+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 29,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 30,
      "type": "tension",
      "title": "The slide uses expert quotes to undermine the company's clinical claims.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 3940,
        "nDataPoints": 0,
        "notes": "The slide uses expert quotes to undermine the company's clinical claims.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.769+00",
          "seconds": 3.778,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/30",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-30",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "It is therefore not surprising that Nevro and its peers appear downright paranoid about doing any long term studies, preferring to cease evaluation at the 3-12 month mark lest they blow up reimbursement.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-5810a509a857",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "It is therefore not surprising that Nevro and its peers appear downright paranoid about doing any long term studies, preferring to cease evaluation at the 3-12 month mark lest they blow up reimbursement. The “Clinical Evidence” page on Nevro’s site has a chart for “Long-Term Responder Rates,” which the footnotes indicate refer to only 12 and 24 month data – an eon in the stim space. We quote one of Nevro’s consultants and highest volume implanters, who despite his enthusiasm notes the rapid fall off in efficacy within 1-2 years; admits that 50% of patients need to consider an explant by year 5; and that stimulators fail to reduce the need for pain medications like opioids. A second Nevro implanter stated that “long term, stimulators don’t work as well.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e902e108-0d2e-45a3-9275-7c46f18357a6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.4
          },
          "kind": "quote",
          "text": "“All of the SCS devices at the five-year mark really start to drop off. I'm always curious about what it is that happens after a year or two for these patients...No one has really studied that. That's the problem. For all SCS devices, I would say 50% have reached the point at 5 years where it's no longer helpful enough to keep using them and maybe even consider an explant. At 5 years they're explants or they move on to a different therapy but continue to use the stim, or they may even stop using the stim. We've seen patients say I am using the stim but I still need injections every three months. Or I need oral opioids. Some go on to have pumps. SCS was originally sold as a good opportunity to avoid having to return to ongoing injections or opioids. There was a retrospective review of changes in opioid use with stim because many companies would say \"Oh, you know, you just how to solve the opioid crisis\", but they found that you know with stim opioids don’t necessarily go down.” – High volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8bc983d3-9a00-43f4-91a4-fbb63a3bcf46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.82
          },
          "kind": "quote",
          "text": "“There were less than 10 neuromodulation studies in 50 years, only 6 even worth quoting. There’s not much evidence.” – Longtime Medtronic executive in SCS",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9dfdbe8f-d32f-4b25-aa6e-1632002f7359",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "“Long term, stimulators don’t work as well. Patient are desperate, say it works, then say it doesn’t work. It’s usually a misleading trial in a patient. The published data says stim doesn’t work in 30% of patients.” – High volume implanter and moderate Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b8e17ab9-0229-4177-a1e4-fbaa5c4e7595",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "All of the SCS devices at the five-year mark really start to drop off. I'm always curious about what it is that happens after a year or two for these patients...No one has really studied that. That's the problem. For all SCS devices, I would say 50% have reached the point at 5 years where it's no longer helpful enough to keep using them and maybe even consider an explant. At 5 years they're explants or they move on to a different therapy but continue to use the stim, or they may even stop using the stim. We've seen patients say I am using the stim but I still need injections every three months. Or I need oral opioids. Some go on to have pumps. SCS was originally sold as a good opportunity to avoid having to return to ongoing injections or opioids. There was a retrospective review of changes in opioid use with stim because many companies would say \"Oh, you know, you just how to solve the opioid crisis\", but they found that you know with stim opioids don't necessarily go down. — High volume Nevro implanter; Long term, stimulators don't work as well. Patient are desperate, say it works, then say it doesn't work. It's usually a misleading trial in a patient. The published data says stim doesn't work in 30% of patients. — High volume implanter and moderate Nevro user; There were less than 10 neuromodulation studies in 50 years, only 6 even worth quoting. There's not much evidence. — Longtime Medtronic executive in SCS",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-5f0aeab55556",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dbddffe5-4ea7-444b-b820-cc227f83f1e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b1ec681-8223-4bf0-ad87-1dde162d9d76",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e4aa18a-fecf-4c39-8ab4-63da164b388c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 31,
      "type": "tension",
      "title": "The slide uses a 'three-point' narrative structure to build a case against the company's safety record.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 1399,
        "nDataPoints": 4,
        "notes": "The slide uses a 'three-point' narrative structure to build a case against the company's safety record.",
        "elementsJson": [
          "paragraph",
          "screenshot",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.627+00",
          "seconds": 3.43,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/31",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-31",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.05,
            "y": 0.51
          },
          "kind": "callout",
          "text": "FDA flags 428 spinal cord stimulator patient deaths, urges more tests before implant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "509f0cab-f35a-459b-aeeb-cc81e0f95ac4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "The letter’s tone suggests alarm, noting ~108,000 MDR’s (medical device reports) received by the FDA including ~78k injuries, 29k malfunctions, and 500 deaths – and concludes by urging providers and patients “to report any adverse events...with SCS” to the FDA.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-761e7e309f8f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.35,
            "x": 0.53,
            "y": 0.51
          },
          "kind": "image",
          "text": "IMPLANTED SPINAL CORD STIMULATORS FOR PAIN RELIEF Illustrating the FDA’s Dangerously Lax Oversight of High-Risk Implantable Medical Devices",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e481467-6a13-433f-b213-68a927de2342",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.05,
            "y": 0.68
          },
          "kind": "paragraph",
          "text": "FDA “Letter to Healthcare Providers” The FDA recently reviewed the medical device reports (MDRs) received between July 27, 2016 and July 27, 2020 associated with spinal cord stimulation devices...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3a434e01-2545-4842-948c-77d3abd18b56",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.53,
            "y": 0.78
          },
          "kind": "paragraph",
          "text": "Lax testing of spinal cord stimulators threatens patient safety, consumer group warns “These deficiencies have resulted in serious injury to tens of thousands of patients”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4fafef8-e005-49f3-a4c0-afb2195b4cb8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "For those who dismiss journalistic investigations and insurer studies in the face of a stock that’s worked, we caution that reimbursement... as well as regulatory scrutiny of stimulators have escalated in recent months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6812cca-b675-49c4-8b9f-6c15d762d722",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“These deficiencies have resulted in serious injury to tens of thousands of patients” — Consumer group warning regarding spinal cord stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-7a708934a3d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "source-note",
          "text": "Source: https://www.medtechdive.com/news/fda-flags-428-spinal-cord-stimulator-patient-deaths-urges-more-tests-befor/584714/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1586fbee-9701-4fd0-8698-010bdb74bd94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a207e8a-7eb5-4edf-9613-05d182d0f43e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c56dc7d7-5893-4c57-aad9-6c87a26f9964",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f6725d57-e5a3-4d0e-93ef-203a0eca0005",
          "evidence": "The slide systematically presents negative regulatory and safety data to undermine the company's market position.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:29.627+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 31,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 32,
      "type": "tension",
      "title": "The slide uses aggressive language ('smoke and mirrors', 'criminal', 'big scam') to frame the company as a bad actor.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 59,
        "componentCount": 7,
        "textChars": 834,
        "nDataPoints": 6,
        "notes": "The slide uses aggressive language ('smoke and mirrors', 'criminal', 'big scam') to frame the company as a bad actor.",
        "elementsJson": [
          "paragraph",
          "bar_chart_vertical",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.54+00",
          "seconds": 3.262,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/32",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-32",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.52,
            "y": 0.8
          },
          "kind": "callout",
          "text": "Reassess the safety of all implanted spinal cord stimulators for pain relief and determine whether any of them should be removed from the market",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e426cb1-0cbb-443a-95a6-42082b3f950d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.48,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "chart",
          "text": "MAUDE Search for Nevro MDR's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "278e0d40-4e0f-4a30-94fc-410fec2ce77c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "MAUDE reports: 2000",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-2bf5d601168e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "paragraph",
          "text": "1. Introduction to Nevro. The FDA's move signals that the SCS space finally has a target on its back. A recall is the last risk on any Nevro investor's mind, but as a poster child for abuses in the space, its high frequency technology strikes us the obvious and lowest hanging fruit for the FDA.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6bd3598-d7db-4c67-9a65-f2c21c57007b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "KOL commentary such as “smoke and mirrors,” “a big scam,” “criminal” data manipulation, and “falsification of data” — Scorpion Capital citing KOLs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-24e58249cd9d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.8,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: FDA MAUDE database searches; https://mkus3lurbh3lbztg254fzode-wpengine.netdna-ssl.com/wp-content/uploads/2526_200610_Spinal-Cord-Stimulator-Report_FINAL.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35521439-7358-48d7-9a9e-2c2aa5285dae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57ed28de-b19f-414d-9fe0-fded1fd50009",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "437f19e3-b5b8-4e9b-a2c7-306cc85dd285",
          "evidence": "The slide explicitly frames the company as a 'poster child for abuses' and alleges 'criminal' data manipulation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:29.54+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 32,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 33,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize specific claims about tolerance and pathological changes.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 9,
        "textChars": 1331,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize specific claims about tolerance and pathological changes.",
        "elementsJson": [
          "paragraph",
          "quote_block"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.883+00",
          "seconds": 6.586,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/33",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-33",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A number of KOL’s stated their belief that Nevro’s high frequency mechanism of action is uniquely dangerous versus conventional low frequency stimulators, a finding supported by extensive posts in Nevro patient support groups on Facebook.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-0c70d87c04cf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A number of KOL’s stated their belief that Nevro’s high frequency mechanism of action is uniquely dangerous versus conventional low frequency stimulators...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64a2e3d6-3bd9-41e1-b780-1960cd896fa4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.75
          },
          "kind": "quote",
          "text": "I’m saying it’s just too much energy and you have to back off. Either the cells are down-regulating and can’t hear the noise anymore...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d13a1cc-aa67-4b68-b199-265a65708b1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5efb5f86-297a-46c6-968a-cd03f352abdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "quote",
          "text": "I believe, and a lot of other doctors believe, that you can only pound on the spinal cord so much. You’re seeing a shift now...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "affb4442-a1c4-4a1a-bbf4-77a6afa9972b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance. If you take two Vicodin a day you need four a day after 6 months to get the same effect because your nervous system is plastic. The pathological changes that may have occurred in patients with Nevro’s HF10 therapy are being studied. — KOL and former Nevro consultant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-13c3795e2959",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "18fc87e5-e46d-4048-b9f7-bdb174bb2c33",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f257971-896f-48c6-99b8-b1836b58ab96",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5eeac726-3b16-48fd-b62c-50db45553936",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "8baf3a8f-979b-4e9b-9cdb-ceb4640d4332",
          "evidence": "The slide frames Nevro's technology as a dangerous, failing product through expert testimony.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-05-02 20:15:32.883+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 33,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 34,
      "type": "tension",
      "title": "Uses social proof/anecdotal evidence to undermine company claims of safety.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 64,
        "componentCount": 7,
        "textChars": 1530,
        "nDataPoints": 0,
        "notes": "Uses social proof/anecdotal evidence to undermine company claims of safety.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:30.692+00",
          "seconds": 4.256,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/34",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-34",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Patients posts on Facebook groups corroborate KOL’s concerns of flooding the spine with high frequency, indicating alarming and widespread problems with Nevro’s device.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-00c15b5b73b7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.52,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "image",
          "text": "Grid of Facebook post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9764c2df-124f-4b54-91c7-3581e0383da2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Patients posts on Facebook groups corroborate KOL’s concerns of flooding the spine with high frequency, indicating alarming and widespread problems with Nevro’s device. Patients use the term “overstimulation” or “overstim” to describe the phenomenon and indicate it subsides when the device is turned off. The seemingly endless number of posts point to its scale: “I was in tears from the level of overstimulation”; “over two years straight, brutal as hell”; “terrified to turn it back on”; “feels like someone hit my legs with a baseball bat; legs and back “burn so bad” like a “blowtorch”; “I was crying” wondering “if I made the right decision” to have the implant; and “nobody will admit to it,” presumably the company.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93ffc662-0fb8-4f24-adfc-0de17753d232",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I was in tears from the level of overstimulation; over two years straight, brutal as hell; terrified to turn it back on; feels like someone hit my legs with a baseball bat; legs and back burn so bad like a blowtorch; I was crying wondering if I made the right decision to have the implant; nobody will admit to it — Patient testimonials from Facebook support groups.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-06d292a2f915",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.65,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups –https://www.facebook.com/groups/213633049377315; https://www.facebook.com/groups/us.nevro; https://www.facebook.com/groups/886079031527511;",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9ca12b5-0105-4989-8bc1-ea34eb97c6e4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd9a9343-ed72-40d0-8c03-8ce94b239c26",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2cc41f5f-bdc7-476c-850a-831690ca8b54",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e6766511-c5ae-4c7c-9b5f-8fa4da2d7588",
          "evidence": "Uses patient testimonials to frame the company as ignoring widespread harm.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:30.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 34,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 35,
      "type": "evidence",
      "title": "The slide uses direct quotes from social media to build a case against the product's efficacy and patient experience.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 7,
        "textChars": 1634,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from social media to build a case against the product's efficacy and patient experience.",
        "elementsJson": [
          "paragraph",
          "screenshot",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:34.348+00",
          "seconds": 7.753,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/35",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-35",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We find it telling that patients report overstimulation symptoms vanish when they turn off the device,",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-3f1c4cd63d1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.9,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "image",
          "text": "Collection of Facebook group post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.348+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3ff4dc8-8595-49e6-a9f4-c289cd5980ba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One patient states her device has been reprogrammed \"at least 40 times over a year by a very experienced rep\" in a futile attempt as her \"legs continue to be overstimulated brutally to a point I have to turn it off every time,\" reporting \"NO overstimulation pain with device off\" and that \"I just can't go back to that overstimulation pain. I just can't.\" Another details two years of \"OS hell\" with variants like burning, frozen toes, or simply \"all hell breaks loose.\" We find it telling that patients report overstimulation symptoms vanish when they turn off the device,",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.348+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eeb49529-23c5-4ebe-91a0-42f9fade120b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“at least 40 times over a year by a very experienced rep” — Patient testimonial; “legs continue to be overstimulated brutally to a point I have to turn it off every time,” — Patient testimonial; “NO overstimulation pain with device off” — Patient testimonial; “I just can’t go back to that overstimulation pain. I just can’t.” — Patient testimonial; “I have been in OS hell. OS causes more pain and aggravates your pains...frozen toes...charle horse pains in legs...all hell breaks loose...” — Patient testimonial; “electric tingles...I’m limping...” — Patient testimonial; “almost a burning sensation...twitching in my calf muscles...” — Patient testimonial; “I turned my HF10 off and the overstimulation subsided about 6 hours later”; “goes away in a few hours” after turning off the device — Patient testimonial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-427879860144",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.8,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.348+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a20d54e-14ff-48ee-8dec-756fc651455e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.348+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "62214c1b-5ddd-44be-8cb9-40763bf577f9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.348+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "68b66e78-750e-4b88-952d-663c6604d25b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 36,
      "type": "tension",
      "title": "The slide uses a 'villain' framing technique by aggregating negative user experiences to undermine the company's product claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 32,
        "componentCount": 6,
        "textChars": 486,
        "nDataPoints": 0,
        "notes": "The slide uses a 'villain' framing technique by aggregating negative user experiences to undermine the company's product claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:29.193+00",
          "seconds": 2.451,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/36",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-36",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One person described it “as if I am being branded” “at least 2-3 times per week” which he appears to blame for sudden-onset leg paralysis and 3 falls.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-d822383c3504",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.62,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "image",
          "text": "Collection of Facebook group post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c8524e94-6bf5-4ec9-85fb-c78c5fa2f79f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "High frequency stimulation rapidly drains the battery, requiring daily recharging, and patients report heating and burning at the battery site as they re-charge...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c10eee43-d655-4da2-aeef-6a2e84f7195b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“as if I am being branded” “at least 2-3 times per week” — Patient",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:23+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-df6424f758e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.75,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b345559-0548-49d6-b50b-65b15c045e55",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.25,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:29.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98f07f14-23ef-4c5b-abfc-8ba23530535c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "51c27fc8-3404-4bdc-a47e-42d53ca53b74",
          "evidence": "Aggregating negative user testimonials to expose product failure and potential company misrepresentation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:29.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 36,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 37,
      "type": "tension",
      "title": "Uses graphic imagery and patient testimonials to frame the company's product as dangerous and the medical practice as profit-driven.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 63,
        "componentCount": 8,
        "textChars": 941,
        "nDataPoints": 0,
        "notes": "Uses graphic imagery and patient testimonials to frame the company's product as dangerous and the medical practice as profit-driven.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:34.098+00",
          "seconds": 7.286,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/37",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-37",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.3,
            "x": 0.64,
            "y": 0.325
          },
          "kind": "callout",
          "text": "Patient asked if others had similar experiences, to which a number said yes",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ac2a46d-6431-456e-a4c6-ec267e2089d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.9,
            "w": 0.58,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "image",
          "text": "Patient photos of surgical sites",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "254bcd1f-2e9b-4d58-bd64-393fbc1edfad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.3,
            "x": 0.64,
            "y": 0.4
          },
          "kind": "list",
          "text": "Patient testimonials from Facebook groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7e93d94-08d3-4d3a-8b1f-40fba7ac5db8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Heating and burning at the battery site appear to cause holes, boils, infections, indicated in pictures in Nevro FB groups. A patient recently posted pictures to show the progression, asking if anyone else had their “battery causing you pain and looking like this?” – to which a number said yes. Note the two batteries protruding in her back – evidence of doctors implanting “one stimulator and then another and another” to make money (p.230-232).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c388de89-61ba-4c4e-87d4-4f89ecbe6fd9",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I was wondering if anyone has had any issues with you battery causing you pain and looking like this? This one on the right has been replaced and relocated 3 times ,the one on the left no problems at all.that boil like thing has popped up as well.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-1c3ea4bad150",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94c53643-ca2c-4b5d-a71c-f3ca36a694e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a02e752f-d44b-4a45-b87c-95f8214409a2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "17078247-a9cb-4c22-985d-1864fad622c6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "16ac1ecb-c468-4e5b-afc1-94f4feae9dbb",
          "evidence": "Frames the company as causing physical harm to patients for profit.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:34.098+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 37,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 38,
      "type": "tension",
      "title": "The slide uses anecdotal evidence (patient social media posts) to frame the company's product as a 'hustle' or 'quackery'.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 11,
        "textChars": 1395,
        "nDataPoints": 0,
        "notes": "The slide uses anecdotal evidence (patient social media posts) to frame the company's product as a 'hustle' or 'quackery'.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:30.624+00",
          "seconds": 3.602,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/38",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-38",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The sense one gets from Facebook posts is not of HF10 programming as a scientific process, but of something akin to shamanism, divination, or witchcraft – in other words, quackery or a hustle.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-f5b342a8b5ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "image",
          "text": "Facebook post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af300ec4-32ab-477d-8b12-a36595758ec2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "Aside from \"overstimulation\" and burning, patients detail endless reprogramming cycles in futile attempts to get the device to work... The sense one gets from Facebook posts is not of HF10 programming as a scientific process, but of something akin to shamanism, divination, or witchcraft – in other words, quackery or a hustle.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6aedf5cb-7789-4781-9fef-78f7515a261e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.2,
            "x": 0.51,
            "y": 0.42
          },
          "kind": "quote",
          "text": "...it's been nothing but having it reprogrammed...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "39c5f7e4-99cb-4277-b48e-a0b6a19c95ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.74,
            "y": 0.42
          },
          "kind": "quote",
          "text": "...have had my nevro a year now and going for my third reprogramming...I know it takes a while to get it right but why???? Thinking of getting mine removed...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a86b77f-4526-472e-a4f0-58b188da5c1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.28,
            "y": 0.42
          },
          "kind": "quote",
          "text": "lost count of all the reprogramming...my pain doc is agreeing with me that it isn't going to ever work....my life was pretty much ruined by the implant as the pain was worse afterwards...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92a0b8e0-f862-4ec8-9df4-f667c16c6fec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.2,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "quote",
          "text": "onto my 7th reprogramming...still not much improvement at all...like a double edged sword every time I get reprogrammed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6654ba5-48c3-4c0e-a6c0-9d24a4742741",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "onto my 7th reprogramming...still not much improvement at all...since my last reprogramming, nothing improved and was worse due to overstimulation...like a double edged sword every time I get reprogrammed — Nevro HF10 Support Group Member",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:24+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b338-fb9f545430fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.8,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "72042e2d-6712-4313-829c-71cb3328ce5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a146b5c1-74b0-4de0-931c-82f50a86c97b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1bde726-1032-4462-8dac-d0b795f18ccf",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d0705c81-6cf3-4f2a-9839-86ba9a95cbf7",
          "evidence": "The slide explicitly frames the company's business model as a 'hustle' and 'billing fraud' using anecdotal evidence.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:30.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 38,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 39,
      "type": "tension",
      "title": "The slide uses screenshots of Facebook posts to build a narrative of corporate negligence and product failure.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 5,
        "textChars": 315,
        "nDataPoints": 0,
        "notes": "The slide uses screenshots of Facebook posts to build a narrative of corporate negligence and product failure.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:44.183+00",
          "seconds": 15.393,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/39",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-39",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.55,
            "w": 0.9,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "image",
          "text": "Collection of Facebook post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e2899051-d74b-477c-9627-b641ee0a159d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We add two final pages of Facebook posts that leave little doubt as to why Nevro has an explants crisis, merits an FDA recall, and echoes Nuvectra before its sudden implosion...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a4f25924-5615-4e49-a8b1-e5412578b407",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aa0e86ae-cc34-4bf4-bd68-cfbc35327c6e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ab21af62-e377-42be-8dd5-6f21726cd52f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20fd67a8-7b63-41cf-998b-0997a854f243",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "702065e4-237d-498b-b38a-6af32c18c164",
          "evidence": "Uses anecdotal social media evidence to allege corporate misconduct and product failure.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:44.183+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 39,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 40,
      "type": "evidence",
      "title": "The slide uses anecdotal evidence from Facebook support groups to build a negative narrative about the company's product performance.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "sparse",
        "densityScore": 20,
        "componentCount": 5,
        "textChars": 327,
        "nDataPoints": 0,
        "notes": "The slide uses anecdotal evidence from Facebook support groups to build a negative narrative about the company's product performance.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:33.431+00",
          "seconds": 5.394,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/40",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-40",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.58,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "image",
          "text": "Collage of Facebook post screenshots",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "54bb7202-8f77-4971-a95b-d6a09e45f337",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We were simply amazed at the number of patients indicating that they turned off Nevro's device, sometimes years ago, without even explanting it. Many said they wish they'd never heard of it...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b88f2cb7-dd76-4a9c-9f6d-72843a7886d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.75,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Nevro Facebook supports groups",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cf644cbc-d44b-4ead-ba24-cad818bef124",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.23,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db16dc7c-5f84-4ff9-8977-5498a7b806c9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.431+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c369f63-a861-4f40-aad5-1246eb0772d4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 41,
      "type": "setup",
      "title": "The slide uses a combination of analyst commentary and a direct testimonial to frame the company as a 'one-trick pony' in decline.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 71,
        "componentCount": 7,
        "textChars": 2128,
        "nDataPoints": 2,
        "notes": "The slide uses a combination of analyst commentary and a direct testimonial to frame the company as a 'one-trick pony' in decline.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:31.229+00",
          "seconds": 2.965,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/41",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-41",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We can't figure it out - they continue to do well on Wall Street, but I do not see any movement or any changes here. If anything, they're shrinking here.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-85bb94130de3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "Irrespective of existential risks due to lack of efficacy, explants, and regulatory scrutiny, we expect 2021 to be a disaster for Nevro and a reckoning for the bull case. Consensus expects comical 26% yoy growth...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9b955d67-d6cc-4039-99ff-84e31ae73e20",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "quote",
          "text": "To be honest, we watch their stock and we're like 'What are we missing?' In our market, we don't see a ton of good outcomes. Omnia has really not done anything. We hear rumbling from Caraway [Nevro Chief Medical Officer] that they're researching more indications, and we just don't know how a one-trick pony makes any headway. We can't figure it out - they continue to do well on Wall Street, but I do not see any movement or any changes here. If anything, they're shrinking here. Frankly, there's very little discussion of Nevro at this point at Medtronic, at our national sales meeting. or really any talk about their taking business away. A lot of the reps that they hired away are now either back with Medtronic or have moved on. That's pretty common from what I can tell in territories across the country.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0c5ab78-4489-4c00-b88b-982d79371feb",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“To be honest, we watch their stock and we’re like ‘What are we missing?’ In our market, we don't see a ton of good outcomes. Omnia has really not done anything. We hear rumbling from Caraway [Nevro Chief Medical Officer] that they're researching more indications, and we just don't know how a one-trick pony makes any headway. We can't figure it out - they continue to do well on Wall Street, but I do not see any movement or any changes here. If anything, they're shrinking here. Frankly, there's very little discussion of Nevro at this point at Medtronic, at our national sales meeting. or really any talk about their taking business away. A lot of the reps that they hired away are now either back with Medtronic or have moved on. That's pretty common from what I can tell in territories across the country.” — Longtime Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-88bf126b9e94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75c9bae9-1bbd-423e-b198-8f169b153312",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cfa1cb54-a48a-4f47-90c9-b40ec0e2d3b4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "1. Introduction to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f2ef63e-fd2e-4522-8024-8a7cca1a518f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ac7b90a6-4fef-4068-aa5b-ff424990ac82",
          "evidence": "The slide frames Nevro as a failing entity ('disaster', 'reckoning', 'one-trick pony') to be dismantled by the activist.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:31.229+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 41,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 42,
      "type": "setup",
      "title": "The slide uses strong, accusatory language typical of activist short reports.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 7,
        "textChars": 1159,
        "nDataPoints": 0,
        "notes": "The slide uses strong, accusatory language typical of activist short reports.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.372+00",
          "seconds": 3.99,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/42",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-42",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We summarize the key findings of each chapter that follows, which lead us to conclude that the bull case – centered on a turnaround and return to growth – is misguided, and that Nevro faces existential risks which the market has failed to appreciate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-c8e700ed94d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.9,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "list",
          "text": "The SENZA-RCT pivotal trial, the foundation upon which Nevro’s entire high frequency gimmick is built, was so distorted by cherry-picking, patient manipulation, and other red flags that ex-employees and KOL’s described it as essentially a fraud to get FDA approval",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aed326ee-2d8c-4f34-86a7-0f6915e8b06e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "list",
          "text": "We researched each of the key claims underpinning the bull case and conclude that they lack credibility and reflect deep investor misunderstanding of Nevro’s product, market, business practices, and prospects.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3abfd2d-9584-4384-ad64-6ee25b06d73c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We summarize the key findings of each chapter that follows, which lead us to conclude that the bull case – centered on a turnaround and return to growth – is misguided, and that Nevro faces existential risks which the market has failed to appreciate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac609e45-8c1a-4473-a8a3-5491e21a14cb",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "A KOL stated that Nevro \"has always played a lot of games\" with another adding the study was \"rigged\" and not reproducible.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-cd4c17f1255d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24ee83b6-32f8-4fe2-a3a2-59142871096b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9cc1eb79-80bc-4b3f-9c6a-ddda021ef73d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "94dfb25e-155e-4d9b-b77f-fdd6c8982189",
          "evidence": "The slide explicitly frames the company's clinical trial as a 'fraud' and 'sham' to undermine the investment thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:32.372+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 42,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 43,
      "type": "tension",
      "title": "The slide uses a strong 'expose contradiction' narrative, contrasting company claims with KOL interviews and clinical studies.",
      "function": "expose_contradiction",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 6,
        "textChars": 730,
        "nDataPoints": 0,
        "notes": "The slide uses a strong 'expose contradiction' narrative, contrasting company claims with KOL interviews and clinical studies.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:35.083+00",
          "seconds": 6.679,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/43",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-43",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Contrary to the astonishing SENZA study data showing nearly twice the efficacy of traditional low-frequency stimulation, high frequency was quickly proven to be the exact opposite: a phony premise.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-71cdff5b9b89",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "paragraph",
          "text": "Far worse than just being clinically undifferentiated and me-too, high frequency was instead a fatal flaw, undermining Nevro's growth as the honeymoon period from its 2015 launch began to fade by 2017/2018...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8d419e12-8cd1-42b5-921f-c6816b592427",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "Contrary to the astonishing SENZA study data showing nearly twice the efficacy of traditional low-frequency stimulation, high frequency was quickly proven to be the exact opposite: a phony premise...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ea05acb7-6f64-4ce1-91b1-16948c381e0f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "They’re all the same. It’s like buying a car. — Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-74050a34bc0a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d2b8a94-0fa8-4e37-be97-d2a8cb5d4b60",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9991e07c-74ac-4fa2-92fe-467cc4e66525",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "87ed8180-aade-4de3-9b32-a6b745e35a93",
          "evidence": "The slide systematically dismantles the company's core value proposition using clinical evidence and expert testimony.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:35.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 43,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 44,
      "type": "resolution",
      "title": "This slide is part of an activist short report, focusing on product failure and management deception.",
      "function": "summarize",
      "rawType": "key_takeaways",
      "block": null,
      "metadata": {
        "slideType": "key_takeaways",
        "slideTypeCanon": {
          "name": "Key takeaways",
          "slug": "key_takeaways",
          "status": "active",
          "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 6,
        "textChars": 1538,
        "nDataPoints": 4,
        "notes": "This slide is part of an activist short report, focusing on product failure and management deception.",
        "elementsJson": [
          "bullet_list",
          "paragraph"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:35.756+00",
          "seconds": 7.073,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/44",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-44",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "With a sham pivotal trial and its sole product based on a false theory, reality predictably dawned as Nevro soon faced a device failure crisis leading to its stimulators being surgically removed (“explanted”) in droves.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-9f36ff5bc646",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.4,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "list",
          "text": "Explant crisis and cover-up: details on high failure rates, conflicting data, and alleged retaliation against doctors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.756+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0fda0496-9115-4d32-9d7a-47b6335dac9a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "list",
          "text": "High frequency is a fatal flaw (cont'd): details on battery drain, programming burden, and management conflict.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.756+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "11805162-6636-4cd6-bb87-0040d21e854b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“paresthesia-free” has backfired and resulted in a patient/doctor support infrastructure that renders the business model broken and permanently unprofitable. — Ex-executives. “paresthesia-free” is a fatally flawed concept and that he observed over half of patients failing to improve and virtually all experiencing lack of efficacy at various times. — Former regional sales director. Nevro found itself “in a bind” with the CEO and management refusing to accept that high frequency is a dud, leading to conflict with the field and sales reps leaving “in droves” despite the best compensation in the industry. — Former regional sales director. “despite repeated reprogramming sessions in the effort to achieve therapeutic optimization” — A January 2020 paper at the annual neuromodulation meeting (NANS). “differ greatly from the results we have found in real world practice.” — A January 2020 paper at the annual neuromodulation meeting (NANS). “disinformation” regarding explants, labeling Nevro’s conduct as “slimy.” — A KOL.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-a23e8a27ec0e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.756+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c7768cd4-4baf-42b3-b1e6-389025e38d88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.756+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6156d1a3-dfc2-442e-835c-b567720d94f3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "08c884b9-a93c-49e8-b40f-95fb5c4d10b0",
          "evidence": "The slide systematically presents evidence of product failure and management deception to support a short thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:35.756+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 44,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 45,
      "type": "setup",
      "title": "This is an activist short-seller report slide. It uses anecdotal evidence from KOLs to build a narrative of systemic failure.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 84,
        "componentCount": 10,
        "textChars": 1184,
        "nDataPoints": 6,
        "notes": "This is an activist short-seller report slide. It uses anecdotal evidence from KOLs to build a narrative of systemic failure.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:36.554+00",
          "seconds": 7.765,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/45",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-45",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Widespread lack of efficacy and explants, on top of other flaws unique to Nevro’s device, are the primary driver of Nevro’s ongoing collapse.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-b6ec0ea02d72",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.86,
            "x": 0.08,
            "y": 0.31
          },
          "kind": "list",
          "text": "Case study #1: A high volume implanter described his initial experience as “almost miraculous,” only to sour after seeing rampant failures within 3-6 months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1226ca94-66b2-4dc0-8d9b-fe6925bbf620",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.08,
            "y": 0.49
          },
          "kind": "list",
          "text": "Case study #3: One of the most prominent KOL’s in the field... described his initial enthusiasm for Nevro’s device only to see 75% of patients experience a quick collapse in efficacy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "58af6291-8a97-492b-9e02-e7d64ad9f6bc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.86,
            "x": 0.08,
            "y": 0.72
          },
          "kind": "list",
          "text": "Case study #4: A fourth KOL corroborated the accuracy of these accounts based on his conversations with “hundreds of physicians”...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "71aa6773-49c4-4670-ab02-9404e7de1e2c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.86,
            "x": 0.08,
            "y": 0.8
          },
          "kind": "list",
          "text": "Case study #5: A fifth KOL, who spent time with Nevro’s CEO, began as “a 100% Nevro believer,” followed by rapid device failures and explants...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7ede43c-639e-4843-b4aa-ff01a72d10e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.86,
            "x": 0.08,
            "y": 0.41
          },
          "kind": "list",
          "text": "Case study #2: A second KOL was also initially impressed with Nevro’s data, only to see patients fail “like clockwork.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb68b80c-844f-4741-9978-eaa77a8c8370",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "The 33% explant rate in the NANS paper was corroborated by one KOL after another during our 20+ interviews... We share five detailed case studies of KOL's we interviewed...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0aa04092-4931-48e9-8733-8a5b816c3b46",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Nevro simply “can’t be used, based on the problems we’re seeing.” — KOL #4",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-b95c19accbde",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5c86460-d844-4f60-93fc-71bb499533b8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7bd6ef0-6162-4a4e-b990-5bfb8b1f6166",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b22791fc-ca9f-4624-8c1a-53241306ed67",
          "evidence": "The slide frames Nevro as the antagonist through negative KOL testimonials.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:36.554+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 45,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 46,
      "type": "setup",
      "title": "This slide uses strong, accusatory language typical of activist short-seller reports to frame the company's culture and market position.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 7,
        "textChars": 1594,
        "nDataPoints": 2,
        "notes": "This slide uses strong, accusatory language typical of activist short-seller reports to frame the company's culture and market position.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.09+00",
          "seconds": 3.207,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/46",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-46",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and attempts to manipulate and pressure doctors and patients into believing the device works – behavior suggestive to us of a company sitting on an explosive, existential secret.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-dc4a85389091",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.86,
            "x": 0.08,
            "y": 0.76
          },
          "kind": "list",
          "text": "High volume implanters, who drive 90% of the industry's volume, have soured on Nevro and moved on.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46f35c08-d3ee-4404-ac0c-17a09e6151be",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.86,
            "x": 0.08,
            "y": 0.22
          },
          "kind": "list",
          "text": "In disturbing contrast to prominent KOL's, the Nevro consultants/speakers we spoke to refused to acknowledge the existence of any explants... The second Nevro-aligned KOL claimed to have only one explant out of hundreds... The more credible implanters we interviewed stated their belief that Nevro is aware of its explant problem... Others reported retaliatory behavior... We presume Nevro will supply the sell-side with doctors who deny any explants problem... Our research interviews revealed a hidden dynamic behind some Nevro implanters claiming they don't have explants: they're simply unaware...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "804e42a9-76a7-4014-927c-24e4058242cf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "paragraph",
          "text": "In the aftermath of a 1) sham study, 2) a phony high-frequency premise, and 3) rampant explants, KOL's, former executives, and competitors indicated where Nevro finds itself now - a one-trick pony crippled in a ditch - in contrast to investors who believe it's on the cusp of a rebound.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d02562d-4d10-47f6-96b4-f83832f03e19",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and attempts to manipulate and pressure doctors and patients into believing the device works – behavior suggestive to us of a company sitting on an explosive, existential secret.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56477d4a-68b4-4a5e-ad70-d5ebd86fd696",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "31b2e057-de4f-4788-962a-4398bc1dabf8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ccc0901-b62a-4def-b9e1-9e28054e6c57",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "1a8d8051-cf35-43ae-a5e2-59d9c3c1c377",
          "evidence": "The slide systematically lists allegations of corporate deception, cover-ups, and falsified data to build a case for a short position.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:32.09+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 46,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 47,
      "type": "setup",
      "title": "This slide uses qualitative evidence from KOLs and ex-employees to build a narrative of corporate failure.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 43,
        "componentCount": 6,
        "textChars": 847,
        "nDataPoints": 0,
        "notes": "This slide uses qualitative evidence from KOLs and ex-employees to build a narrative of corporate failure.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:31.524+00",
          "seconds": 2.701,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/47",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-47",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The centerpiece of Nevro's turnaround plan – the Omnia stimulator launched in Nov 2019 – is a Hail Mary and colossal flop that has not only failed to re-ignite growth but undermined the high frequency/HF10 message that Nevro has pushed for a decade.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-edc1bf23a65f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "list",
          "text": "Nevro's current predicament - a one-trick pony stuck in a ditch - and drivers of its ongoing growth collapse (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "289b81fa-edc4-428b-909b-864ff8742233",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.64
          },
          "kind": "list",
          "text": "The centerpiece of Nevro's turnaround plan - the Omnia stimulator launched in Nov 2019 - is a Hail Mary and colossal flop that has not only failed to re-ignite growth but undermined the high frequency/HF10 message that Nevro has pushed for a decade.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "290b6825-5327-4ca8-88bd-11e72da2daa8",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Nevro was \"the first kid on the block\" with paresthesia-free but doctors who \"were enthralled with Nevro are not as enthralled\" now. — Former high-volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:25+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b339-f077302d8673",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13220a2d-2030-40e7-acd6-3e278f35dfb4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:31.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ccb4b35-d725-4e52-8977-0a3025c5d3dc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4216045a-b4fe-4b92-aab7-e2d7fffd141a",
          "evidence": "The slide uses negative testimonials and internal contradictions to argue for a structural failure in the company's business model.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-05-02 21:26:31.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 47,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 48,
      "type": "tension",
      "title": "The slide uses strong, aggressive language to discredit the company's product claims and growth strategy.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 6,
        "textChars": 1213,
        "nDataPoints": 1,
        "notes": "The slide uses strong, aggressive language to discredit the company's product claims and growth strategy.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.39+00",
          "seconds": 2.846,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/48",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-48",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The centerpiece of Nevro’s turnaround plan – the Omnia stimulator launched in Nov 2019 – is a Hail Mary and colossal flop.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-3c1b0bd8b21f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "list",
          "text": "The centerpiece of Nevro's turnaround plan – the Omnia stimulator launched in Nov 2019 – is a Hail Mary and colossal flop (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5bb91896-7839-4089-939b-a085384ef713",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "list",
          "text": "Painful diabetic neuropathy (PDN) and other new indications that Nevro has recently begun to hype are as unlikely to restart growth or a turnaround as its failed Omnia launch.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "66f1db3f-ee86-4abf-b45c-691cade0e8a7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Omnia is a joke I think to most doctors...even the doctors that were loyal Nevro users.\" — KOL; \"a marketing move\" — Nevro implanter; \"an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device.\" — Former Nevro user; \"window dressing with Grossman\" — Former Nevro executives and sales reps; \"just re-packaging of an old product,\" — Former Nevro executives and sales reps; \"nobody’s going to buy Omnia\" — Former Nevro executives and sales reps; \"a lie.\" — KOL; \"it’s impossible to capture\" — KOL; \"so stupid\" — KOL; \"just dopey.\" — KOL; \"value to Wall Street and no one else.\" — KOL; \"putting lipstick on a pig,\" — KOL; \"smoke and mirrors\" — KOL; \"trying to hoodwink,\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-400401689a5f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3f28226d-67c2-4dec-b1db-f77d4ca016b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.18,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3cc819a1-d673-49ab-9d14-94b447d38a01",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "5fecc442-5c7e-470e-b7ec-1e70c113b903",
          "evidence": "The slide explicitly labels company claims as 'fraudulent narrative', 'a lie', and 'misleading'.",
          "framework": null,
          "confidence": 0.95,
          "extraction": {
            "at": "2026-05-02 20:15:32.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 48,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 49,
      "type": "setup",
      "title": "This is a text-heavy slide summarizing negative findings from expert interviews (KOLs and former executives).",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 40,
        "componentCount": 6,
        "textChars": 728,
        "nDataPoints": 0,
        "notes": "This is a text-heavy slide summarizing negative findings from expert interviews (KOLs and former executives).",
        "elementsJson": [
          "bullet_list",
          "paragraph"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:31.781+00",
          "seconds": 2.177,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/49",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-49",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "With Omnia a flop and PDN a mirage, we expect investors betting on a Keith Grossman-driven turnaround to shortly face a rude awakening.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-14c5cf056a15",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "list",
          "text": "With Omnia a flop and PDN a mirage, we expect investors betting on a Keith Grossman-driven turnaround to shortly face a rude awakening.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.781+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ddfb025-0271-444f-97bd-737b3a1780df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "list",
          "text": "Painful diabetic neuropathy (PDN) and other new indications are unlikely to re-start growth or a turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.781+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "87faa294-ce79-4ecc-8ba9-f03137c274cc",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"In the 1980's, half of the patients we implanted with stimulators were for PDN.\" — High volume Nevro user; \"I don't believe anything they say...every Nevro study is the same.\" — KOL; \"I think they're lying.\" — KOL; \"no long term plan there,\" — Former executives regarding Keith Grossman.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-1884d3c73de3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.781+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e8e081e4-9067-4dd2-9930-821d37576ab5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:31.781+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ec04d1d-e8e6-49bb-9ccc-b801b1d0d613",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 50,
      "type": "setup",
      "title": "The slide uses anecdotal evidence from former executives to build a bearish case against Nevro's turnaround and acquisition potential.",
      "function": "summarize",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 34,
        "componentCount": 5,
        "textChars": 640,
        "nDataPoints": 1,
        "notes": "The slide uses anecdotal evidence from former executives to build a bearish case against Nevro's turnaround and acquisition potential.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:34.543+00",
          "seconds": 4.744,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/50",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-50",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Investors betting on a Keith Grossman-driven turnaround will shortly realize that the emperor has no clothes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-03e1b7ae0e5e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.75,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "list",
          "text": "Investors betting on a Keith Grossman-driven turnaround will shortly realize that the emperor has no clothes (cont'd)...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6e52af4-c235-48e7-b949-984ac6c6a30b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "One former executive stated he is “very underwhelmed” at Grossman’s efforts, which he called “window-dressing,” indicating Nevro has “boxed themselves into a corner and now they’ll die of a thousand cuts.” — Former Executive. “Grossman doesn’t have a strategy,” — Longtime C-level executive. “I would not invest in Nevro today.” — Former Executive.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-05c2aa2d11e4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d620809c-1f9f-46ea-97d1-6cea760167ab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:34.543+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c64814d6-c337-4651-bd27-b4f18ddc64f9",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 50,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 21,
          "name": "The Struggle",
          "beatId": "88afdd76-4cd8-403f-9d7e-4634fdd1d420",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Struggle",
            "slug": "overcoming-monster-the-struggle",
            "status": "active",
            "canonId": "019dd9b8-3d24-71b1-9262-9a8f9850fda3",
            "version": 1,
            "description": null
          },
          "evidence": "The deck details the struggles faced by Nevro's patients and the company's response",
          "position": 1,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Development",
            "slug": "development",
            "status": "active",
            "canonId": "019dd9b8-0332-7008-b3aa-11b0840a57b1",
            "version": 1,
            "description": "The middle stretch in arcs that have one. Often where length problems creep in."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 51,
      "type": "resolution",
      "title": "This slide uses aggressive, activist-style language to frame Nevro as a failing company and Saluda as a disruptive competitor.",
      "function": "summarize",
      "rawType": "key_takeaways",
      "block": null,
      "metadata": {
        "slideType": "key_takeaways",
        "slideTypeCanon": {
          "name": "Key takeaways",
          "slug": "key_takeaways",
          "status": "active",
          "canonId": "019de52d-06e7-7674-a891-9f7de3b11b6d",
          "version": 1,
          "description": null
        },
        "function": "summarize",
        "functionCanon": {
          "name": "Summarize",
          "slug": "summarize",
          "status": "active",
          "canonId": "019de52d-1541-704f-b86f-bf7b75056373",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 90,
        "componentCount": 12,
        "textChars": 1873,
        "nDataPoints": 1,
        "notes": "This slide uses aggressive, activist-style language to frame Nevro as a failing company and Saluda as a disruptive competitor.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:33.931+00",
          "seconds": 4.077,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/51",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-51",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The launch of Saluda Medical’s “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-14dcd0f3367f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "The launch of Saluda Medical's “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2b4064fa-fb12-4915-be0b-ae9f5dca3e1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.64
          },
          "kind": "list",
          "text": "The superlatives used by KOL's, including high-volume Nevro implanters, when we asked about Saluda suggest an impending fervor and reinforce the severity of the threat.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34695e00-0331-4900-9390-694c2a07128d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.17
          },
          "kind": "list",
          "text": "A longtime C-level executive in the spinal cord stimulator space provided an equally devastating assessment of Nevro's M&A prospects.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37e9c613-1240-437b-ba84-bcbc964c8403",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.08,
            "y": 0.73
          },
          "kind": "list",
          "text": "Industry executives and KOL's stated that Saluda has locked up the most influential KOL's, whose control and leverage over papers, conferences, and other doctors ensures that Saluda will drive substantial conversion to its device.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b1379c3-89d2-42cd-b8cc-dc22ee5b6009",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.08,
            "y": 0.57
          },
          "kind": "list",
          "text": "A Nevro ex-executive stated that Nevro is the most vulnerable among SCS players to Saluda, given that it attracted a fickle implanter base that quickly bounces to the next hot launch.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "671fc9c9-2aaf-4eb7-bc1e-5662b79b0839",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.48
          },
          "kind": "list",
          "text": "As an ominous sign that share loss may be far worse than this estimate, we note that the authors of Saluda's US study - published earlier this year - are the lead investigator for Nevro's pivotal SENZA trial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d0871c9-8715-42ff-af66-c3d0c4229ffb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.39
          },
          "kind": "list",
          "text": "Interviews with KOL's, Nevro ex-executives/reps, and competitors indicate tremendous enthusiasm and anticipation for Saluda's device, including among some of Nevro's highest volume implanters.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f7e48482-34b7-4df3-bd54-25c1fb3fedf6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Investor hopes of a Nevro acquisition are delusional and misinformed (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65378496-8d4f-40a7-aa59-d21c663c63a1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“is becoming increasingly competitive” — A longtime C-level executive in the spinal cord stimulator space; “never seen anything like it”; “very exciting”; “the best tonic data ever”; “beats Nevro’s data.” — KOLs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-1b1fc4bd6878",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "216944dd-de78-40a6-8e71-94c84b680b80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:33.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27ce227e-d3ca-467c-94ce-80a2dbbec5b0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "AIDA Model",
            "slug": "aida-model",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-86fc-773c-813f-d416714b8413",
            "version": 1,
            "bodyDocId": null,
            "description": "Attention, Interest, Desire, Action - classic persuasion sequence",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "b2d9a3f9-18d2-4b43-afc4-5766bc892f5c",
          "evidence": "The launch of Saluda Medical’s “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:32.537774+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 51,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Call to action",
            "slug": "call-to-action",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4bbb-702a-9ead-82daf188bb7c",
            "version": 1,
            "bodyDocId": null,
            "description": "Explicit prescription of what the audience should do next.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "fab8ba74-81f5-49fb-94cf-0cef45c03065",
          "evidence": "The launch of Saluda Medical’s “closed loop” spinal cord stimulator – supported by the best pain relief data ever published in the space - is an impending disruptive threat to Nevro within 6 to 12 months.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:32.569937+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 51,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 52,
      "type": "analysis",
      "title": "The slide uses strong, accusatory language typical of activist short reports to frame the company's business model as fundamentally broken.",
      "function": "diagnose_problem",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "diagnose_problem",
        "functionCanon": {
          "name": "Diagnose problem",
          "slug": "diagnose_problem",
          "status": "active",
          "canonId": "019de52d-176d-761f-b608-cf52262d2ab2",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 39,
        "componentCount": 5,
        "textChars": 780,
        "nDataPoints": 2,
        "notes": "The slide uses strong, accusatory language typical of activist short reports to frame the company's business model as fundamentally broken.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:32.485+00",
          "seconds": 2.311,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/52",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-52",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The price war is yet another nail in the coffin of Nevro’s illusory turnaround and acquisition prospects.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-6513eb4471f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.8,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "list",
          "text": "A critical driver of Nevro’s ongoing growth collapse is price pressure and discounting... The SCS market growth story pushed by Nevro and Wall Street is false and undermined by escalating payor backlash.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.485+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2990c9c7-54ca-48da-822e-558f3b824d52",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“discounting is part of Nevro’s approach now” — Former Nevro executive; “a stupid move”; “one of the dumbest moves you could ever make.” — Ex-executive; “drastically” cut pricing... “cutting off your nose to spite your face” — Competitor; “Nevro really wins this”... “it’s a price war because none of the stim companies have created great customers.” — Ex-Nevro executive; “the hardest it has ever been” — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-688eaa9128f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.485+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "55e3677f-f2be-4c10-a5ef-7f18778318a6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:32.485+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e24c8f7e-6ce6-4ea0-a0a9-b9955090b26c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Executive summary",
            "slug": "executive-summary",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4b63-72d5-9734-da757d91ca61",
            "version": 1,
            "bodyDocId": null,
            "description": "A condensed view of the entire argument on a single slide / block.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "436ea900-b7a1-44f5-b8b3-95a8ea4bf6d4",
          "evidence": "Summary of key findings",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-16 23:09:32.635205+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 52,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "bb3febbc-16ba-4173-a8fb-238365126cf9",
          "evidence": "The slide explicitly claims 'data fabrication' and 'false' market growth stories to expose the company's narrative.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:32.485+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 52,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 53,
      "type": "tension",
      "title": "The slide uses strong, accusatory language to frame the company's business model as legally compromised.",
      "function": "expose_contradiction",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 50,
        "componentCount": 6,
        "textChars": 908,
        "nDataPoints": 2,
        "notes": "The slide uses strong, accusatory language to frame the company's business model as legally compromised.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:33.366+00",
          "seconds": 3.122,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/53",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-53",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business hinges on kickbacks to high-volume implanters, who otherwise would have stopped using its HF10 technology due to lack of efficacy and explants.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-2b4c21b09174",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "Bullet points detailing DOJ fraud alerts, CMS OpenPayments data, former executive testimony, and allegations of bribery in Europe.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.366+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fbcb5a8f-e9e5-46d4-ae38-f10e3f747783",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "We believe that Nevro’s business hinges on kickbacks to high-volume implanters... In our opinion, based upon research we detail, Nevro’s payments to doctors are inducements and blatant violations of the anti-kickback statute...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.366+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3552184-56d6-44a9-b68b-00964f3271f5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“they’ll throw a lot of money your way” or “it’s basically like a reward system.” — Former Nevro executives and KOLs; “everyone knows” — Former Nevro executive; “100%” — Former Nevro consultant; “their whore for California,” “a guy who takes money,” “borderline unethical,” “coin-operated.” — KOLs and executives",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-2e94963c4909",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.366+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2579bc3-d8c2-4428-afd8-510b62bced56",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:33.366+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d58c864-9aeb-4805-bce3-04c6229883d6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "0274d216-94f8-4ae1-be2f-bdea23bc03d6",
          "evidence": "The slide systematically presents evidence of alleged illegal kickbacks and bribery to expose corporate fraud.",
          "framework": null,
          "confidence": 0.95,
          "extraction": {
            "at": "2026-05-02 20:15:33.366+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 53,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 54,
      "type": "analysis",
      "title": "This is a classic activist short-seller slide designed to frame the company's business model as inherently fraudulent and legally precarious.",
      "function": "diagnose_problem",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "diagnose_problem",
        "functionCanon": {
          "name": "Diagnose problem",
          "slug": "diagnose_problem",
          "status": "active",
          "canonId": "019de52d-176d-761f-b608-cf52262d2ab2",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 34,
        "componentCount": 5,
        "textChars": 628,
        "nDataPoints": 2,
        "notes": "This is a classic activist short-seller slide designed to frame the company's business model as inherently fraudulent and legally precarious.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "paragraph"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:35.064+00",
          "seconds": 4.801,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/54",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-54",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Investors are oblivious to one of Nevro’s greatest risks: its business model, far more than any other stimulator company, is predicated in our opinion on reps and other employees engaging in the unauthorized practice of medicine.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-acb1ea36dd71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.8,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Numerous Nevro former executives, sales reps, and KOL's described over-utilization, unnecessary implants, and the exploitation of patients – particularly the psychiatrically vulnerable - as key drivers of the spinal cord stimulation business...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.064+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da9ab70a-fcdb-4b08-bfd4-485720926132",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "the rep is kind of an extension of your practice. — One of Nevro’s highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-b0ce1d30cd80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.064+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4db56a8-e7b3-458c-8374-ecfe51d8de8f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.064+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd502105-dc90-4f5d-be51-9e32c39a9089",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b81150c2-431e-47fc-9c67-19c292a064ae",
          "evidence": "The slide systematically lists allegations of illegal/unethical conduct to build a case for regulatory or legal risk.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:35.064+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 54,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 55,
      "type": "tension",
      "title": "This slide focuses on the legal/ethical risk of reps performing clinical duties.",
      "function": "expose_contradiction",
      "rawType": "executive_summary",
      "block": null,
      "metadata": {
        "slideType": "executive_summary",
        "slideTypeCanon": {
          "name": "Executive summary",
          "slug": "executive_summary",
          "status": "active",
          "canonId": "019de52d-06be-73ff-81b3-f99fe7f0025e",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 9,
        "textChars": 1934,
        "nDataPoints": 0,
        "notes": "This slide focuses on the legal/ethical risk of reps performing clinical duties.",
        "elementsJson": [
          "headline_text",
          "bullet_list"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:35.881+00",
          "seconds": 4.711,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/55",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-55",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s business model is predicated in our opinion on reps and other employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-527d8cd7c5ba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.09,
            "y": 0.46
          },
          "kind": "list",
          "text": "The second ex-executive stated that Nevro's reps and clinical specialists are “not health care providers in any way, shape, or form” but are “responsible for the care of patients.” He added that patients would be “pretty concerned” if they knew the credentials of these employees.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3cfe0887-d79e-4302-9dfe-56b893c60746",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.09,
            "y": 0.19
          },
          "kind": "list",
          "text": "Another of Nevro's highest volume implanters stated that he simply outsources patient care to reps if they still have pain. He stated that reps use x-rays to diagnose the patient and to re-program the device, and that if the rep fails, that a central call center – the “Therapy Optimization Team” – takes over.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6637c43a-7fcd-4ea2-8d53-d0340efd8579",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.09,
            "y": 0.38
          },
          "kind": "list",
          "text": "Two former Nevro executives detailed why “reps engaging in the practice of medicine has always been the concern,” suggesting that the risk is well-known inside the company. One stated that programming their device is so time intensive that its entire value proposition and business model are predicated on doctors outsourcing patient care to Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6e3b4287-5ca3-4aa3-98e7-4a01483d61ef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "list",
          "text": "Nevro's business model is predicated in our opinion on reps and other employees engaging in the unauthorized practice of medicine (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af9dafb4-9ed1-4e5b-8d90-73ed9dec62c9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.85,
            "x": 0.09,
            "y": 0.27
          },
          "kind": "list",
          "text": "A former Nevro executive described the role of the central team – and that of reps generally – in a manner we believe to be identical to the practice of medicine: having “a list of patients they were in charge of”; “high patient contact”; using trial and error to determine and direct the correct dosage of stimulation – we note that dosage goes to the heart of practicing medicine.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8137f89-ca2e-4a87-85ca-e05ad4942a75",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“a list of patients they were in charge of”; “high patient contact”; “reps engaging in the practice of medicine has always been the concern,”; “not health care providers in any way, shape, or form”; “responsible for the care of patients.”; “pretty concerned” — Former Nevro executives",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:26+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-577abd170337",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05294c1c-e13b-4d3d-a00c-6f2a0126da38",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "2. Summary of key findings",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "967b9699-45d0-4607-be08-e247d6c2a3ac",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e28af46e-993b-4a32-9627-59e187bb2f78",
          "evidence": "The slide explicitly frames the business model as predicated on unauthorized practice of medicine, a common activist short thesis.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:35.881+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 55,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 56,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize the specific claims being challenged.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 8,
        "textChars": 921,
        "nDataPoints": 8,
        "notes": "The slide uses yellow highlighting to emphasize the specific claims being challenged.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:35.387+00",
          "seconds": 4.153,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/56",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-56",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The SENZA-RCT pivotal trial is the foundation upon which Nevro's high frequency gimmick is built.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-7b81d7fff1b2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.9,
            "x": 0.05,
            "y": 0.43
          },
          "kind": "list",
          "text": "Key highlights of our SENZA-RCT pivotal study are as follows: HF10 therapy was nearly twice as successful... HF10 therapy was 1.5 times as successful... HF10 therapy provided a 69.2% reduction... HF10 therapy provided a 72.8% reduction...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c66d07d-2f4d-4f15-a389-7f44f983184b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The SENZA-RCT pivotal trial is the foundation upon which Nevro's high frequency gimmick is built. The data from this trial enabled the company to claim dramatic superiority versus traditional low-frequency stimulators...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1ce5bc1f-6583-48be-8a3d-b9e010b67795",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“the first pivotal RCT in the history of SCS and the only randomized study with a head-to-head comparison of SCS systems.” — Nevro Corp.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-7ca244819657",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: Press release https://www.nevro.com/...; prospectus https://www.sec.gov/...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9652bbf8-bea5-49c5-9e2c-b75183639382",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c0435cca-940b-4a34-abe9-95da48d03f13",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eff1f713-d364-4060-be5e-385785043cde",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.05,
            "y": 0.38
          },
          "kind": "title",
          "text": "Nevro IPO prospectus",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eb876cbd-319c-4c2f-8d44-37c5104a05a8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f2a6409c-bc59-49c2-bb45-08313547ae1f",
          "evidence": "Contrasts company IPO claims with allegations of fraud.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:35.387+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 56,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 57,
      "type": "tension",
      "title": "The slide uses a combination of academic citation and visual data to frame the study as potentially fraudulent.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 10,
        "textChars": 1414,
        "nDataPoints": 16,
        "notes": "The slide uses a combination of academic citation and visual data to frame the study as potentially fraudulent.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "bar_chart_grouped",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:36.654+00",
          "seconds": 4.927,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/57",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-57",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.18,
            "x": 0.78,
            "y": 0.35
          },
          "kind": "callout",
          "text": "Back pain responder rates of ~80% for HF10 vs. ~50% for traditional SCS",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34e26668-ec3c-4666-87f5-b33dce376a91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.18,
            "x": 0.78,
            "y": 0.65
          },
          "kind": "callout",
          "text": "Leg pain responder rates show roughly similar superiority",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "feff9381-e041-40b9-bbd7-f2c23867a453",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.65,
            "w": 0.28,
            "x": 0.48,
            "y": 0.25
          },
          "kind": "chart",
          "text": "SENZA-RCT 24 month outcomes charts (A and B)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Grouped bar chart",
              "slug": "bar-grouped",
              "status": "active",
              "canonId": "019de52c-ff3b-751e-a8ff-f21ff11097b1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-grouped",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a81f7a2-d783-4bc1-80c5-dae7853c7887",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "responder rates: 80%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-cedff8d6a4af",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "paragraph",
          "text": "SENZA-RCT 24 month outcomes paper\nComparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-Month Results From a Multicenter, Randomized, Controlled Pivotal Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "553a2891-9c44-430f-a661-7165373bd89d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro claims that the SENZA-RCT data showed ongoing, dramatic back and leg pain reduction at longer intervals of 12 and 24 months versus traditional low-frequency stimulators. A Nevro press release touted the paper's selection by the journal Neurosurgery as its “Top Pain Paper of the Year.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae098142-9264-4298-81df-82cf0a79d54c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Nevro claims that the SENZA-RCT data showed ongoing, dramatic back and leg pain reduction at longer intervals of 12 and 24 months versus traditional low-frequency stimulators. A Nevro press release touted the paper's selection by the journal Neurosurgery as its “Top Pain Paper of the Year.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-cb4b1ede57a2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://academic.oup.com/neurosurgery/article/79/5/667/2835700; https://www.nevro.com/English/us/investors/investor-news/investor-news-details/2017/Neurosurgery-Selects-the-SENZA-RCT-24-Month-Outcomes-Publication-as-the-Top-Pain-Paper-of-the-Year/default.aspx.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32d6e1b1-b187-4795-96a1-aad02b35c5c2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f9f6b58-8c0f-4285-850a-25da87f88834",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76b3caa2-2ea2-43b5-b1fd-f12b3ac5b058",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "97a1b477-43bf-4d51-8bd3-8921eb6edc34",
          "evidence": "The slide explicitly frames the study as a 'fraud' and uses data to challenge the company's claims.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:36.654+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 57,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 58,
      "type": "tension",
      "title": "Uses excerpts from a press release and a clinical paper to highlight study design flaws.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 9,
        "textChars": 2027,
        "nDataPoints": 0,
        "notes": "Uses excerpts from a press release and a clinical paper to highlight study design flaws.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:29.724+00",
          "seconds": 3.929,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/58",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-58",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.45,
            "x": 0.49,
            "y": 0.61
          },
          "kind": "callout",
          "text": "As with any clinical trial, there are limitations. Study investigators and subjects were not masked to the assigned treatment group. Subject masking was impractical because low-frequency SCS produces paresthesias, whereas high-frequency SCS does not; thus, the therapies themselves become immediately known to the subjects. Due to the differences in stimulator lead placement, intraoperative testing, and device programming between the treatment groups, the study investigators could not be masked. The effect of the lack of masking in this randomized study is not known; nonetheless, the protocol was based on best practices guidance for comparative efficacy trial designs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1726cbb4-de58-425f-82ed-b3df7f014fe7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "other",
          "text": "Source: https://news.bostonscientific.com/news-releases?item=58980; SENZA-RCT paper https://s24.q4cdn.com/932612397/files/doc_downloads/Comparison_of_10_kHz_High_Frequency_and.97253.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "23b6438f-8ab1-4a71-a3e1-49045072dd1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Red flags in the study design are apparent at the outset, as one might expect in a sham exercise designed to enable an IPO and FDA approval. The study compared Nevro’s new high frequency device against the Boston Scientific Precision Plus - a legacy, low frequency stimulator system launched many years prior in 2007. Notably, the study wasn’t blinded: patients knew whether they were the unlucky ones being implanted with an ancient stimulator or the fortunate few receiving the latest breakthrough.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "description",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f9656130-52e3-4041-884f-55a9f785efde",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.06,
            "y": 0.53
          },
          "kind": "paragraph",
          "text": "SENZA-RCT paper describing comparator arm and study limitations due to lack of patient and investigator blinding",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48eb7300-ef95-4bbf-a217-26a167ff4c38",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "paragraph",
          "text": "Boston Scientific July 2, 2007 press release",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "83ed1506-c3ba-4a9e-90a4-e17c98a5a790",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "paragraph",
          "text": "Boston Scientific Announces Launch of New Precision Plus™ Spinal Cord Stimulation System",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c8c41cce-1398-49e6-b0f3-bfe9c61cb605",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.45,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "paragraph",
          "text": "Subjects were randomized 1:1 to receive stimulation with either an HF10 therapy system (Senza system; Nevro Corp., Redwood City, California) or a commercially available SCS system (Precision Plus system; Boston Scientific, Natick, Massachusetts). Both SCS systems consisted of two 8-contact leads.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f87ece34-1789-41b8-99ae-373ed1bd6998",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eee0d043-8c7b-42c4-8d82-a123b8c7a0c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "917e0a93-aa80-4cc3-bf21-7b59711ece04",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "469e1b07-8db6-4c19-98d9-b802f0c22cf1",
          "evidence": "The slide explicitly frames the clinical trial as a 'sham exercise' and 'fraud' to expose potential corporate misconduct.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:28:29.724+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 58,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 59,
      "type": "tension",
      "title": "The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 8,
        "textChars": 1566,
        "nDataPoints": 0,
        "notes": "The slide uses a visual aid of a standard pain scale to highlight the subjectivity of the clinical trial's primary endpoint.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:36.068+00",
          "seconds": 3.975,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/59",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-59",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The potential for bias and patient manipulation is self-evident as the primary endpoint was based on a patient questionnaire called a “Visual Analog Scale” (VAS).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-e64939c9736f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.5,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "image",
          "text": "Visual Analog Scale (VAS) diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "952b6d5e-c75b-4a82-ab4c-cab780954c12",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The potential for bias and patient manipulation is self-evident as the primary endpoint was based on a patient questionnaire called a “Visual Analog Scale” (VAS). Patients needed to report VAS pain score reductions of 50% to be considered a responder.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1eefc7e0-ca53-47ec-8389-83ad50288cf7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.35,
            "x": 0.6,
            "y": 0.37
          },
          "kind": "quote",
          "text": "“This was all nebulous because pain management and neuromodulation are subjective... The problem is it’s very subjective... There’s a major psychological component, which is why a psychiatric evaluation is required for permanent implant.” – Former Nevro regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0059d302-cd01-45b7-b041-67e43a5407be",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“This was all nebulous because pain management and neuromodulation are subjective. The primary endpoint in the Nevro trials was VAS reductions. The problem is it’s very subjective. Patients’ pain and location can change hour to hour and day to day. It’s such a tough specialty because it’s so nebulous. If the diagnosis is an ACL tear, the surgeon can confirm it with imaging. The problem with chronic pain is that it’s not one specific modality. There’s a major psychological component, which is why a psychiatric evaluation is required for permanent implant.” — Former Nevro regional sales director, head of a large multi-state territory",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-e9017be9c492",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: http://www.ericlinmd.com/back-vas-form.php; expert consultation calls",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4cab1035-7057-4a88-aca6-7db50a702df6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1895527c-2615-482a-ac5a-4a3a936e7f80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "10c35c84-29a6-41b8-9539-92e7cd16cd50",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "9e271d9f-9c93-44de-bf37-89e5352bd2ab",
          "evidence": "The slide explicitly frames the clinical trial as a 'fraud' based on subjective methodology.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:36.068+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 59,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 60,
      "type": "tension",
      "title": "Uses direct quotes to undermine the credibility of the company's primary clinical evidence.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2291,
        "nDataPoints": 0,
        "notes": "Uses direct quotes to undermine the credibility of the company's primary clinical evidence.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:37.506+00",
          "seconds": 5.045,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/60",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-60",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "There was a lot of bias in the Nevro pivotal trial. We had to talk people into the study, and then they'd go home and pray they got the new stimulator and then they'd get the old one and be grumpy. It wasn't a pristine way to set up a study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-4827df0135b8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "We conducted a detailed interview with a key, influential player in the SENZA-RCT trial, a prominent physician in the pain space. His proximity to the trial cannot be overstated, making him intimately knowledgeable about what actually occurred. Shockingly, he conveyed personal discomfort with the conduct of the study, that he didn’t believe the results, that he hadn’t moved his patients to Nevro’s device, and that the entire high frequency premise was false. We have never seen a trial investigator – a recipient of money from Nevro and someone friendly with and sympathetic to Nevro’s management – so readily contradict the party line. His comments were so blunt that we simply asked “Do you think the Nevro pivotal study you conducted was bs?” to which he replied:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ce670f3-760c-4d26-af9e-38586a847657",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "“I’m different than most guys Nevro markets to. I need higher evidence. I haven’t switched my patients over to Nevro.” – KOL and key player in the SENZA-RCT pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6001a29f-489e-4d18-8f98-12ada0ceb533",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "quote",
          "text": "“I hope the study wasn’t bs. It does bother me. I’m going to say it was done honestly. It’s just that as the study unfolded, I could see the bias.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93f8e78f-518e-4416-a765-690137f8afe1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "quote",
          "text": "“There was a lot of bias in the Nevro pivotal trial. We had to talk people into the study, and then they’d go home and pray they got the new stimulator and then they’d get the old one and be grumpy. It wasn’t a pristine way to set up a study.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9a430a8b-8c36-4ac5-b86c-4ffec73ae1c5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "There was a lot of bias in the Nevro pivotal trial. We had to talk people into the study, and then they'd go home and pray they got the new stimulator and then they'd get the old one and be grumpy. It wasn't a pristine way to set up a study. I hope the study wasn't bs. It does bother me. I'm going to say it was done honestly. It's just that as the study unfolded, I could see the bias. I'm different than most guys Nevro markets to. I need higher evidence. I haven't switched my patients over to Nevro. — KOL and key player in the SENZA-RCT pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-4c148f803018",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation call with expert",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8639ab1b-abb8-456b-9360-579b1db77c43",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL’s, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "092f7788-417f-43c9-9702-291846ca9468",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6fb5384e-9cd5-4a2c-82b5-93a1a8da1c45",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "de06857c-bf98-4f93-aa20-6c65fda8d95c",
          "evidence": "The slide explicitly frames the clinical trial as a fraud based on expert testimony.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:37.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 60,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [
        {
          "to": 60,
          "from": 50,
          "loop": {
            "name": "27_cost_of_inaction",
            "slug": "27-cost-of-inaction",
            "status": "active",
            "bestFor": "Urgent budget requests, compliance, risk mitigation",
            "canonId": "019dd956-70d1-7395-a15b-857ba858b394",
            "version": 1,
            "bodyDocId": "019df22a-2420-77be-bc41-ded96d08cb21",
            "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
            "description": "Quantify what happens if the audience does nothing",
            "familyLabel": null
          },
          "matchId": "d046baf7-54ed-409a-b6fc-7a2d900bc1ce",
          "evidence": "The deck emphasizes the risks of not addressing Nevro's problems",
          "position": 1,
          "objective": "Highlight the cost of inaction",
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 22:01:16.92243+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": "doc-narrative-v1"
          }
        }
      ],
      "locked": true
    },
    {
      "page": 61,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key accusations regarding the validity of the 10kHz frequency and the integrity of the clinical trial data.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2188,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key accusations regarding the validity of the 10kHz frequency and the integrity of the clinical trial data.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:37.646+00",
          "seconds": 5.052,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/61",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-61",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro knew about this and launched a disinformation campaign.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-013f5ff23742",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The KOL stated that European implanters were skeptical of the US pivotal study's results, which came out in 2014. Nevro's HF device had launched in 2010 in Europe, achieving some minor sales and providing European doctors with years of real-world outcomes data unavailable in the US - which never matched the dramatic results claimed in the SENZA-RCT trial. He stated that Nevro \"launched a disinformation campaign\" in response to European implanters' incredulity at data from the US pivotal trial. He further characterized Nevro's 10kHz frequency – the core of its IP – as a meaningless gimmick in which he didn't believe.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42c2ac42-6663-40d3-8d5a-6a12034619a0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "quote",
          "text": "Nevro has tried to bash the study. Simon has consulted with Boston Scientific, so there's some of that. Boston didn't fund the trial and I believe the PROCO study. Nothing has convinced me to date that 10kHz is better than 1kHz.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ad9f005-b67f-49a4-9b35-ea0ecb873dcf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.88,
            "x": 0.06,
            "y": 0.5
          },
          "kind": "quote",
          "text": "Nevro took 10kHz as a frequency and threw a dart at the wall. They chose it because they could get IP on it. 10kHz is not a magic number. The PROCO study by Simon Thompson shows that. It was a crossover study design that evaluated 1,4,7, and 10kHz stimulator frequencies. Each patient received each frequency for 2 to 4 weeks at a time and then rated their pain. Patients had no preference, suggesting there was no difference in pain relief by frequency.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "964d95a1-b97f-4aea-9d84-17cce033f99e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.39
          },
          "kind": "quote",
          "text": "European implanters scratched their heads and said that we've been using Nevro for 3 to 4 years and our experience is not like your Nevro pivotal study. I was at [redacted] and I mentioned to [redacted] that we were getting calls like this. Nevro knew about this and launched a disinformation campaign.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fca29a08-09f1-4fe2-b643-ca617e9884d2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“European implanters scratched their heads and said that we’ve been using Nevro for 3 to 4 years and our experience is not like your Nevro pivotal study. I was at [redacted] and I mentioned to [redacted] that we were getting calls like this. Nevro knew about this and launched a disinformation campaign.” — KOL and key player in the SENZA-RCT pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-06ed41e79b4d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation call with expert",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7dc4123-f2e4-49bd-9cb5-489c4700e7dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d215447-9d7e-4bca-89a2-8c16c1b77ff6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c441b61d-ce2f-48d2-9ea7-8ec16e6cb6a8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e8c2c9ce-9c62-4d87-9bbf-6061fec61e63",
          "evidence": "The slide explicitly frames the clinical trial as a fraud and the company's actions as a disinformation campaign.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:37.646+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 61,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 62,
      "type": "tension",
      "title": "Uses red circles to highlight specific names and study titles to draw attention to the contradiction.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2569,
        "nDataPoints": 0,
        "notes": "Uses red circles to highlight specific names and study titles to draw attention to the contradiction.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:37.085+00",
          "seconds": 4.293,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/62",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-62",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.51,
            "y": 0.46
          },
          "kind": "callout",
          "text": "Adnan Al-Kaisy said he had switched over to Nevro and then he started seeing what you've noted. He had seen 20 to 30 patients with no sustained benefit. He was seeing explants. So he started spreading his business around. He didn't bash Nevro completely. But he's gotten to a point where he thinks other devices like Boston Scientific are a better option.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a77d4e6-6797-48dc-b5ff-83bcb9435447",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "The sheen is off Nevro. I've known [Nevro senior executive] for [redacted] years. I don't know that he's the right guy. I wouldn't buy stock in Nevro right now. Their story is getting stale.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-2e47a924f697",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "He concluded his already devastating comments by stating that a UK-based KOL saw no sustained benefit from Nevro's high frequency either and preferred other devices – and that Nevro was now a stale story in which he wouldn't buy stock. Comically, this UK doctor was the lead author on Nevro's key European 24 month HF study – the US equivalent of the SENZA-RCT pivotal trial. His study is the first that Nevro cites on the “Clinical Evidence” page of its site. This European study and the US SENZA-RCT are Nevro's two 24-month outcomes studies - the foundation upon which Nevro's high frequency's claims rest. Deep skepticism of Nevro's study from one and apparent skepticism by the other is telling.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6c3d66f-4351-4104-bd07-35c6aa65f7f2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "paragraph",
          "text": "Sustained effectiveness of 10 kHz high-frequency spinal cord stimulation for patients with chronic, low back pain: 24-month results of a prospective multicenter study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dbf84f3d-2979-41e5-9e23-e014e07e2501",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.51,
            "y": 0.73
          },
          "kind": "quote",
          "text": "“Nevro came out with something new and got a lot of share in a crowded space. The sheen is off Nevro. I've known [Nevro senior executive] for [redacted] years. I don't know that he's the right guy. I wouldn't buy stock in Nevro right now. Their story is getting stale.” – KOL and key player in the SENZA-RCT pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9d8822ac-70b2-4ef2-bb1d-3df3b2e2b1b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.51,
            "y": 0.63
          },
          "kind": "quote",
          "text": "[Doctor name redacted] in my state switched over completely to Nevro. Then he had issues with Nevro. I think he switched away again.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fa99459-3e4a-4ee6-a3f0-2635c423a20c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Adnan Al-Kaisy said he had switched over to Nevro and then he started seeing what you've noted. He had seen 20 to 30 patients with no sustained benefit. He was seeing explants. So he started spreading his business around. He didn't bash Nevro completely. But he's gotten to a point where he thinks other devices like Boston Scientific are a better option. — KOL and key player in the SENZA-RCT pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-3209be8d18b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: http://www.ericlinmd.com/back-vas-form.php; consultation call with expert.",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5928ddfd-f1a6-4cec-ac85-5cc08e491e23",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "266836ac-8b40-49b2-b215-ccf863a30b5d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cb1055cd-5cf5-4851-b81d-baedaf8631a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "title",
          "text": "Nevro's key European 24-month HF study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "454cd4cd-c45d-47ce-8d04-34a3bf8b9526",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.51,
            "y": 0.42
          },
          "kind": "title",
          "text": "Comments by key US player in SENZA US pivotal trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6433d347-fa30-4ced-9dc2-fd0675127ad9",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f42abb1e-7cc3-410f-b849-2ed82c9b1512",
          "evidence": "The slide explicitly frames the company's clinical evidence as a 'fraud' by contrasting it with the testimony of the lead investigator.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:37.085+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 62,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 63,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize key accusations of trial manipulation.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2445,
        "nDataPoints": 0,
        "notes": "The slide uses yellow highlighting to emphasize key accusations of trial manipulation.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:38.585+00",
          "seconds": 5.737,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/63",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-63",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "That the study's results were a sham appears to be an open secret in the SCS field.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-95ebb455112b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "list",
          "text": "Comments by 5 different KOL's and high volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e451f73c-5d30-4373-a3a9-5bb1c8c2900b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Our research indicates that disbelief and mistrust of Nevro's SENZA-RCT study is widespread among high volume implanters and leading KOL's - including recipients of payments from Nevro - as well as among the company's former executives and employees. That the study's results were a sham appears to be an open secret in the SCS field. One of the most well-known KOL's stated that \"there were so many problems that we just shook our heads....\" Others conveyed the view that Nevro has \"always played a lot of games\" with their trials.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3c737402-7c53-4088-bd16-c06bb1672309",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "I initially had high hopes for Nevro's high frequency. From the very beginning though, the trial wasn't a fair fight. They were comparing brand new technology with a 3 year old one. That study was flawed.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09b7de33-b70e-4030-b373-0223112d55d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "I've read every study from every company. Nevro says it's better but there's no superiority data for HF10 to Burst, or HF10 to 1200 hz or whatever. Interestingly, there's nothing comparing these devices to placebo or sham.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5506ce7d-b2ee-42a8-8c28-ca6fbd367170",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.74
          },
          "kind": "quote",
          "text": "The Hawthorne effect is well documented in science. If a person knows they're getting the experimental product or treatment they tend to have more of a placebo effect. Every patient in Nevro's study knew which device they got. Doctors believe the Hawthorne effect completely skewed Nevro's results. It happens in all their studies. Everybody knows which device they're getting. Nevro's always played a lot of games.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c415f301-d315-4b18-9cf5-42c2e8fe1472",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.36
          },
          "kind": "quote",
          "text": "Nevro definitely designed their HF10 trial to make their product look better. There's no question about it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cb8335f9-15ed-4c27-b22e-88a8325a45d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "When Nevro first launched, we looked at this and said, \"There could be something to a high rate of stimulation. You're basically flooding the zone. What a great idea.\" And then you start going through the study design, and you start looking at real outcomes, and there were so many problems. Huge problems with their study, the Kapural study. There were so many problems that we just shook our heads in some of our doctor groups.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d77980eb-d8a6-4d63-b502-cf9f26a1ed57",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"there were so many problems that we just shook our heads....\" — KOL; \"Nevro definitely designed their HF10 trial to make their product look better. There's no question about it.\" — KOL; \"Nevro's always played a lot of games\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33a-9a2ac44f45f2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b63da243-4859-442f-8a21-cb701f92b04d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0c8b74c-e65a-448a-926b-ed728467f10c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5e5d1893-5571-4a5a-9156-a37063732e78",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "2610f999-6655-4102-a60e-e7c3fe5317ba",
          "evidence": "The slide systematically presents expert testimony to allege fraudulent trial design.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:38.585+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 63,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 64,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key accusations of study manipulation and corruption.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 11,
        "textChars": 2756,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key accusations of study manipulation and corruption.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:37.785+00",
          "seconds": 4.923,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/64",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-64",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's and former employees elaborated on the reasons for their skepticism, beginning with the center and the physicians who led the trial, offering opinions which implied that they were corrupt and paid to deliver only certain kinds of study results.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-6213f2f98352",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's and former employees elaborated on the reasons for their skepticism, beginning with the center and the physicians who led the trial, offering opinions which implied that they were corrupt and paid to deliver only certain kinds of study results.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7daf486a-9b0b-4516-816f-b7fe096cfd92",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "paragraph",
          "text": "Comments by 4 different KOL's and high volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ebd20499-8469-46fe-92de-7feba1864ea0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "quote",
          "text": "[Doctor name redacted] has a factory. His center just does tons of studies. I only know of one negative study they've produced. I didn't even interpret it as negative, though the manufacturer did. Their whole thing is to design studies to win. I do study design on a regular basis. The guys involved like [name redacted] – he knows where the money is. I wouldn't trust a lot of the places in the multicenter study. It's an industry what [name redacted] and [name redacted] do. [Name redacted] and [name redacted] get so hot on things and then they peter out. It's just business.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "55e136e7-064c-4f0d-b8ec-103023499ecf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "quote",
          "text": "The way Nevro compared themselves to Boston Scientific in the study was bogus. It's all about study design. [Name redacted] and [name redacted] give you a study that's designed to win. That's why you get the data. You have to understand the study design.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94439748-7a46-4ba4-9474-0f81afe86800",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.7
          },
          "kind": "quote",
          "text": "The [name redacted]-led study - they were paid to do that. If you're paid to do a study, there's a significant amount of bias. That's why you have to have the investigator blinding. There are so many reasons why it's a wishy washy study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6e93d39-8549-4a51-a6b7-962cc5d1a8ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "quote",
          "text": "[Investigator name redacted] got launched into stardom with Nevro. They couldn't go to the usual considered experts, the guys who were real because eventually the cat would be out of the bag. They would know that what Nevro was selling was bullshit. That's why they tended to develop their own new breed of experts, KOL's and so forth.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9322ebb-ab4e-4361-a41e-fb14d880b540",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "[Doctor name redacted] has a factory. His center just does tons of studies. I only know of one negative study they've produced. I didn't even interpret it as negative, though the manufacturer did. Their whole thing is to design studies to win. I do study design on a regular basis. The guys involved like [name redacted] – he knows where the money is. I wouldn't trust any data from him. I wouldn't trust a lot of the places in the multicenter study. It's an industry what [name redacted] and [name redacted] do. [name redacted] and [name redacted] get so hot on things and then they peter out. It's just business. — Anonymous KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:27+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-65dd13fb51ff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6181dd3c-7b06-43ca-b906-01b6f76bb549",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b9faffaf-81cd-4f21-9833-e9bc36d70d3d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d25a1231-f9aa-4948-be13-648d0f4aeb23",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 65,
      "type": "tension",
      "title": "The slide uses anecdotal evidence from public review sites to attack the character of a key study investigator.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2795,
        "nDataPoints": 0,
        "notes": "The slide uses anecdotal evidence from public review sites to attack the character of a key study investigator.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:36.616+00",
          "seconds": 3.585,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/65",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-65",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The opinions that KOL's and former employees shared of the SENZA-RCT's lead investigator appear consistent with patient reviews – with one patient warning \"Please beware this clinic and this man.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-91bf15d7c300",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The opinions that KOL's and former employees shared of the SENZA-RCT's lead investigator appear consistent with patient reviews – with one patient warning \"Please beware this clinic and this man.\" We caution that these reviews are from a public doctor review site, that we have not verified their accuracy or authenticity, and that they therefore may be neither.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a5384984-bd10-4c52-aeb4-f16044f4d016",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "quote",
          "text": "Dr. [redacted] is the greatest doctor in the world, and if you don't believe it just ask him. His explanations are poor, doesn't seem to want to listen to the patient.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28f666c8-00ea-4f25-a597-4358ea04d8c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "quote",
          "text": "I was seen by this clinic several times... the nastier/louder he got, until he was literally standing in front of me, yelling at me. In the end, he yelled he wouldn't treat me any more, and yelled from down the hall for me to leave. He absolutely did not care about anything I had to say. Please beware of this clinic and this man.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ffa6d04-fc10-4621-9a9c-559cb9b0eb3f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "I felt he was trying to SELL me a spinal stimulator, rather than explain what it is. He blatantly lied about the size of battery and the pain level associated with it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "817063f1-1628-4869-8a9e-a5d75be981c6",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I was seen by this clinic several times, a different person each time, and only on the last visit did I get to see the lauded Dr. [redacted]. He stormed into the room, introduced himself, and told me, without hearing a word from me, what he had determined I needed to do next, which was another procedure. When I told him I was not interested at this point in that procedure, and tried to discuss what I had come to talk about, which was concerns about contraindication with the medicine he had prescribed, he raised his voice and began telling me about how his way is the only way that works, and all my other doctors are incompetent. The longer I tried to get back to what I needed to speak with him about, the nastier/louder he got, until he was literally standing in front of me, yelling at me. In the end, he yelled he wouldn't treat me any more, and yelled from down the hall for me to leave. He absolutely did not care about anything I had to say. Please beware of this clinic and this man.\" — Patient review, 11/11/2019; \"I felt he was trying to SELL me a spinal stimulator, rather than explain what it is. He blatantly lied about the size of battery and the pain level associated with it.\"- Patient review 6/26/2018; \"Dr. [redacted] is the greatest doctor in the world, and if you don't believe it just ask him. His explanations are poor, doesn't seem to want to listen to the patient.\" — Patient review 11/1/17",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-940e87bf2f58",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Healthgrades.com",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3bae6ad0-549c-4401-8e8b-6065b6824027",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0370a34-2bbf-47b3-bf5b-7a30b87913e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee01dcea-e271-4c5c-bc23-72bd6493ef94",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "40deb260-b2a4-49c0-9c50-030b8ac19c01",
          "evidence": "The slide explicitly frames a specific doctor as a villain to undermine the credibility of a clinical study.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:36.616+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 65,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 66,
      "type": "tension",
      "title": "The slide uses a series of pull-quotes to build a narrative of fraud, specifically highlighting the 'cherry-picking' of patients to skew study results.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 10,
        "textChars": 1797,
        "nDataPoints": 0,
        "notes": "The slide uses a series of pull-quotes to build a narrative of fraud, specifically highlighting the 'cherry-picking' of patients to skew study results.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:37.931+00",
          "seconds": 4.496,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/66",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-66",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro cherry-picked patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-7a55b3df3934",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Of the various games used to manipulate the pivotal trial, KOL's and other experts repeatedly pointed to the cherry-picking of patients. Physicians slammed Nevro for constructing a study cohort that was wildly unrepresentative of “real world” stimulator patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4113c6f5-1e40-491a-ae8c-525d001c5ff6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "quote",
          "text": "They programmed the Boston Scientific patients the same as they had always been done. But in the Nevro arm, we'll pick our patients... They did a good job in cherry-picking patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27106884-e1c4-4c0d-88f5-428810262f7e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.47
          },
          "kind": "quote",
          "text": "I mean, they ruled out workers comp patients. They ruled out a significant opioid use. They ruled out even prior spinal cord stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6f68020e-8732-4ca3-88e9-2c28dab81623",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.71
          },
          "kind": "quote",
          "text": "The biggest problem with their study was the exclusion criteria. They committed the cardinal sin, which is to cherry-pick.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c669f2c1-4cc1-49a8-affc-3fc07ff22cee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "quote",
          "text": "Nevro cherry-picked patients... It wasn't a real world study.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd0a5a21-57d2-46a1-92ee-22565ea9883e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro cherry-picked patients. The criteria to be in the HF10 study was one or less back surgeries... It wasn't a real world study.\" — Longtime head of one of Medtronic's largest territories; \"I mean, they ruled out workers comp patients. They ruled out a significant opioid use. They ruled out even prior spinal cord stimulation.\" — KOL and one of Nevro's highest volume KOL's/accounts; \"They programmed the Boston Scientific patients the same as they had always been done. But in the Nevro arm, we'll pick our patients, like virgin patients with only one back surgery... They did a good job in cherry-picking patients.\" — Longtime head of one of Medtronic's largest territories; \"The biggest problem with their study was the exclusion criteria. They committed the cardinal sin, which is to cherry-pick.\" — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-7c77216584bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07b98dce-e4d6-47ad-8292-6dc4838fdd1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0bcbd4b-5ae5-43e5-9f3a-ec5e81473af0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7afe0c3d-2f23-4744-9d18-71315c53888e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "bb4e4de8-c3d0-4ad9-ab9e-a9050db39007",
          "evidence": "The slide systematically presents testimonials to allege fraudulent study design.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:37.931+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 66,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 67,
      "type": "tension",
      "title": "The slide uses testimonials from former executives to build a case of fraud against the company's clinical trial methodology.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 11,
        "textChars": 3797,
        "nDataPoints": 0,
        "notes": "The slide uses testimonials from former executives to build a case of fraud against the company's clinical trial methodology.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:38.342+00",
          "seconds": 4.545,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/67",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-67",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "In addition to cherry-picking and bias from lack of blinding, some of the most troubling allegations about the conduct of the trial came from former executives of Nevro, who described Nevro’s approach to studies at “highly unethical” and suggested Nevro’s skill at manipulating study patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-a68300cf0736",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "In addition to cherry-picking and bias from lack of blinding, some of the most troubling allegations about the conduct of the trial came from former executives of Nevro, who described Nevro's approach to studies at “highly unethical” and suggested Nevro's skill at manipulating study patients. The most damning comments below are by a former executive who we believe to maintain relationships with the CEO and management team, who suggested that Nevro suppresses data which contradicts their high frequency trial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5222a170-6ef6-4072-b186-4bf7e449f725",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "quote",
          "text": "The RCT patients were so closely followed up, so closely managed and optimized with full time field clinical engineers dedicated to them, that then going to a general population and not having that same support infrastructure, yeah, of course you're going to see some fall off [in efficacy versus the pivotal trial].",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f72e921-71fc-436a-a839-8fc3aa6ea74e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "quote",
          "text": "What assisted Nevro with the Kapural study was interaction bias. It’s all about how the study was designed and how the study team interacted with patients in the Boston Scientific arm versus the Nevro arm. The Boston patients' stimulators were re-programmed the same as always. But the Nevro arm had a team come in. The patient knows it’s a new stimulator. The study team is excited to see you. You have 5 to 6 people at your programming session. They were methodical with patients in between sessions as well. Patients were managed differently. Nevro's PDN study would have managed patients exactly the same way, I'm sure. They compared Nevro to CMM [conservative medical management], and CMM is a very low bar.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3636adab-a559-49c6-afcd-67f26b9b3624",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.53
          },
          "kind": "quote",
          "text": "I have concerns and issues with how Nevro manages data especially around clinical research. If a study didn't produce results congruent with their high frequency trial, they wouldn't publish it. I feel that's highly unethical. They'd pay the study out and close it. I had a huge problem with that.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70dc77e0-09f4-4f3f-8cac-808ab4995e3b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.63
          },
          "kind": "quote",
          "text": "Another factor is how Nevro managed patients post-implant is create their own placebo effect. Nevro has a management system that sees when to call a patient, what questions to ask. Pain patients have psychological comorbidities. It creates a crutch. Nevro is commercially savvy in the interaction cycle with the patient. My concern is that they do this during clinical trials.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8133922f-9428-48f3-94bd-422cb52486f7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“What assisted Nevro with the Kapural study was interaction bias. It’s all about how the study was designed and how the study team interacted with patients in the Boston Scientific arm versus the Nevro arm... They compared Nevro to CMM [conservative medical management], and CMM is a very low bar.” — Former executive; “I have concerns and issues with how Nevro manages data especially around clinical research. If a study didn’t produce results congruent with their high frequency trial, they wouldn’t publish it. I feel that’s highly unethical.” — Former executive; “Another factor is how Nevro managed patients post-implant is create their own placebo effect... My concern is that they do this during clinical trials.” — Former executive; “The RCT patients were so closely followed up, so closely managed and optimized with full time field clinical engineers dedicated to them, that then going to a general population and not having that same support infrastructure, yeah, of course you’re going to see some fall off [in efficacy versus the pivotal trial].” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-ab5106eb9e62",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "99bff252-46d6-4646-8267-b21c02cf0fb4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "817fe9ae-60f9-4a29-9021-7a494136705a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a81c7d57-08df-4cec-97c6-1b8074c5a8cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.06,
            "y": 0.3
          },
          "kind": "title",
          "text": "Comments by two former Nevro executives",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f061c99-0512-494c-9bf3-217f5f21fc22",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "94bc5bf1-4038-437d-8663-dee0d883d998",
          "evidence": "The slide systematically presents allegations of unethical behavior and data manipulation to discredit the company's clinical trial results.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:38.342+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 67,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 68,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 10,
        "textChars": 2151,
        "nDataPoints": 1,
        "notes": "The slide uses yellow highlighting to emphasize key phrases within the quotes, such as 'rigged' and 'manipulated the patients'.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "at": "2026-07-17 03:50:12.515+00",
          "seconds": 6.222,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/68",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-68",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Another prominent KOL stated that the study was \"rigged,\" not reproducible, and that Nevro's approach in general was to \"rig their studies.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-d63b97a61da9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's corroborated these comments by Nevro's former executives. One influential KOL - who interacted extensively with Nevro and its management - bluntly stated that the company systematically manipulated study patients to engineer a favorable pivotal study. Another prominent KOL stated that the study was \"rigged,\" not reproducible, and that Nevro's approach in general was to \"rig their studies.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "description",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56ee0a41-b52e-4090-8f6b-d9d1e4abbdee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "quote",
          "text": "\"Nevro manipulated the patients in the pivotal study to show the results they wanted... It was clear to me that they were trying to sell the company and looking for data to show 50% pain relief.\" - Former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f80780e-bcbd-4e4d-acc8-8f53d44179c6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.86,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "quote",
          "text": "\"My international colleagues, the ones in the original Nevro study that got them the IPO, showed great data. What they didn't tell you is how much time the rep was spending in the doctor's office to make the results good.\" -High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f7f1ad4-0ce1-4666-be76-9d6185e77662",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.14,
            "w": 0.86,
            "x": 0.06,
            "y": 0.7
          },
          "kind": "quote",
          "text": "\"I know Al-Kaisy... I think Nevro's high frequency study was rigged. I've stated that no one would be able to repeat the those results... They only pick sites so that they can rig their studies. I'm convinced of it.\" -High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b10b225-a72e-4d39-8510-d8457c19fe6b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro manipulated the patients in the pivotal study to show the results they wanted. They ask leading questions. They have a whole algorithm of leading questions to get the patient to say the magic word, 50% pain relief. As soon as they say 50%, bang, they're out of there.\" — Former high volume Nevro implanter; \"What they didn't tell you is how much time the rep was spending in the doctor's office to make the results good.\" — High volume implanter; \"I think Nevro's high frequency study was rigged. I've stated that no one would be able to repeat the those results... They only chose sites so that they can rig their studies. I'm convinced of it.\" — High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-d889eb9fae7c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.17,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation call with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a34a16b-9082-464e-b357-f0d020e441de",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.49,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "subtitle",
          "text": "Comments by 3 different KOL's and high volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "82d821ee-2793-42e7-8f16-c6131385a3ce",
              "version": 1,
              "description": "Header-zone supporting text near the title (= ex body.description with bbox)."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "79f1a395-32b0-425f-afbb-2a76788366e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.63,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b34e746-57cf-4fb9-a6fc-8906009ad2a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.42,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ec5002d-06ef-4b7a-a5b7-47e413b96aa7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Anadiplosis",
            "slug": "anadiplosis",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
            "version": 1,
            "bodyDocId": null,
            "description": "Ending one clause with a word that begins the next",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "cbdb1c7c-b7fe-4644-84ac-c8ea458ecae6",
          "evidence": "Multiple quotes from different KOLs and experts corroborating similar concerns about Nevro's practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:45.883422+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 68,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Call-and-Response",
            "slug": "call-and-response",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
            "version": 1,
            "bodyDocId": null,
            "description": "Engaging audience by creating pattern they complete mentally",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "fcc7269a-5cdc-464d-8365-40c985307873",
          "evidence": "The use of quotes from KOLs and experts in response to allegations about Nevro's practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:45.926246+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 68,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "6c4a18f3-e3b7-4166-a3e1-96d17aa6cf0e",
          "evidence": "Allegations of rigged studies and manipulated patient data to engineer favorable outcomes.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:50:12.515+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 68,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 69,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key accusations of data manipulation and criminal behavior.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2593,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key accusations of data manipulation and criminal behavior.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:40.269+00",
          "seconds": 5.587,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/69",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-69",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "So, it was a big scam. The way that they manipulated the data was criminal. I would say that the bigger names in neuromodulation who weren't getting paid by them, think of Nevro with disgust.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-cef8573088d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Another KOL indicated that Nevro reps who were involved in the pivotal trial admitted that patients were manipulated into providing the answers that Nevro wanted. He indicated that other KOL's confirmed this in their own discussions with reps. We note that this KOL was one of Nevro's highest volume and most enthusiastic implanters, in addition to being a consultant and speaker for Nevro. He stopped using Nevro completely after having to surgically remove the vast majority of their devices due to failure – we discuss his experience in depth in the section on Nevro's explants crisis.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91e7a513-1e87-4ead-8b2a-9ce274e2d364",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "quote",
          "text": "We subsequently found out, as we spoke to former Nevro reps who were involved in the Senza study, that the manipulation in statements from the patients was crazy. They had very leading questions like, “in certain times of the day do you feel that your pain is this much better, that much better?” It wasn’t an overall global pain assessment scale. These were very, very specific questions to manipulate the answer that they wanted.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3edae76-b946-4e47-9a8b-6d55c405d7dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "I wasn’t the only one who found this out. Other doctors who I respect greatly in the field also got the same input from other reps who were formally working for Nevro. So, it was a big scam. The way that they manipulated the data was criminal. I would say that the bigger names in neuromodulation who weren’t getting paid by them, think of Nevro with disgust.” –KOL and former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fad572b1-503a-429e-a099-50bae8ecb26d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“We subsequently found out, as we spoke to former Nevro reps who were involved in the Senza study, that the manipulation in statements from the patients was crazy. They had very leading questions like, ‘in certain times of the day do you feel that your pain is this much better, that much better?’ It wasn’t an overall global pain assessment scale. These were very, very specific questions to manipulate the answer that they wanted. I wasn’t the only one who found this out. Other doctors who I respect greatly in the field also got the same input from other reps who were formally working for Nevro. So, it was a big scam. The way that they manipulated the data was criminal. I would say that the bigger names in neuromodulation who weren't getting paid by them, think of Nevro with disgust.” — KOL and former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-d1620e5a6a52",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with expert",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80555089-0366-442d-9be6-a6f015eb0c1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "3. Trial investigators, KOL's, and ex-employees painted the SENZA pivotal study as a fraud",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7214662b-80a3-4065-9168-a19144cec5dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dbbcb109-652f-485d-86c0-d810116f24b3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "971f2126-5854-4159-8519-4db02d020542",
          "evidence": "The slide explicitly frames the content as exposing a fraud in a clinical trial.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:40.269+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 69,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 70,
      "type": "tension",
      "title": "Uses highlighted text to emphasize critical claims from experts.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2776,
        "nDataPoints": 0,
        "notes": "Uses highlighted text to emphasize critical claims from experts.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:43.765+00",
          "seconds": 9.026,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/70",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-70",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL interviews indicate widespread skepticism that 10kHz stimulation is any more efficacious than stimulation at lower frequencies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-5606516ee092",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL interviews indicate widespread skepticism that 10kHz stimulation is any more efficacious than stimulation at lower frequencies. Even Nevro's most ardent loyalists and highest volume implanters - consultants, speakers, and/or trial investigators - were at best ambivalent in their support of high frequency as a mechanism of action. The comments below by a high volume KOL and Nevro user are representative: that high frequency was nothing more than a marketing ruse, that even Nevro knows that high frequency is a dud, and that 10kHz results are no better than traditional stimulators operating at 70-90% lower frequency - in other words, that Nevro basically has no IP.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3df2bc11-082a-40c7-95b6-22039fda46d6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "quote",
          "text": "You don't need 10kHz like they claim. Once you reach 2-3kHz it works better than old systems which had 3-500Hz. You don't need the magic 10kz high frequency. Clinically, less is ok and you don't need Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0968e1c0-d306-40c5-ba40-2736600ab7d3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "I'm not a believer that 10kHz is so much better than 1 or 3kHz. High frequency is just sort of keeping them afloat, and if they had not done this, the company would not have survived. But they had to do this because they realized that their initial predictions, their initial claims were just simply not true.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "358ea5c9-75eb-4de2-8ba8-a76b946c6ffe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "quote",
          "text": "Chronic pain is such a unique and idiosyncratic thing that for a company to claim that this one method will work and be good for everyone - really, I'm surprised that Nevro was able to essentially fool the world.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "99491887-f8ef-40de-a377-b3a0b194bb94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "quote",
          "text": "The science showing that 10kHz is so much better than 3kHz is weak, and I don't believe that it is so much better than even something in the 1kHz range or a little bit higher. I don't believe 10kHz is a holy number. I just don't believe that. I haven't seen any better efficacy with 10kHz versus other frequencies.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a175fb32-931c-4010-a31d-b69e93e3a623",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Chronic pain is such a unique and idiosyncratic thing that for a company to claim that this one method will work and be good for everyone - really, I'm surprised that Nevro was able to essentially fool the world. I'm not a believer that 10kHz is so much better than 1 or 3kHz. High frequency is just sort of keeping them afloat, and if they had not done this, the company would not have survived. But they had to do this because they realized that their initial predictions, their initial claims were just simply not true.\" — High volume implanter/KOL and Nevro user; \"You don't need 10kHz like they claim. Once you reach 2-3kHz it works better than old systems which had 3-500Hz. You don't need the magic 10kz high frequency. Clinically, less is ok and you don't need Nevro\" — High volume implanter/KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-58db01818d91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c30ebe28-32ca-45cc-a73d-876ed87405bf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c5048905-16e4-4a3f-9af5-5079ff1514be",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.765+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34915e66-19f7-47ec-a97e-e2af0ee8de3a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 71,
      "type": "tension",
      "title": "Uses highlighted quotes to build a case against the company's core technology claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2145,
        "nDataPoints": 0,
        "notes": "Uses highlighted quotes to build a case against the company's core technology claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:39.517+00",
          "seconds": 4.722,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/71",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-71",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Numerous KOL's pointed to tolerization as a reason for high frequency's failure, suggesting that Nevro's device overwhelms the spinal cord with current, which backfires by resulting in a faster adaptive response than traditional stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-06bd59d295b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Numerous KOL's pointed to tolerization as a reason for high frequency's failure, suggesting that Nevro's device overwhelms the spinal cord with current, which backfires by resulting in a faster adaptive response than traditional stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bfa1109-ccfb-4ab3-998a-2ede648c8f48",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "quote",
          "text": "I've observed, when I and other doctors get together and talk about this, that patients tune out of high frequency faster than traditional stimulators. In one year the devices are all the same and the curves converge. There's no difference in efficacy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "53464fb3-491d-451c-8b15-a0d0adfa99c6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "quote",
          "text": "People get used to high frequency. My hypothesis is that the neurons may re-learn and then the pain can come back.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6173c724-ed3e-4082-8829-cf8e1a78939a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.59
          },
          "kind": "quote",
          "text": "You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance. I'm saying it's just too much energy and you have to back off.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7d52c26-7abb-4dd7-8f06-201a80080371",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"People get used to high frequency. My hypothesis is that the neurons may re-learn and then the pain can come back.\" — KOL in Europe; \"I've observed, when I and other doctors get together and talk about this, that patients tune out of high frequency faster than traditional stimulators. In one year the devices are all the same and the curves converge. There's no difference in efficacy. Maybe a little bit on the front end but it disappears by 12 months.\" — High volume implanter/KOL and Nevro user; \"You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance. I'm saying it's just too much energy and you have to back off. Either the cells are down-regulating and can't hear the noise anymore, or there's an inflammatory response to high frequency and you get cell formation that's impeding the electrical signal.\" — KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-085b280f013b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e1339c84-1bdf-472f-b683-14001d0272bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "33aa76c3-93c0-4531-9d5d-c1b5f43646ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0493608-eabf-4884-949c-ddaeb3d8774d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "884adeeb-caaa-4798-bed6-09695d3e1181",
          "evidence": "Frames the company's technology as a 'phony premise' and uses expert testimony to undermine it.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:39.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 71,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 72,
      "type": "tension",
      "title": "The slide highlights a specific clinical study (PROCO) to undermine the competitive advantage of the subject company's core technology.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 8,
        "textChars": 809,
        "nDataPoints": 3,
        "notes": "The slide highlights a specific clinical study (PROCO) to undermine the competitive advantage of the subject company's core technology.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box",
          "bar_chart_vertical"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:38.022+00",
          "seconds": 3.151,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/72",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-72",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.28,
            "x": 0.68,
            "y": 0.38
          },
          "kind": "callout",
          "text": "Conclusions: The PROCO RCT provides Level I evidence for equivalent pain relief from 1 to 10 kHz with appropriate titration of pulse width and amplitude.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7703724c-d4a7-46e2-ae3a-0f755a44374b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.2,
            "x": 0.75,
            "y": 0.58
          },
          "kind": "chart",
          "text": "Bar charts showing Back Pain, Leg Pain, and Overall Pain across frequencies",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Vertical bar chart",
              "slug": "bar-vertical",
              "status": "active",
              "canonId": "019de52c-fe9d-70f2-b3b7-a9ae294f5917",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-vertical",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7373881-dcaa-4f8e-bb39-36d7a2e8eb76",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.65,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "image",
          "text": "PROCO study abstract screenshot",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7526f48e-73ba-42ae-8ab5-5fc0d32e2771",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "An influential study presented in 2018 at the key annual NANS conference... corroborated what physicians were seeing in clinical practice – that high frequency provided no benefit over lower ones.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2eead3a-4bd6-47b0-be26-4a64c01a04af",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Conclusions: The PROCO RCT provides Level I evidence for equivalent pain relief from 1 to 10 kHz with appropriate titration of pulse width and amplitude. — PROCO Randomized Controlled Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-bd0fbec558b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5814855/pdf/NER-21-67.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e766569b-80bf-45a1-937e-0986d1857708",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "788715e1-29cd-4f36-a5f4-b2662c5faad4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "17e296f6-6c88-4710-9fe7-9f00ee361ac2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d101c589-9a95-4ce4-9dd5-61c145c536bf",
          "evidence": "The slide explicitly frames the company's core technology as a 'phony premise' using clinical data to contradict marketing claims.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:38.022+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 72,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 73,
      "type": "tension",
      "title": "The slide uses testimonials to undermine the company's core product claim.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2801,
        "nDataPoints": 0,
        "notes": "The slide uses testimonials to undermine the company's core product claim.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:42.776+00",
          "seconds": 7.777,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/73",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-73",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "10kHz is not a magic number. The PROCO study by Simon Thompson shows that. It was a crossover study design that evaluated 1,4,7, and 10kHz stimulator frequencies. Each patient received each frequency for 2 to 4 weeks at a time and then rated their pain. Patients had no preference, suggesting there was no difference in pain relief by frequency.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-6ef9822da23e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "Although Nevro has tried to trash the PROCO study, our interviews indicate widespread belief in its results, even by a key investigator who is close to Nevro management and played a critical role in their pivotal trial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "89abe667-1a1b-4db1-a8be-efb3d9b6865a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "quote",
          "text": "Nevro took 10kHz as a frequency and threw a dart at the wall. They chose it because they could get IP on it. 10kHz is not a magic number. The PROCO study by Simon Thompson shows that... Nothing has convinced me to date that 10kHz is better than 1kHz.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1246cafd-f44a-430b-8e0c-f32a0c03f510",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "quote",
          "text": "There was a revolution with Nevro's HF10. It was very attractive initially. Then Boston Scientific showed there's nothing magical with 10kHz... It's the biggest device by far. It requires way, way more recharging. It needs a lot more reprogramming.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37e67772-0d18-4958-b26e-03adfa794b07",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "The Boston Scientific data throws a monkey wrench in Nevro's data. It creates reasonable doubt even for someone like me who likes Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57a35910-c5e0-4641-94b0-4c3bba5fba74",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"10kHz is not a magic number. The PROCO study by Simon Thompson shows that. It was a crossover study design that evaluated 1,4,7, and 10kHz stimulator frequencies. Each patient received each frequency for 2 to 4 weeks at a time and then rated their pain. Patients had no preference, suggesting there was no difference in pain relief by frequency. Nevro has tried to bash the study. Simon has consulted with Boston Scientific, so there's some of that. Boston didn't fund the trial and I believe the PROCO study. Nothing has convinced me to date that 10kHz is better than 1kHz.\" — KOL and key player in Nevro's pivotal SENZA-RCT trial; \"The Boston Scientific data throws a monkey wrench in Nevro's data. It creates reasonable doubt even for someone like me who likes Nevro.\" — High volume implanter and significant Nevro customer; \"There was a revolution with Nevro's HF10. It was very attractive initially. Then Boston Scientific showed there's nothing magical with 10kHz. Nevro was the first kid on block with their paresthesia-free, kind of like Tesla with the first electric vehicle. Now everyone has electric vehicles. The advance Nevro had is now outweighed by the compromises of it. It's the biggest device by far. It requires way, way more recharging. It needs a lot more reprogramming than any other device. If reps spend a lot of time reprogramming in your office, they need a lot more reps to support docs. It's a business model issue.\" — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-7292c5bc2897",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3f32358a-b182-4ea5-b47a-256a41d55912",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70214a09-9939-40a6-81ff-bf6ff047bb5b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3ad056e-8f42-45a6-98f0-f1ead6a72009",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "3b091dae-7d71-45de-998a-fd5bcb6dd9b3",
          "evidence": "Framing Boston Scientific and the PROCO study as the truth-tellers against Nevro's 'phony' claims.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:42.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 73,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 74,
      "type": "tension",
      "title": "Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 1468,
        "nDataPoints": 2,
        "notes": "Includes a quote from a 'West coast-based high volume implanter' and a visual annotation of study results.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "line_chart",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:39.586+00",
          "seconds": 4.162,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/74",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-74",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Two lines are HF and conventional stimulation, showing no meaningful difference at various intervals up to a year, on several endpoints measuring pain.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-1f226bdf602e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.43,
            "x": 0.06,
            "y": 0.4
          },
          "kind": "image",
          "text": "DeAndre study snippet",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "12e56ae0-5892-406d-b111-98747aa85566",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.4,
            "x": 0.54,
            "y": 0.81
          },
          "kind": "legend",
          "text": "Two lines are HF and conventional stimulation, showing no meaningful difference at various intervals up to a year, on several endpoints measuring pain.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Legend",
              "slug": "legend",
              "status": "active",
              "canonId": "31361933-3d22-4c70-bbad-0801e9fffc0c",
              "version": 1,
              "description": "Color/symbol decoder placed adjacent to a chart or diagram."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "de10306f-f59e-4189-9a66-cc0a286e13c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "In addition to the PROCO study, KOL's pointed to the DeAndre study published in 2017. The study compared high frequency head to head versus stimulators operating at conventional frequencies, reaching the same conclusion...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c2f9e8a-a31a-4e88-903f-b731283ee24a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.4,
            "x": 0.54,
            "y": 0.4
          },
          "kind": "quote",
          "text": "De Andres did a blinded outcomes assessment with Nevro to Medtronic. In other words, they blinded the outcomes assessors, like you're supposed to do in medicine to eliminate investigator bias.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a31d3fb9-96bf-478f-9d80-77c518390014",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"De Andres did a blinded outcomes assessment with Nevro to Medtronic. In other words, they blinded the outcomes assessors, like you're supposed to do in medicine to eliminate investigator bias. They also made sure that the programming time was equal for each system so that there wasn't bias. Nevro, in their Senza and other studies, doesn't do that. Nevro biased patients by talking about [the comparator device with] paresthesia as evil, while the De Andres study showed that there was no difference between Nevro and Medtronic.\" — West coast-based high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-228a6df7072c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://academic.oup.com/painmedicine/article/18/12/2401/4591682",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a466da2-7051-41c3-977c-9015706e412b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4561bfba-a648-491d-9096-db32e5148ace",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce10d9ef-85a0-477c-ba08-a7e032ef2f82",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "63060c41-1088-4b13-b860-6df6001b0934",
          "evidence": "The slide explicitly frames the company's core technology as a 'phony premise' and highlights investigator bias.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:39.586+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 74,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 75,
      "type": "tension",
      "title": "The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 74,
        "componentCount": 9,
        "textChars": 1215,
        "nDataPoints": 0,
        "notes": "The slide uses a quote from a former Medtronic employee to reinforce the argument that the technology is not unique or effective.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:42.492+00",
          "seconds": 6.994,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/75",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-75",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.25,
            "w": 0.4,
            "x": 0.55,
            "y": 0.6
          },
          "kind": "callout",
          "text": "Conclusion: This is the first randomized double-blind study on SCS. HFSCS was equivalent to sham for the primary outcome...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5bd5ce27-e88c-436f-b099-3e392ed10e84",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "Conclusion: This is the first randomized double-blind study on SCS. HFSCS was equivalent to sham for the primary outcome (improvement of PGIC) as well as for both the secondary outcomes (VAS and EQ-5D index) [...] It appears that the effect of HFSCS and sham is equal...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-e945a698fdc8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.45,
            "x": 0.05,
            "y": 0.4
          },
          "kind": "image",
          "text": "Analgesic Efficacy of High-Frequency Spinal Cord Stimulation: A Randomized Double-Blind Placebo-Controlled Study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37d40d0d-6305-476c-9f58-19ec8cd6254a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "We find a third study, published the year before Nevro’s SENZA-RCT, even more devastating. The study compared high frequency stimulation to a sham...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b523e14f-7bc0-4bb4-bbd6-935f54224ee2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.55,
            "y": 0.4
          },
          "kind": "quote",
          "text": "It’s amazing how much mindshare Nevro got. They didn’t invent 10kHz high frequency. Medtronic did high frequency studies and they were no better than placebo.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0261c6b7-d976-4ce7-aef5-d385ec2748a8",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "It’s amazing how much mindshare Nevro got. They didn’t invent 10kHz high frequency. Medtronic did high frequency studies and they were no better than placebo. It’s just a stimulator like everything else. It’s not a panacea. — Former Medtronic neuromodulation employee",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:28+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33b-ed4fd6757a61",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://pubmed.ncbi.nlm.nih.gov/23425338/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "afd14412-e4ec-4830-aefa-794c24451799",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d241717a-2782-4a4b-82fa-44a75ac2523e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d76e267c-ff16-41e4-b4ff-8b39d685a39f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "5f70e7ec-729b-4ac9-a692-97f98173a607",
          "evidence": "The slide explicitly contrasts Nevro's claims with a double-blind study showing no efficacy.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:15:42.492+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 75,
          "frameworkName": "expose_contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 76,
      "type": "tension",
      "title": "Uses testimonials to undermine the company's core value proposition.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 10,
        "textChars": 1888,
        "nDataPoints": 0,
        "notes": "Uses testimonials to undermine the company's core value proposition.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:39.713+00",
          "seconds": 3.805,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/76",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-76",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Our research indicates that their dismissiveness toward Nevro’s purported differentiation is now the norm in the SCS field.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-3fff389bc843",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "It is therefore no wonder that even Nevro loyalists state bluntly that all stimulators are a commodity. We quote three implanters below. The first doctor is a longtime Nevro whale and consultant in one of the largest metro's in the northeast. OpenPayments lists him as a recipient of significant payments from the company. The second and third doctors are heavy and moderate-volume Nevro implanters, respectively, on the west coast and east coast. Our research indicates that their dismissiveness toward Nevro's purported differentiation is now the norm in the SCS field.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b46b4fe0-4697-4f46-8e17-c1a7d70493e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "If somebody came in today and had traditional back and leg pain from spinal surgery, you can achieve meaningful and significant results with any of the devices. That's for sure and that includes even some outdated systems that are still on the market.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b9e28031-4e58-4875-a05b-11228edf3904",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "quote",
          "text": "There's not much of a difference between the devices. They're all the same. It's like buying a car.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef019448-984d-48c9-8a7b-b81651419de9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "quote",
          "text": "All these devices are similar. It just depends on the puts and takes with a patient.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f80148c7-a9e7-4877-a97a-0e11415149fa",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"If somebody came in today and had traditional back and leg pain from spinal surgery, you can achieve meaningful and significant results with any of the devices. That’s for sure and that includes even some outdated systems that are still on the market.\" — High volume Nevro loyalist and KOL in the northeast; \"There’s not much of a difference between the devices. They’re all the same. It’s like buying a car.\" — High volume Nevro implanter on west coast; \"All these devices are similar. It just depends on the puts and takes with a patient.\" — Moderate volume Nevro implanter on east coast",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:29+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-400e4756cd2f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://pubmed.ncbi.nlm.nih.gov/23425338/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da6bf086-5d07-41f6-a4ac-ea694f33241e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "4. HF10 is a phony premise and mechanism of action",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd5b117e-9053-4790-84cc-d654b43d1bef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02d1f834-1664-4676-8413-f0111544da37",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "title",
          "text": "Comments by 3 different implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d3915f0-c870-40a4-9588-134efcf4c0ed",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "0adf7fae-fad6-43e7-8076-9f0ee56c759f",
          "evidence": "Uses quotes from industry experts to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:39.713+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 76,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 77,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key pain points regarding battery life and charging frequency.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 4396,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key pain points regarding battery life and charging frequency.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:40.509+00",
          "seconds": 4.332,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/77",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-77",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The patient burden and resulting non-compliance and dissatisfaction were a recurring theme of our KOL interviews.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-17265afa18b2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Unlike conventional stimulators, high frequency devices impose a number of significant tradeoffs on patients and doctors. By definition, they consume large amounts of power and rapidly drain the battery implanted inside the patient, requiring the patient to be next to a charging paddle for long periods of time on a daily basis. On Facebook groups some patients report charging times that can approach an hour. The patient burden and resulting non-compliance and dissatisfaction were a recurring theme of our KOL interviews.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d3532c53-3cc7-40e5-929e-468ec1d68841",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "The average duration between recharges is one of the biggest detriments for high frequency. Patients are charging daily. For the older folks who struggle with technology, it's a significant detriment. I won't implant Nevro in folks over 60. It's a big turn off for me and my patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4837600b-d86f-43d9-a80f-24db818a8a93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "quote",
          "text": "There were a couple of other problems with Nevro besides loss of efficacy. One, the size of battery. When you put in a huge generator like Nevro's original device, you can't hide it well. The other is charging it every day. It's a burden and now you see Abbott going huge into non-rechargeable devices. Their device lasts 5-7 years. When I switch people out of Nevro or whatever into an Abbott they're like, \"I don't have to charge it? Are you kidding me, why didn't we do this in the first place?\" Patients don't understand the burden of charging every day until they actually have to charge it every day. Initially people don't mind, but after 6 months it becomes a problem.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "904f663a-58cf-43bc-8a99-c2da14451b64",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "quote",
          "text": "The problem with a 10kHz device is that battery is going to be gone in a day. You have to recharge it like your iPhone. You don't need to do that. You can have 1kHz, and you have the same outcome. That's been shown.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c5ae206-ed03-4985-a740-7712018c44ff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.74
          },
          "kind": "quote",
          "text": "I haven't seen any better efficacy with 10kHz versus other frequencies. I would also say that one of the downsides of Nevro is that because of the high energy requirements, patients need to recharge very frequently and there are patient populations who may not be compliant and there's data on that, patients don't charge them, that the devices don't last as long and that the patients just don't use the device as much.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac7918d3-82bd-4b7e-84b0-82734e2a4e3e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.86
          },
          "kind": "quote",
          "text": "Nevro has to be charged every couple of days or every day versus others every 1 or 2 weeks.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e39ca8f6-c9e3-4d75-978b-c7d7561b1ae9",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"There were a couple of other problems with Nevro besides loss of efficacy. One, the size of battery. When you put in a huge generator like Nevro’s original device, you can’t hide it well. The other is charging it every day. It’s a burden and now you see Abbott going huge into non-rechargeable devices. Their device lasts 5-7 years. When I switch people out of Nevro or whatever into an Abbott they’re like, 'I don’t have to charge it? Are you kidding me, why didn’t we do this in the first place?' Patients don’t understand the burden of charging every day until they actually have to charge it every day. Initially people don’t mind, but after 6 months it becomes a problem.\" — KOL and former high volume Nevro implanter and consultant; \"The problem with a 10kHz device is that battery is going to be gone in a day. You have to recharge it like your iPhone. You don’t need to do that. You can have 1kHz, and you have the same outcome. That’s been shown.\" — KOL and high volume implanter; \"The average duration between recharges is one of the biggest detriments for high frequency. Patients are charging daily. For the older folks who struggle with technology, it’s a significant detriment. I won’t implant Nevro in folks over 60. It’s a big turn off for me and my patients.\" — KOL and high volume implanter; \"I haven’t seen any better efficacy with 10kHz versus other frequencies. I would also say that one of the downsides of Nevro is that because of the high energy requirements, patients need to recharge very frequently and there are patient populations who may not be compliant and there’s data on that, patients don’t charge them, that the devices don’t last as long and that the patients just don’t use the device as much.\" — High volume implanter; \"Nevro has to be charged every couple of days or every day versus others every 1 or 2 weeks.\" — High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-18b7a8dfa595",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34b0e668-2d1b-490a-9b6a-b1bc2dfb3c0b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "5. High frequency is Nevro's fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a598946-5645-4dee-823f-c2076fdd59c7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "652fe91c-c037-4af3-b232-ac6eebdb4c29",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "title",
          "text": "Comments by 5 different KOL's and high volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8f5a9075-61df-4984-b31a-98fd6d98aa6e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Call-and-Response",
            "slug": "call-and-response",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a254-7484-a9b7-721eb21444a5",
            "version": 1,
            "bodyDocId": null,
            "description": "Engaging audience by creating pattern they complete mentally",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "3ee1c2f8-bf8e-4791-bb0b-db44b5142adf",
          "evidence": "The slide includes multiple quotes from KOLs and experts, creating a call-and-response structure to build a narrative.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:33.192531+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 77,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "c548cbb4-6075-430b-a024-9cd11c828670",
          "evidence": "The slide frames Nevro's high-frequency technology as a 'fatal flaw' and a burden to patients.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:40.509+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 77,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 78,
      "type": "tension",
      "title": "Uses direct quotes from company filings and website to frame the 'paresthesia-free' claim as a vulnerability.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 84,
        "componentCount": 12,
        "textChars": 1529,
        "nDataPoints": 0,
        "notes": "Uses direct quotes from company filings and website to frame the 'paresthesia-free' claim as a vulnerability.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:41.717+00",
          "seconds": 5.341,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/78",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-78",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "callout",
          "text": "\"Our proprietary paresthesia-free HF10 therapy, delivered by our Senza system, was demonstrated in our SENZA-RCT study to be superior to traditional SCS therapy...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1d143be8-0fe4-4e2d-ab6b-782e26402078",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.38,
            "x": 0.58,
            "y": 0.72
          },
          "kind": "callout",
          "text": "\"While traditional spinal cord stimulation (SCS) has been around for over 30 years, Nevro created a disruption by offering a next-generation approach called HF10 therapy...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84d1aece-c2d9-4eeb-85b5-b1346df97618",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "callout",
          "text": "\"Traditional SCS therapy generates paresthesia... We believe the ability of HF10 therapy to deliver pain relief without paresthesia provides a substantial benefit...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d1fa824f-3c01-4ecc-9de8-56f66361c96d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "The core of the high frequency premise – and Nevro’s entire reason for existence – is based on the notion of “paresthesia-free”.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-84880846b853",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.5,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "image",
          "text": "Nevro's \"About\" page",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c464636-fc11-4e29-8f67-370b565a07a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "paragraph",
          "text": "Opening paragraph of Nevro's 2020 10K",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "995a1fee-bb0d-4ce3-949d-32235cd859dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The core of the high frequency premise – and Nevro's entire reason for existence – is based on the notion of \"paresthesia-free\". Traditional, lower frequency stimulators cause tingling, known as paresthesia, in an attempt to mask the pain.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3009704-4e95-4bf4-bad1-39591db438fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "paragraph",
          "text": "Excerpt from 10K, which mentions \"paresthesia\" 36 times across various sections",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eb7b1915-f2ad-4db1-965f-cbb0f6f5820a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Our proprietary paresthesia-free HF10 therapy, delivered by our Senza system, was demonstrated in our SENZA-RCT study to be superior to traditional SCS therapy, with HF10 therapy being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy.” — Nevro 2020 10K",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-88aa3d14818e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: Nevro 10K; https://www.nevro.com/English/us/about/overview/default.aspx",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fba5efc9-3e63-4c0a-bb6a-f51b7f49edc2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "5. High frequency is Nevro's fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2dcdd77f-fa52-4aee-b9c6-2b3cf997d462",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c17735e-f6bf-46ef-827a-d138b1667872",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "37214cad-50c4-41b9-b417-5cc887922d42",
          "evidence": "Frames the company's core technology as a 'fatal flaw' and 'disruption' that is actually a weakness.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:41.717+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 78,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 79,
      "type": "tension",
      "title": "Uses testimonials to contradict the company's marketing claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 9,
        "textChars": 2823,
        "nDataPoints": 1,
        "notes": "Uses testimonials to contradict the company's marketing claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:40.244+00",
          "seconds": 3.653,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/79",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-79",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro had supposedly found the holy grail: eliminating pain versus masking it with paresthesia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-9c37cc0c1cd4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro had supposedly found the holy grail: eliminating pain versus masking it with paresthesia. Traditional stimulators are implanted with the patients awake to enable paresthesia-mapping: the physician adjusts the placement of stimulator leads along the spine in a trial-and-error process until the patient reports tingling that overlaps with the area of pain. Nevro touted that it eliminated the need for \"paresthesia-mapping,\" but quickly discovered upon launch that a large percentage of doctors and patients strongly preferred paresthesia. Comments from a KOL and two former employees are representative.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0eb44a98-cc8c-433b-a242-1486246a238d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.76
          },
          "kind": "quote",
          "text": "If the leads move even a little bit the Nevro reps get lost and they don't know where to program because there's no buzzing or tingling, no paresthesia. So they don't know what to do. They're programming blind.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ff8b85b-0fba-48cc-82fe-086a1c096c99",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "The HF10 results don't pan out over time, correct. Again, that's my personal opinion. It's the reason Omnia is out. A lot of people wanted the paresthesia. Even right from the start, probably 50% of the doctors that I came across wanted paresthesia as an option for patients. They were saying, what if a patient wants it? We'd say, no, no, we have to follow the evidence and we can only do it this way.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9060974-d5aa-4112-aad8-df987e079e24",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "quote",
          "text": "Nevro didn't want the patient to feel paresthesia, but what you'll find is that they crave the paresthesia. Once they feel it, they think that that's the indication of whether the device is working or not. You can't just get rid of paresthesia unilaterally and say it's a great thing because there are definitely reasons for it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f333eb13-5ad0-4f3c-84de-f8d6297f055a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro didn’t want the patient to feel paresthesia, but what you’ll find is that they crave the paresthesia. Once they feel it, they think that that’s the indication of whether the device is working or not. You can’t just get rid of paresthesia unilaterally and say it's a great thing because there are definitely reasons for it.\" — High volume implanter/KOL; \"The HF10 results don’t pan out over time, correct. Again, that’s my personal opinion. It's the reason Omnia is out. A lot of people wanted the paresthesia. Even right from the start, probably 50% of the doctors that I came across wanted paresthesia as an option for patients. They were saying, what if a patient wants it? We’d say, no, no, we have to follow the evidence and we can only do it this way.\" — Former Nevro territory manager; \"If the leads move even a little bit the Nevro reps get lost and they don’t know where to program because there’s no buzzing or tingling, no paresthesia. So they don’t know what to do. They’re programming blind.\" — High volume implanter/KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-a2eff9c8a51d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38d292cc-3e7c-4252-9f65-d45837b0c811",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "5. High frequency is Nevro's fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "538bff10-bd34-4920-898f-f1ec918da35d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.244+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14994901-4c40-4c9c-9341-c29e741fe08e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 80,
      "type": "tension",
      "title": "Uses expert testimony to frame the company's core technology as a liability.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2654,
        "nDataPoints": 0,
        "notes": "Uses expert testimony to frame the company's core technology as a liability.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:40.27+00",
          "seconds": 3.141,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/80",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-80",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The executive described the resulting patient support burden as a driver of Nevro's broken business model.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-44fd8644a2f1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "A former Nevro executive, who oversaw a key function, elaborated on the programming difficulties unique to high frequency and explained how the lack of paresthesia undermined the company's value proposition and backfired.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24f61371-3588-4fb8-a128-0a19a91b11f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.37
          },
          "kind": "quote",
          "text": "High frequency comes with challenges. The patient doesn't get feedback from paresthesia... They just crank the device up and have more pain.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0685ac1a-6c27-4cf4-9701-c3d296da2e6f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "quote",
          "text": "Nevro put together a brand new patient support and programming team... For one algorithm, you'd spend a week and a half just on that algorithm... If they didn't get correct pain coverage, they'd have to bring the patient back in for reprogramming.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "679654dd-524f-46a0-8d5c-e78502648ddd",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"High frequency comes with challenges. The patient doesn't get feedback from paresthesia. They either feel pain or don't. That's where the challenge comes in for Nevro. There's a whole psychological issue with paresthesia that plays into it. The patients are dependent on opioids. The device could be working, but patients say it's not working, and then the patients want opioids. Patients have to be in a mindset to be patient to be cooperative. If they had a low frequency device, they're used to making programming changes on the fly, which you can't with high frequency. Some patients are compliant. A good number are not. They just crank the device up and have more pain.\" — Former Nevro executive; \"Nevro put together a brand new patient support and programming team. It's role was to work with patients, call the patient on a daily basis, and advise the patient to turn the stimulator on or off. It was a big organization. They would have a list of patients they were in charge of. They would call them daily during the trial, right after, after the procedure, to make sure the stim is set correctly. No other neuromodulation company had that. It was unique to HF10. A lot of times the patient had to be patient. We'd lower or increase the stimulation. We'd start at a low frequency, would wait 24 to 48 hours, would increase it by 1, then wait, then increase it again. For one algorithm, you'd spend a week and a half just on that algorithm. The reps would ask on the phone if you're getting pain coverage, take notes, then add 3 milliamps. They'd have to go through this over the next 3 to 4 weeks to get correct coverage. If they didn't get correct pain coverage, they'd have to bring the patient back in for reprogramming to see which programs work or don't work.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-4b1201572156",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7946a956-995c-4404-b308-e713d00232ac",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "5. High frequency is Nevro's fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6b6c21eb-226f-4b3b-b034-f974b8880ae7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e17c5f06-5ebc-47d2-b334-54b568f3a90c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "97f90da2-7d72-4aa5-900d-d615435a9883",
          "evidence": "Frames the company's core product as the source of its failure.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:40.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 80,
          "frameworkName": "villain_critique"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 81,
      "type": "tension",
      "title": "The slide uses a testimonial to frame the company's core product feature as a business liability.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 8,
        "textChars": 1223,
        "nDataPoints": 1,
        "notes": "The slide uses a testimonial to frame the company's core product feature as a business liability.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:40.574+00",
          "seconds": 3.388,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/81",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-81",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.47
          },
          "kind": "paragraph",
          "text": "Since its launch, Nevro was completely against paresthesia mapping of any form. This created unique challenges for the field staff. It consumed significantly more time and would require significantly more programming.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1f90eca2-a5e3-48fe-8c16-f2e8456fb846",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "paragraph",
          "text": "Reps could be there all day trying to make the patient happy. Paresthesia-free led to a mess in the field. The Omnia launch was an acknowledgement that they needed to change course because the novelty of high frequency has worn off.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a49f58e-bc25-49b4-a65b-7497878fd8fc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "Nevro’s salesforce attrition was due to unique challenges for the sales team in managing patient outcomes. It’s a derivative of the fact that Nevro touts a paresthesia-free experience for the patient. With Nevro, there’s no clear way of mapping.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3c813925-3046-4899-93bf-1dca976146ba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "paragraph",
          "text": "More than 50% of patients required interventions for more than one re-programming session within the first 90-120 days. For new field reps, a session could take 45 to 90 mins.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5fa8fb87-9e9a-4b1e-9b87-238b4fb5db1f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "quote",
          "text": "A former regional sales director... stated that “paresthesia-free” created chaos in Nevro’s field sales organization... programming a high frequency device took “twice as long if not longer” than competing devices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f924f24f-da05-43d5-88f0-df001409dc93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "30467f94-9ec4-402a-b2f0-0aff0290cbaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "5. High frequency is Nevro’s fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "767fca67-a842-4b46-90b7-39d5cf99c3ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "724d9ab6-28b7-477a-b4b5-dd5af7f0e84c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "2d6152b6-9b29-4d68-af95-3e8cfd9a2c88",
          "evidence": "The slide frames the company's product as the 'villain' causing operational chaos.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:40.574+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 81,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 82,
      "type": "tension",
      "title": "The slide uses expert testimony to undermine the company's core value proposition.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 2328,
        "nDataPoints": 5,
        "notes": "The slide uses expert testimony to undermine the company's core value proposition.",
        "elementsJson": [
          "paragraph",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:41.818+00",
          "seconds": 4.563,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/82",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-82",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "callout",
          "text": "The disconnect between the clinical data and actual results is that the data said you get 70-75% pain reduction with high frequency. Probably less than 20% of patients in my region got that. 25% of patients were non-responders. They weren't responsive to high frequency at all. 50% had pain relief but not to RCT-reported levels. For those 50% of patients, competitor devices fared better.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a5951978-f1bd-4c96-9b90-8df4e03438c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "callout",
          "text": "The lack of therapeutic efficacy affected significantly more than 50% of patients at some point. 100% of patients experienced it at some point.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5fa016d-7240-46c5-9600-341541ed65a2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "The disconnect between the clinical data and actual results is that the data said you get 70-75% pain reduction with high frequency. Probably less than 20% of patients in my region got that.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-e6c59a7e786c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Given the size of his territory and the volume of patient outcomes that he witnessed, we find his comments on Nevro’s lack of efficacy to be illuminating. He stated that “less than 20% of patients” experienced results consistent with Nevro’s pivotal trial and that almost all suffered periods with no efficacy at all. He offered a pithy explanation for why “paresthesia-free” is a fatally flawed concept: paresthesia-based devices only need to provide some masking for the patient to feel relief, but without a compensatory tingling sensation to substitute for the pain, Nevro’s device has to provide 100% pain relief, which is impossible.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "22c9508d-c3fe-44b0-91c9-4fbdab7d4111",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "paragraph",
          "text": "With high frequency, patients are waiting for pain relief versus pain masking. Paresthesia has an immediate effect on leg pain because it masks it. High frequency requires going from painful to no pain. It requires 100% pain relief which never happens. The patient still feels pain. The patient wants zero pain.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ed2cf101-0e68-482b-b44e-5906963fb58f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The disconnect between the clinical data and actual results is that the data said you get 70-75% pain reduction with high frequency. Probably less than 20% of patients in my region got that. 25% of patients were non-responders. They weren't responsive to high frequency at all. 50% had pain relief but not to RCT-reported levels. For those 50% of patients, competitor devices fared better.\" — Former Nevro regional sales director and now at a competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-e9577fbc2245",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92dff8b2-54dc-4fee-9d8c-1cef17d69093",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.5,
            "y": 0.68
          },
          "kind": "source-note",
          "text": "– Former Nevro regional sales director and now at a competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e50b699d-c4a3-44c1-ad22-a9c7a330ccc1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "5. High frequency is Nevro’s fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bde93457-a28f-4d45-95bd-5cad8ed814d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "187a3252-4b2c-4acb-b198-14cb3b326766",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "549f9af1-a035-48ac-8af2-8a5b496cc4cd",
          "evidence": "The slide frames the company's technology as a 'fatal flaw' and uses expert testimony to discredit it.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:41.818+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 82,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 83,
      "type": "tension",
      "title": "The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2491,
        "nDataPoints": 0,
        "notes": "The slide uses testimonials from a former employee to frame management as incompetent and the product as obsolete.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:41.663+00",
          "seconds": 3.854,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/83",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-83",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro refused to acknowledge the product was responsible. The product didn’t work as well as senior leadership would say.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-fd70b78a9a32",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "He explained what happened next: Nevro found itself “in a bind” with the CEO and management refusing to accept that high frequency is a dud that never lived up to the hyped-up “data,” which led to conflict with the field organization and sales reps leaving “in droves” despite the best compensation and benefits in the space. He added that Nevro’s message no longer resonates and that the space has moved on.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df83755a-1b14-435d-83ca-616afdeb84c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "Nevro’s paresthesia-free message doesn’t resonate anymore. Competitors have waveforms that mimic paresthesia-free pretty closely. Boston Scientific and Abbot for sure. Or they have paresthesia-light. Abbott brought out paresthesia-light with the Burst DR platform. It’s been out for a few years now. Boston Scientific has Wavewriter.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9630e12e-f279-422b-9407-1b5a1d147d11",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "Nevro refused to acknowledge the product was responsible. The product didn’t work as well as senior leadership would say. This led to conflict with the CEO and a disconnect between headquarters and the field. It led to significant attrition, despite how generously they compensated the field and benefits which are unmatched in medical device sales. Candidates would fall over in their chairs when they heard the benefits, but reps still left in droves.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "96f67870-c1e7-4167-9183-8e24788c6d57",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "quote",
          "text": "The real world results that Nevro had in the field didn’t live up to the clinical data they were purporting. They found themselves in a bind. The initial response was to try and re-educate doctors on why it would work because the data says it would and they just need to keep believing.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bcce458d-2f90-4845-8bf1-f5ba6249ad1b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“The real world results that Nevro had in the field didn’t live up to the clinical data they were purporting. They found themselves in a bind. The initial response was to try and re-educate doctors on why it would work because the data says it would and they just need to keep believing.”; “Nevro’s paresthesia-free message doesn’t resonate anymore. Competitors have waveforms that mimic paresthesia-free pretty closely. Boston Scientific and Abbot for sure. Or they have paresthesia-light. Abbott brought out paresthesia-light with the Burst DR platform. It’s been out for a few years now. Boston Scientific has Wavewriter.” — Former Nevro regional sales director now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-02093119bba1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.76
          },
          "kind": "source-note",
          "text": "– Former Nevro regional sales director now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "112712b1-c2d4-4a6f-bb1e-3b5476c7275b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "286db570-bac1-4282-9f78-d35c9cd4687e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "5. High frequency is Nevro’s fatal flaw and dooms any turnaround",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a20c9b7-d999-4247-b6ac-dc9035d49dcf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ec191f3-2673-4130-b29f-ff976f518db7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "36c3d2cd-16ac-43e9-ab36-498d474e83ee",
          "evidence": "Frames management as the villain causing the company's failure.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:41.663+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 83,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 84,
      "type": "tension",
      "title": "The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 62,
        "componentCount": 7,
        "textChars": 1006,
        "nDataPoints": 4,
        "notes": "The slide uses a screenshot of a Nevro investor presentation to expose a contradiction in their reported explant rates.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "callout_box"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:42.388+00",
          "seconds": 4.349,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/84",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-84",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.06,
            "w": 0.35,
            "x": 0.615,
            "y": 0.345
          },
          "kind": "callout",
          "text": "Nevro claims that only 1.2% of Wave writer devices are explanted because of failure, and that only 3.7% are explanted overall",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a857a9f0-271d-45ef-a763-f1a38d840537",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.53,
            "w": 0.77,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "image",
          "text": "Screenshot of Nevro investor slide showing 'Real World Results' and 'Lowest Explant Rate' claims.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7cd89cb2-70da-4538-b223-088a8a02ac02",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 3.7%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:30+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33c-bb0107e30fa0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.93,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Having run a sham pivotal study and with its sole product based on a flawed theory, reality dawned on Nevro as doctors and patients began to see the device fail. Nevro took the space by storm at launch in 2015, on the heels of exciting “data” that led doctors to try the device. Our research indicates that doctors soon began to notice problems with the device, which caused them to abandon Nevro in droves and explant (surgically remove) its stimulators. We begin by noting Nevro’s absurd claim of having the lowest explant rate in the industry.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "50fe53d0-a94f-4b71-a76f-ae5ffebfd26e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.7,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Nevro Q1 2019 investor slides https://s24.q4cdn.com/932612397/files/doc_presentations/Nevro-IR-Presentation_Q12019_050919.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f045e8bc-3edd-478e-9ded-0b739de8f96d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.41,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f3bbebf5-f906-4112-bdb9-a2df99ae1213",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.48,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "71136403-15cf-4d82-9dcf-3ffb6085fe47",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "8ee3c7f5-5bcd-4e2f-9b37-0187bbd65211",
          "evidence": "The slide explicitly contrasts a corporate claim with research findings to expose a contradiction.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:42.388+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 84,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 85,
      "type": "tension",
      "title": "The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claims",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 8,
        "textChars": 797,
        "nDataPoints": 4,
        "notes": "The slide uses a screenshot of a medical journal article to highlight author conflicts of interest and a table of explant data to challenge the company's claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "data_table",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:41.85+00",
          "seconds": 3.643,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/85",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-85",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.3,
            "w": 0.48,
            "x": 0.47,
            "y": 0.58
          },
          "kind": "callout",
          "text": "Conflict of Interest: T. Stauss, G. Surges, D. Sayed, F. El Majdoub, W. S. Rosenberg, L. Kapural, R. Bundschu, A. Lalkhen, M. Maarouf and N. Patel are consultants to Nevro Corp... B. Gliner, J. Subbaroyan, and A. Rotte are employees of Nevro Corp.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f0b0172-609f-445d-b109-2401d7b8d2a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "image",
          "text": "Journal article header and author list",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2f590da-82be-42c1-b8cc-9cbffb919d9c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "nul",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-79cb3342ac0f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "This claim of a low single-digit explant rate is based on a 2018 “study” that analyzed outcomes at a mere 8 cherry-picked clinics. The study - which appears to be written by a Nevro medical writer with 3 employees as authors - is a barely-disguised marketing brochure masquerading as a legitimate paper.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e3cd90f-a053-41e6-87c7-7e70aec73905",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://onlinelibrary.wiley.com/doi/epdf/10.1002/acn3.720",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a9eca79-0c48-4887-8ee8-da35f8312194",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.4,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "table",
          "text": "Table 2. Details of device explants in the population.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bf4ebd1-6df2-4fd2-9c2b-d423e81e28cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "21ff4df9-2158-4ce2-a727-dea4c8c8726b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cc7272c8-6612-4544-85cd-246a828668a5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ef71dff6-ecf3-4070-9d23-6706a4d0bf90",
          "evidence": "The slide explicitly frames the study as a 'marketing brochure masquerading as a legitimate paper' to expose corporate deception.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:41.85+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 85,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 86,
      "type": "tension",
      "title": "The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 9,
        "textChars": 2385,
        "nDataPoints": 6,
        "notes": "The slide uses a red circle to highlight a specific table from a medical paper, emphasizing the discrepancy between real-world outcomes and company claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "data_table",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:42.005+00",
          "seconds": 3.694,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/86",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-86",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.82
          },
          "kind": "callout",
          "text": "“10 kHz SCS therapy showed promise as a treatment for refractory low back and lower extremity pain in the SENZA-RCT study […] These data differ greatly from the results we have found in real world practice. In the current study, we looked at explant rate of the 10 kHz SCS device as the primary outcome and found that over 20% of implanted stimulators were either explanted outright or exchanged for traditional SCS over two years and that at least 32.5% were explanted or exchanged over the course of the four years of data collection despite repeated reprogramming sessions in the effort to achieve therapeutic optimization.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c38e2d59-fa5c-46b7-b10a-f972f70cc3e4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "A paper presented in January 2020 at NANS, the key annual neuromodulation meeting, indicated explant rates of 22% within 2 years and 33% within 4 years for Nevro’s product “despite repeated reprogramming sessions in the effort to achieve therapeutic optimization” – dwarfing the 1.2-3.7% rates Nevro’s own “paper” claimed by ~10-30x.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-ca739d0cdb92",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.55,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "image",
          "text": "Explantation rates of high frequency spinal cord stimulation in two outpatient clinics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6170fb52-e131-4b65-bd1f-1ea09b999db6",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 33%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-d35c7a341157",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A paper presented in January 2020 at NANS, the key annual neuromodulation meeting, indicated explant rates of 22% within 2 years and 33% within 4 years for Nevro’s product “despite repeated reprogramming sessions in the effort to achieve therapeutic optimization” – dwarfing the 1.2-3.7% rates Nevro’s own “paper” claimed by ~10-30x. The study indicated that the purported results in Nevro’s pivotal SENZA study “differ greatly from the results we have found in real world practice.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fa2c0c31-4e4a-4860-a443-f795d82db6b9",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“10 kHz SCS therapy showed promise as a treatment for refractory low back and lower extremity pain in the SENZA-RCT study […] These data differ greatly from the results we have found in real world practice. In the current study, we looked at explant rate of the 10 kHz SCS device as the primary outcome and found that over 20% of implanted stimulators were either explanted outright or exchanged for traditional SCS over two years and that at least 32.5% were explanted or exchanged over the course of the four years of data collection despite repeated reprogramming sessions in the effort to achieve therapeutic optimization.” — NANS 2020 paper",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-cc4e522a326e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: NANS 2020 poster",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4777ef41-46ef-4bda-a20c-35f7af0566e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.36,
            "x": 0.58,
            "y": 0.33
          },
          "kind": "table",
          "text": "Years after implant (years) | Cumulative risk of explantation (95% CI) | Patients at risk | Number of patients explanted",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f41dccce-64af-4621-aa9b-6463c30d43dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "228b85aa-bf8f-4ffb-84c2-86a747b74181",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "7d5f6b4b-d1d9-414a-ae75-77df89b9b55f",
          "evidence": "The slide explicitly contrasts company claims with real-world data to allege a cover-up.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:42.005+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 86,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 87,
      "type": "tension",
      "title": "The slide uses a series of quotes from KOLs (Key Opinion Leaders) to build a narrative of systemic failure and industry skepticism.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 4351,
        "nDataPoints": 0,
        "notes": "The slide uses a series of quotes from KOLs (Key Opinion Leaders) to build a narrative of systemic failure and industry skepticism.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:43.692+00",
          "seconds": 5.228,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/87",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-87",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The talk attracted an overflow crowd, and numerous doctors in attendance confirmed that they too had seen similarly abnormal rates of explants. Another KOL indicated that Nevro would try to undermine the presenter.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-3d35ea58eb2d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The paper generated significant buzz at the NANS conference, despite representing early data from only two sites. Our research indicates that other papers and studies on Nevro's explants rate may either be in process or in peer review, to expand upon the initial data and findings, which we expect to further undermine Nevro's credibility with KOL's and its trajectory. We believe it was the first time doctors publicly began to confront the elephant in the room regarding Nevro's explant rates. We spoke to several KOL's who were in attendance or intimately familiar with the research and its authors. The talk attracted an overflow crowd, and numerous doctors in attendance confirmed that they too had seen similarly abnormal rates of explants. Another KOL indicated that Nevro would try to undermine the presenter.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac1f405a-1b4f-4ba4-8075-32810c76b886",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "After Nevro's explant rate was publicly presented, several doctors came up to say that more research needs to be done on this because we're seeing a lot of explants as well. A lot of pain doctors aren't willing to say much about the negative aspects of spinal cord stimulation, but a lot of them at the conference approached the author about their explant rates. They said we're seeing about the same numbers. They of course didn't look into their data. When you're a provider, you're noticing trends. It's not a day to day thing, but you're thinking that for some reason in the past few months I'm explanting a lot of high frequency spinal cord stimulators.\" – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "366e1e0b-9077-4e71-b451-5bd2caa70717",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "The NANS talk was well-attended. I was surprised. It was at 6AM and a lot of people came. It filled up like three rooms. They had to take the dividers out. I'd say there were 100 to 150 attendees – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8281a2bb-7071-4f26-88cc-484a61b2678c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.85
          },
          "kind": "quote",
          "text": "The most important thing the presenter said was that 5 or 6 implanters came up to him after the talk and said they had the same experience. Another paper shows that doctors who did big volumes had the same explant rate. This study will be big and show what's going on because right now Nevro is going to try and throw [redacted] under the bus and say [redacted] is getting paid by somebody else to do this.\" – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d74d0816-fb69-487d-ba2f-fff8693748c2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "There are doctors that are saying, \"I saw [doctor name redacted] speak at NANS, and I saw [doctor name redacted's] outcomes and other doctors' outcomes, and I dug into it, and I'm having the same outcomes. I'm not using high-frequency anymore.\" – One of the most senior and plugged in executives in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3d2af11-0a06-4d8c-ba58-8404c8192960",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"There are doctors that are saying, 'I saw [doctor name redacted] speak at NANS, and I saw [doctor name redacted's] outcomes and other doctors' outcomes, and I dug into it, and I'm having the same outcomes. I'm not using high-frequency anymore.'\" — One of the most senior and plugged in executives in the SCS space; \"The NANS talk was well-attended. I was surprised. It was at 6AM and a lot of people came. It filled up like three rooms. They had to take the dividers out. I'd say there were 100 to 150 attendees\" — KOL; \"After Nevro's explant rate was publicly presented, several doctors came up to say that more research needs to be done on this because we're seeing a lot of explants as well. A lot of pain doctors aren't willing to say much about the negative aspects of spinal cord stimulation, but a lot of them at the conference approached the author about their explant rates. They said we're seeing about the same numbers. They of course didn't look into their data. When you're a provider, you're noticing trends. It's not a day to day thing, but you're thinking that for some reason in the past few months I'm explanting a lot of high frequency spinal cord stimulators.\" — KOL; \"The most important thing the presenter said was that 5 or 6 implanters came up to him after the talk and said they had the same experience. Another paper shows that doctors who did big volumes had the same explant rate. This study will be big and show what's going on because right now Nevro is going to try and throw [redacted] under the bus and say [redacted] is getting paid by somebody else to do this.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-41bcc2968401",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64591eab-d8cd-41c7-9338-593164d34006",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2212162-144f-42d4-baac-c6ebe76e6819",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.692+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e64414d1-1c6a-49c2-8762-f4ea85bc6009",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 88,
      "type": "tension",
      "title": "The slide uses direct quotes from a KOL to frame the company's behavior as unethical and retaliatory.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 74,
        "componentCount": 8,
        "textChars": 2033,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from a KOL to frame the company's behavior as unethical and retaliatory.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:46.785+00",
          "seconds": 8.236,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/88",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-88",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "They have a good disinformation approach.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-5efc62626ea8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "Another KOL suggested that Nevro may have tried to retaliate prior to the presentation, and stated his belief that Nevro prevented the explants paper from being listed in the program and tore the data presentation from the wall. The doctor referenced previous retaliatory behavior by Nevro and “disinformation” regarding their explant rates, characterizing the company’s conduct as “slimy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a17d362-fdd5-413b-8d43-c2214189b895",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "quote",
          "text": "“I talked to [KOL name redacted]. One creepy thing – the paper that had been posted got torn down after the first day. Somebody tore it down. And then the talk wasn’t listed in the program, which is weird. The first thing we all thought was that it sounds like Nevro. We all said, yup that sounds like a Nevro deal…[KOL name redacted] called me and said, do you think it’s weird that [name redacted’s] talk was not in the program? So I picked up the program and was like, wow it’s not. It’s weird. As this had to do with Nevro, it doesn’t surprise me.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6643a01e-e30c-430e-8f5b-7b3fabce3dcf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "“They have a good disinformation approach. They nationally vilified [redacted, doctor who was critical of Nevro’s explant rates]. They actually sent a rebuttal to all their implanters talking about how [redacted] had some vendetta. They’ve done that before historically. It’s a slimy company, hands down.” –KOL and former Nevro consultant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76c42dba-a6d6-40ad-a187-6684c7210e60",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I talked to [KOL name redacted]. One creepy thing – the paper that had been posted got torn down after the first day. Somebody tore it down. And then the talk wasn’t listed in the program, which is weird. The first thing we all thought was that it sounds like Nevro. We all said, yup that sounds like a Nevro deal…[KOL name redacted] called me and said, do you think it’s weird that [name redacted’s] talk was not in the program? So I picked up the program and was like, wow it’s not. It’s weird. As this had to do with Nevro, it doesn’t surprise me.” — KOL and former Nevro consultant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-61bd16301b8a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eeabda8d-ce1c-4cea-af15-6d556e95a224",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c354d04f-1e18-48f0-a0e3-861831df06ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.785+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b5c3d17-d1f0-48c3-82ed-8cbdf9be7908",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 89,
      "type": "tension",
      "title": "Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 92,
        "componentCount": 12,
        "textChars": 2733,
        "nDataPoints": 1,
        "notes": "Uses testimonial-style quotes to build a narrative of corporate deception regarding product failure rates.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:34.463+00",
          "seconds": 3.974,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/89",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-89",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe Nevro sales hit the wall because of a covered-up explants crisis, and that fatal flaws specific to its high frequency mechanism of action are an albatross that dooms its trajectory.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-8f1c155f7684",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "list",
          "text": "A KOL in Europe, with extensive experience implanting Nevro’s devices, stated that the company’s device failure rate is common knowledge in Europe, where Nevro launched several years before the US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "118c27fb-52cc-462b-b52f-3db950087383",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "list",
          "text": "US KOL’s stated that Nevro was lying about it explant rate, that “everyone” thinks its high, and that the rate was “talked about at every meeting.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc0ba540-e603-42d4-833b-b6516ce19332",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The 33% explant rate found in the NANS paper was corroborated by one KOL after another during our 20+ research interviews with doctors...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4834623-3e8f-4d15-a84e-90dcb1b37415",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.65,
            "x": 0.11,
            "y": 0.73
          },
          "kind": "quote",
          "text": "The Nevro marketing materials that state a 2% explant rate are just a flat out lie.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32c333a4-d289-461f-9c4f-2586769f0468",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.83,
            "x": 0.11,
            "y": 0.46
          },
          "kind": "quote",
          "text": "A lot of doctors in Germany are saying that Nevro’s device only works for 2 to 2 ½ years and then the patient comes back with more pain. They say it fails and then they have to put in an Abbott or Boston Scientific device. It’s a big issue here in Germany. These are credible people. People who do a lot of surgeries and are involved with the society. Every time there’s a spinal cord stim meeting, this is an issue that colleagues talk about. People have become nervous and become afraid to use Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6e533423-f676-4b9e-8c8b-db00bb092ef0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.11,
            "y": 0.78
          },
          "kind": "quote",
          "text": "Everyone thinks Nevro has a high explant rate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8a5b8614-ad3f-4afc-bc94-193e3ac55a9c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.83,
            "x": 0.11,
            "y": 0.83
          },
          "kind": "quote",
          "text": "The Nevro explant rate was known all over. At every meeting, colleagues talked about the explant rate being high. [KOL name redacted] explants a bunch of Nevro a week. He was a big Nevro advocate and has a lot of explants. Everyone was drinking the Nevro kool-aid at the beginning.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d83b8853-bcac-49bd-9481-b60f16dda073",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "A lot of doctors in Germany are saying that Nevro's device only works for 2 to 2 ½ years and then the patient comes back with more pain. They say it fails and then they have to put in an Abbott or Boston Scientific device. It's a big issue here in Germany. These are credible people. People who do a lot of surgeries and are involved with the society. Every time there's a spinal cord stim meeting, this is an issue that colleagues talk about. People have become nervous and become afraid to use Nevro. — High volume European implanter; The Nevro marketing materials that state a 2% explant rate are just a flat out lie. — High volume KOL; Everyone thinks Nevro has a high explant rate. — High volume implanter; The Nevro explant rate was known all over. At every meeting, colleagues talked about the explant rate being high. [KOL name redacted] explants a bunch of Nevro a week. He was a big Nevro advocate and has a lot of explants. Everyone was drinking the Nevro kool-aid at the beginning. — KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-90e903be86af",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "74f57a9d-c41e-43a1-bd83-13467c653780",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "919d4bf1-62de-4027-8ae3-beabaf5ffc9c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d52939e8-e6d1-4872-bf6f-76346f33d474",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "494a77f8-080f-497b-98dc-280d64f65022",
          "evidence": "The slide explicitly frames the company's reported data as a 'lie' and 'covered-up' crisis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:34.463+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 89,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 90,
      "type": "tension",
      "title": "The slide uses testimonials to build a narrative of industry-wide dissatisfaction and lack of transparency regarding explant data.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 94,
        "componentCount": 13,
        "textChars": 2917,
        "nDataPoints": 3,
        "notes": "The slide uses testimonials to build a narrative of industry-wide dissatisfaction and lack of transparency regarding explant data.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:43.21+00",
          "seconds": 3.911,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/90",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-90",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The explant rate is higher for Nevro than anyone else.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-a98c904c6d8e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "KOL's stated that Nevro's explant rate was the highest in the industry and an outlier, and questioned why the company won't publish proper explant data",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f7d4ab9-a8ee-4b71-984b-250fbb12dcf8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.18
          },
          "kind": "list",
          "text": "Doctors confirmed the ~33% explant rates in the NANS paper. Some provided figures a bit lower based on their own experience, while others (as we shall detail) said their personal explant rates for Nevro were 80%+.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a49d13db-6846-4ccc-991f-2f7044a311ea",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 33%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-b13352eded34",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.8,
            "x": 0.1,
            "y": 0.25
          },
          "kind": "quote",
          "text": "The explant rate was more than 25%. It was a lot. A lot of time I’d replace Nevro with a Medtronic unit because it was so tiny.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "541e061b-8a37-430d-8a5e-fa2a60af72d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.1,
            "y": 0.75
          },
          "kind": "quote",
          "text": "What is the explant data? Nevro will not publish it. They have to keep information on every patient that gets explanted. With Nevro's high frequency device, I have never seen so many explants from one company.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5630f1a6-487f-4682-87b6-ad7dd6896fe5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.1,
            "y": 0.33
          },
          "kind": "quote",
          "text": "For every 100 Nevro devices implanted, 30% of them will be explanted within a year or two. What Nevro has done hurts the rest of us because then people are less likely to use any company's devices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "68d355a0-7d26-451f-a6c9-1fa3bb27070b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.1,
            "y": 0.53
          },
          "kind": "quote",
          "text": "I had stopped using Nevro. I know so many of their devices that were explanted because patients couldn't stand the size and programs that drain battery life. The explant rate is higher for Nevro than anyone else.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7baada2-da1f-4aaf-9980-8bd204c3bf7c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The explant rate was more than 25%. It was a lot. A lot of time I’d replace Nevro with a Medtronic unit because it was so tiny.\" — High volume KOL; \"For every 100 Nevro devices implanted, 30% of them will be explanted within a year or two. What Nevro has done hurts the rest of us because then people are less likely to use any company’s devices. What one greaseball does affects the rest of us. It’s flawed. Nevro’s research is deeply flawed.\" — High volume KOL; \"I had stopped using Nevro. I know so many of their devices that were explanted because patients couldn’t stand the size and programs that drain battery life. The explant rate is higher for Nevro than anyone else. I’m so frustrated with how I put it in. I’ve had zero results with Nevro in trials and it’s so unusual. I’ve had more failed Nevro trials than with any other device. I don’t have an explant rate with other devices. Maybe some three to fours years out. Maybe once a year I explant out of someone. Colleagues tell me Nevro’s explant rates are higher than anything else. I hear that from other doctors. Walk around the next NANS meeting and ask people about explant rates.\" — High volume KOL; \"What is the explant data? Nevro will not publish it. They have to keep information on every patient that gets explanted. With Nevro’s high frequency device, I have never seen so many explants from one company. Every once in a while, I’ll see a crap Medtronic or Abbott device and I need to put in something else. But just in terms of lack of efficacy and explants, Nevro is clearly number one.\" — High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-ace09776714e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98a0b9c3-b1fa-4541-9c0f-f459b52c69ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "title",
          "text": "The 33% explant rate (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af7b1d20-2ef8-4dac-a7d1-afda1d927707",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e1705937-ca78-472c-9a9f-944758ee6fb0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.4,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.21+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "587f8618-cf01-4949-8c04-9d2c99f183ee",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 91,
      "type": "tension",
      "title": "The slide uses highlighted quotes to emphasize the severity of the alleged device failures and the high volume of Nevro patients requiring salvage therapy.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 12,
        "textChars": 3141,
        "nDataPoints": 2,
        "notes": "The slide uses highlighted quotes to emphasize the severity of the alleged device failures and the high volume of Nevro patients requiring salvage therapy.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:44.353+00",
          "seconds": 4.253,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/91",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-91",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Another high volume KOL provided a separate data point substantiating Nevro's abnormal explant rate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-747ee433f02c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "list",
          "text": "KOL’s who didn’t provide exact explant percentages nonetheless provided qualitative color that was similar",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "252940ef-92d5-44ec-929c-6098e56ab664",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.64
          },
          "kind": "list",
          "text": "Another high volume KOL provided a separate data point substantiating Nevro’s abnormal explant rate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "97529a37-841c-48ba-9321-2d9093c24fbe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.19
          },
          "kind": "list",
          "text": "Doctors indicated that Nevro’s devices begin to fail fast, requiring explantation as soon as 6 months out",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cc470fad-dd5b-4954-b498-d1ed91304d1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.5
          },
          "kind": "quote",
          "text": "High frequency seemed to have a lot of traction when it first started off. We’re trying to figure out if the initial pain improvement is still there, a year out, two years out, five years out. It seems like a lot of the high frequency implants have been explanted, or exchanged for something else.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "036a1ffd-22f0-41b7-8c21-a1cb304b2249",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.23
          },
          "kind": "quote",
          "text": "It’s rare to see a device not working at all, but I’ve seen with Nevro at 6 months that it’s not helping patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81cee776-8466-432a-9ed2-67994fe33f09",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.11,
            "y": 0.3
          },
          "kind": "quote",
          "text": "The biggest reason for Nevro explants is device failure. That’s probably the biggest reason, over 80-90%. And then infection rates. But it’s almost always failure. Anecdotally and from the data there’s a range, but it seems to be within about a year. But some of them fail later, within three years.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e4399d8-036f-4f7c-8dec-9b890954fd05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.11,
            "y": 0.68
          },
          "kind": "quote",
          "text": "Abbott is currently doing a study called Prolong. The study’s not specifically going up against Nevro. It’s just using the Abbott device as a salvage therapy for failed spinal cord stimulation patients. But, most of the salvage appears to be for Nevro patients. I think almost 50% of the enrollment so far in the study has been Nevro patients. Abbott’s study was never meant to be a superiority study. The study wasn’t meant to bash Nevro. But Nevro didn’t like that the overwhelming majority of patients that needed to be salvaged in the study were all theirs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c9bb8d5f-1740-452a-9dff-03baf1f5e9f5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"It’s rare to see a device not working at all, but I’ve seen with Nevro at 6 months that it’s not helping patients.\" -KOL; \"The biggest reason for Nevro explants is device failure. That’s probably the biggest reason, over 80-90%. And then infection rates. But it’s almost always failure. Anecdotally and from the data there’s a range, but it seems to be within about a year. But some of them fail later, within three years.\" -KOL; \"High frequency seemed to have a lot of traction when it first started off. We’re trying to figure out if the initial pain improvement is still there, a year out, two years out, five years out. It seems like a lot of the high frequency implants have been explanted, or exchanged for something else.\" -KOL; \"Abbott is currently doing a study called Prolong. The study’s not specifically going up against Nevro. It’s just using the Abbott device as a salvage therapy for failed spinal cord stimulation patients. But, most of the salvage appears to be for Nevro patients. I think almost 50% of the enrollment so far in the study has been Nevro patients. Abbott’s study was never meant to be a superiority study. The study wasn’t meant to bash Nevro. But Nevro didn’t like that the overwhelming majority of patients that needed to be salvaged in the study were all theirs.\" -KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-7be6c23b56c8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d0a50f8-abdb-42ac-a89f-7558e40d58a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis\nThe 33% explant rate (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "89cb037a-0f6b-4aaf-bbac-4d50d898e50e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3230dddb-3df0-4ef4-9c69-1f6a50ec0f36",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "539a6459-5c11-461c-8eeb-70f3fba80650",
          "evidence": "The slide systematically presents expert testimony to expose alleged device failures and cover-ups.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:44.353+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 91,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 92,
      "type": "tension",
      "title": "Uses highlighted quotes to emphasize negative feedback from medical professionals.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 1806,
        "nDataPoints": 1,
        "notes": "Uses highlighted quotes to emphasize negative feedback from medical professionals.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:44.161+00",
          "seconds": 4.046,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/92",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-92",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's provided other reasons for explants beyond device failure and lack of efficacy, such as “intolerable” patient discomfort, “untenable” recharging requirements, adverse effects, and improper indications.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-20914d4c7d7c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.18
          },
          "kind": "paragraph",
          "text": "KOL's provided other reasons for explants beyond device failure and lack of efficacy, such as “intolerable” patient discomfort, “untenable” recharging requirements, adverse effects, and improper indications.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7753cd77-f996-4f4a-bef5-c6d97f76678e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.83,
            "x": 0.11,
            "y": 0.44
          },
          "kind": "quote",
          "text": "I've explanted a lot of Nevro because of lot of my colleagues started implanting it for indications I didn't agree with. You need some form of neuropathic pain like a previous surgery or trauma. It won't work for regular back pain like if it's your joints or a disc.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92df2316-89e4-461d-a60c-af0bf39f2807",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.83,
            "x": 0.11,
            "y": 0.27
          },
          "kind": "quote",
          "text": "Senza had a very high explant rate because of patient discomfort. The frequency of recharging was untenable. Some patients got sore skin from the charging coil. Having to do it every day could make the skin sore. It became intolerable to some patients. I have a friend who explanted 3 Nevro devices in one day. He's not a big Nevro guy anymore.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2865355-ff08-4ae0-9eca-f169b9327e8b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Senza had a very high explant rate because of patient discomfort. The frequency of recharging was untenable. Some patients got sore skin from the charging coil. Having to do it every day could make the skin sore. It became intolerable to some patients. I have a friend who explanted 3 Nevro devices in one day. He’s not a big Nevro guy anymore.” —KOL; “I’ve explanted a lot of Nevro because of lot of my colleagues started implanting it for indications I didn’t agree with. You need some form of neuropathic pain like a previous surgery or trauma. It won’t work for regular back pain like if it’s your joints or a disc.” —KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-262a819dd003",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3cb2e067-a30e-4205-8463-34c2df91440b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis\nThe 33% explant rate (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b45d6889-ba3a-4990-83a0-5e9be7aff0fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9ef13d2-1efb-4d7d-a181-ee9e136fcb22",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e0c87612-2ce2-43ab-a254-7159026176af",
          "evidence": "Uses KOL quotes to validate the claim of high explant rates.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:44.161+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 92,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 93,
      "type": "tension",
      "title": "Uses expert testimony to challenge official company data.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 84,
        "componentCount": 9,
        "textChars": 2010,
        "nDataPoints": 1,
        "notes": "Uses expert testimony to challenge official company data.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:43.39+00",
          "seconds": 3.194,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/93",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-93",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A number of KOL’s indicated why the 33% explants rate in the NANS paper actually underestimates how often Nevro’s device fails: many patients just turn the device off and don’t bother to have it surgically removed because “they don’t want to go back to their doctor because he sold them on the idea.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-2866b11da4e2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 33%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-3354eb95f626",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A number of KOL's indicated why the 33% explants rate in the NANS paper actually underestimates how often Nevro's device fails: many patients just turn the device off and don't bother to have it surgically removed because “they don't want to go back to their doctor because he sold them on the idea.” It's therefore not technically an explant, but still a device failure.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b210e0a7-56a7-418b-9d1d-9debf884e68f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "The explant rate is also underestimated because the device would stop working and the patient doesn't want it pulled out.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d08cb0e-2271-499c-b997-9dc65c3421ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "You have to include another population of patients when you talk about explants, something which happens a lot. You ask patients how it's going and they say \"I don't use the stimulator.\" I ask why and they say, I just don't feel like it's working that well.\" There are people that aren't explants. They just leave it in, and they don't even use it but they don't want to explant. They don't want to go back to their doctor because he sold them on the idea.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b60105f-6984-4380-9e68-1c15c54ccdf1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“The explant rate is also underestimated because the device would stop working and the patient doesn’t want it pulled out.” — High volume KOL; “You have to include another population of patients when you talk about explants, something which happens a lot. You ask patients how it’s going and they say \"I don't use the stimulator.\" I ask why and they say, I just don't feel like it's working that well.\" There are people that aren't explants. They just leave it in, and they don't even use it but they don't want to explant. They don't want to go back to their doctor because he sold them on the idea.” — High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-2e849f333f42",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b8e9abe-9571-4bb7-b2e0-c1e682b06a04",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b655924-5c44-4d6d-b982-68fee0c1819b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b68dee9f-52e3-403b-b30d-43e0cd51ba47",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "dde8c5c9-5513-4617-90e7-4cfc80aed157",
          "evidence": "The slide explicitly frames the company's reported data as a 'covered-up' crisis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:43.39+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 93,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 94,
      "type": "tension",
      "title": "Uses testimonial-style quotes from competitor employees to undermine company disclosures.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 1492,
        "nDataPoints": 2,
        "notes": "Uses testimonial-style quotes from competitor employees to undermine company disclosures.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:43.917+00",
          "seconds": 3.287,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/94",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-94",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One indicated that the largest clinic he sells to had an 80% explant rate with Nevro's device and \"won't let Nevro back in.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-ee4d74797676",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Aside from both KOL’s and former employees indicating rampant device failures and explants, we provide confirmatory color from territory managers at key competitors, for whom Nevro’s explants problem appear to be common knowledge.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bca3caaf-0e8b-47de-9d76-6c527a3002df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "“I’ve heard upwards of an 80% explant rate, at the biggest clinic that we sell to. They won’t let Nevro back in. They said about 80% of their Nevro devices have come out.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7fa71db-18bb-46af-b708-ab7695decfeb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "quote",
          "text": "“Nevro defines explants differently. Their study on explant rates said it’s just 1%. The Europe study [that indicated high explant rates] looked at the real world. I had a doctor in my territory who put in 25 Nevro devices and explanted all of them.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ea7717e6-1f21-4921-8ea8-f3da06b7b546",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I've heard upwards of an 80% explant rate, at the biggest clinic that we sell to. They won't let Nevro back in. They said about 80% of their Nevro devices have come out.\" — Longtime Medtronic territory manager, running a large midwestern region; \"Nevro defines explants differently. Their study on explant rates said it's just 1%. The Europe study [that indicated high explant rates] looked at the real world. I had a doctor in my territory who put in 25 Nevro devices and explanted all of them.\" — Longtime Medtronic territory manager, running a larges multi-state region on the east coast",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33d-f0d100b21796",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ba1b080-f9a3-4e58-bc82-9d9fa795f701",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "6. A covered-up device failure and explants crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c8fd2d4-7dfe-4f1f-b218-52cf81593bb5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0184a202-0560-4f0a-b38a-e45971106f74",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4573d62a-7002-4e4b-9795-0091658bbae9",
          "evidence": "Contrasts company-reported 1% explant rate with anecdotal 80% claims from competitors.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:43.917+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 94,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 95,
      "type": "evidence",
      "title": "The slide uses a 'case study' format to provide qualitative evidence of product failure.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 3001,
        "nDataPoints": 4,
        "notes": "The slide uses a 'case study' format to provide qualitative evidence of product failure.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:46.047+00",
          "seconds": 5.288,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/95",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-95",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The 33% explant rate in the NANS paper is massively underreported and that the actual rate is “tremendous” and possibly 50-60%; that Nevro’s reps couldn’t get the devices to work again; that the device harms patients; that Nevro “just lies”.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-86e80aecb863",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "As additional corroboration, we share five detailed case studies of KOL's, each of whom was initially excited by Nevro's device only to experience an explant crisis, and who provided remarkably consistent and damning feedback about Nevro's technology and conduct. We begin with case study #1: a high volume implanter who described his initial experience with Nevro as \"almost miraculous,\" only to sour after seeing rampant failures within 3-6 months. He states that the 33% explant rate in the NANS paper is massively underreported and that the actual rate is \"tremendous\" and possibly 50-60%; that Nevro's reps couldn't get the devices to work again; that the device harms patients; that Nevro \"just lies\"; and that he's never seen anything like this with other stimulators. He bluntly stated that \"patients hate the Nevro device\" and that it's a \"piece of shit.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "43885398-54ad-47ec-938f-634f91894f2f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.56
          },
          "kind": "quote",
          "text": "The reps would then come out and go through their very rigid algorithm. And most of them couldn't get the implants working again. And then I noticed that the high frequency started hurting patients.. It went from being great to not working to irritating.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "032ee275-0f89-4afa-a08e-df7faec68c05",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "quote",
          "text": "I worked with Nevro for a while, but I had a bad experience with them. When they first released [in the US] they had a study from Australia that showed that they were head over heels better than the other stimulators. I started implanting them, and it was almost miraculous. Patients loved it. Everything was great for a few months. But then I noticed that for a lot of the patients, the device stopped working after three to six months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c64f39a-31eb-46d0-a039-a42fc45d9202",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.8
          },
          "kind": "quote",
          "text": "I've worked with others to study their explant rate, because it's tremendous. I've been implanting for a long time and I rarely explant. Sure, sometimes stimulators don't work. But rarely do they stop working and irritate a patient. I mean, it's happened but not at the numbers we saw with Nevro. I would rarely explant people. I would say 1 or 2%, if that.\" -High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6e7edb7a-f7f2-4a7d-8998-749be415af27",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.66
          },
          "kind": "quote",
          "text": "The 33% explant rate for Nevro devices [in the NANS paper] is definitely low. It's significantly higher. Patients hate the Nevro device. That thing is a piece of shit. The explant rate could easily be 50-60%. It definitely doesn't work much more often than it does 6-12 months out. The high frequency is causing the nerves to become hypersensitive. The company just lies. They're full of it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "78aaa0f7-8367-4517-bd3d-6628f9b8ec14",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I worked with Nevro for a while, but I had a bad experience with them... Patients hate the Nevro device. That thing is a piece of shit. The explant rate could easily be 50-60%... The company just lies. They're full of it.” — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-8a7438c11c06",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98e5de4e-e85e-4c57-9d6b-a0bb86f82107",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "667087e9-3899-48e0-ab3c-7abe8f1faf1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.047+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ecf15ed8-4a58-40b5-a313-36b80bbe3f28",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 96,
      "type": "evidence",
      "title": "The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 11,
        "textChars": 3017,
        "nDataPoints": 4,
        "notes": "The slide uses highlighted text to emphasize key negative performance metrics and qualitative feedback.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:46.207+00",
          "seconds": 5.399,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/96",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-96",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "He states that he didn’t have a single back/leg pain patient who made it past a year, and that only 2 out of 90 patients he implanted with Nevro still have the device – an explant rate approaching 100%.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-066eda8461a8",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 100%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-0d4eed391981",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #2: A high volume implanter and KOL who was also initially impressed with Nevro's data, only to see patients fail \"like clockwork\" within 3-6 months. He states that he didn't have a single back/leg pain patient who made it past a year, and that only 2 out of 90 patients he implanted with Nevro still have the device – an explant rate approaching 100%. He added that \"a lot, a lot of doctors\" have had the same experience with a \"70-80% explant rate.\" Similar to the first case study, the KOL emphasized that his explant rate with other companies' stimulators is negligible.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c8d07e95-8fe0-4b5d-bea5-7ae8fedf3ee0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "quote",
          "text": "\"A third of my explants were because the device sucks. The device stops working - call that the reason a third or fifty percent of the time. The vast majority of my explants were because the device stopped working. The remainder were because of the rep not being able to program it. If the leads move even a little bit the Nevro reps get lost and they don't know where to program because there's no buzzing or tingling, no paresthesia. So they don't know what to do. They're programming blind.\" - High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6eeb510d-8b1c-4e3a-bc3e-c81bdccd3aca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "\"The patients' pain just came back. It was pretty consistent. It was between three to six months almost across the board, or if not then by 8 months. I didn't have a single patient that made it past a year except for the ones with abdominal pain. Every other patient - like every one of them - I might have 2 back patients that still have it out of 90 I implanted with Nevro. That's not unheard of. There are a lot, a lot, of doctors who have had that experience. I know of a lot of doctors who had a 70-80% explant rate. My overall explant rate is very low. No one can say that my Nevro explants were due to my patient selection\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7ace8ee-f19d-4465-904f-2b7835b7630b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "\"But then the failures just kept coming. People just kept getting explanted or the pain just kept coming back. I used to use Nevro for just about everything, like low back pain, leg pain, and neck pain. But after three to six months it was like clockwork that patients just started shitting the bed. So I just stopped using it. In 2016 and 2017 Nevro was 40% of my implant volume and then a drop in 2018 and 2019. I've only used two Nevro devices this year.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca0719da-93b8-40fc-af91-07f9b242eabc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "quote",
          "text": "\"When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and I was very impressed with it in the beginning.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d73fca77-1e3e-414a-ae52-66c011c4f21d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“When Nevro launched in 2015, I was really interested in the data and how much better it worked than regular spinal cord stimulation. So I used it and I was very impressed with it in the beginning.” — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:31+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-09092cc22531",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "de56ea6d-dde8-4a52-8170-cd48b8a3b4a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "be31d777-c038-4ccd-b12d-d44a866b8a68",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.207+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d32cf136-2cc4-4bd9-8b67-28f675029de8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 97,
      "type": "evidence",
      "title": "Case study #3 of 5.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 9,
        "textChars": 2828,
        "nDataPoints": 3,
        "notes": "Case study #3 of 5.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:49.776+00",
          "seconds": 8.619,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/97",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-97",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "He stated that patients started off well, only to experience a quick collapse in efficacy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-6e647c0820ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #3: One of the most prominent KOL’s in the field – a former Nevro consultant and speaker – described his initial enthusiasm for Nevro’s device, implanting 80 within the first 18 months. He stated that patients started off well, only to experience a quick collapse in efficacy. As a well-known figure, he regularly conducts group sessions with other “busy implanters,” whose experience with high frequency failure was similar to the point that they also became “hesitant to use the product.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ed30ba00-05d4-4e0a-a8c1-dfdd1a489255",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "“When Nevro first came out I was using primarily Boston Scientific. At the time I thought it was the best product on the market but I was convinced to try Nevro. I had a couple of patients that weren’t getting relief with Boston, so we hooked them up to a Nevro device and it did very well. So that precipitated my journey from Boston Scientific to Nevro several years ago. And probably the first 18 months I put in close to 80 Nevro implants and did 100 trial implants which is a fair amount.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "29679fb2-e4db-4bfc-a432-997040bd0db8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "quote",
          "text": "“I’ve consulted at length for Boston Scientific, Abbott, Nuvectra, and of course Nevro over the course of my career. I have been doing implants for 20 years. I’ve put in probably several thousand over the years and probably do about 5 or more per month. I actually am [role redacted] at [medical journal name redacted] which is kind of the bible for neuromodulation. I would review papers on stimulation every month as a peer-reviewer so I’m quite versed with the field.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "789b20bb-4a28-4e1d-a0b5-5025321bcaea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "“What I noticed is that initially almost everybody did really well and subsequently there was a big fall off. We would hold round tables where we would have 15 implanter leaders and I and two other moderators would talk about the space in general and I found that I was not alone and that other busy implanters also had the same experience, where initially things looked good and then there was a significant drop off to where many doctors were hesitant to use the product.” -Ex-Nevro consultant/speaker and one of the most prominent KOL’s in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fcd7eed0-34b2-411f-b039-455a054ccde4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I’ve consulted at length for Boston Scientific, Abbott, Nuvectra, and of course Nevro over the course of my career. I have been doing implants for 20 years. I’ve put in probably several thousand over the years and probably do about 5 or more per month. I actually am [role redacted] at [medical journal name redacted] which is kind of the bible for neuromodulation. I would review papers on stimulation every month as a peer-reviewer so I’m quite versed with the field.” — Ex-Nevro consultant/speaker and one of the most prominent KOL’s in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-716cf301a541",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.93
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f68dd460-3847-4234-90ef-e2640c8ae3b8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro’s explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL’s",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "71b81bfd-2ef0-44a0-be13-c3c1fa5b3bb4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:49.776+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f14a7b4-79c3-45e6-841e-4a8dda7389bb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 98,
      "type": "evidence",
      "title": "The slide uses highlighted text to emphasize critical data points regarding patient satisfaction and explant rates.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 90,
        "componentCount": 10,
        "textChars": 2159,
        "nDataPoints": 5,
        "notes": "The slide uses highlighted text to emphasize critical data points regarding patient satisfaction and explant rates.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:46.374+00",
          "seconds": 5.158,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/98",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-98",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "If all the patients were included, the explant rate in the study would have been closer to 50% [versus the 33% in the paper].",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-54bc8253f495",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "explant rate: 50%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-5c6e965f2aba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #3 (cont'd): He elaborated that 75% of Nevro patients experienced a collapse in efficacy, with explants beginning within 6 months and then accelerating. This KOL was familiar with the NANS paper which reported a 33% explant rate, and stated that the rate would have actually been ~50% if not for methodology constraints. Notably, he added that other papers on Nevro's alarming explant rates are in peer review “to be published shortly.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ff186534-1d10-4054-b5fd-7e9245b4dd47",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“I noticed that 50% of patients were not getting relief by end of one year, and within 18 months, 75%. I think the efficacy drop off was present at a year, but it may have taken us 18 months to really delve into how many patients weren't getting relief.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "668b3dab-01e3-49bd-82f9-580d7556a18f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "“I would say overall probably 25% of the patients are satisfied with Nevro, maybe less. We first started seeing a diminution at about 6 months, and it really became prevalent at close to a year. I would say on average, towards the end of the first year of the implant, we saw a huge drop off in efficacy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8f6f01d1-7dc7-41f3-9e0d-539cf223b421",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.59
          },
          "kind": "quote",
          "text": "“If all the patients were included, the explant rate in the study would have been closer to 50% [versus the 33% in the paper]. Including the patients he wasn't able to follow, the explants would have been worse. There was another doctor [name redacted] who had a high implanting volume. Exact same story. Other papers on explant rates are in peer review to be published shortly.” —Ex-Nevro consultant/speaker and one of the most prominent KOL's in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4cd6810-3bc9-44ea-a1f7-d7541a761cd3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I would say overall probably 25% of the patients are satisfied with Nevro, maybe less. We first started seeing a diminution at about 6 months, and it really became prevalent at close to a year. I would say on average, towards the end of the first year of the implant, we saw a huge drop off in efficacy.” — Ex-Nevro consultant/speaker and one of the most prominent KOL's in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-5827dcbe8080",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.25,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee751743-88be-49cc-8fd9-89a623147441",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "929dc980-97ed-40c4-828c-6c88fb9002ac",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.374+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76a8152b-d8e9-4bb2-964c-a8a90d27294d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 99,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key allegations of fraud and data manipulation.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2210,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key allegations of fraud and data manipulation.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:50.906+00",
          "seconds": 8.612,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/99",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-99",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "He referenced conversations with Nevro reps who admitted as much, leading him to label it \"a big scam\" with \"criminal\" data manipulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-8bb9f43a21ef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "But with Nevro, two things made them the big bang success at the beginning... I know how this works, and in everything we did we would augment [the data] a little bit to get manipulation of statistics and so forth, but for this kind of number, this was like...what??",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "108abd5a-db9e-49ed-b4ab-d44752273a63",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "quote",
          "text": "If a doctor says I use Medtronic, Boston Scientific, or Abbot, the outcomes would be relatively similar... the reality is they are so similar that it's not that different.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "612e61e7-24c0-41f5-ae40-69870245424e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "quote",
          "text": "Case study #3 (cont'd): He stated that he was initially excited by Nevro's SENZA pivotal study data... leading him to label it \"a big scam\" with \"criminal\" data manipulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ea77da2e-2c6c-4a51-a952-fa153a12931d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "We subsequently found out, as we spoke to former Nevro reps who were involved in the Senza study, that the manipulation in statements from the patients was crazy... The way that they manipulated the data was criminal. I would say that the bigger names in neuromodulation who weren't getting paid by them, think of Nevro with disgust.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef632730-1dd4-4244-8d78-bb996563beed",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"If a doctor says I use Medtronic, Boston Scientific, or Abbot, the outcomes would be relatively similar... the reality is they are so similar that it's not that different.\" ... \"But with Nevro, two things made them the big bang success at the beginning. They came out with the Senza study which showed just amazing outcomes... I know how this works, and in everything we did we would augment [the data] a little bit to get manipulation of statistics and so forth, but for this kind of number, this was like...what??\" ... \"We subsequently found out, as we spoke to former Nevro reps who were involved in the Senza study, that the manipulation in statements from the patients was crazy... So, it was a big scam. The way that they manipulated the data was criminal. I would say that the bigger names in neuromodulation who weren't getting paid by them, think of Nevro with disgust.\" — Ex-Nevro consultant/speaker and one of the most prominent KOL's in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-8fb07a93e3f5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5a7401c-d329-4f15-acee-1ca48534fd90",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e08a4c1-3607-4453-b596-678ac31605cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a518e75c-4220-43f5-952a-88d9e3e38156",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "34004c08-996a-4490-aec1-38e4279b966c",
          "evidence": "The slide explicitly frames the content as exposing fraudulent data manipulation in a clinical study.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:50.906+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 99,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 100,
      "type": "evidence",
      "title": "The slide uses a 'case study' format to expose product failure and corporate ethics issues.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3267,
        "nDataPoints": 0,
        "notes": "The slide uses a 'case study' format to expose product failure and corporate ethics issues.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.589+00",
          "seconds": 5.201,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/100",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-100",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I realized this shit doesn't work. I'm not beholden to a company. Whichever device I'm using now, if I think there's a better mousetrap I'm jumping to it. I don't have any brand loyalty.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-e70335e0a2fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #3 (cont'd): The KOL described visiting Nevro's headquarters to address rampant device failure and explant rates. The company sent their top experts who spent 4 months flailing in their attempts to get the therapy working again, at which point the KOL ceased using Nevro. He said he had a strong relationship with Nevro; that they \"paid me a lot of money\" as a consultant/speaker; but concluded the technology just \"doesn't work\" despite working \"hard with them to try to accomplish this.\" He expressed dismay at Nevro's ethics and ongoing \"smoke and mirrors\" – calling it \"crazy.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bfc3791c-f49e-4602-95a8-631476196969",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "quote",
          "text": "\"I had a good relationship with Nevro. They took really good care of me. They flew me all over the country to speak, paid me a lot of money, put me in first class which is unusual for consultants, so I didn't have any animosity towards them. It was just that the patient outcomes never showed up. I worked with them thinking their device was good stuff. I know how to do neuromodulation, so when Nevro's devices didn't work, I thought maybe there's a different way to change the program, change the location, do something different. I worked hard with them to try to accomplish this and I was beating my head against the wall because it just wasn't happening. I tried everything to make the devices work, as a scientist. I wanted to see where the problem was. When I looked at their data I was like, ok that's not what I got, am I doing something wrong? So I worked hard with them to rectify it, but there was nothing to rectify.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4aa53556-c12d-43f1-90f0-2c3f722daf93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "quote",
          "text": "\"We went to Nevro's headquarters to discuss the high explant rates and for four months they had their top couple of programmers come down to my office to see a bunch of my patients and \"optimize their therapy.\" It got to the point where I was like, we can't do this anymore. After 18 months I stopped implanting Nevro. I realized this shit doesn't work. I'm not beholden to a company. Whichever device I'm using now, if I think there's a better mousetrap I'm jumping to it. I don't have any brand loyalty.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "55468618-41f4-40e5-8f74-e892327b2221",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.81
          },
          "kind": "quote",
          "text": "\"I don't understand how these people can...I worked my ass off to make Nevro's device work and spent days and days in my office trying to figure out this stuff and nothing was working and it wasn't because I was a shitty implanter..I don't understand how Nevro can continue to keep the smoke and mirrors going, I really don't. I mean, it's crazy. It's a cult, for sure.\" -- Ex-Nevro consultant/speaker and one of the most prominent KOL's in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5dcfc06a-0a57-443c-ba1c-f6450a961826",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“We went to Nevro’s headquarters to discuss the high explant rates and for four months they had their top couple of programmers come down to my office to see a bunch of my patients and ‘optimize their therapy.’ It got to the point where I was like, we can’t do this anymore. After 18 months I stopped implanting Nevro. I realized this shit doesn’t work.” — Ex-Nevro consultant/speaker and one of the most prominent KOL’s in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-e85f50b6a24c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3e49e825-3dab-4127-b86b-4be3decbcdcc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1623e50a-a5cc-42ad-a427-098811456f95",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.589+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbd92b47-3003-4649-a6c1-b75dbe91d694",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 101,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize critical claims about medical device safety and physiological impact.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2152,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize critical claims about medical device safety and physiological impact.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:53.218+00",
          "seconds": 10.813,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/101",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-101",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.4
          },
          "kind": "callout",
          "text": "You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance. The pathological changes that may have occurred in patients with Nevro's HF10 therapy are being studied.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "300393d6-4976-4765-b00f-8d753dbbf4ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "callout",
          "text": "I'm saying it's just too much energy and you have to back off. Either the cells are down-regulating and can't hear the noise anymore, or there's an inflammatory response to high frequency and you are get cell formation that's impeding the electrical signal.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "722716c4-0d24-47af-aa73-6c63cfc30a4f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "callout",
          "text": "I believe, and a lot of other doctors believe, that you can only pound on the spinal cord so much. You're seeing a shift now, where other companies are pulsing the energy where it's on for 30 seconds, off for a couple of minutes, repeat.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6f1020e-b61c-4bdb-b183-1814f0326573",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "The pathological changes that may have occurred in patients with Nevro’s HF10 therapy are being studied.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-ffdca9fc838e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #3 (cont'd): The KOL offered detail on why he and \"a lot of other doctors\" believe Nevro's technology fails and is actually harmful to the spinal cord. Similar to other KOL's, he stated that high frequency overwhelms the spinal cord, inducing tolerization.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c1f3ba4-992c-47b0-8db8-df0ced468450",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“You can only beat on the spinal cord so long before a refractory response happens. Look at drugs – ones that effect the nervous system lead to tolerance... The pathological changes that may have occurred in patients with Nevro’s HF10 therapy are being studied.”; “I believe, and a lot of other doctors believe, that you can only pound on the spinal cord so much. You’re seeing a shift now, where other companies are pulsing the energy... as a potential way to mitigate the tolerance that occurs in the nervous system.”; “I’m saying it’s just too much energy and you have to back off. Either the cells are down-regulating and can’t hear the noise anymore, or there’s an inflammatory response to high frequency and you are get cell formation that’s impeding the electrical signal.” — Ex-Nevro consultant/speaker and one of the most prominent KOL’s in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-01415ea43407",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb0389f8-a966-4351-b5b5-9c4821e88206",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.72,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e940750e-3fce-4b65-9c10-6eb2e548bf36",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fffef00d-fb28-42d3-a917-b04b342e982b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Anadiplosis",
            "slug": "anadiplosis",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-a0a5-75f9-a98c-7b7d8ee377a1",
            "version": 1,
            "bodyDocId": null,
            "description": "Ending one clause with a word that begins the next",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "f0c11bd8-0b0f-4882-bb7d-241cc6d99f74",
          "evidence": "The use of repeated phrases and ideas, such as the concept of 'beating on the spinal cord' and 'refractory response,' demonstrates anadiplosis.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-16 23:09:34.393631+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 101,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Villain slide",
            "slug": "villain-slide",
            "status": "active",
            "bestFor": "In activist decks where the personality matters",
            "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
            "version": 1,
            "bodyDocId": null,
            "description": "A dedicated slide presenting the named villain visually",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "cbd71043-0948-48b0-a12c-505a4195f79a",
          "evidence": "The slide presents a critical view of Nevro, highlighting concerns about its product's effectiveness and safety, which aligns with the villain slide technique.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": "In activist decks where the personality matters",
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-16 23:09:34.3603+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 101,
          "whyItWorks": "Makes the antagonist concrete",
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "c597402b-63fb-4f31-804d-b556c51f677d",
          "evidence": "The slide frames the company's technology as the 'villain' causing harm to patients.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:53.218+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 101,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 102,
      "type": "evidence",
      "title": "The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.",
      "function": "illustrate_case",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 66,
        "componentCount": 7,
        "textChars": 1883,
        "nDataPoints": 0,
        "notes": "The slide uses a pull-quote to highlight negative sentiment from a key opinion leader.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:46.004+00",
          "seconds": 3.585,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/102",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-102",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "His take on Nevro is slimy people, falsification of data.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-b60f85de7b8c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #3 (cont’d): The KOL concluded with comments we found particularly withering given his previous role as a Nevro consultant/speaker/advocate – that there is “no question” that anyone not influenced by Nevro payments “has the exact same clinical experience with explants that I had” and that the company is viewed by the most credible and ethical KOL’s in the field as “slimy people” with “falsification of data.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.004+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2b97fdc1-6318-4d8c-adc6-4151c1b573c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "quote",
          "text": "“No question, no question, that anybody who’s not in the Nevro cult has the exact same clinical experience that I had with explants. Not a question. Additionally, you should talk to [KOL name redacted]. He is the former chairman of [redacted] at [redacted] University and then former chairman of [redacted] at the University of [redacted]. He knows every inside story about everything. His take on Nevro is slimy people, falsification of data. Everything we have talked about but amplified. He can’t stand them. He’s a real ethical guy.” -- Ex-Nevro consultant/speaker and one of the most prominent KOL’s in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.004+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b88afbff-0ab0-407c-9124-32c1c5f51c02",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"No question, no question, that anybody who’s not in the Nevro cult has the exact same clinical experience that I had with explants. Not a question. Additionally, you should talk to [KOL name redacted]. He is the former chairman of [redacted] at [redacted] University and then former chairman of [redacted] at the University of [redacted]. He knows every inside story about everything. His take on Nevro is slimy people, falsification of data. Everything we have talked about but amplified. He can’t stand them. He’s a real ethical guy.\" -- Ex-Nevro consultant/speaker and one of the most prominent KOL's in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-ba318c76eb1e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.004+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "95d3e038-4116-4e0b-aebd-f1161af7eb4c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro’s explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL’s",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.004+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ba6641ce-f784-4b9c-8ce9-a8e2924af6c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:46.004+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1d0b159c-f538-4615-af32-d5feaffa8696",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 103,
      "type": "evidence",
      "title": "The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2877,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's product reliability and transparency.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.636+00",
          "seconds": 5.187,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/103",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-103",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I made the decision that Nevro can't really be used, based on the problems we're seeing. So, the percentage of my implants that are Nevro is zero. None.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-9fbef13317f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #4: A fourth high-volume implanter and KOL corroborated the accuracy of the previous case studies in detail. He stated he is friendly with some of Nevro's top engineers, and that his conversations with \"hundreds of physicians across the US and internationally\" – in his capacity as a speaker/educator – underscored the widespread nature of Nevro's device failure and explants crisis. He personally came to the conclusion that Nevro simply \"can't be used, based on the problems we're seeing,\" and questioned Nevro's refusal to publish real explant data.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3c63c7c4-10e7-413a-a108-911ad3e562f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "quote",
          "text": "\"I can tell you from talking to hundreds of physicians across the United States and internationally, because I did speaking programs internationally, it's about explants. The number of explants that you see...you can do the math. Why doesn't Nevro publish its explant data? We've asked them to do that, and they refused. You put a stimulator in, life is good for a little while. Then the honeymoon's over. Nevro doesn't talk about explant data long-term, and you need that because that's real life.\" – High volume implanter/speaker/KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "987d8eb7-c023-4acd-95a8-33daacecc51b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "quote",
          "text": "\"Some of the engineers at Boston Scientific went to Nevro. I know a couple of them very well. There was a pretty significant falloff in Nevro usage after the honeymoon period of something new and sexy hitting the market. There were significant problems, including in evaluating their studies. We saw this before with St. Jude. Based on Nevro's study design and based on the number of explants that I and other doctors have had to do, I made the decision that Nevro can't really be used, based on the problems we're seeing. So, the percentage of my implants that are Nevro is zero. None.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0b194ae-e358-434f-9bb9-c183138ad45f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.3
          },
          "kind": "quote",
          "text": "\"I use Boston Scientific, but I'm not hard-core. I haven't done slideshows for them in three years, maybe more, so it's not like I'm a sheltered animal, I just wound-up evolving to use them. I implant maybe 75 stimulators per year, sometimes 100.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b634aa8e-0a35-4b98-9737-270db09101cb",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Some of the engineers at Boston Scientific went to Nevro. I know a couple of them very well. There was a pretty significant falloff in Nevro usage after the honeymoon period of something new and sexy hitting the market. There were significant problems, including in evaluating their studies. We saw this before with St. Jude. Based on Nevro’s study design and based on the number of explants that I and other doctors have had to do, I made the decision that Nevro can't really be used, based on the problems we're seeing. So, the percentage of my implants that are Nevro is zero. None.” — High volume implanter/speaker/KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:32+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-a352a93a74ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ee738d6-ce69-4401-9f4f-947a619ff698",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4ff72c01-739d-4aa9-873b-f2b75ca8c2a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.636+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4ace6129-67df-4506-9905-626912ed4329",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 104,
      "type": "evidence",
      "title": "The slide uses highlighted text to emphasize critical quotes from a medical professional.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3215,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize critical quotes from a medical professional.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.27+00",
          "seconds": 4.488,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/104",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-104",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "He stated that Nevro’s product was designed for “lazy” or “greaseball” implanters who don’t care about patient outcomes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-2f3359dd7097",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #4 (cont’d): The KOL – identical to the other case studies – said he was initially excited by Nevro’s data only to become disillusioned by “huge problems” at which “we just shook our heads” during peer meetings. He stated that Nevro’s product was designed for “lazy” or “greaseball” implanters who don’t care about patient outcomes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d0b93ca7-d65b-456f-95b5-ba12ef19da7d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "quote",
          "text": "If you're a lazy implanter and you don't want to look for the right spot to implant and actually program patients, Nevro is perfect for you. You put the leads in exactly the same spot every single time, don't have to do any work, the rep turns it on and there you go. This requires physicians that don't care what the outcomes are, that are greaseballs, or that are just lazy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "046886c0-9c33-4454-8747-618e9352df6f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "quote",
          "text": "When Nevro first launched, we looked at this and said, \"There could be something to a high rate of stimulation. You're basically flooding the zone. What a great idea.\" And then you start going through the study design, and you start looking at real outcomes, and there were so many problems. Huge problems with their study, the Kapural study in 2015. There were so many problems that we just shook our heads in some of our small doctor groups.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "143f7774-8554-4a62-a078-6e7d73e5d2c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "quote",
          "text": "Some people use statistics to bend the truth. We catch Nevro on the little things, but the overall gestalt is that their device needs to work for a long period of time. We know from the Kumar study that stimulating with one modality, one waveform, fails as time goes on. You need to come up with something else that the body doesn't get used to. We've known that for years. Nevro is just starting to figure that out. They're behind on the eight-ball.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a48cc71-e57f-43af-bb71-44caa9754a92",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“When Nevro first launched, we looked at this and said, \"There could be something to a high rate of stimulation. You're basically flooding the zone. What a great idea.\" And then you start going through the study design, and you start looking at real outcomes, and there were so many problems. Huge problems with their study, the Kapural study in 2015. There were so many problems that we just shook our heads in some of our small doctor groups.” “If you're a lazy implanter and you don't want to look for the right spot to implant and actually program patients, Nevro is perfect for you. You put the leads in exactly the same spot every single time, don't have to do any work, the rep turns it on and there you go. This requires physicians that don't care what the outcomes are, that are greaseballs, or that are just lazy.” “Some people use statistics to bend the truth. We catch Nevro on the little things, but the overall gestalt is that their device needs to work for a long period of time. We know from the Kumar study that stimulating with one modality, one waveform, fails as time goes on. You need to come up with something else that the body doesn't get used to. We've known that for years. Nevro is just starting to figure that out. They're behind on the eight-ball.” — High volume implanter/speaker/KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-33b5006db37e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f0e014be-74d2-4437-a50d-88f8e2e5edac",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro’s explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL’s",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "558bf5aa-21ef-4ca4-8afc-7ad9bb4ba224",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.27+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a36a4217-59c1-4480-8fdb-af6b1039e70e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 105,
      "type": "evidence",
      "title": "The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 11,
        "textChars": 2770,
        "nDataPoints": 0,
        "notes": "The slide presents a qualitative case study (KOL #5) to support the thesis of widespread device failure.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:48.259+00",
          "seconds": 5.391,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/105",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-105",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I used to be a 100% Nevro believer in the beginning. They can say or claim whatever they want but it's not true in clinical practice. It’s absolutely not true that it can handle back and leg pain. Nevro is a one trick pony.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-ce7e9739457a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Case study #5: We include detailed color from a fifth KOL - who spent time with Nevro's CEO - whose experience implanting Nevro is a carbon copy of the previous four doctors: initial enthusiasm as \"a 100% Nevro believer,\" followed by rapid device failures and explants the likes of which he \"had never had before.\" He stated that 6 to 7 doctors he compares notes with had the same experience, and expressed skepticism of doctors who claim otherwise, saying their purported lack of explants is not credible. He described widespread disillusionment among implanters, said Nevro's clinical claims are false, and that it's a \"one-trick pony.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "101950d7-2d36-4dff-85fa-21c1953ca62e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.79
          },
          "kind": "quote",
          "text": "\"I used to be a 100% Nevro believer in the beginning. They can say or claim whatever they want but it's not true in clinical practice. It's absolutely not true that it can handle back and leg pain. Nevro is a one trick pony.\" - High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20f0b81d-a422-440a-8efd-18bf21a2023f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.69
          },
          "kind": "quote",
          "text": "\"I compare notes with 6 to 7 other doctors in the area. Nevro gets one guy to try their device and be excited, and then the initial excitement wears off. Surgeons who used to only use Nevro have all gone back to Medtronic or St. Jude.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c4d930d-1abb-45bc-afa8-5bee2cce4786",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.47
          },
          "kind": "quote",
          "text": "\"For a while we all believed we had to have high frequency, like it was the holy grail. I'm not sure if it was just a placebo effect at the beginning with high frequency, because patients liked the idea of new technology. I don't expect device failure in the first 6 or 12 months. Nevro bragged about their 24 month success rate. I was dismayed after I got 3 to 4 failures within the first 2 to 3 months. I had never had that before.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "630aec09-e28a-41ac-9c08-f3bb24bd0a0a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "\"A local doctor [name redacted] says he's done 450 Nevro implants without any explants and none of us other implanters in the area believe his data.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b85ff8e3-c40f-4652-a434-77c86a4f445d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "quote",
          "text": "\"I started using Nevro in late 2015. Before that I split my volume between Abbott and Medtronic. I got excited by Nevro. I thought it was the Tesla of spinal cord stimulators. It got a lot of interest among implanters. Now everyone is doing high energy stimulation. I stopped using Nevro toward the end of 2018. I became increasingly frustrated as I began to see a lot of failures with the device. I had dinner with the CEO.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d33ab3d5-0881-48c5-b735-57a088166ffc",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I used to be a 100% Nevro believer in the beginning. They can say or claim whatever they want but it's not true in clinical practice. It’s absolutely not true that it can handle back and leg pain. Nevro is a one trick pony. — High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33e-d17d229bdcf0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8029cd08-4651-4578-9e3d-4cd577b4ea04",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "7. Nevro's explants crisis is pervasive yet unknown to most investors: case studies of 5 KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3606ecf4-52df-4d5c-99e6-f2228ec4cedb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.259+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d997e51-1fca-4f25-9f6e-d522fac1eb53",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 106,
      "type": "tension",
      "title": "The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2823,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from two KOLs to highlight perceived contradictions between their public statements and the reality of device performance.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.202+00",
          "seconds": 4.124,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/106",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-106",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-150416048d0a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "In striking contrast to some of the most prominent implanters/KOL’s in the field, the Nevro loyalists we spoke to stridently denied the existence of explants. We spoke to two of Nevro’s key “KOL’s,” both among their highest volume implanters and widely known as go-to doctors for their studies. We believe they are near the top of the leaderboard for speaking/consulting fees. The first melodramatically claimed that he has personally never seen, nor is aware of anyone else who has ever seen, a Nevro device fail. Then he falsely claimed he has no financial connection with Nevro, contradicting his own conflict-of-interest disclosures in multiple papers. Comically, we learned from his colleague that he’s dismayed with Nevro after experiencing pervasive explants himself. The second Nevro adherent claimed he has only one Nevro explant out of hundreds – logarithmic magnitudes below Nevro’s own purported rates. We found him belligerent at the slightest question, emphasizing his awards and accusing us of working for a Nevro competitor.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38a41873-873c-4110-8aca-8fe97b9ec4aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "Nevro loyalist KOL #1: \"I have never seen a person who used Nevro and say it didn't work. I haven't seen one....I have no financial connection with Nevro or any other company...Ask people who use Nevro and find one who says it doesn't work...There are doctors who are really against Nevro despite using only one implant but opposing it from beginning. They complain it's not working. It's just their opinion. It's never backed up with quality studies. We produce a lot of papers based on science.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "363c2931-08c7-4bfc-8a7e-3b2f81fd3fbf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "quote",
          "text": "Nevro loyalist KOL #2: \"I like Nevro because of its efficacy and long term outcomes. We've removed one device. That's a great achievement out of the hundreds of devices implanted...I got a lot of accolades for the study. I got 7 awards for the publication.\" Our question: How confident are you of the Senza pivotal study? \"Of course it's not a blinded study. Are you aware of any blinded studies? How can it be blinded? Are you a consultant for Boston Scientific??\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c85db99-6380-4c48-bb34-14d973c8eab0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I have never seen a person who used Nevro and say it didn't work. I haven't seen one....I have no financial connection with Nevro or any other company...Ask people who use Nevro and find one who says it doesn't work...There are doctors who are really against Nevro despite using only one implant but opposing it from beginning. They complain it's not working. It's just their opinion. It's never backed up with quality studies. We produce a lot of papers based on science. — Nevro loyalist KOL #1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-1ab44c641f68",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84d03ee1-742e-496a-9d34-f4ca07e18595",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f99dfa2d-fa28-4050-87a6-78f8c302b014",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.05
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ac85ec31-cd4c-424f-9746-7e32a08dd2c5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "a25ec51d-9623-4e6b-836b-a755ee179d43",
          "evidence": "The slide explicitly frames the KOLs' statements as 'false' and 'contradicting' disclosures to expose potential corporate malfeasance.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:47.202+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 106,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 107,
      "type": "tension",
      "title": "The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.",
      "function": "expose_contradiction",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 8,
        "textChars": 1911,
        "nDataPoints": 1,
        "notes": "The slide uses heavy yellow highlighting to emphasize damning statements from anonymous industry experts.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "at": "2026-07-17 03:50:50.788+00",
          "seconds": 37.794,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/107",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-107",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-5e5707521915",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's stated their belief that the company is aware of its explant problem but \"couldn't care less\" and made a \"conscious decision\" to ignore it, but that doctors were nonetheless starting to 'pick up on it.' A former Nevro regional sales director... indicated that Nevro kept explant rates \"very well hidden from the field reps.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "description",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fe00ad8-d0cf-4a9a-9afb-49b76bcfe372",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.6
          },
          "kind": "quote",
          "text": "\"Nevro keeps explant rates very well hidden from the field reps... The explant rate was a hell of a lot higher than [the stated] 2%... Don't ask questions you don't want to know the answer to.\" - Former Nevro regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "04352ddd-3fa1-4401-b5ab-4ecee36db61e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.39
          },
          "kind": "quote",
          "text": "\"I don't get it because Nevro's device is a piece of crap. I think people are picking up on it, especially when they start reading papers... The company couldn't care less about explant rates. They know. It's obvious... They just want to sell the company.\" - High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c5db718-b315-4a61-b5cd-cb22f878b145",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I don't get it because Nevro's device is a piece of crap. I think people are picking up on it... The company couldn't care less about explant rates. They know. It's obvious. They don't want to hear from doctors because they already know this stuff. They've made a conscious decision. They don't give a shit. They just want to sell the company. — High volume implanter and KOL; Nevro keeps explant rates very well hidden from the field reps... The explant rate was a hell of a lot higher than [the stated] 2%. I don't know that people asked for it, because ignorance is bliss. I didn't want to know. Don't ask questions you don't want to know the answer to. My peers in the field felt the same way. — Former Nevro regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-6338265a41a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2799c7c3-c3b4-4a29-808e-6328e12680a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dbfc966e-9931-485d-9d37-26ef554399f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.42,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:50.788+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "750e78e6-e5e2-4c11-b726-e27fe452100a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Authority citation",
            "slug": "authority-citation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
            "version": 1,
            "bodyDocId": null,
            "description": "Quoting an authority figure, study, or precedent to lend weight.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "f2e9224f-5907-443b-ad97-bf3cee9c882f",
          "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:46.052872+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 107,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        },
        {
          "tool": {
            "name": "Villain slide",
            "slug": "villain-slide",
            "status": "active",
            "bestFor": "In activist decks where the personality matters",
            "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
            "version": 1,
            "bodyDocId": null,
            "description": "A dedicated slide presenting the named villain visually",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "64b51001-1d86-40a8-8073-924666f9a732",
          "evidence": "The slide is explicitly titled 'villain_critique' and presents critical information about Nevro's response to its explants crisis.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": "In activist decks where the personality matters",
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:55:46.010804+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 107,
          "whyItWorks": "Makes the antagonist concrete",
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 108,
      "type": "tension",
      "title": "The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3062,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from former consultants to substantiate claims of corporate misconduct.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.57+00",
          "seconds": 3.731,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/108",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-108",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-46999b7e7523",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "8. Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37db53ba-dc3b-45e4-830e-8189298e538b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "A KOL and former Nevro consultant reported other tactics beyond simply denying explants, describing behavior which sounds potentially retaliatory in trying to “discredit” doctors who criticize the company’s device, using the words “cult,” “Scientology,” “crazy,” and “fanatical” – labels identical or similar to those used by a number of other KOL’S. In particular, he detailed Nevro’s reaction to a paper which he stated showed that high frequency stimulation was degrading neurons and burning the myelin sheath. Another KOL alleged that Nevro planted doctors in conference audiences and gave them talking points.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b94d7e60-e76e-4581-a4a3-4797dd6f754b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.56
          },
          "kind": "quote",
          "text": "“Someone mentioned this article to someone else and next thing you know Nevro’s Chief Medical Officer quickly sent an email to Nevro’s entire sales force and to every one of their key opinion leaders accusing a doctor having written the article, just because the doctor happened to mention the article to somebody else. So they’re very fanatical. They’re very intense and anytime there’s the slightest bit of negative press they send out these massive press releases to all their doctors basically discrediting it and anybody who doesn’t believe it is not part of our camp and that’s it. They’re very intense.” – Former Nevro consultant and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "532e6dd4-19cd-4cb2-a344-8bd434045bf1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.05,
            "y": 0.32
          },
          "kind": "quote",
          "text": "“I was a consultant and speaker for Nevro from [redacted] to [redacted]. I was on the board of [society name redacted]. I just got tired of the company. I’m really well published in the field and it’s nothing personal against Nevro. Their devices just stopped working. Nevro is like a cult, like us versus them. It’s crazy. It’s like Scientology. They’ll cut you out, jump all over you. They’ll ostracize you and they’re very intense about it. There was a publication that [name redacted] did showing that high frequency stimulation was causing degradation of neurons. It was burning the sheath that goes around the axon, the myelin. People heard about this publication for a year or two before it came out.” – Former Nevro consultant and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a6487e1c-8c5b-4f3f-8a1a-4b6bdb76c39c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.76
          },
          "kind": "quote",
          "text": "“The doctors that use Nevro are very quick to raise their hands at conferences. It seems like Nevro gives them talking points. They train them on how to speak and what to bring up if someone says anything negative about Nevro.” - KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc006c5c-6f55-40ff-993c-2586ae138fc0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I was a consultant and speaker for Nevro from [redacted] to [redacted]. I was on the board of [society name redacted]. I just got tired of the company. I’m really well published in the field and it’s nothing personal against Nevro. Their devices just stopped working. Nevro is like a cult, like us versus them. It’s crazy. It’s like Scientology. They’ll cut you out, jump all over you. They’ll ostracize you and they’re very intense about it.” — Former Nevro consultant and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:33+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-491c3d939ad4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91096312-c8bd-4001-87f8-3f4b0c8aa0f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.57+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a58f041-4a35-4a41-955e-34b9cde18d34",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 109,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2902,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs to frame the company's management as deceptive and manipulative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.947+00",
          "seconds": 4.086,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/109",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-109",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-039fb009532e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "High volume KOL's who met with Nevro management regarding explant rates described a disinterested CEO and a company strategy of denial, deflection, and disingenuously blaming the patient or the implanter – which keeps low procedure volume doctors in line as they are easily manipulated by aggressive sales reps. One of the KOL's said Nevro had \"excuses for everything,\" blaming him and other doctors who raised the issue for having poor patient selection. The KOL methodically explained why Nevro's attempts to blame others were simply a deflection tactic.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8c4d390f-c1b6-4d41-861c-8e614f65f475",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.69
          },
          "kind": "quote",
          "text": "\"We had dinner with higher ups at Nevro to talk about explant rates. We didn't go to Rami [previous CEO]. He didn't want to hear about it. They have excuses for everything. They were just - whatever they could think of as an excuse. You have bad patient selection, you have more workers comp patients. I'd say all I've ever done are workers comp patients and they've always done great with other stimulators. My stats have always been comparable to regular patients. Nevro would make a bunch of excuses for explants by blaming the patients or blaming the doctors.\" – High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c455d0c-b329-4bb9-92b9-f0aa7744764b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "\"Most doctors that do stimulators only implant six a year. They don't do that many, so they're nervous. They're insecure about it. And the reps are knowledgeable and very aggressive They can run the show. So when you're doing half a dozen a year and they're not all with Nevro and you've had a couple of bad outcomes, the reps blame you, and the doctor accepts it.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91ad953a-a7e0-45b2-bddc-30a743f8305a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "quote",
          "text": "\"But I've been doing hundreds of these per year over my career and [doctor name redacted] is the same way. And we told Nevro, no, we do not have bad patient selection. Your stimulator outcomes just suck. Then Nevro would say, well you have more workers comp patients. And I'd say, yeah I've always had more workers comp patients and they've always done great on other stimulators. Nevro complained about [doctor name redacted, who criticized Nevro's explant rates], saying he had bad patient selection. He had the same patient selection he had for years. Same types of patients. He would switch them over to Nevro, when they needed a new one or the battery died.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a4e91c43-01b4-4824-b22a-a92c7b4466b0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Most doctors that do stimulators only implant six a year. They don't do that many, so they're nervous. They're insecure about it. And the reps are knowledgeable and very aggressive They can run the show. So when you're doing half a dozen a year and they're not all with Nevro and you've had a couple of bad outcomes, the reps blame you, and the doctor accepts it.” — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-05ae5729df36",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e2f264b-beae-4efa-a5fa-0b4e23042303",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "22baa8e7-5fbf-4259-aadf-ba5770ba6986",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7f710b18-5f02-43f9-aaf9-d6ff16ed32b7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4851a86d-55ec-4d54-851b-f75a0917ccb3",
          "evidence": "Frames Nevro management as the antagonist using KOL testimonials.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:47.947+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 109,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 110,
      "type": "tension",
      "title": "The slide uses a direct quote to frame the company's behavior as deceptive.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2782,
        "nDataPoints": 0,
        "notes": "The slide uses a direct quote to frame the company's behavior as deceptive.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:51.889+00",
          "seconds": 7.673,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/110",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-110",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro had given him talking points to convince me to come back. So they admitted, yes, you’re getting explants, but they wanted to convince me I wasn’t getting that many. I’ve heard they’ve done this with a lot of other doctors as well.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-32e61c732ba5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.06,
            "y": 0.16
          },
          "kind": "paragraph",
          "text": "Another KOL described in detail how Nevro denies the existence of explants and attempted to manipulate him into thinking that his device failure and explant rate wasn’t high. He indicated that Nevro tried the same tactics on “a lot of other doctors.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2704cd66-eef4-4631-8441-aaecd268bda1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "\"So I printed out an entire list of every patient I had ever implanted with them and I said \"You left this person out. You left this person out. You left this person out.\" I went down the list and said \"Of those that you say still have it, half of those don't. And you left off all the patients that got explanted\". Nevro had given him talking points to convince me to come back. So they admitted, yes, you're getting explants, but they wanted to convince me I wasn't getting that many. I've heard they've done this with a lot of other doctors as well.\"- KOL, former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5482684b-48bb-41c0-aa90-64a3d65eb5ea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "quote",
          "text": "Question: Did ever try talking to Nevro about these explant rates or were they just not receptive? \"They deny it. When Nevro saw my volumes drop off so substantially, they flew in a VP I had a relationship with. After bullshitting for an hour at dinner he says \"So what's going on, are you not with us anymore\" and I said \"Guys, I'm having all these explants.\" And they came prepared with ammunition to try and say \"Oh, here all the patients that are succeeding. The explants aren't as high as you think they are.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7edf416-7f36-4add-aa3c-bff048374af7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“They deny it. When Nevro saw my volumes drop off so substantially, they flew in a VP I had a relationship with. After bullshitting for an hour at dinner he says \"So what's going on, are you not with us anymore\" and I said \"Guys, I’m having all these explants.\" And they came prepared with ammunition to try and say \"Oh, here all the patients that are succeeding. The explants aren’t as high as you think they are.\" So I printed out an entire list of every patient I had ever implanted with them and I said \"You left this person out. You left this person out. You left this person out.\" I went down the list and said \"Of those that you say still have it, half of those don’t. And you left off all the patients that got explanted\". Nevro had given him talking points to convince me to come back. So they admitted, yes, you’re getting explants, but they wanted to convince me I wasn’t getting that many. I’ve heard they’ve done this with a lot of other doctors as well.” — KOL, former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-34caacc9bd38",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "436c15d1-e379-4971-b436-0a3c523f8c15",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "8. Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f969c91-c692-4d94-8876-338698447b69",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e43e522-f562-45b9-9f1b-6884b935f8cd",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "06984559-c29f-43a1-9ce8-c9b47583583c",
          "evidence": "The slide contrasts the company's official stance with a KOL's experience of manipulation.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:51.889+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 110,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 111,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3413,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs to frame the company as unethical and manipulative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:48.358+00",
          "seconds": 4.077,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/111",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-111",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-a817d176361b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Nevro may produce doctors, perhaps via sell-side reports, who attest that they haven't seen abnormal explant rates. KOL's advised us to be skeptical, dismissing them as inexperienced, willfully ignorant, or being paid by Nevro. One KOL stated that these Nevro loyalists were on the fringe, as reputable implanters and thought leaders wouldn't work with the company. The KOL implied Nevro was similar to a \"Scientology cult,\" a characterization we heard several times during our research. A second KOL indicated that Nevro's device was tailor-made for \"unethical, corrupt doctors\" who \"couldn't care less if there's a high explant rate.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34b46115-441e-4fb2-b038-3c948c4f8b49",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "\"If you put doctors into boxes, Money Mike couldn't care less if there's a high explant rate. It's just about the price you give him for the device. He could care less about whether it works or not. Yes, there are unethical, corrupt doctors. In that population, Nevro is the best thing since sliced bread.\" -KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77883a14-3a60-42e1-9c78-183d3bb02c37",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "quote",
          "text": "\"When Nevro first started, if you look at the doctors in the forefront, true thought leaders, key opinion leaders, the white shoe reputable people - that's not who they got. They brought in a bunch of guys - I wouldn't say they were outcasts, but... it was like a Scientology thing. They did these retreats at some huge mansion, like crazy stuff, and I remember coming back and telling my rep, \"What the heck was that?\" There are a few guys like [name redacted, one of Nevro's highest volume implanters and key study authors] who got in with them right away and they pumped him up. He went from 0 to 90 mph because of Nevro. He was on every committee and pumped it up at NANS. Nevro is not science. It's a cult and I am blown away because every doctor I know that does a lot of implant volume doesn't use Nevro except for a small cult.\" -KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7dbef950-7c24-4e59-9c19-516e3d69e6da",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"When Nevro first started, if you look at the doctors in the forefront, true thought leaders, key opinion leaders, the white shoe reputable people - that’s not who they got. They brought in a bunch of guys - I wouldn’t say they were outcasts, but... it was like a Scientology thing. They did these retreats at some huge mansion, like crazy stuff, and I remember coming back and telling my rep, \"What the heck was that?\" There are a few guys like [name redacted, one of Nevro’s highest volume implanters and key study authors] who got in with them right away and they pumped him up. He went from 0 to 90 mph because of Nevro. He was on every committee and pumped it up at NANS. Nevro is not science. It’s a cult and I am blown away because every doctor I know that does a lot of implant volume doesn’t use Nevro except for a small cult.\" — KOL, former high volume Nevro implanter; \"If you put doctors into boxes, Money Mike couldn’t care less if there’s a high explant rate. It’s just about the price you give him for the device. He could care less about whether it works or not. Yes, there are unethical, corrupt doctors. In that population, Nevro is the best thing since sliced bread.\" — KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-adad322861fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2beaa2cb-592d-49c4-95e9-e706ed6c99ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f299164-ae0c-4701-b8b3-b59df26f1766",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e2f2bdec-f873-44bc-9b8d-985bdcecdde6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c1d417c3-7c0a-4fb4-bc34-9aa44c06936a",
          "evidence": "The slide frames Nevro and its associated doctors as a 'cult' and 'unethical' to discredit them.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:48.358+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 111,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 112,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2562,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key claims about doctor behavior and financial incentives.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:47.777+00",
          "seconds": 3.292,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/112",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-112",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Several KOL’s indicated that doctors who deny the existence of explants do too few implants per year to notice or care that they’re failing.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-eb5d12415f59",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Several KOL's indicated that doctors who deny the existence of explants do too few implants per year to notice or care that they're failing.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ff9fd77-829e-4770-9e08-ec81b9c76161",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "quote",
          "text": "Then you have Kaiser docs like one who said to me that he thinks patients like Nevro. I said, \"You think patients like it because you do 10 implants a year and you really don't know.\" So there are a lot of Nevro doctors that don't do many implants, and then you have higher volumes ones at these surgery centers where it's a financial decision because of the price.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52dcf537-bff9-40b3-8907-2ed1e0d021d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "quote",
          "text": "For the low volume implanters, Nevro said, hey you don't have to test, you don't have to elicit paresthesias, you just put it in this one place T9/10 and that's all you have to do. The ease of implanting took the whole thought process out. When we used to teach neuromodulation 10-15 years ago, there were all kinds of algorithms. So that was incredibly attractive to implanters who didn't really do many - this is easy. You just put it in. And initially those few implants did really well. You thought things are good. After a while it didn't do so good, but you weren't doing enough neuromodulation to really pay attention to it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "58c9ab0f-cf5c-4d56-b4f3-cb360779c589",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Then you have Kaiser docs like one who said to me that he thinks patients like Nevro. I said, \"You think patients like it because you do 10 implants a year and you really don't know.\" So there are a lot of Nevro doctors that don't do many implants, and then you have higher volumes ones at these surgery centers where it's a financial decision because of the price.” —KOL, former high volume Nevro implanter; “For the low volume implanters, Nevro said, hey you don't have to test, you don't have to elicit paresthesias, you just put it in this one place T9/10 and that’s all you have to do. The ease of implanting took the whole thought process out. When we used to teach neuromodulation 10-15 years ago, there were all kinds of algorithms. So that was incredibly attractive to implanters who didn't really do many - this is easy. You just put it in. And initially those few implants did really well. You thought things are good. After a while it didn't do so good, but you weren't doing enough neuromodulation to really pay attention to it.” —KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-eca232a8b76b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ff7a8daf-f998-4a07-a09b-33236c72e4d3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8058294-3fb8-46c0-9f90-695942e85c82",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:47.777+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b7ca41e-b720-45c0-8ac7-8d1c16882fa1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 113,
      "type": "tension",
      "title": "The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insy",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2548,
        "nDataPoints": 0,
        "notes": "The slide uses aggressive, accusatory language and highlights specific quotes from KOLs to frame Nevro's business practices as unethical and similar to the Insys scandal.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:48.7+00",
          "seconds": 4.131,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/113",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-113",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The only way I know to change that doctor's practice paradigm is bribing. It works. You give a doctor some money and they will say whatever you want.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-d0494d91c117",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "paragraph",
          "text": "Comments by 3 different KOL's or high volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46b98f0a-6b30-4fe5-9afc-ab23557993e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "A KOL implied that doctors who deny Nevro's device failure and explants problems are consultants and speakers for the company who are being “bribed” to “say whatever you want.” He compared Nevro's practices to those of Insys, the notorious fentanyl vendor which went bankrupt after executives went to prison for a speaker and consulting program-driven pay-to-play scheme. Two other KOL's stated bluntly that doctors who deny Nevro's explants are “really lying,” “not following” up with their patients, or financially conflicted.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b617b1dc-31cf-4050-b521-2e942c4cc3ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "“Nevro has an almost cult-like following saying that this is really the best thing since sliced bread and no one's explanted. It's just not true. If you say that, then you're probably either really lying or not following your patients.” –High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "21c28d43-3771-430d-bb55-915d404657dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "quote",
          "text": "“I could give you two real strong advocates you can call on Nevro. They're very positive on it. But they've done studies with Nevro and work with them. Patients would say the opposite.” –KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "641ddcb7-1333-4c2b-981a-7dab3cb917e2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.36
          },
          "kind": "quote",
          "text": "“Doctors that implanted a lot of devices, they hated Nevro. I don't know doctors who were high volume Nevro implanters that liked it and continued with their device. The high volume Nevro implanters today who are involved with Nevro's studies – I saw the guys who went to jail for prescribing the Insys fentanyl drug. An Insys VP was saying how he hired hookers and strippers. You have to remember the doctor runs the show. And the only way I know to change that doctor's practice paradigm is bribing. It works. You give a doctor some money and they will say whatever you want. I would imagine Nevro probably doesn't give them money. They just hire them as consultants, pay them to give lectures and to teach classes. Doctors are whores.” –KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2806eef-7a87-4c9f-a931-ebee46551a7d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Doctors that implanted a lot of devices, they hated Nevro. I don't know doctors who were high volume Nevro implanters that liked it and continued with their device... The only way I know to change that doctor's practice paradigm is bribing. It works. You give a doctor some money and they will say whatever you want.\" — KOL, former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-d6e23ef643e4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af5d9545-f821-467d-8908-ef309684a084",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4ae53d49-7e73-4072-864b-d418585cce1f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aa35cadf-39a9-48a3-9362-b2746f25ecfc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e92bbe39-1adc-42fb-8bd0-8f40fc961e3d",
          "evidence": "The slide explicitly compares Nevro's practices to the Insys fentanyl scandal to frame them as fraudulent.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:48.7+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 113,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 114,
      "type": "tension",
      "title": "Uses a 'gotcha' interview format to frame the company's business model as deceptive.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2710,
        "nDataPoints": 0,
        "notes": "Uses a 'gotcha' interview format to frame the company's business model as deceptive.",
        "elementsJson": [
          "paragraph",
          "quote_block"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:54.494+00",
          "seconds": 9.836,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/114",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-114",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.81
          },
          "kind": "callout",
          "text": "Our question: So, you're saying that the doctors who say that they don't have huge explant rates are just checked out after they implant, and outsource everything to the rep?\n\"Yes, unequivocally.\" – Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "921fa3f4-c743-47bd-8435-82dff81dbfd6",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-751e204e88ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Interviews with KOL's and industry experts revealed an under-appreciated but astonishing dynamic behind some Nevro implanters claiming they don't have explants: they're simply unaware, as doctors outsource all patient follow-up to Nevro reps, who feed them misinformation about how their patients are actually doing. A longtime executive - one of the most tenured in the space - indicated that Nevro \"did a very good job of managing and buffering the patient from the physician.\" He repeatedly emphasized the significance of this dynamic and stated that this ignorance - willful or otherwise - was \"unequivocally\" responsible for doctors who refuse to acknowledge explants. He provided examples of KOL's who discovered explants crises in their practices only after bypassing reps.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "772b5dfb-92d8-4784-97bb-24a306551e9f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "\"Here's the reason that [the doctor who stopped using Nevro because of explants] started to look at his patients. Physicians would say, \"I'm getting phenomenal results with Nevro.\" And I would say, \"Okay. How do you know that?\" And they would say, \"Well the trial was phenomenal. The patients love it. The patient is saying that the results they're getting are, I've got 90% pain relief.\" \"How do you know that?\" \"Well, the rep tells me.\" \"When was the last time a patient told you?\" And physicians would have an aha moment, and Nevro did a very good job of managing and buffering the patient from the physician.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d353f73-12a1-4785-879e-3e93de018252",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "\"If a doctor says, my explant ratio is the same as Nevro's as it is with everybody else, you should ask \"Okay, how often do you meet with your Nevro patients? Are you there for the actual programming? When the rep re-programs a Nevro patient, are you there for the re-programming?\" I'll bet you 9 out of 10 of them or 10 out of 10 of them aren't there; they don't know. I've challenged physicians. Your first 10 Nevro implants, call those patients yourself and ask them how they're doing. Don't ask the rep; call the actual patient. So, a bunch of them did, and that's how [doctor name redacted] found out [the device wasn't working].\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7d4c368a-5bb1-4698-9a98-a62f16af2fe1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Nevro “did a very good job of managing and buffering the patient from the physician.” — Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-79531ea8d796",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f3af2d62-b9f5-4e70-a4ee-1592d9d154dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f32300e-ef8e-4407-8f0c-ca281ba78406",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ccaf5b53-6383-4924-9c50-e5e55c2ddf36",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "377e8e32-b367-4563-94b9-e6bff09afa2b",
          "evidence": "Physicians would have an aha moment",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 114,
          "frameworkName": "aha-moment"
        },
        {
          "matchId": "f57d04ce-107a-4242-82e3-edae630ee35f",
          "evidence": "Using expert testimony to contradict the company's narrative of success",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:54.494+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 114,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 115,
      "type": "tension",
      "title": "Uses testimonial evidence from KOLs to support the claim of corporate deception.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 70,
        "componentCount": 7,
        "textChars": 1951,
        "nDataPoints": 1,
        "notes": "Uses testimonial evidence from KOLs to support the claim of corporate deception.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.094+00",
          "seconds": 7.052,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/115",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-115",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One of Nevro’s biggest implanters had about 300 Nevro devices implanted and he didn’t know that they were all failing because the reps were fielding all the patient calls.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-a1b855cf1b90",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation. We caution investors to be mindful of this dynamic, if Nevro parades doctors who deny they have an explants problem. Several KOL's described a related driver: when a Nevro device fails, that patient goes to a different doctor for explantation, and the original implanter remains blissfully ignorant that his/her Nevro patients are being removed. One KOL had a third of his Nevro devices explants, but didn't realize it for 1-2 years.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "561ad66e-b752-4eb4-bff9-e3c39a97a79b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "One of Nevro's biggest implanters had about 300 Nevro devices implanted and he didn't know that they were all failing because the reps were fielding all the patient calls. Patients were told, if you have any problems just call Nevro or call your rep. Don't call the doctor. He didn't know until a year or two later that a third of his patients had gotten explanted at other practices. So, a lot of Nevro's high volume implanters split.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "045db6db-1f39-4327-8b39-9b7c262abbb8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "There's dispersion in Nevro feedback, because one of the biggest challenges with explants is that the guy who implants the stimulator is not the guy who explants it. The patient says I don't want to see the doctor who implanted this again.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3fe57372-3341-4848-a232-5b5bc7e71ee3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“One of Nevro’s biggest implanters had about 300 Nevro devices implanted and he didn’t know that they were all failing because the reps were fielding all the patient calls. Patients were told, if you have any problems just call Nevro or call your rep. Don’t call the doctor. He didn’t know until a year or two later that a third of his patients had gotten explanted at other practices. So, a lot of Nevro’s high volume implanters split.” — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-a50d95d0a74d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44f31189-edee-4506-8545-fb238dd729a0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94c7aef2-df3b-4b70-a722-00ed61e0f008",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f8e1a2ba-4999-49ca-bdfa-c5f37be92c64",
          "evidence": "Uses expert testimony to contradict company narrative of device success.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:52.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 115,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 116,
      "type": "tension",
      "title": "The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 9,
        "textChars": 2006,
        "nDataPoints": 0,
        "notes": "The slide uses a direct quote from a KOL to frame the company's sales tactics as unethical and deceptive.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:50.075+00",
          "seconds": 3.69,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/116",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-116",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Note that Nevro can only sell a permanent implant if the patient achieved 50% pain relief during the temporary trial period that lasts a few days, creating a powerful incentive for sales reps to bulldoze the patient into uttering the magic phrase, and creating a patient base in whom the device never worked and will eventually need to be explanted.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-989f0ccbbde2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "A KOL who experienced high rates of explants described in detail how Nevro reps manipulated and pressured patients into saying the device worked, when the same patients were telling the doctor that it didn't.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c7e1b443-8711-4065-95d4-5307ae5274c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.61
          },
          "kind": "quote",
          "text": "Patients complain and tell me they want this piece of crap device out and the Nevro rep then goes and talks to them. One of my patients described to me in detail how the reps then manipulate them.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4ba2d9b2-4caf-4598-a11b-56dc7d1a89cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.73
          },
          "kind": "quote",
          "text": "She explained what Nevro reps would say to patients... And that's how the reps coax the patient to say they got 50% pain relief. I confirmed with other patients that this is how Nevro reps get the patient to say they're getting relief. – Prominent KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d277a58-43af-48de-aab4-26b379436472",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.44
          },
          "kind": "quote",
          "text": "What really upset me was I'd get two different stories, one from the patient and a different one from the rep. I would talk to a patient and they'd be like, get this piece of shit out of me. Then I'd send a rep to see them who'd say the patients had 50% pain relief.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7050fe2b-de18-4cd0-bc40-80c0324f14f7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "What really upset me was I’d get two different stories, one from the patient and a different one from the rep. I would talk to a patient and they’d be like, get this piece of shit out of me. Then I’d send a rep to see them who’d say the patients had 50% pain relief. That was Nevro’s big thing. 50% pain relief. I had various discussions with them. I’d go to dinner with the higher ups. And they’re all talking 50% pain relief, and I’m like don’t you ever want to try getting better than 50%? — Prominent KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-9f6105d278cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "482a7745-1e97-424b-9091-ff86c3f01746",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8231415-4ff3-4378-9be2-cad93fbfea43",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46092b60-b8c6-43ed-ba1f-c531c98ed6e3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "9ccea823-6c64-4691-96d1-fa5a79677d3f",
          "evidence": "Uses KOL testimonial to contradict company sales claims",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:50.075+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 116,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 117,
      "type": "tension",
      "title": "Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 68,
        "componentCount": 7,
        "textChars": 2865,
        "nDataPoints": 0,
        "notes": "Uses testimonial-style quotes from KOLs to build a case of corporate misconduct.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:54.421+00",
          "seconds": 7.987,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/117",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-117",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-b980717a7431",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation. Numerous KOL's confirmed similar experiences. A second characterized Nevro's conduct as falsifying patient outcomes and potentially illegal. A third described reps using “leading questions” as “patient manipulation” and catching reps who were telling patients what to say. He indicated that reps are “very very incentivized” to push patients into an implant. Aside from the entire high frequency premise being a flop, we believe that a key driver of Nevro's explants crisis is patients being bulldozed into devices that never worked for them during the trial phase.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6467c0c9-4b83-4dfe-9a05-77091080e11f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "“Leading questions are one area of patient manipulation. I've caught reps specifically telling patients what they have to say. It's an incentive-based thing for reps. Reps are very very incentivized to want the permanent implant and they'll tell patients what to say. The rep will ask, what's your pain relief? A patient comes in and their pain is an eight, and after the trial implant the patients says well now it's a five. The rep says, “If you want this device you'll have to say you have 50% pain relief, and you want the device right?” And the patient says, “Well I guess so, I mean, I guess it helped me a little bit.” – High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f67e15a-9ca2-4d0d-a027-c46ddeaa8173",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.39
          },
          "kind": "quote",
          "text": "Our question: So what specifically have you seen Nevro reps do that crosses the line into illegality? “Falsify outcomes. A lot of times patients won't report back to the doctor about how the stimulator trial went. They talk to the rep, and the rep says, \"Oh my gosh, I talked to the patient who's at home now, enjoying their trial. The patient is getting 90% relief.\" So, they falsify the actual outcome from the patient and they persuade the patient irrespective of the patient's opinion. I've heard it. The rep will say, \"Isn't this great? Aren't you doing well?\" You can hear the back and forth and that that's not what the patient said. There are a lot of unethical things.” – High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4411bbc-25fe-4ed4-9efe-14ccb41005c3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Falsify outcomes. A lot of times patients won't report back to the doctor about how the stimulator trial went. They talk to the rep, and the rep says, \"Oh my gosh, I talked to the patient who's at home now, enjoying their trial. The patient is getting 90% relief.\" So, they falsify the actual outcome from the patient and they persuade the patient irrespective of the patient's opinion. I've heard it. The rep will say, \"Isn't this great? Aren't you doing well?\" You can hear the back and forth and that that's not what the patient said. There are a lot of unethical things. — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:34+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b33f-bd60fced7237",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6cce5e41-2de4-4475-81f1-a07166da1658",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e94cdf82-54ca-4cb1-b502-aa679fae170a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "71fd09e6-89f5-4b2f-a90d-23b8484a5a3c",
          "evidence": "The slide explicitly frames the narrative around unethical and illegal conduct to expose corporate fraud.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:54.421+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 117,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 118,
      "type": "tension",
      "title": "The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 65,
        "componentCount": 7,
        "textChars": 1686,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from consultants to substantiate claims of corporate misconduct.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:33.262+00",
          "seconds": 2.752,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/118",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-118",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A fourth KOL - a current Nevro consultant, recipient of significant payments from the company, and one of their highest volume KOL's - was nonetheless candid about reps being \"an extension of your practice\" and \"steering\" and \"pushing\" patients into stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-491b47b7e516",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "other",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0196d41e-cdd8-42de-a809-fd0965482b94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "8. Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation. A fourth KOL - a current Nevro consultant... was nonetheless candid about reps being \"an extension of your practice\"...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fd58b866-71cd-4f9a-b902-7b2e11bfa422",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "quote",
          "text": "\"What I noted psychologically is that the rep would often be present at the patient's follow-up... patients were embarrassed to say anything in front of the rep...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7458f05-5ef7-4d6f-a5fc-430ff0a83887",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "\"The rep is kind of an extension of your practice... I've seen some really egregious things where the feedback is really negative about what the rep did in terms of steering a patient...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3ba5524-febf-4ca6-8afa-f91dfc3b3104",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The rep is kind of an extension of your practice. I've seen some really egregious things where the feedback is really negative about what the rep did in terms of steering a patient that was unsure and pushing them towards implant... That's the kind of nonsense that can go on.\" — Nevro consultant and KOL; \"What I noted psychologically is that the rep would often be present at the patient's follow-up and when I would talk to patients with the rep, they'd say they were having some issues... patients were embarrassed to say anything in front of the rep so there was this co-opting of the patient that I think, had they not been there, we would probably have found out sooner than later [that the device wasn't working].\" — Nevro consultant and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-4d2e2b4cc2f1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c729ab66-88db-42ec-905b-e91bc06d686e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Chiasmus",
            "slug": "chiasmus",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-9f90-77d2-92d7-9a9780d23677",
            "version": 1,
            "bodyDocId": null,
            "description": "Reversing structure in successive phrases for emphasis (A-B then B-A)",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "c6e1a903-de8e-4968-b0fd-2ec80ef3d7c1",
          "evidence": "The use of contrasting ideas and quotes to highlight the contradictions in Nevro's practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:55:46.137154+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 118,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "9d884d04-adb7-4dc3-9d2d-de2958c30b47",
          "evidence": "The slide explicitly frames the content as exposing corporate misconduct and manipulation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-17 03:28:33.262+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 118,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 119,
      "type": "tension",
      "title": "The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3590,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from a KOL to support the claim of unethical sales practices and patient manipulation.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.01+00",
          "seconds": 5.19,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/119",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-119",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-1909f94f1e64",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "A sixth KOL elaborated on the “tremendous potential for abuse in the role the rep plays with the patient,” describing reps who were “full of crap,” “acted unethically, and were “just very sleazy.” He described a toxic dynamic of quid pro’s quo’s between stimulator reps and doctors. Another KOL illustrated how the paresthesia-free nature of high frequency is tailor made for patient manipulation. Because patients feel no tingling – and therefore can’t even feel whether the device is on or off – they are particularly susceptible to the rep convincing them it’s working. He added that Nevro was “very sneaky” at launch in hiring reps who were good at handling patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "556b4c37-1d57-4506-b1fe-e08a16e796f1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "“You bring a patient in for a trial implant and then you turn it on. The patient is like, when are you going to turn it on? Especially if they're used to the feeling of paresthesia. And I'd say, no, the device is already on. Patients never felt the device being on. It was always just a leap of faith that the thing was working. So when it stopped working, Nevro's reps could use that tactic against the patient. You're not doing this, you're not doing that. How do you even know when the battery is dead? The whole time, the patient just has to believe that the device is on and that it's working. You could probably get a placebo effect. Whether it's on or off, they just always think it's on. Nevro did another thing which was very sneaky. When they first launched, they hired all the best reps in the country. The ones that did the best because they are very good with the patients. A patient who likes their rep will be happy and report a successful stimulator. Even if the device is turned off. I'm telling you, it is all about the reps.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b6b252f9-3171-4569-bc33-bee2ed18784c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.88,
            "x": 0.06,
            "y": 0.4
          },
          "kind": "quote",
          "text": "“There's tremendous potential for abuse in the role the rep plays with the patient. I have refused to work with reps who have acted unethically and that I knew were full of crap. There's no question that they influence the patient during the trial. There's no question about it, that there's the ability to influence. It just depends on your judgment. It's more common with younger implanters and people who work in private practice, who are trying to get a business out there. The reps are saying I'll do this for you, I'll do that for you, I'll introduce you to doctors. It's natural. No question, I've seen over the years reps that are just very sleazy. I have told companies straight out: I will not work with these people.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dad48abf-bef9-47f8-a5f7-591c149946c1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "There's tremendous potential for abuse in the role the rep plays with the patient. I have refused to work with reps who have acted unethically and that I knew were full of crap. There's no question that they influence the patient during the trial. There's no question about it, that there's the ability to influence. It just depends on your judgment. It's more common with younger implanters and people who work in private practice, who are trying to get a business out there. The reps are saying I'll do this for you, I'll do that for you, I'll introduce you to doctors. It's natural. No question, I've seen over the years reps that are just very sleazy. I have told companies straight out: I will not work with these people. — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-1ecd0e4c61b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f86007be-8a20-4261-b875-a2fd22beb162",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "8. Nevro’s response to its explants crisis appears to be marked by denial, cover-up, retaliation, and patient/doc manipulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8db5adde-7a32-402d-9410-d7023b87c40e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a891e4ca-4e8b-431b-8620-9bb50bfb4e07",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "2b40eee4-20b1-4a3f-b26b-ffcc42106161",
          "evidence": "The slide frames the sales representatives as the antagonist manipulating patients.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:52.01+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 119,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 120,
      "type": "tension",
      "title": "Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 94,
        "componentCount": 11,
        "textChars": 3487,
        "nDataPoints": 4,
        "notes": "Uses testimonials to frame the company as a 'one-tick pony' with a shrinking user base.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:51.506+00",
          "seconds": 4.666,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/120",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-120",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "It’s the high volume doctors souring on Nevro. It’s a big deal that other companies can give you paresthesia-free stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-5c5a41499a00",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.56
          },
          "kind": "list",
          "text": "One of Nevro’s highest volume implanters stated his usage is down, that the honeymoon is over, and that doctors are skeptical the device works. A second user said the pool of Nevro die-hards “has shrunk” with “not much more growth to be captured” in Nevro’s base.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b641569-913c-487f-845a-697195c18e1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "list",
          "text": "One of the most well-known KOL’s in the space stated that 10% of doctors drive 90% of industry volume, and that these high-volume implanters are the ones “souring on Nevro.” He stated that Nevro’s sole innovation – paresthesia-free stimulation – is now widely offered by competitors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81697307-820a-4a37-9915-a1fba7b38af6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "KOL’s and former Nevro executives outlined where the company finds itself now: after the hype from its pivotal study and 2015 launch wore off by 2018, sales growth went to zero. With the honeymoon period now over, Nevro’s “turnaround” finds itself stuck in a ditch: high volume implanters – who drive 90% of industry volume – have soured on the company; KOL’s now believe the initial data was dubious and that the technology doesn’t work; and even Nevro loyalists have migrated back to Medtronic/Abbott/Boston Scientific devices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "056650c2-1e73-4af2-9eda-b960c0f647bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.8,
            "x": 0.1,
            "y": 0.74
          },
          "kind": "quote",
          "text": "When we poll at conferences, initially doctors who were doing Nevro were all or nothing. They had a very dedicated following. That pool has shrunk. Now more us are finding that we like to spread it around. Of the 15 to 20 implanters in New York like me, all of us are doing some Nevro and there’s not much more growth to be captured among this circle.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81bd8a55-d5ec-47c3-8452-635c3950fad4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.8,
            "x": 0.1,
            "y": 0.41
          },
          "kind": "quote",
          "text": "There are 10 to 20 doctors like me in the country, maybe a little more, that implant stimulators at these high volumes. People like me are the majority of the implants. It’s a 90/10 rule. By and large, it’s the high volume doctors souring on Nevro. It’s a big deal that other companies can give you paresthesia-free stimulation. And Medtronic’s Intelis came on like gangbusters. It’re really tiny. I was really excited by it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ff041bc-fe20-4835-88a3-9056a686c020",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.8,
            "x": 0.1,
            "y": 0.66
          },
          "kind": "quote",
          "text": "Nevro is down to 50% of my share. Two years ago I used two-thirds Nevro. Nevro is overused. The honeymoon phase, that Nevro will solve all, is over. You’ll find doctors that tell you Nevro doesn’t work.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aeae646b-4e68-4be4-bbe1-950178b05aed",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "There are 10 to 20 doctors like me in the country, maybe a little more, that implant stimulators at these high volumes. People like me are the majority of the implants. It’s a 90/10 rule. By and large, it’s the high volume doctors souring on Nevro. It’s a big deal that other companies can give you paresthesia-free stimulation. And Medtronic’s Intelis came on like gangbusters. It’re really tiny. I was really excited by it. — One of the most well-known KOL’s in the stimulator space; Nevro is down to 50% of my share. Two years ago I used two-thirds Nevro. Nevro is overused. The honeymoon phase, that Nevro will solve all, is over. You’ll find doctors that tell you Nevro doesn’t work. — KOL and one of Nevro’s highest volume implanters; When we poll at conferences, initially doctors who were doing Nevro were all or nothing. They had a very dedicated following. That pool has shrunk. Now more us are finding that we like to spread it around. Of the 15 to 20 implanters in New York like me, all of us are doing some Nevro and there’s not much more growth to be captured among this circle. — High volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-6029a73b9746",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db4ea571-25cd-4a79-8ca6-393b10625ba4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e80a0ae-9e2f-4a85-ad3e-6debd1d1cd13",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "82f625eb-ae48-4db6-819e-62c51f5ae287",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "96ace6ae-db75-4b99-9e71-8daf83da2b1b",
          "evidence": "Citing KOLs and high-volume implanters to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:51.506+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 120,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 121,
      "type": "tension",
      "title": "Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 2962,
        "nDataPoints": 0,
        "notes": "Uses direct quotes to frame Nevro as a 'one-trick pony' lacking sophistication compared to competitors.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:34.476+00",
          "seconds": 3.572,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/121",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-121",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro “still feels like a boutique” one-trick pony that’s “not really as sophisticated as they say they are.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-b071d9c921db",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A senior Nevro ex-executive provided a key reason why growth hit a wall: the legacy SCS incumbents – Medtronic, Boston Scientific, and Abbott – who were asleep at the wheel when Nevro launched in 2015, have quickly caught up, while Nevro “still feels like a boutique” one-trick pony that’s “not really as sophisticated as they say they are.” A KOL provided identical feedback: Nevro is a “one-trick pony” and that everyone now offers paresthesia-free stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15add36a-1a3e-4594-9103-095a8d1045f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.83,
            "x": 0.11,
            "y": 0.41
          },
          "kind": "quote",
          "text": "We embarrassed the legacy competition but over time that forced them to create new platforms, software, better technology, better interfaces, quicker trial times. They’ve done a lot more for their customers. Nevro still feels like a boutique company. They’re not really as sophisticated as they say they are. When you go to North American Neuromodulation Society meeting every January, you’re seeing an amazing amount of new technology. All the other companies create different types of platforms for different patients. They have optionality, which is a superior sales tactic with the patient saying, “Hey, this didn’t work, but I have other frequencies and waveforms for you and I have this and this and this.”” – Senior Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d049005-e18d-4c2b-b18c-fd146beb2a2d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.83,
            "x": 0.11,
            "y": 0.73
          },
          "kind": "quote",
          "text": "Nevro disrupted the industry with high frequency. Then everyone developed sub-threshold paresthesia-free waveforms. Now companies who don’t even have high frequency have these waveforms. There are lots of competitor pipelines. They’re a one-trick pony. They’re not versatile. That I truly believe. It’s hard to tell a difference clinically.” – High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8a608cfc-1652-4313-817c-facce18fc799",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“We embarrassed the legacy competition but over time that forced them to create new platforms, software, better technology, better interfaces, quicker trial times. They’ve done a lot more for their customers. Nevro still feels like a boutique company. They’re not really as sophisticated as they say they are. When you go to North American Neuromodulation Society meeting every January, you’re seeing an amazing amount of new technology. All the other companies create different types of platforms for different patients. They have optionality, which is a superior sales tactic with the patient saying, ‘Hey, this didn’t work, but I have other frequencies and waveforms for you and I have this and this and this.’” — Senior Nevro ex-executive; “Nevro disrupted the industry with high frequency. Then everyone developed sub-threshold paresthesia-free waveforms. Now companies who don’t even have high frequency have these waveforms. There are lots of competitor pipelines. They’re a one-trick pony. They’re not versatile. That I truly believe. It’s hard to tell a difference clinically.” — High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-b711138b8847",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cdb0037c-fbd1-4808-884a-7be6e7ae79f2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9647e157-c3f0-4627-8692-b294696c6ab8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b58968a-c957-4f93-aeb2-ad6d52a4d87d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c3647620-6d7f-48bc-b642-69350f090a0b",
          "evidence": "Uses expert testimony to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:34.476+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 121,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 122,
      "type": "tension",
      "title": "Uses direct quotes to undermine the company's value proposition.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 3613,
        "nDataPoints": 0,
        "notes": "Uses direct quotes to undermine the company's value proposition.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.212+00",
          "seconds": 4.524,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/122",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-122",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One KOL after another labeled Nevro a “one-trick pony” and pointed to the influx of paresthesia-free waveforms from key competitors as eliminating Nevro’s sole selling point.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-d9941ca4091d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.05,
            "y": 0.28
          },
          "kind": "list",
          "text": "A KOL and former Nevro loyalist stated that doctors are no longer \"as enthralled,\" and that Nevro's differentiation has evaporated as everyone introduced paresthesia-free stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "386bbfb3-afbf-47c2-8ebc-664aa908a051",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "list",
          "text": "A KOL explained that as Abbott and Medtronic caught up, his Nevro usage dropped",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70ec168c-cbb8-4b63-aaca-5dddb0a93b2b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.52
          },
          "kind": "list",
          "text": "A key investigator in Nevro's pivotal trial said the \"sheen if off,\" the story is \"stale,\" and that he \"wouldn't buy stock.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bf76a0f-305a-4a5b-8789-e4d8454a4159",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.15
          },
          "kind": "paragraph",
          "text": "One KOL after another labeled Nevro a \"one-trick pony\" and pointed to the influx of paresthesia-free waveforms from key competitors as eliminating Nevro's sole selling point. A former Nevro loyalist stated that \"they were the first kid on the block\" but doctors who \"were enthralled with Nevro are not as enthralled\" now. A key investigator in Nevro's pivotal trial said the \"sheen is off,\" that the story is \"stale,\" and that he wouldn't buy the stock.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7ee257d-8bbc-468e-9eb8-9b58b18b2782",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.08,
            "y": 0.77
          },
          "kind": "quote",
          "text": "\"Abbot's Burst and Medtronic's Intellis are what changed my usage of Nevro the most. It was a big switch for me was when Burst came out. Then Intellis came out and was smaller than anything anyone has ever been by quite a bit. My average patient doesn't' want a big device sticking out of their ass. And Intellis is one charge a week.\" - High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "066369c7-edc3-46fe-8fe6-dc9d3d4e1b45",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.08,
            "y": 0.35
          },
          "kind": "quote",
          "text": "\"Colleagues who were enthralled with Nevro are not as enthralled with it now. They were the first kid on the block. Now it's 4 companies. Abbot doesn't call their device high frequency, just Burst but it ramps up and down. Same with Medtronic. Then Wavewriter from Boston Scientific The uniqueness of paresthesia-free isn't there anymore and that was the main selling point for Nevro, and then you have the bulky battery.\" - KOL, previously a high-volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c93bbdf-871d-4dd3-97fe-2e0f7786867c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.08,
            "y": 0.58
          },
          "kind": "quote",
          "text": "\"Nevro came out with something new and got a lot of share in a crowded space. I doubt they can hang on to the IP, and it's not the only IP out there. The sheen is off Nevro. I've known [Nevro executive, redacted] for many years. I don't know that he's the right guy. I wouldn't buy stock in Nevro right now. Their story is getting stale.\" - KOL and Nevro trial investigator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df1d638a-06f1-4d6b-a408-f2b7144823ea",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Colleagues who were enthralled with Nevro are not as enthralled with it now. They were the first kid on the block. Now it’s 4 companies. Abbot doesn’t call their device high frequency, just Burst but it ramps up and down. Same with Medtronic. Then Wavewriter from Boston Scientific The uniqueness of paresthesia-free isn’t there anymore and that was the main selling point for Nevro, and then you have the bulky battery.” — KOL, previously a high-volume Nevro user; “Nevro came out with something new and got a lot of share in a crowded space. I doubt they can hang on to the IP, and it’s not the only IP out there. The sheen is off Nevro. I’ve known [Nevro executive, redacted] for many years. I don’t know that he’s the right guy. I wouldn’t buy stock in Nevro right now. Their story is getting stale.” — KOL and Nevro trial investigator; “Abbot’s Burst and Medtronic’s Intellis are what changed my usage of Nevro the most. It was a big switch for me was when Burst came out. Then Intellis came out and was smaller than anything anyone has ever been by quite a bit. My average patient doesn’t want a big device sticking out of their ass. And Intellis is one charge a week.” — High volume implanter and KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-de80d1a93661",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b0b49bd2-4503-4730-b071-d7719c4da823",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.1
          },
          "kind": "title",
          "text": "9. Nevro's current predicament - a one-trick pony stuck in a ditch - and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bce2507c-7005-4b0b-bfeb-5ae24e17562d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.212+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64d65bbc-e0b3-45e1-9c83-e6727ab165fa",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 123,
      "type": "tension",
      "title": "The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 1598,
        "nDataPoints": 2,
        "notes": "The slide uses expert testimony to frame Nevro's business model as unsustainable once 'low-hanging fruit' markets are exhausted.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.318+00",
          "seconds": 4.558,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/123",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-123",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We can see from spreadsheets where our sales have accelerated or decelerated relative to Nevro’s presence. We know from data that if you do a clinical trial in a hospital, your sales there accelerate. We definitely saw growth decelerating for Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-796c8238ae24",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "quote",
          "text": "An executive in Medtronic’s spinal cord stimulation division explained Nevro’s trajectory in great detail... Nevro’s SCS market share has remained flat at ~15% since 2017.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0b28b145-63d7-4475-8e90-30118b8144d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "quote",
          "text": "“Nevro cherry-picked the lowest hanging fruit at launch... It’s a lot easier to get from 0% to 15% share than from 15% to 30%.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59e5a994-4ce1-45bd-b967-f4c357000aed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.59
          },
          "kind": "quote",
          "text": "“A big piece of their wins were all class 1 teaching hospitals... You need a very different playbook to expand from 15% to 20% share than what Nevro has used.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "741d1b7a-ef24-49bc-9a20-ce5c5b778404",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“When we look at our revenue and where we got beaten... They’ve taken as much share as they’re going to take in class A cities.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aacb7165-0490-4157-9ee4-62ea968f67f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.76
          },
          "kind": "quote",
          "text": "“We can see from spreadsheets where our sales have accelerated or decelerated relative to Nevro’s presence... We definitely saw growth decelerating for Nevro.” – Medtronic SCS executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cb0af23c-7d2a-45ed-8a0e-41319b24a311",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro cherry-picked the lowest hanging fruit at launch. They went to the 25 best places like New York, Los Angeles, Atlanta. They went to teaching institutions who are receptive to new stuff. It’s a lot easier to get from 0% to 15% share than from 15% to 30%. Zero to 3% is hard, 3% to 10% is easy, and after 15% it’s trying to grow in Buffalo versus New York City.” — Medtronic SCS executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-7eaae37979d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32bd9893-3d6b-4700-8363-f116188f30ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "960ec1a2-04bd-4a13-a40a-c43a6b75a47d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e136a0ef-0af3-4db9-9903-e6e5c0685f23",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "566b77ad-2139-45f1-a674-8ac8f6d9aee8",
          "evidence": "Framing Medtronic as the expert observer exposing Nevro's flaws.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:52.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 123,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 124,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key claims about market share loss and device failure.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 2945,
        "nDataPoints": 4,
        "notes": "The slide uses highlighted text to emphasize key claims about market share loss and device failure.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:57.875+00",
          "seconds": 9.923,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/124",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-124",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "But the success was fleeting: \"almost all Nevro devices\" have since been explanted and doctors soured on Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-92d4f99572d2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Another Medtronic employee - in charge of one of their largest spinal cord stimulation territories - offered ground level color on Nevro’s predicament. At launch in 2015, Nevro poached Medtronic’s senior rep and lured most of their “whale implanters” in the region to their device. But the success was fleeting: “almost all Nevro devices” have since been explanted and doctors soured on Nevro. By late 2016/early 2017, Nevro rapidly gave back the market share it gained in the region – mostly back to Medtronic, and some to Abbott.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bda9fac-2b69-48b2-b0c2-20f5116b3cab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.6
          },
          "kind": "quote",
          "text": "In 2015/16 they came out with their guns and probably took, just from those two big accounts that I'm referring to, probably $4-million or $5-million. They had the cool new thing and the data from their pivotal HF10 trial was compelling. They had a good story, and everyone bought into the story. The docs trusted the rep who had been around for 20 years. Everyone was on board and thought it was the sexy new thing to offer their patients. Give or take the fall of 2016, our numbers started picking back up and then significantly in the spring of 2017. Medtronic had come out with a new algorithm to try to combat Nevro and we saw some good results, and we made significant changes to how we were talking to patients. It was good timing as Nevro was starting to see some failures and patients having different outcomes than what their study said.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f6c4add-276e-47fc-a29f-2599b86e1a22",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.85
          },
          "kind": "quote",
          "text": "Of the $5-million or $6-million we lost to Nevro at the peak of their taking share, Abbott took one big chunk of that. They probably got $2-million, and we probably got back the rest. – Medtronic regional manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bca64fae-d7f4-4965-99eb-283bf31b391b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "quote",
          "text": "Since then, almost all Nevro devices have been either explanted, or they're trying to salvage a little bit with Omnia. But there really has been a significant decline in our market from their high frequency device. The doctors just didn't see the outcomes the studies were presenting. Their reps in town are trying to discuss the new technology and new research that they're touting, but it's been really slow to get a pickup from the physicians here. They continue to ask for a price premium and the surgeons in town aren't willing to pay for that.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cb5e559b-bf0b-444c-8418-8d400d608217",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "In 2015, Nevro hired away the senior partner of our sales territory, which had quite an impact for 2016. Most of the big whale implanters in our territory made a full switch over to Nevro. That lasted, and really hurt us, for about a year.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e254d5c0-ea09-408c-9a22-bcb28d371072",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"In 2015, Nevro hired away the senior partner of our sales territory, which had quite an impact for 2016. Most of the big whale implanters in our territory made a full switch over to Nevro. That lasted, and really hurt us, for about a year.\" — Medtronic regional manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:35+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-94380e03a25a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c0d4d9e2-534e-4cc6-aada-1842e659ee98",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d84b270-0ea2-45b7-a339-5c43cc5f26cb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.875+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8e4fedca-a188-4c96-9a9a-66de4178e788",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 125,
      "type": "tension",
      "title": "The slide uses expert testimony to undermine the company's market position and stock performance.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3481,
        "nDataPoints": 0,
        "notes": "The slide uses expert testimony to undermine the company's market position and stock performance.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.031+00",
          "seconds": 4.026,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/125",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-125",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The Medtronic regional manager stated that Nevro “lost all of that revenue” from their launch and that “all of [the doctors they poached] are done with Nevro. They won’t even listen to them.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-6a5d1215920f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The Medtronic regional manager stated that Nevro “lost all of that revenue” from their launch and that “all of [the doctors they poached] are done with Nevro. They won’t even listen to them.” The primary reason was lack of efficacy and explants, followed by the device’s bulkiness and lack of MRI compatibility. He stated that the sales reps Nevro poached have all either returned to Medtronic or left Nevro, adding he was incredulous at Nevro’s stock given what he sees in territories across the US: a lack of clinical outcomes; the new Omnia device flopping; and “shrinking” market share. He stated Medtronic now views Nevro as irrelevant.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bad27ffb-6601-44f7-aa78-30cf4cdb0e68",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.05,
            "y": 0.69
          },
          "kind": "quote",
          "text": "To be honest, we watch their stock and we’re like \"What are we missing?\" In our market, we don't see a ton of good outcomes. Omnia has really not done anything. We hear rumbling from Caraway [Nevro’s Chief Medical Officer] that they're researching more indications, and we just don't know how a one-trick pony makes any headway. We can't figure it out - they continue to do well on Wall Street, but I do not see any movement or any changes here. If anything, they're shrinking here. Frankly, there's very little discussion of Nevro at this point at Medtronic, at our national sales meeting. or really any talk about their taking business away. A lot of the reps that they hired away are now either back with Medtronic or have moved on. That's pretty common from what I can tell in territories across the country.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2ca340c9-d5ea-4b2c-9f49-d77671916466",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.48
          },
          "kind": "quote",
          "text": "Basically, Nevro lost all of that revenue from docs that came on their initial wave. All of them are done with Nevro. They won’t even listen to them. Their number-one complaint was lack of efficacy. Patients just weren’t getting the pain relief that they were promised or presented in the RCT. Number two was the size of their device. They really had a lot of problems with the bulkiness and the size of it. And three, the lack of MRI compatibility. They were running into MRI centers not willing to do MRIs even though they had the full-body MRI label for the percutaneous systems, and it just got to be too much of a headache.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "629a67b8-3817-4d46-baa1-7650f921318c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.35
          },
          "kind": "quote",
          "text": "Then in 2018, we had a huge rebound year. Medtronic launched a new product called Intellis, and we were also getting a lot of Nevro explants. We had a phenomenal year in 2019. Abbott with their non-rechargeable device dinged us a little bit in a couple of different spots. All in all, we've been able to maintain our growth, and hopefully, we'll continue to do so",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fd5e34d3-2a35-4b68-98bc-ddc46c4217eb",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Basically, Nevro lost all of that revenue from docs that came on their initial wave. All of them are done with Nevro. They won’t even listen to them. Their number-one complaint was lack of efficacy. Patients just weren't getting the pain relief that they were promised or presented in the RCT. Number two was the size of their device. They really had a lot of problems with the bulkiness and the size of it. And three, the lack of MRI compatibility. They were running into MRI centers not willing to do MRIs even though they had the full-body MRI label for the percutaneous systems, and it just got to be too much of a headache.” — Medtronic regional manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-6e270d28501d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cc9a0635-782b-477f-9539-a7d6f78f3ea8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-trick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4022fb9-6a75-45cb-af87-bc68c260b3e1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.031+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abd49e28-610b-465a-93a2-f363774f298e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 126,
      "type": "tension",
      "title": "The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 7,
        "textChars": 2703,
        "nDataPoints": 1,
        "notes": "The slide uses a testimonial from a former employee to undermine the credibility of the company's historical clinical trial success.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:51.302+00",
          "seconds": 3.187,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/126",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-126",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "But this all worked because the data they were selling was based on choosing the exact patients they wanted. A lot of it was just biased. It wasn’t real-world data.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-3b42a2338e5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "One of Nevro’s most tenured district sales managers... offered a detailed account of Nevro’s trajectory and current plight... He began by describing Nevro’s launch: “the easiest sale ever because everyone wanted to try this paresthesia-free stimulator”, with the company quickly getting to 15% share of the SCS market. Then he explained that “this all worked” because Nevro was selling “biased” data that “wasn’t real world.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae59a055-42d4-4bf6-8968-7fd0016420cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "quote",
          "text": "“Nevro changed the entire dynamic of the spinal cord stim industry... It was the best data that we’ve seen... It was the easiest sale ever... So let’s go back to 2015... But this all worked because the data they were selling was based on choosing the exact patients they wanted. A lot of it was just biased. It wasn’t real-world data.” – Former Nevro district sales manager, now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3eb87933-5511-42bc-b77c-64280b2504f0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“the easiest sale ever because everyone wanted to try this paresthesia-free stimulator” — Former Nevro district sales manager; “this all worked” — Former Nevro district sales manager; “Nevro changed the entire dynamic of the spinal cord stim industry. They created excitement. It was the first company to do a head-to-head level one RCT study against the competitor and their data was remarkable. It was the best data that we’ve seen and so, that’s one of the main reasons I went there. There were doctors that were reaching out to me—it was the easiest sale ever, because everyone wanted to try this paresthesia-free stimulator that sort of crushed axial, back, and leg pain. The only thing I had to bring in was the stim and it sold itself.” — Former Nevro district sales manager; “So let’s go back to 2015. We’re growing. The trials always did very well with Nevro and with HF10 and across the board, trials typically do very well in this industry because it’s sort of like the patients get this burst of: “Wow! Pain relief.” It’s remarkable, right? They only have this for seven days and, you know, the representatives, they’re reaching out to them, they make sure everything is going well, so the trials always did very, very well at Nevro.” — Former Nevro district sales manager; “We went up to around 15% of the market. But this all worked because the data they were selling was based on choosing the exact patients they wanted. A lot of it was just biased. It wasn’t real-world data.” — Former Nevro district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-3debde39d8a7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4dfe80b1-66af-4c35-abca-43a06eee2dfe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2df014e-8813-4268-af6d-ed3005636768",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd150166-de82-4638-957b-ab8911eb1af4",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "3d79026e-b850-49b9-a567-19c134991948",
          "evidence": "The slide explicitly frames the company's success as a result of 'biased' data and 'not real-world' results to expose a contradiction in their market performance.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:51.302+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 126,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 127,
      "type": "tension",
      "title": "The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 11,
        "textChars": 2761,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from a former employee to frame the company's therapy as ineffective compared to marketing claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:59.133+00",
          "seconds": 10.905,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/127",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-127",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The company attempted to manage the crisis by building a team of “Therapy Support Specialists” to “hound these patients” to the say magic phrase “50% pain relief.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-1cab253ac954",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.52
          },
          "kind": "paragraph",
          "text": "So, you have the RCT and then you have real world. Once you start to funnel thousands of patients in the real world, you start to notice that, “Hmm, it’s not working as well...”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44eea9b5-3a70-443a-947f-57d694f2cb1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Within 6 months of Nevro’s launch, he began to notice that clinical outcomes failed to match the results purported in the pivotal trial. He stated that Nevro started seeing this as well and “started freaking out” 18 months after launch. He stated the Nevro’s sales reps in Europe, where Nevro had launched a few years earlier and achieved some modest sales, had already experienced the same disillusionment: “I realized that high frequency therapy wasn’t what Nevro said it was.” The company attempted to manage the crisis by building a team of “Therapy Support Specialists” to “hound these patients” to the say magic phrase “50% pain relief.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b350a934-17cf-4def-b332-70125d6c16a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.41
          },
          "kind": "quote",
          "text": "But then, six months in, I started to notice that the implants were not comparing to the outcomes we were getting from the trials. I started seeing it and then, the company started seeing it. We weren’t getting the results that we thought we were going to get.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52ef02e1-aa01-4dac-9db7-6b278d152afc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "quote",
          "text": "Before I realized that high frequency therapy wasn’t what Nevro said it was, I trained in Europe because HF10 was on the market there for two and a half years prior to launching in the U.S. In Europe the reps weren’t super gung-ho about it, so I think they’ve always known that it was very patient-specific from the very beginning. I started seeing within the first twelve months that it wasn’t the therapy that everyone thought it was going to be and I think the company realized that at the 18 month mark and they started freaking out.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ba67552-56da-4faa-872c-c0f39c225428",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.75
          },
          "kind": "quote",
          "text": "So, we put a team in place called Therapy Support Specialists TSS, where they would call the patients every single week, the implanted patients, they’d call the implanted patients every single week until they got at least 50% pain reduction, so then they said, “ All right, we’re just going to hound these patients so they know that they’re supported at home and hopefully, we can turn this around that way.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "88cd71a9-90f1-41e0-a086-41377a0a3a28",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“But then, six months in, I started to notice that the implants were not comparing to the outcomes we were getting from the trials. I started seeing it and then, the company started seeing it. We weren’t getting the results that we thought we were going to get.” — Former Nevro district sales manager, now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-23a08ab82d80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ad009fc-d2f1-4393-bdf3-ac38bf1b0c31",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.6,
            "y": 0.86
          },
          "kind": "source-note",
          "text": "– Former Nevro district sales manager, now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65041b48-b688-46ed-81ac-da5e0857f6dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9d02f1e3-e0de-480a-9ea3-69188adad097",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ee3384d-08db-4716-b0a4-e5d5bf257763",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "bd638ea2-dd3b-4ba8-bb10-cbbed4081a31",
          "evidence": "The slide uses expert testimony to allege a discrepancy between clinical trial results and real-world performance, framing it as a corporate deception.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-05-02 20:15:59.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 127,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 128,
      "type": "tension",
      "title": "The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 11,
        "textChars": 3430,
        "nDataPoints": 2,
        "notes": "The slide uses yellow highlighting to emphasize key negative feedback points from the former employee.",
        "elementsJson": [
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:53.892+00",
          "seconds": 5.412,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/128",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-128",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The ex-Nevro district manager’s comments reveal the severity of what we believe the company has covered up: that “sort of every KOL was saying the device isn’t working”; that sales reps across the country came to the same conclusion; the company refused to acknowledge the situation and blamed the reps instead; and that he personally couldn’t look customers “in the eye and ask them for visits anymore, because I didn’t believe in the therapy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-f0e736a05cd3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "“Sort of every KOL was saying the device isn’t working. We had this one doctor in New York who implanted 13 Nevro systems. He removed 10 of them within a year. Nevro saw that a lot of these doctors were going away. They saw that their sales reps, like me, were leaving and the number one reason was because the therapy wasn’t living up to expectations.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "802ca4c5-0b34-422d-b761-c988a92662ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "paragraph",
          "text": "“They hired a really experienced sales force and they relied heavily on the field to let them know what was going on. Upper level management never wanted to say this. They’d tell the field that they missed a step in the algorithm, to go back and start over. No matter what we did in the field, it didn’t work. But the company was like, “You guys missed something. We have the level one evidence. It has to work.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "99c614e5-477b-4f60-a3f7-70cfcd60ea78",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "paragraph",
          "text": "“I’ve been in the spine field for a long time, and a lot of these customers are my friends. I couldn’t look them in the eye and ask them for visits anymore, because I didn’t believe in the therapy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc8d4191-f585-43d6-a57e-6b253a9db052",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.81
          },
          "kind": "paragraph",
          "text": "“One reason for explants is that patients get sick of recharging, which can cause heating at the site and cause infections. Patients just get pissed off because they have to recharge. The higher the frequency, the more energy it uses. Patients had to charge once a day for 30 to 45 minutes. A second reason is that the therapy wasn’t working so patients would just get fed up. So they didn’t want to charge anymore, and then, they would just have the device explanted, so loss of therapy and just, burden and the burden of recharging every day.” - Former Nevro district sales manager, now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e28069e3-f138-4324-b22d-747f64c90f13",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.59
          },
          "kind": "paragraph",
          "text": "“The field reps were always communicating across the nation. The discussions among the reps were, “We’re in a tough situation here.” The company treated us very, very well. They paid us well. I appreciated everyone I worked with there, but it was—as months went on, it became very - I would have a hard time selling this device when I didn’t believe that it’s right.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e765acf6-6fcb-4cef-a856-da2cfda6c40b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "quote",
          "text": "The ex-Nevro district manager’s comments reveal the severity of what we believe the company has covered up: that “sort of every KOL was saying the device isn’t working”; that sales reps across the country came to the same conclusion; the company refused to acknowledge the situation and blamed the reps instead; and that he personally couldn’t look customers “in the eye and ask them for visits anymore, because I didn’t believe in the therapy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20e4e500-f82d-41b0-ad6f-b6449b0d4c39",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Sort of every KOL was saying the device isn’t working. We had this one doctor in New York who implanted 13 Nevro systems. He removed 10 of them within a year. Nevro saw that a lot of these doctors were going away. They saw that their sales reps, like me, were leaving and the number one reason was because the therapy wasn’t living up to expectations.” — Former Nevro district sales manager, now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-f7c1b9f40615",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "67c53a9b-4938-4df5-ae4d-c6f6d8e42ec7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7baafd96-31c2-46d9-bbd6-e8c368b7b297",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:53.892+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24a470a5-b59e-4655-9835-4f8afc7d5185",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 129,
      "type": "tension",
      "title": "The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 10,
        "textChars": 2309,
        "nDataPoints": 1,
        "notes": "The slide uses a Q&A format to highlight the discrepancy between appropriate clinical use and the company's sales practices.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:57.133+00",
          "seconds": 8.283,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/129",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-129",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro is pushing stimulators onto patients who simply aren’t appropriate candidates.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-c0fa15738eef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A second former Nevro territory manager, also part of the launch team as one of the company’s earliest reps and a long-tenured rep in the SCS field, echoed these comments and added that Nevro is pushing stimulators onto patients who simply aren’t appropriate candidates. He expressed dismay toward Nevro’s conduct and stated that stimulators will never work for the patients the company’s physicians are selecting.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16cefe91-4bec-4331-b783-fd2e4fc07732",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.05,
            "y": 0.57
          },
          "kind": "paragraph",
          "text": "Question: So it sounds like that's the target market - last line patients, but it's so chronic and nothing has worked, so what's the point of a stimulator? Is that the point you're getting at?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "79a8d6bd-4cf2-4f1a-a768-7f743683c1f8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "quote",
          "text": "That is exactly what I'm getting at. Of 10 patients coming into the doctor's office, I would say 3-4 have neuropathic pain that does very well with a stimulator. Patients 5,6,7, are questionable... And the other three or four, they don't know what to do with them, and a last resort is the stimulator...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e2739ce-792a-48f2-95ef-37a0d9acc5dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.43
          },
          "kind": "quote",
          "text": "A lot of patients that you see in the spinal cord stimulator market are patients that have had three, four, five surgeries... Is a stimulator appropriate for that patient? Possibly. You can come to your own conclusion on how I painted that picture.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76034b57-111d-423d-9bd4-5040dbc2b119",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.27
          },
          "kind": "quote",
          "text": "The indications that are approved for spinal cord stimulation are chronic pain of the trunk and limbs. You can't treat mechanical pain with a spinal cord stimulator... A stimulator is not going to help that patient.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "957d8d12-1d31-4192-ad0d-9924c14d4936",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "That is exactly what I'm getting at. Of 10 patients coming into the doctor's office, I would say 3-4 have neuropathic pain that does very well with a stimulator. Patients 5,6,7, are questionable. They are multi-surgical, with no more surgery available, on medications and a challenge for long-term success. And the other three or four, they don't know exactly what to do with them, and a last resort is the stimulator, and that's somebody that had the discectomy, the laminectomy, the fusion, the adjacent level fusion, the revision of the fusion, and now they've had 3, 4, 5, or 6 surgeries, and then they show up at the pain doctor. — Former Nevro territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b340-c44408a020d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4a5fa77a-1c8b-479f-ad97-ad33ac27f2b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "9. Nevro’s current predicament – a one-tick pony stuck in a ditch – and drivers of its ongoing growth collapse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3d5b6fb-39d6-4002-a03d-3699cc6d1220",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8cf86d58-fafe-4456-b668-3e487dd9e2f8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ff410af8-7b42-4dbf-b588-aec0cd66be3b",
          "evidence": "The slide frames the company as the antagonist by using former employees to expose unethical sales practices.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:57.133+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 129,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 130,
      "type": "tension",
      "title": "Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 10,
        "textChars": 1834,
        "nDataPoints": 1,
        "notes": "Uses a diagram to contrast the company's marketing claims against the activist's critical interpretation of the product's 'versatility'.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "screenshot",
          "infographic"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:52.59+00",
          "seconds": 3.706,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/130",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-130",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The Omnia signaled a 180 degree turn in strategy versus the positioning of the past decade: the company would now offer every frequency and waveform under the sun and throw the kitchen sink at doctors and patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-1fc91652bded",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.25,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "diagram",
          "text": "Maximum Versatility / Multiple Mechanisms diagram",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Hub and spoke",
              "slug": "hub-spoke",
              "status": "active",
              "canonId": "019de52d-04db-73e6-81ca-a234f2f23fc1",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "hub-spoke",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "577ec31d-d957-439d-ba00-9c7e44990fc8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.55,
            "x": 0.05,
            "y": 0.46
          },
          "kind": "image",
          "text": "One System. All Frequencies. Maximum Versatility.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Illustration",
              "slug": "illustration",
              "status": "active",
              "canonId": "019de52c-fe76-7772-a5ac-c0b7294d7615",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "illustration",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "477a9303-f5ad-436e-99ec-123c9cf8cb54",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.4,
            "x": 0.55,
            "y": 0.6
          },
          "kind": "list",
          "text": "Direct Neural Inhibition / Paired Waveforms / Dorsal Column Stimulation",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "19c7a9a4-5502-4219-8057-ed835a5a55d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "On November 5, 2020 Keith Grossman announced the launch of the new Omnia spinal cord stimulator - the centerpiece of his plan to turn Nevro around. The company's previous Senza stimulators offered only high frequency stimulation, Nevro's sole claim to fame. The Omnia signaled a 180 degree turn in strategy versus the positioning of the past decade: the company would now offer every frequency and waveform under the sun and throw the kitchen sink at doctors and patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "06c3ccc1-717f-4a92-912a-f2dbab8b5b88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.33
          },
          "kind": "quote",
          "text": "Other SCS systems on the market are limited to a frequency below 1500 hertz. Omnia delivers the widest range of frequencies of any SCS system, between 2 and 10,000 hertz. In addition to HF10, Omnia offers the most waveforms in a single product and can be programmed to provide waveforms independently or paired with HF10.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "119e97a2-b213-4700-a37e-0310de4b3319",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Other SCS systems on the market are limited to a frequency below 1500 hertz. Omnia delivers the widest range of frequencies of any SCS system, between 2 and 10,000 hertz. In addition to HF10, Omnia offers the most waveforms in a single product and can be programmed to provide waveforms independently or paired with HF10. — Press release 11/5/2019",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-20eaea69c34c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://s24.q4cdn.com/932612397/files/doc_news/archive/383ad665-1d67-4ea5-88aa-f4321006b014.pdf;; https://www.nevro.com/English/us/providers/omnia/default.aspx",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "51573ffe-4572-4bed-b3d6-3f6e84343a89",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3118f140-8c4c-47e6-9878-1d6c80b4a523",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.3,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "23a5cd41-9ac6-485d-84a9-a4b8f01030cf",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "3ac62f65-cceb-4135-ac06-7f2bcad64249",
          "evidence": "The slide frames the Omnia product as a 'Hail Mary' and 'colossal flop' to undermine the CEO's turnaround strategy.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:52.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 130,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 131,
      "type": "tension",
      "title": "Uses direct quotes from the company's own SEC filings to highlight hypocrisy.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 1539,
        "nDataPoints": 1,
        "notes": "Uses direct quotes from the company's own SEC filings to highlight hypocrisy.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:54.009+00",
          "seconds": 4.743,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/131",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-131",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.39
          },
          "kind": "callout",
          "text": "Nevro S-1 filing\n\"Traditional SCS therapy is a long-established pain treatment that utilizes low frequency stimulation... Paresthesia is often considered unpleasant or uncomfortable... Our HF10 therapy is designed to overcome many of the limitations of traditional SCS therapy...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92b3ee27-db80-4fcc-bf03-33fdfe0d44e1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "We find Nevro’s about-face and embrace of low-frequency stimulation interesting and suggestive of desperation, given that the company has spent the last decade disparaging it as useless and dangerous.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-9a2f5528d689",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.32,
            "w": 0.66,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "Limitations of Traditional SCS Therapy: Limited clinical evidence, Lack of evidence supporting efficacy in back pain, Paresthesia, Paresthesia mapping.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6abe0a35-ecc3-40aa-938d-9d48b120c528",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We find Nevro’s about-face and embrace of low-frequency stimulation interesting and suggestive of desperation, given that the company has spent the last decade disparaging it as useless and dangerous...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4df4ebd5-6cbe-47ee-8de3-62abf6ab7b1e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Traditional SCS therapy is a long-established pain treatment that utilizes low frequency stimulation... Paresthesia is often considered unpleasant or uncomfortable, sometimes causes a shocking or jolting sensation with changes in posture and is a continuous reminder of the patient's chronic condition [...] Our HF10 therapy is designed to overcome many of the limitations of traditional SCS therapy, offering benefits to patients, physicians and hospitals. — Nevro S-1 filing",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-23 01:18:10+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-70f3-714d-84b6-9e11a422968c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Nevro S-1 and 10K; transcript of management comments at JMP conference 6/24/15",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2352d63c-e3e2-45b7-b17b-9c50da4b5b0e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9eaa9842-bb12-4402-8b08-f65565162107",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ed70ebb4-134d-4c94-9d4a-a59ca0b8904a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "58a2cda2-14fd-4eb3-b305-5209cfd09ae6",
          "evidence": "Contrasts current company strategy with historical S-1 filing statements.",
          "framework": null,
          "confidence": 0.95,
          "extraction": {
            "at": "2026-05-02 20:15:54.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 131,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 132,
      "type": "tension",
      "title": "Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 9,
        "textChars": 3381,
        "nDataPoints": 2,
        "notes": "Uses a direct quote from the CEO to highlight a discrepancy between expected adoption of new features and actual usage.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:59.281+00",
          "seconds": 9.058,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/132",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-132",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "callout",
          "text": "On an August 26, 2020 group call during an investor conference, we asked the CEO what percentage of Omnia patients are currently using lower-frequency and other waveforms., and reminded him of his May comments. He repeated the same figure as above. Contrary to his May comments that “the use of lower frequencies standalone or combined would increase over time,” it is abundantly clear that Omnia remains just another high frequency stimulator – even about a year after launch.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0095b37d-61ea-47f3-be98-25a64985b4b5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "Contrary to his May comments that “the use of lower frequencies standalone or combined would increase over time,” it is abundantly clear that Omnia remains just another high frequency stimulator – even about a year after launch.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-51c65a8b5d1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Omnia is Nevro’s Hail Mary to re-invent itself now that high frequency has come and gone as a one-trick pony. Both the CEO and the sell-side have emphasized Omnia’s centrality to Nevro’s story going forward. We shall shortly provide color from Nevro’s own loyalist doctors, KOL’s, the company’s former executives, and competitors indicating that Omnia is a flop. However, the clearest indication that Omnia has bombed comes from the CEO directly: he admits that Omnia is still programmed for high frequency stimulation 85-90% of the time, rendering the new frequencies and waveforms irrelevant. One year into launch, Omnia has failed to alter how Nevro is perceived and used.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "30e9906d-af05-4bfe-8fd8-7872e5a00c80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "paragraph",
          "text": "Keith Grossman, Nevro CEO, comments on May 5, 2020 earnings call that only 10-15% of Omnia patients are augmenting high frequency stimulation with lower frequency or other waveforms.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f5ea9e54-52df-49a6-ac06-bc804991bb30",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "quote",
          "text": "In terms of how patients are actually being treated, we expected this to take a little bit of time. Given the certainty we had that the early adoption of Omnia would be among our existing customers and our existing customers skew to those customers who have a heavy belief in high frequency as a standalone therapy. So we knew that over time the use of paired waveforms, the use of lower frequencies standalone or combined would increase over time. But I think as we sit here today we look out over our very early patient population, I think it's something in the range of 10% to 15% of our patients are already using particularly paired waveforms with high frequency and other lower frequencies. And I think that's probably right about where we thought it would be at this point in time.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb98e5dd-97c5-4eef-941c-46a267137ba0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“In terms of how patients are actually being treated, we expected this to take a little bit of time. Given the certainty we had that the early adoption of Omnia would be among our existing customers and our existing customers skew to those customers who have a heavy belief in high frequency as a standalone therapy. So we knew that over time the use of paired waveforms, the use of lower frequencies standalone or combined would increase over time. But I think as we sit here today we look out over our very early patient population, I think it's something in the range of 10% to 15% of our patients are already using particularly paired waveforms with high frequency and other lower frequencies. And I think that's probably right about where we thought it would be at this point in time.” — Keith Grossman, Nevro CEO",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-5423bc58036e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: Earnings call transcript 5/5/20; group call with CEO 8/26/20.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91415681-3daf-4345-a8ef-c8910e2473ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b178c68c-7885-4e2f-8612-3b8297150b4b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56162393-ae5a-46cf-bcf4-ad3ffd8fda71",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "00f41c11-dce5-434c-b783-ae2b3e133d74",
          "evidence": "The slide explicitly contrasts the CEO's stated expectations with his later admission of stagnant adoption rates.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:59.281+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 132,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 133,
      "type": "tension",
      "title": "Uses CEO quote to undermine management credibility.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 57,
        "componentCount": 6,
        "textChars": 1964,
        "nDataPoints": 0,
        "notes": "Uses CEO quote to undermine management credibility.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:55.094+00",
          "seconds": 4.46,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/133",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-133",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Grossman’s tentative and artful choice of words on the August 5th and November 4th earnings calls suggest all is not well with the Omnia launch",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-05421ca7f38d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop. Grossman’s tentative and artful choice of words on the August 5th and November 4th earnings calls suggest all is not well with the Omnia launch, which he stated is “doing as well as we could have hoped on a relative basis” and “again, from a relative standpoint, we think we continue to do well with Omnia” – not exactly the tenor one would expect for the launch at the center of his turnaround hopes. We note the ongoing lack of metrics to help investors assess the launch.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5935a687-3936-4cf5-a659-0f4adfaf09db",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "quote",
          "text": "Keith Grossman, Nevro CEO, comments on August 5, 2020 earnings call: “So the -- I think the response to the Omnia launch has been very good. And as I mentioned in my remarks, we've now just launched Omnia in Europe and Australia following approvals there, respectively. I think the Omnia launch is doing as well as we could have hoped on a relative basis, obviously the COVID interruption aside, we felt extremely good about what Omnia was doing in the U.S. in the first quarter coming into COVID. And again, from a relative standpoint, we think we continue to do well with Omnia.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "915cc81b-dcc3-4658-82c6-7b0af945bb7b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "So the -- I think the response to the Omnia launch has been very good. And as I mentioned in my remarks, we've now just launched Omnia in Europe and Australia following approvals there, respectively. I think the Omnia launch is doing as well as we could have hoped on a relative basis, obviously the COVID interruption aside, we felt extremely good about what Omnia was doing in the U.S. in the first quarter coming into COVID. And again, from a relative standpoint, we think we continue to do well with Omnia. — Keith Grossman, Nevro CEO, comments on August 5, 2020 earnings call",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-092e2d6f99f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.18,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Earnings call transcript 8/5/20.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb8d2a2d-9dcb-40f5-9e88-df44fb49bf18",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4d83c9ca-b437-49fc-842d-f5463248f032",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "bead9769-440f-43be-9a13-14644894590a",
          "evidence": "The slide explicitly contrasts the CEO's quote with the author's interpretation of the product launch failure.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:15:55.094+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 133,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 134,
      "type": "tension",
      "title": "Uses testimonial quotes to undermine company narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2464,
        "nDataPoints": 0,
        "notes": "Uses testimonial quotes to undermine company narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:56.091+00",
          "seconds": 4.611,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/134",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-134",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Most doctors, even loyal Nevro users, view Omnia as \"a joke\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-cbe29caddb28",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.78
          },
          "kind": "list",
          "text": "Another of Nevro’s highest volume implanters belittled Omnia as just “a marketing move” that won’t “move the needle much”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "054a21d8-7fc5-4039-a6c6-ced10713e03c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.57
          },
          "kind": "list",
          "text": "One of Nevro’s highest volume implanters - closely aligned with the company and involved with their studies - has disparaged Omnia as “nothing”, according to a KOL who’s friends with him",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "214458f0-dc23-4b4c-9f25-ddda9139300c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.39
          },
          "kind": "list",
          "text": "Most doctors, even loyal Nevro users, view Omnia as “a joke”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "acfc1d89-e2f0-4d85-989a-e0f8b76e40d0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Over the course of 20+ interviews with KOL’s and interviews, including Nevro loyalists, one doctor after another slammed Omnia as a me-too, irrelevant, late to the game product that muddles Nevro’s message...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "915a5222-d6ad-4b2b-8184-ece445687350",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.83
          },
          "kind": "quote",
          "text": "I think that that Omnia was more of a marketing move than anything else. I've been in this field for a long time. In my practice it wasn't a game changer...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a8cf8e9-153c-4778-82dd-c6011b328025",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.08,
            "y": 0.43
          },
          "kind": "quote",
          "text": "Omnia is a joke I think to most doctors. Nevro's tried to make you forget about six years of marketing where they said paresthesia is the enemy...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35bc1572-c78e-41a1-a8bc-bd4f439b7aa3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.08,
            "y": 0.63
          },
          "kind": "quote",
          "text": "Doctors who are implanting the Omnia, like my friend in [state name redacted] who’s one of Nevro’s highest volume implanters in the world - even he doesn’t think it's as great as they are making it out to be...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df768ff8-fff5-45a2-b40d-be50797a07b1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Omnia is a joke I think to most doctors. Nevro's tried to make you forget about six years of marketing where they said paresthesia is the enemy, and now they're trying to make you forget they said that by launching a paresthesia-based device. Most people thought it was a joke, even the doctors that were loyal Nevro users. Doctor's don't talk about it as a game-changer or anything.\" — KOL and former high volume Nevro implanter; \"Doctors who are implanting the Omnia, like my friend in [state name redacted] who's one of Nevro's highest volume implanters in the world - even he doesn't think it's as great as they are making it out to be. He says the device is a little bit smaller and the programmer is a little bit different. But it's not like patients are raving about it. There's no wow. It's nothing. It's nothing that changes the space.\" — KOL and former high volume Nevro implanter; \"I think that that Omnia was more of a marketing move than anything else. I've been in this field for a long time. In my practice it wasn't a game changer. I don't think it will move the needle much in Florida.\" — High volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-cc0305f8ee75",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fc9102b-2289-44a6-ab2b-7e9a4996d938",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a451144-aa35-47ac-893a-9e0e98aec706",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14c7e500-6be6-4101-94a0-702b19f0c342",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c531a8fb-c9ec-41b8-9642-86311b3e8435",
          "evidence": "Frames the company's product as a 'colossal flop' through expert testimony.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:56.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 134,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 135,
      "type": "tension",
      "title": "Uses authority-citation framework to undermine the company's product launch.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 14,
        "textChars": 3038,
        "nDataPoints": 0,
        "notes": "Uses authority-citation framework to undermine the company's product launch.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:57.402+00",
          "seconds": 5.653,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/135",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-135",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Comments from one KOL after another were consistent and devastating in their assessment of Omnia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-8249ef263684",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "list",
          "text": "Omnia is \"an attempt to save market share with beleaguered cohort of doctors that are sick of explanting the device\" when high frequency fails",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1545bebd-f10d-456e-ab53-4f3e6c919040",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.51
          },
          "kind": "list",
          "text": "Even the most positive comments indicate Omnia is merely no better and no worse than other stimulators",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24e3ff9f-531b-4965-ac2b-51032ac75b5f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.19
          },
          "kind": "list",
          "text": "Omnia is irrelevant, a me-too device, and not \"a game changer\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc57d735-21ca-4e32-b8ed-86bc47b6196f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "list",
          "text": "Omnia is an admission of high frequency's problems and a forced move to prevent the company from going out of business",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e03e21aa-dfd6-4b98-babb-df07ed401937",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.8,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Comments from one KOL after another were consistent and devastating in their assessment of Omnia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56acfcab-c0d1-4d7d-a276-842a5c74dea2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.8,
            "x": 0.1,
            "y": 0.37
          },
          "kind": "quote",
          "text": "\"So Nevro had a good idea but they failed to maintain programming options having thrown their entire emphasis behind 10,000Hz. When it was proven that 1,000Hz was equal in efficacy, Nevro quaked in their boots. The Omnia is an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device when the 10,000 Hz programming fails to work.\" –KOL, former high volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1518ae6d-37f4-4eb6-bbf5-4bf196487b06",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.8,
            "x": 0.1,
            "y": 0.56
          },
          "kind": "quote",
          "text": "\"Omnia has burst, tonic, HF10, intermediate frequencies, and you can use multiple programs. When it came out, if one program doesn't work, I can change to another. I've started using it. It hasn't been any better than Boston Scientific but it works.\"–KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "69dea7c7-c6a5-41a5-9fa3-591ec53ade2c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.8,
            "x": 0.1,
            "y": 0.23
          },
          "kind": "quote",
          "text": "\"I don't think Omnia matters. All of the other manufacturers are pretty much doing the same thing with their batteries. It's not a game changer.\" – KOL in the SCS field with prominent papers published",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad9dacf1-93d4-44d0-b308-af1f8a0b1619",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.8,
            "x": 0.1,
            "y": 0.72
          },
          "kind": "quote",
          "text": "\"If HF10 was as groovy as they thought it was, they wouldn't have had to change the device to do paresthesia. They were forced into Omnia or they would have gone out of business.\" – KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b42f38a0-21f6-411c-a356-02beb4947478",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I don’t think Omnia matters. All of the other manufacturers are pretty much doing the same thing with their batteries. It’s not a game changer. — KOL in the SCS field with prominent papers published; So Nevro had a good idea but they failed to maintain programming options having thrown their entire emphasis behind 10,000Hz. When it was proven that 1,000Hz was equal in efficacy, Nevro quaked in their boots. The Omnia is an attempt to save market share with a beleaguered cohort of doctors that are sick of explanting the device when the 10,000 Hz programming fails to work. — KOL, former high volume Nevro user; Omnia has burst, tonic, HF10, intermediate frequencies, and you can use multiple programs. When it came out, if one program doesn’t work, I can change to another. I’ve started using it. It hasn’t been any better than Boston Scientific but it works. — KOL and high volume implanter; If HF10 was as groovy as they thought it was, they wouldn’t have had to change the device to do paresthesia. They were forced into Omnia or they would have gone out of business. — KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:36+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-864cfb3ad59a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35b57542-3411-46ff-8df2-64dfe6493444",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4adadc19-4b6c-4a58-9006-590d6745b9d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "369dbfac-b7a8-4830-bd14-ae3198334b3b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d919fe73-d2af-4469-b3ac-d02a07defd1a",
          "evidence": "Uses multiple KOL quotes to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:57.402+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 135,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 136,
      "type": "tension",
      "title": "Uses highlighted quotes to emphasize negative sentiment from industry experts.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 3846,
        "nDataPoints": 0,
        "notes": "Uses highlighted quotes to emphasize negative sentiment from industry experts.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:03.174+00",
          "seconds": 11.025,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/136",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-136",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The feedback was equally devastating whether from current Nevro users, former high volume Nevro implanters, or other KOL's.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-e692ec9dd8ea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.62
          },
          "kind": "list",
          "text": "One of Nevro’s highest volume implanters, and a consultant who receives significant payments from the company, dismissed Omnia as cannibalizing existing Nevro users without gaining new ones",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57dd5405-781b-4421-bffb-c125d2e8a222",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "list",
          "text": "A KOL and former high volume Nevro user slammed Omnia’s claims of special waveforms, deriding it as a me-too device with nothing “brand new or innovative.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "925051ef-7abb-433e-b5a7-79d02035dd14",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.43
          },
          "kind": "list",
          "text": "One of the highest volume implanters in New York, who still uses some Nevro, hasn’t bothered to try Omnia, calling it “incremental” with no effect on his share",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe712cb2-fffb-4575-b96f-a557e57ab339",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The feedback was equally devastating whether from current Nevro users, former high volume Nevro implanters, or other KOL's.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2bded92-aed7-493c-958f-4b959438cc7e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.26
          },
          "kind": "quote",
          "text": "They try to call Omnia a high-frequency tonic [low frequency stimulation] which is bullshit. It's the same thing. They try to claim that they have burst which is also like a high-frequency burst. Bullshit. There's no data. They never did a study. Omnia is what everyone else's device can already do, just packaged in a little Nevro box. If a doctor already left Nevro because their device sucks, there's nothing Omnia does that's brand new or innovative that you can't do with whatever company you already use.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3debfcd7-48f3-4fc0-adcb-eb64cfe5882a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.1,
            "y": 0.49
          },
          "kind": "quote",
          "text": "I haven't implanted the Omnia. It's an incremental benefit. It will be better than Senza. I don't think it'll be a game changer. It won't bump my Nevro share any more. Every stim company comes up with a new device every couple of years. It's an incremental, evolutionary advancement. Not revolutionary.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fec0682-a2a6-486a-b84b-b2558b92165b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.1,
            "y": 0.68
          },
          "kind": "quote",
          "text": "The impact of Omnia is incremental. I think it's incremental for the Nevro users that were concerned about Nevro's limitations and therefore gave some cases to other companies. I don't know how much it gains new doctors. By now you've either used Nevro or you haven't. They're not really converting people from other companies all of a sudden because of the Omnia. They've almost exclusively converted over the previous Senza and Senza 2 users to Omnia but at the same time, I don't think it's a as big of a leap as the first time around with HF10 versus paraesthesia-based stim.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "852b4e93-0dd4-4786-93ca-94e26372e970",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"They try to call Omnia a high-frequency tonic [low frequency stimulation] which is bullshit. It's the same thing. They try to claim that they have burst which is also like a high-frequency burst. Bullshit. There's no data. They never did a study. Omnia is what everyone else's device can already do, just packaged in a little Nevro box. If a doctor already left Nevro because their device sucks, there's nothing Omnia does that's brand new or innovative that you can't do with whatever company you already use.\" — KOL and former high volume Nevro implanter; \"I haven't implanted the Omnia. It's an incremental benefit. It will be better than Senza. I don't think it'll be a game changer. It won't bump my Nevro share any more. Every stim company comes up with a new device every couple of years. It's an incremental, evolutionary advancement. Not revolutionary.\" — High volume implanter; \"The impact of Omnia is incremental. I think it's incremental for the Nevro users that were concerned about Nevro's limitations and therefore gave some cases to other companies. I don't know how much it gains new doctors. By now you've either used Nevro or you haven't. They're not really converting people from other companies all of a sudden because of the Omnia. They've almost exclusively converted over the previous Senza and Senza 2 users to Omnia but at the same time, I don't think it's a as big of a leap as the first time around with HF10 versus paraesthesia-based stim.\" — KOL and high volume Nevro implanter and consultant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:37+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b341-e8bc96a18e12",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "74e2cb46-fb25-4fb4-83d8-f5550881c3c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aed39e7e-6ab5-4b6b-9fbb-ca88f10d1396",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "433833d6-be2b-43d0-8796-206a1014d1c3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 137,
      "type": "tension",
      "title": "Uses expert quotes to undermine the company's product strategy.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2705,
        "nDataPoints": 0,
        "notes": "Uses expert quotes to undermine the company's product strategy.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:00.856+00",
          "seconds": 8.479,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/137",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-137",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The uniformity of negative comments suggests that an Omnia-fueled turnaround is a delusion.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-37b66c160222",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.2
          },
          "kind": "list",
          "text": "A KOL who still uses Nevro as 25% of his device mix described Omnia as “nothing special” and me-too",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14bcc7e8-a5e9-4825-a895-509b99968407",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "Omnia is just an attempt to “salvage the company” after doctors began to abandon high frequency",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "768b022f-994f-4d52-b1de-c5914355568a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "list",
          "text": "Doctors have no reason to use Omnia’s low-frequency option versus current low-frequency devices",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c0ec29c-0ffa-4858-ba2d-6126d572d468",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The uniformity of negative comments suggests that an Omnia-fueled turnaround is a delusion.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ed31060-6e74-4b62-ac3c-e895c6915c5e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.1,
            "y": 0.7
          },
          "kind": "quote",
          "text": "Abbott came out with a device you don't ever have to recharge for 10 years... If the high frequency doesn't work, why would you use their low frequency device over someone else's?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "00c92d22-1f58-4cd6-a2f9-875569751f20",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.1,
            "y": 0.5
          },
          "kind": "quote",
          "text": "Omni's not a game-changer. The rest of the world moved on from Nevro so Omnia is just using the low-frequency therapy Nevro claimed they were better than, to salvage the company.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "75ffdc7b-379c-42c9-adfb-2785ddde6572",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.25
          },
          "kind": "quote",
          "text": "To tell you the truth, I was always relatively pessimistic on Nevro... what they're doing is nothing special, that's the bottom line. They're coming around to every other company which says that you need to offer everything.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fffd543-195b-465a-9f7e-8ce28062a822",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"To tell you the truth, I was always relatively pessimistic on Nevro. In fact, I had to write an article in one of the journals a few years ago saying that Nevro will not last unless they provide other waveforms and the company wrote nasty letters back to me because I believed even at that time that it's not a one-size-fits-all. What they're doing with Omnia - what they're doing is nothing special, that's the bottom line. They're coming around to every other company which says that you need to offer everything. I don't consider this a gamechanger at all. Omnia is nothing dramatic. That Nevro has come out with this is not earth-shattering.\" — High volume implanter; \"Omni's not a game-changer. The rest of the world moved on from Nevro so Omnia is just using the low-frequency therapy Nevro claimed they were better than, to salvage the company. But you could do low frequency with Abbott, Medtronic, or Boston Scientific, and you have a device that's MRI compatible and one you don't have to recharge.\" — KOL and former high volume Nevro user; \"Abbott came out with a device you don't ever have to recharge for 10 years, or you implant Medtronic and it's MRI compatible. If the high frequency doesn't work, why would you use their low frequency device over someone else's? Nevro's entire campaign at launch was about how much better they were than low frequency, but now they're using low frequency to salvage themselves.\" — KOL and former high volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-3822c5778fad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "26507b79-7e7c-48a9-8e96-366fba515815",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5519073d-5dcd-46c6-888b-8d2196111843",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "284798c0-826a-4688-a834-dba516a48fb7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f36fabda-f1f5-4422-ba96-bbbe8ebc6eee",
          "evidence": "Frames Nevro's product as a 'colossal flop' and 'delusion' to build a case against the company.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:00.856+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 137,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 138,
      "type": "tension",
      "title": "Uses direct quotes from KOLs to undermine the company's product launch narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 84,
        "componentCount": 10,
        "textChars": 2230,
        "nDataPoints": 0,
        "notes": "Uses direct quotes from KOLs to undermine the company's product launch narrative.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:55.903+00",
          "seconds": 3.429,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/138",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-138",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Omnia merely caters to Nevro users who turned away versus expanding the company's base",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-d26609a45397",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "list",
          "text": "Omnia merely caters to Nevro users who turned away versus expanding the company’s base",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "07d951eb-9b5d-4388-8414-e9251e93f1b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "list",
          "text": "Omnia is an attempt to re-position the company after hitting the wall due to explants, but it’s “old stuff” as Nevro’s competitors have offered multiple wave form devices for most of this decade",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "543c7d98-bada-4105-aac3-bb615f71aaba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Although five pages of KOL commentary on Omnia may be overkill, the launch is key to the bull case and a broad sample of real-world doctor feedback may be useful to investors betting on Omnia as Nevro’s savior.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "96e713f3-c8d7-4365-a766-11f99a753d0e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.84,
            "x": 0.1,
            "y": 0.27
          },
          "kind": "quote",
          "text": "The Omnia works best for heavy Nevro users who stopped being users... The Nevro device is still big, just not as big as it was. They’re just going from zero share to 10% of my share.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d47e6069-f076-4d10-a29a-d3f65f9b3e0f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.84,
            "x": 0.1,
            "y": 0.53
          },
          "kind": "quote",
          "text": "Now all of a sudden Nevro realizes that with their explants rate, they’re going to have to do something new and sexy with Omnia [...] They’ve basically turned themselves into Boston Scientific... This is old stuff.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e2c95469-5f74-449a-be7c-1fe40a150a25",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The Omnia works best for heavy Nevro users who stopped being users. My share is 10% Nevro, 40% Boston, 25% Medtronic and 25% Abbot. Nevro's share will stay at 10%. I wasn't that happy with the anchor. If takes an extra half hour with the anchor it's a hassle. It's the biggest rechargeable there is. The only bigger stimulator is the Abbot non-rechargeable. The Nevro device is still big, just not as big as it was. They're just going from zero share to 10% of my share. These are chronic pain patients and if you give them something uncomfortable they'll complain about it a lot more. It's the population you're dealing with.\" — KOL, former heavy Nevro user who now uses it sparingly; \"Now all of a sudden Nevro realizes that with their explants rate, they're going to have to do something new and sexy with Omnia [...] They're basically turned themselves into Boston Scientific which has offered multiple waveforms ever since Spectrum launched in 2013. This is old stuff. They're saying 'I guess we better be competitive because our differentiation at 10khz failed.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-d5cc51ddb932",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d856f817-4d05-4a1d-b2b6-45f9bdaf1f51",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6337f76-dfec-436f-87cb-aafe662de02e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98ce7b7a-f4ef-4e71-b7ac-286f5d3eae0c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "47f67e14-0c55-47c1-8f8c-118b7fd0cf09",
          "evidence": "Frames the company's product as a 'colossal flop' and 'old stuff' via expert testimony.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:55.903+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 138,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 139,
      "type": "tension",
      "title": "The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2623,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from a former executive to undermine management's credibility and the product's market viability.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:35.009+00",
          "seconds": 3.757,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/139",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-139",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I think there’s a lot of window-dressing with Grossman and that’s why you’re not seeing this big uptake in revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-03b22e655756",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "list",
          "text": "The senior ex-executive described the CEO as engaged in “window-dressing” and questioned the lack of “uptake” despite “a hundred more reps.” He bluntly stated that “nobody’s going to buy Omnia” unless they’re essentially bribed via study participation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "61b850ce-e97c-43f4-ae68-603fbb8f7542",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "list",
          "text": "He added that few of their “hardcore customers” are even utilizing Omnia and described a declining company that is on the precipice of competitive irrelevance",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86f00fe2-cd75-4b1b-833b-e73637350e04",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A broad sample of former Nevro executives and sales reps, some still in touch with the CEO and management team, concurred with KOL’s and doctors in their scathing assessments of Omnia’s potential. We found the level of consensus and conviction among both sets of experts notable. We begin with comments by a senior and plugged-in former Nevro executive: just “window-dressing with Grossman”; “nobody’s going to buy Omnia” unless essentially bribed via study participation fees; that it’s “just repackaging of an old product”; and that he’d “be shocked” if it drives growth. He described a core business in decline and a company on the precipice.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2da398e2-bca7-47ad-9eaf-1954e3e0bd55",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.09,
            "y": 0.62
          },
          "kind": "quote",
          "text": "I watch this very, very carefully - out of all those really Nevro hardcore customers, how many are actually utilizing Omnia? Not a lot. So, what does Nevro really have? They have a core group of customers. They’re not growing the business. The stock is doing well, so it’s providing some stability. Then Saluda comes in, Nalu comes in, and all of a sudden they’re going directly after them.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63a35e71-7423-4b23-903e-5abde3e2b8da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.09,
            "y": 0.42
          },
          "kind": "quote",
          "text": "I think there’s a lot of window-dressing with Grossman and that’s why you’re not seeing this big uptake in revenue. If Omnia is so good and you’ve got a hundred more reps out on the field and you’re doing all this great selling and all these customers are happy, why is it not going up? They’ve eroded their price. Nobody’s going to buy Omnia, unless you’re getting paid a couple thousand bucks to be put in a study to use it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9659718c-0d6a-42a0-b08c-6867ba9294fa",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I think there’s a lot of window-dressing with Grossman and that’s why you’re not seeing this big uptake in revenue. If Omnia is so good and you’ve got a hundred more reps out on the field and you’re doing all this great selling and all these customers are happy, why is it not going up? They’ve eroded their price. Nobody’s going to buy Omnia, unless you’re getting paid a couple thousand bucks to be put in a study to use it. — Senior Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-064f91b5fed2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d83da9f7-e769-4f38-904f-8a1892cfc207",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "524e33b6-2974-4ff8-9280-3e3003257fa9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:35.009+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "274d0494-1ad5-446e-9a87-fb01aae9f9ed",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 140,
      "type": "tension",
      "title": "Uses expert testimony to undermine company narrative regarding product success.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 92,
        "componentCount": 11,
        "textChars": 3001,
        "nDataPoints": 2,
        "notes": "Uses expert testimony to undermine company narrative regarding product success.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:36.46+00",
          "seconds": 3.874,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/140",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-140",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "They think Omnia's going to be a big thing. I just don't see it. Grossman even said on the earnings call that non-high frequency is utilized only 15% of the time.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-4e501063b26a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "list",
          "text": "Two former Nevro territory managers independently stated that Nevro’s “not going to get more patients because of Omnia.” One is now at a key competitor and sees no impact from Omnia from his seat.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02365ce1-4673-4ff4-9d83-1c6f3afb8848",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "list",
          "text": "The former sales executive stated that Omnia is “nothing new” and a dud, noting that Grossman has admitted that it’s still used as a high frequency device 85% of the time.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1219a140-a026-420d-b137-d92255dee0c8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "other",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "661671b6-dadd-4eb0-a094-092230726f55",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Another former executive, in a key sales role and now at a large competitor, offered an identical assessment that Omnia is a dud. In addition, two territory managers, both part of Nevro’s launch team and one now at a key competitor, concurred that they see no market impact.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7c2199f-fc7f-4542-86fd-a1bdc6c230ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.84,
            "x": 0.1,
            "y": 0.58
          },
          "kind": "quote",
          "text": "The market's not changing because of Omnia. The spinal cord stim market is what the spinal cord stim market is. You're not going to get more patients because of Omnia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "279143e0-b1ee-48db-b3e1-37ada60d9d73",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.84,
            "x": 0.1,
            "y": 0.68
          },
          "kind": "quote",
          "text": "I don't hear anything, from my team or anyone in my territory, that Nevro’s adoption with Omnia is now so much better. Some doctors are trying it out but I haven't heard anything revolutionary about it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b03fe17-6d36-4e33-a5e8-f97e6bf4b61a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.84,
            "x": 0.1,
            "y": 0.31
          },
          "kind": "quote",
          "text": "They think Omnia’s going to be a big thing. I just don't see it. Grossman even said on the earnings call that non-high frequency is utilized only 15% of the time. There's nothing new...Nevro does not feel that a lot of these other waveforms are going to be utilized with Omnia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fe7d402-5b67-4fa2-8e3d-fe8d87cbc01e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "They think Omnia's going to be a big thing. I just don't see it. Grossman even said on the earnings call that non-high frequency is utilized only 15% of the time. There's nothing new...Nevro does not feel that a lot of these other waveforms are going to be utilized with Omnia. It is rather to provide physicians with the perception that they have more options. The utilization of low-frequency and other waveforms besides high frequency will be very low, because one, a lot of Nevro's people don't know how to program those patients well because they've been utilizing the high-frequency algorithm and two, most of the time Senza is what people want. — Senior Nevro ex-sales executive; The market's not changing because of Omnia. The spinal cord stim market is what the spinal cord stim market is. You're not going to get more patients because of Omnia. Right now, you're just playing around in the same old market you've always been playing in, the same market I've been playing in my whole career, and the market's not really changing. — Former Nevro territory manager, one of the longest tenured SCS reps; I don't hear anything, from my team or anyone in my territory, that Nevro's adoption with Omnia is now so much better. Some doctors are trying it out but I haven't heard anything revolutionary about it. — Former Nevro territory manager now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-53037e9c79a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b06788c7-4620-4453-b7a5-faaac4fec009",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "be92508a-6b74-45e1-bfe9-26cef81e29fd",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "List presentation",
            "slug": "list-presentation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-4ef7-777d-ba68-9074c2b3bcf1",
            "version": 1,
            "bodyDocId": null,
            "description": "Bulleted, numbered, or checklist enumerations.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "81979259-12c2-496d-8a76-9d4a302a80a5",
          "evidence": "The use of bullet points to present multiple quotes and testimonials from experts.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:46.221862+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 140,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "0722a249-9fdb-4684-bf7d-b015ee933638",
          "evidence": "Uses former employees to frame the company's product as a failure.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-07-17 03:28:36.46+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 140,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 141,
      "type": "tension",
      "title": "The slide uses direct quotes from former employees to undermine the company's product strategy.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 9,
        "textChars": 1621,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from former employees to undermine the company's product strategy.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:56.236+00",
          "seconds": 3.574,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/141",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-141",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-ecc24e77779e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We include additional Omnia commentary by former executives and sales reps, which we found as universal and harsh as the feedback from KOL’s and doctors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "708b924f-49d5-4c5d-bc7b-a9bd5a9f8d30",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.11,
            "y": 0.81
          },
          "kind": "quote",
          "text": "Omnia is not a game changer. It’s just that the remote and recharger are a little more aesthetically pleasing. It wasn’t the best idea because it lets the competition undermine the high frequency technology that Nevro was built for.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aac0b649-cada-4972-9a40-fcb1871fc092",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.11,
            "y": 0.56
          },
          "kind": "quote",
          "text": "The feedback from my doctor contacts as well as industry contacts is that Omnia is not changing the paradigm at all. Will it lead to more market share or reversal of sales declines? I’d be shocked if it was a driver of sales growth.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad4f5cef-d53a-4231-b9fe-688f93026a39",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.8,
            "x": 0.11,
            "y": 0.31
          },
          "kind": "quote",
          "text": "His understanding of the technology that he’s speaking to, and the way that’s going to be received by physicians, is naïve. Grossman describes Omnia as really just the marketing... It's basically just a repackaging of an old product.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fc1638c8-673b-49fa-a4ef-893ee5ec1cf2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "His understanding of the technology that he’s speaking to, and the way that’s going to be received by physicians, is naïve. Grossman describes Omnia as really just the marketing, like the same marketing spin that was being presented at NANS. I don’t think he understands the way that these physicians work and their desire to have new and innovative products. Omnia is not a new or innovative product. It's basically just a repackaging of an old product. — Former Nevro sales executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-f2669e5775e4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "051a888f-07f8-4802-baa8-8fdfcb2b86f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c00aed57-a262-4ec7-9b40-3b52b2a83274",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "40231639-34fe-4a9e-a963-4d9e9c926755",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4b99c812-8697-4070-8bdc-569604c02a72",
          "evidence": "Using former employees to validate claims",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:56.236+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 141,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 142,
      "type": "tension",
      "title": "Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.",
      "function": "illustrate_case",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 9,
        "textChars": 2339,
        "nDataPoints": 3,
        "notes": "Uses highlighted text blocks to emphasize key negative quotes from industry experts regarding Nevro's product launch.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.9,
        "extraction": {
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "at": "2026-07-17 03:50:37.353+00",
          "seconds": 22.11,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/142",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-142",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Omnia isn’t impacting the market by letting them capture market share. Doctors use everyone. They’re not loyal. The only loyal ones are ones being paid a lot of money to put in devices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-4ccc4a8b45a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.6
          },
          "kind": "list",
          "text": "A longtime C-level executive in the SCS space stated that a me-too product like Omnia wouldn't shift any share to Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "334579c2-7572-4c74-bdda-08fe4ffa3b89",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "list",
          "text": "A territory manager with 20 years of SCS experience, overseeing one of the largest multi-state regions for one of Nevro's 3 key competitors, described a few doctors dabbling with Omnia but no material market share impact.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "831bb42e-29fd-4567-97e5-51e8c490e305",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.21,
            "w": 0.83,
            "x": 0.11,
            "y": 0.36
          },
          "kind": "quote",
          "text": "\"Omni rolled out in Q3 2019. We're seeing it all over social media... Omnia isn't impacting the market by letting them capture market share. Doctors use everyone. They're not loyal. The only loyal ones are ones being paid a lot of money to put in devices.\"",
          "attrs": {
            "highlighted": true
          },
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "95bbe90e-4f6d-483c-8f43-1990c9218537",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.83,
            "x": 0.11,
            "y": 0.68
          },
          "kind": "quote",
          "text": "\"Are they shifting share from Boston Scientific with Omnia? I doubt it because Boston Scientific, their IPG, has those capabilities, and I think their programming is better.\"",
          "attrs": {
            "highlighted": true
          },
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0743819-8339-454b-b93e-12ee97a721df",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Omni rolled out in Q3 2019. We’re seeing it all over social media. Doctors are saying Omnia’s a good battery, that it gives them options but that the results are no better than anyone’s else. They got some more play with it. One of our doctors will do a couple of cases with it and see how it goes. You have your Nevro loyalists like [name redacted] and [name redacted] who are being paid. They’re on their studies. Every day doctors though have gotten smarter and use everyone’s device. Omnia isn’t impacting the market by letting them capture market share. Doctors use everyone. They’re not loyal. The only loyal ones are ones being paid a lot of money to put in devices. Everyone gets their piece of the pie.” — Territory manager at one of Nevro’s 3 key competitors; “Are they shifting share from Boston Scientific with Omnia? I doubt it because Boston Scientific, their IPG, has those capabilities, and I think their programming is better.” — Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-50c5402a67d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "478c1fe0-a20e-482e-8f1d-375cb77afa15",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro's turnaround hopes, is a Hail Mary and colossal flop\nExecutives, regional managers, and sales reps at Nevro's competitors... offered ground-level color on Omnia, corroborating remarks by doctors and ex-employees that it's a failed launch with little to no market impact.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28c5c1ac-3a39-40a7-a370-02b8c750ded5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eae5e698-f04f-4479-9bf1-85940addd4d2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Audience Definition",
            "slug": "audience-definition",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-7f2a-775d-aeee-ff099bcb7756",
            "version": 1,
            "bodyDocId": null,
            "description": "Six key questions: Who are they? What do they know? What do they believe? What do they care about? What do they fear? What decisions can they make?",
            "familyLabel": null,
            "categoryName": "Block",
            "categorySlug": "block"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "b331783e-b247-40e6-8307-813d90602ebd",
          "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices and target audience.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.5,
          "extraction": {
            "at": "2026-07-17 03:55:46.306279+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 142,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "70abdf40-3d9d-4365-936f-adba9ecb7f43",
          "evidence": "Citing a territory manager with 20 years of SCS experience and a longtime C-level executive to validate the short thesis.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-07-17 03:50:37.353+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 142,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 143,
      "type": "tension",
      "title": "Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 3536,
        "nDataPoints": 0,
        "notes": "Uses testimonial-style quotes from a competitor's regional sales manager to undermine the target company's product launch.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:57.665+00",
          "seconds": 4.832,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/143",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-143",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Competitor color on Omnia’s lack of traction was consistent around the country: “a dud.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-9c47b0be67f8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.53
          },
          "kind": "list",
          "text": "He indicated that Omnia undermines Nevro’s positioning and credibility, and that its field salesforce isn’t even trained in the paresthesia-mapping required to implant a low-frequency stimulator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9585b224-9638-495b-a4da-aefd96b14e72",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "A longtime regional manager overseeing one of the largest territories for a key competitor expects Omnia to be “a dud” and that he has seen no material “uptick for Omnia.” He stated that competitors are leveraging Nevro’s about-face toward low-frequency stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bed1992d-7c9a-49f9-b8d7-b887292be710",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Competitor color on Omnia’s lack of traction was consistent around the country: “a dud.” A regional manager explained that Nevro’s salesforce isn’t even trained in paresthesia-mapping, the method by which low-frequency stimulators are implanted – yet another reason why Omnia, per Grossman’s comments, remains almost exclusively a high frequency stimulator.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d84f8e65-c148-436f-b805-fb81189cb5ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.36
          },
          "kind": "quote",
          "text": "“I have not seen a big uptick for Omnia in our territory. I think it'll be a dud. We've been pushing hard against their being all in on high frequency, and now allowing low-dose and multiple waveforms even though everything they've done and all their studies are around 10khz. They're trying to get Omnia into some of their old accounts now. If a patient comes in requesting Nevro, that’s about the only time that Nevro is getting implanted in other accounts” – Regional sales manager at one of Nevro’s largest competitors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "74815f0a-547b-41b3-85cb-5cdba36a76d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.85,
            "x": 0.09,
            "y": 0.6
          },
          "kind": "quote",
          "text": "“Part of Nevro’s messaging is that it's easy to implant. You throw the leads in; you scan T9/T10; there's no in or out testing. It's very simple. But if you need to switch to low-dose and you need to do mapping, you have no idea what you're getting into as a doctor. Nevro never trained a lot of their reps on it. Now they're asking their field to retrain on classic spinal cord stimulation. We leverage that. You've done an about-face and now all of a sudden you're trying to do what every other company is doing. At least in our market, high frequency hasn't been the silver bullet you promoted and now you're just like everybody else.” – Regional sales manager at one of Nevro’s largest competitors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "acab5fee-63ba-4036-a395-63331487ce50",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I have not seen a big uptick for Omnia in our territory. I think it'll be a dud. We've been pushing hard against their being all in on high frequency, and now allowing low-dose and multiple waveforms even though everything they've done and all their studies are around 10khz. They're trying to get Omnia into some of their old accounts now. If a patient comes in requesting Nevro, that's about the only time that Nevro is getting implanted in other accounts” — Regional sales manager at one of Nevro's largest competitors; “Part of Nevro's messaging is that it's easy to implant. You throw the leads in; you scan T9/T10; there's no in or out testing. It's very simple. But if you need to switch to low-dose and you need to do mapping, you have no idea what you're getting into as a doctor. Nevro never trained a lot of their reps on it. Now they're asking their field to retrain on classic spinal cord stimulation. We leverage that. You've done an about-face and now all of a sudden you're trying to do what every other company is doing. At least in our market, high frequency hasn't been the silver bullet you promoted and now you're just like everybody else.” — Regional sales manager at one of Nevro's largest competitors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-a02b018fe997",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c79f177a-4343-4b38-bdab-99af26a1ea87",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2ec730d-e496-442a-9721-c8a34aa5ed09",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:57.665+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3bda7cec-1ebc-4ecc-b2e5-f9af8f4187fb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 144,
      "type": "tension",
      "title": "Uses quotes from KOLs and former users to frame the company as a 'one-trick pony' facing inevitable decline.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 3116,
        "nDataPoints": 0,
        "notes": "Uses quotes from KOLs and former users to frame the company as a 'one-trick pony' facing inevitable decline.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:59.378+00",
          "seconds": 6.307,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/144",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-144",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "After spending a decade pushing high frequency stimulation and trashing low-frequency as ineffective and dangerous, experts described the company’s sudden embrace of low-frequency as an admission of defeat and a sign the company is going \"the way of the Dodo.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-6776f8e7ea1d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "list",
          "text": "KOL’s state the industry has moved on from high-frequency and that Omnia is an admission of failure",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "25654287-526e-42fc-a793-9e07f8249f77",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "list",
          "text": "Omnia indicates that Nevro’s future is “problematic” and that it’s going “the way of the Dodo bird” with price pressure and new entrants",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a87d20fa-df48-41a3-b74d-dc99586d12e8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Comments by former Nevro executives/reps, competitors, and KOL’s/doctors indicate that Omnia is not only a dud, but that it erodes Nevro’s credibility and muddles their message. After spending a decade pushing high frequency stimulation and trashing low-frequency as ineffective and dangerous, experts described the company’s sudden embrace of low-frequency as an admission of defeat and a sign the company is going “the way of the Dodo.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2f2f6ee-1fd3-4516-a0a1-e841a099bde2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.09,
            "y": 0.32
          },
          "kind": "quote",
          "text": "“Nevro initially tried to blow everybody out of the water with, \"Look, we have 10khz frequency\" And I know the key engineer over there. When the PROCO study came out, it showed excellent sub-perception outcomes at 1khz. All of a sudden everybody said, \"Who needs 10k?\" And they then said \"Nobody can have 10khz but us,\" and Boston Scientific and the other companies said, \"It's all yours.\" So, Nevro failed with 10k. Now what they have to do is reinvent themselves, so they re-marketed Omnia. Here's a company that said, \"Paresthesia is awful.\" Now they have to give in and offer paresthesia.” - KOL and former high volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "00c4d9de-d479-4c1f-a83e-851c77ef2532",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.09,
            "y": 0.51
          },
          "kind": "quote",
          "text": "“If paresthesia-free was such a good thing, why come out with supposedly new technology? Maybe it’s marketing.” - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46d5c057-a241-4f3f-ad60-cda7218913ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.09,
            "y": 0.64
          },
          "kind": "quote",
          "text": "“I give them a lot of credit that they've been able to survive financially being a one-trick pony, but the fact that they came out with Omnia does mean the future is problematic, because now they've realized that they're not anything special, they're just another stimulator company—what is going to distinguish them from the other companies.” - High volume implanter and moderate Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4bcf3a87-9eed-4fb7-9455-e9c7e19d24a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.09,
            "y": 0.77
          },
          "kind": "quote",
          "text": "“There are going to be more entrants to the market, and that's going to cause price pressure. Nevro is going to go the way of the Dodo bird eventually. That's why they had to do Omnia.” - KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8298202-4349-47f5-81ff-a7db64b9f6ab",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro initially tried to blow everybody out of the water with, 'Look, we have 10khz frequency' And I know the key engineer over there. When the PROCO study came out, it showed excellent sub-perception outcomes at 1khz. All of a sudden everybody said, 'Who needs 10k?' And then they sued and said 'Nobody can have 10khz but us,' and Boston Scientific and the other companies said, 'It's all yours.' So, Nevro failed with 10k. Now what they have to do is reinvent themselves, so they re-marketed Omnia. Here's a company that said, 'Paresthesia is awful.' Now they have to give in and offer paresthesia.\" — KOL and former high volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-6b22fef58e66",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84c07f97-814e-42ff-a69f-fcf6d93bfb3c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "66be8472-c773-4d34-8b42-e2c1d9054525",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.378+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eabbe4dc-0128-4ef0-b9d3-9073a72dd320",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 145,
      "type": "tension",
      "title": "The slide uses expert quotes to frame the company's strategic pivot as a sign of desperation and loss of identity.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 3167,
        "nDataPoints": 0,
        "notes": "The slide uses expert quotes to frame the company's strategic pivot as a sign of desperation and loss of identity.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:02.47+00",
          "seconds": 9.24,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/145",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-145",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The Omnia launch admits that all of Nevro’s previous clinical data is “hogwash.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-003a0318855d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "list",
          "text": "A former Nevro sales executives stated that Omnia erases Nevro’s identity, and that Medtronic and Boston Scientific already tried and failed with the same all-things-to-all-people product strategy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2aa2c9e6-3516-44cd-a6f0-696e0efeac93",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.06,
            "y": 0.19
          },
          "kind": "list",
          "text": "The Omnia launch admits that all of Nevro’s previous clinical data is “hogwash.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6084900c-6c58-4e07-a838-f6d4e844136a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Omnia erodes Nevro’s credibility and muddles the company’s message (cont'd)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4739da2f-3973-4cf5-9582-700feb5a38d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.65
          },
          "kind": "quote",
          "text": "“The Omnia launch was an acknowledgement that they needed to change course because the novelty and newness of high frequency has worn off.” – Former regional sales manager in charge of one of Nevro’s largest territories",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "55f3417c-2eda-40ac-bb20-fd6380bea4d0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.44
          },
          "kind": "quote",
          "text": "“Omnia is not going to do it for Nevro. The issue is that they’ve now lost their identity. They’re now the same as everyone else... Omnia is not differentiated... Medtronic and Boston Scientific already went to market saying we can do other waveforms and things and it hasn’t worked for them.” – Former sales executive now at a key competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57152d05-5a82-4326-9812-8fff100f6e71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.24
          },
          "kind": "quote",
          "text": "“All of their clinical data that they first gained market share with - they have now said through their actions of launching Omnia that it was all hogwash, because they now offer a product that does lower frequency.” – Longtime C-level executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bfd3a7c2-5dad-4ad3-8440-03a9c25da084",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.78
          },
          "kind": "quote",
          "text": "“Nevro has lost their identity. Going toward they’re positioning around Omnia which can do everything. They’re no longer differentiated which creates a big problem. Being different is one of the key things in the SCS market.” – Former sales executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fdf073a4-7a97-4ba3-bffd-fbaffafe0245",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“All of their clinical data that they first gained market share with - they have now said through their actions of launching Omnia that it was all hogwash, because they now offer a product that does lower frequency.” — Longtime C-level executive in the SCS space; “Omnia is not going to do it for Nevro. The issue is that they’ve now lost their identity. They’re now the same as everyone else. The only product in the space that’s differentiated is the Abbot IPG. Nevro, Boston Scientific, others are all saying exactly the same thing. They’re all saying burst, different, waveforms, etc. Omnia is not differentiated. It has nothing specific that will hit the nail on the head for doctors. Omnia’s burst waveform isn’t actually a burst. They’re claiming it’s something it’s not. I just don’t see it being an effective strategy. Medtronic and Boston Scientific already went to market saying we can do other waveforms and things and it hasn’t worked for them.” — Former sales executive now at a key competitor; “The Omnia launch was an acknowledgement that they needed to change course because the novelty and newness of high frequency has worn off.” — Former regional sales manager in charge of one of Nevro’s largest territories; “Nevro has lost their identity. Going toward they’re positioning around Omnia which can do everything. They’re no longer differentiated which creates a big problem. Being different is one of the key things in the SCS market.” — Former sales executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-07d63b579efc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4ddfe99-5a0d-4dfd-b791-f81d93a1784a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f9c9be97-dec7-4949-a4fd-cedd3498fe66",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.47+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c3f57d74-0410-4055-b10f-ca3e56747316",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 146,
      "type": "tension",
      "title": "Uses yellow highlighting to emphasize key claims of deception.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 2797,
        "nDataPoints": 0,
        "notes": "Uses yellow highlighting to emphasize key claims of deception.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:03.456+00",
          "seconds": 9.702,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/146",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-146",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro, in our opinion, has pushed a fraudulent narrative that Omnia represents a new technology or product strategy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-fcbaf396eb88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.33
          },
          "kind": "list",
          "text": "KOL’s stated that Omnia isn’t “anything new,” that the devices “could always do low frequency,” and that Nevro already offered this capability to doctors, especially those with high explant rates from high frequency.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "561b8415-e29d-4a14-9813-a04521d00a0a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Interestingly, former employees and KOL’s stated that Omnia isn’t even a new offering: Nevro’s previous stimulators already included the capability to offer low-frequency stimulation, which the company downplayed for fear that it would undermine its claims of high frequency’s supposed efficacy. Multiple interviews indicated that Nevro’s HQ and field reps long offered it to KOL’s who soured on high-frequency. Nevro, in our opinion, has pushed a fraudulent narrative that Omnia represents a new technology or product strategy. If shipping low-frequency with previous devices failed to prevent Nevro’s sales crash, we wonder why it would be the company’s savior now.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bf4394dd-c334-4a1f-aafa-50ea283c4eae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "quote",
          "text": "“Even a few years before Omnia came out, Nevro was allowing doctors in certain segments of the country to shift their devices to low frequency. Nevro didn’t advertise it. But if you had a high explant rate or were deemed an important person, they would fly out one of their head engineers and say \"Listen, because you’re you, we’re going to let you do tonic [low frequency stimulation] for the patients that are failing.” – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1803be28-43f8-4241-b348-f8893eeeb32c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "quote",
          "text": "“Nevro’s device could always do low frequency, but they put restrictors on it because they didn’t want the reps doing that. Nevro knew what was always going to happen: a person fails high frequency and it’s natural to put them back into low frequency stimulation. Nevro didn’t do anything new [with Omnia]. They just used a new case and rebranded it without the restrictor.” – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24188fe3-ad8a-4b6c-9d58-91e986e38ae0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "“If you speak to reps from other stim companies, they’ll tell you that Senza had all of that capability in there and just never used it. I met with [a key Nevro engineer] a few weeks ago to have him explain to me what’s in the guts of the Omnia and he admitted to me that a lot of its capabilities were there in the previous device but they never marketed it.” – KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "621ac989-0270-400a-9e65-d4f11e7ef6d0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "If you speak to reps from other stim companies, they’ll tell you that Senza had all of that capability in there and just never used it. I met with [a key Nevro engineer] a few weeks ago to have him explain to me what’s in the guts of the Omnia and he admitted to me that a lot of its capabilities were there in the previous device but they never marketed it. — KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-03cb8034577a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a132e898-c733-4919-b6a4-7fcdc8e29782",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c5d94cc3-b157-4c4b-b255-c985d7692b21",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36c1940f-ef55-4c2a-92f2-397f2d85edaa",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e77e3001-9043-418f-bbbd-b1b7c86f8f56",
          "evidence": "The slide explicitly claims a 'fraudulent narrative' regarding product innovation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:03.456+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 146,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 147,
      "type": "tension",
      "title": "Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2721,
        "nDataPoints": 0,
        "notes": "Uses testimonial quotes to build a narrative of corporate malfeasance and clinical deception.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:58.275+00",
          "seconds": 3.839,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/147",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-147",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Although Nevro already bundled low-frequency capability with devices prior to Omnia, KOL's and former employees suggest that the company was paranoid that it would expose its high frequency data as a sham.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-967483d068a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.85,
            "x": 0.06,
            "y": 0.21
          },
          "kind": "list",
          "text": "Nevro sales reps who independently activated low-frequency when high frequency failed allegedly faced retaliation from the company.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c21b0f8-5501-40af-ae80-5ae0f415c66d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Although Nevro already bundled low-frequency capability with devices prior to Omnia, KOL’s and former employees suggest that the company was paranoid that it would expose its high frequency data as a sham.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "66b7cecb-4d78-4f67-bb5c-510133527ee9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.09,
            "y": 0.63
          },
          "kind": "quote",
          "text": "“Nevro didn’t want the patient to feel paresthesia because what you’ll find is that they crave the paresthesia. Once they feel it, they think that that’s the indication of whether the device is working or not.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "799e149a-77b2-4c1c-ba52-d43f60e157f3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.27
          },
          "kind": "quote",
          "text": "“Nevro had a rep in [area redacted] who was reprogramming their devices to use low frequency to try and save failed [high frequency] patients, and Nevro threatened him with an injunction... Nevro was afraid it would disprove their entire clinical trial.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4a6fe38-f49b-48a9-b61c-666429ebb0c0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“In order to grow the business, some reps would do the paresthesia [low-frequency], and some reps were doing high frequency just like the textbook... the clinical team of Nevro, if they saw that you were doing that, that would be a reduction in your commission percentage.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c92234ad-80cf-42b0-bb84-97b10317882c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro had a rep in [area redacted] who was reprogramming their devices to use low frequency to try and save failed [high frequency] patients, and Nevro threatened him with an injunction. Like, if you tell anybody that it worked we're going to sue you and take away your 401k, Stuff like that. Nevro was afraid it would disprove their entire clinical trial. Several of their reps were doing that.\" — KOL and former high volume Nevro implanter; \"In order to grow the business, some reps would do the paresthesia [low-frequency], and some reps were doing high frequency just like the textbook, and then they wouldn't get cases because the docs were asking them, \"Can you program the patient, so they feel it? Give them both options.\" Well, the clinical team of Nevro, if they saw that you were doing that, that would be a reduction in your commission percentage.\" — Former district manager and part of Nevro's launch team; \"Nevro didn't want the patient to feel paresthesia because what you'll find is that they crave the paresthesia. Once they feel it, they think that that's the indication of whether the device is working or not. You can't just get rid of paresthesia unilaterally and say it's a great thing because there are definitely reasons for it.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-9a5299d1d4f4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2722692b-62e6-474e-8bcb-e37a60621700",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a8aedbc8-e242-4620-a20e-c84aba814930",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abfa17b1-1746-4e57-a07f-0d2966bdbec1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "41b18648-83af-41e0-9760-25c4cb33dd47",
          "evidence": "The slide contrasts the company's public clinical claims with internal reports of suppressing alternative treatment methods.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:15:58.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 147,
          "frameworkName": "expose_contradiction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 148,
      "type": "tension",
      "title": "Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 9,
        "textChars": 2121,
        "nDataPoints": 0,
        "notes": "Uses a combination of internal research claims and external clinical literature to expose a contradiction in the company's product claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:36.617+00",
          "seconds": 4.663,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/148",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-148",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Our research interviews suggest that Omnia is just a marketing ploy and stock promotion – “lipstick on a pig” according to one KOL.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-8267d4b150c7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.45,
            "x": 0.52,
            "y": 0.52
          },
          "kind": "paragraph",
          "text": "Comparison of 10-kHz High-Frequency and Traditional Low-Frequency Spinal Cord Stimulation for the Treatment of Chronic Back and Leg Pain: 24-Month Results From a Multicenter, Randomized, Controlled Pivotal Trial",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "042149a4-813e-4bec-a08a-cd16999f6584",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Our research interviews suggest that Omnia is just a marketing ploy and stock promotion – “lipstick on a pig” according to one KOL. Even Grossman apparently expected the “new” device to remain as mostly a high frequency product, according to former employees. Our research uncovered another reason which confirms that Omnia was never meant to be anything more than a high frequency device: its leads are still placed along specific vertebrae (T9/T10) which Nevro has always stipulated for high frequency stimulation. However, leads for low-frequency stimulation are typically placed at different points on the spine (T7/T8) based on trial-and-error via paresthesia mapping – ie, low frequency requires an entirely different type of surgical procedure, rendering the entire premise of Omnia clinically absurd. We note a paper by members of Nevro’s Scientific Advisory Board comparing lead placement for high vs. low frequency, as well as similar color from the publication for Nevro’s pivotal trial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "539e9357-abfb-47eb-896d-39b6d2c7b688",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.52,
            "y": 0.65
          },
          "kind": "paragraph",
          "text": "Lead position for HF10 therapy was based on extensive empirical observation that most patients respond to stimulation application near T9/10, while allowing for patient variation by covering T8-T11. For traditional low-frequency SCS, leads were placed at vertebral levels based on intraoperative paresthesia mapping involving patient feedback, typically resulting in parallel lead tip placement at T7-T8.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b1daff32-f4c5-413f-81fc-a33d40982762",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“lipstick on a pig” — one KOL.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-84513926714b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.7,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4660894/pdf/pme0016-0934.pdf; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058646/pdf/neu-79-667.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7268d1fc-a636-406e-a35e-11ea9344bf4f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "table",
          "text": "Comparison of HF10 SCS with traditional SCS table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd598829-2352-4537-9bf8-ea4b3c166b63",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28f71cc2-0f79-4c55-af97-a0a0cc3fe781",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7219e6c9-dfca-4b7a-bb55-d5ab7c98ae9b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "44d2482d-08cb-4060-af82-8c9840c5d1c4",
          "evidence": "The slide explicitly frames the product as a 'marketing ploy' and 'stock promotion' to expose a clinical contradiction.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:36.617+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 148,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 149,
      "type": "tension",
      "title": "Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.",
      "function": "expose_contradiction",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 8,
        "textChars": 3155,
        "nDataPoints": 1,
        "notes": "Uses expert testimony (KOLs) to expose a technical contradiction in the product's value proposition.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:00.001+00",
          "seconds": 5.096,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/149",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-149",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Toggling a device between high frequency and low frequency – the entire point of Omnia - is clinically unrealistic and reckless.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-b94578551018",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Toggling a device between high frequency and low frequency – the entire point of Omnia - is clinically unrealistic and reckless. When doctors implant Omnia leads at the vertebrae used for high frequency stimulation, they render it irrelevant and/or dangerous for low-frequency stimulation which requires lead insertion in a different location. Investors should therefore not be surprised at Grossman’s comments that Omnia is still used for high frequency 85-90% of the time. One KOL after another highlighted the lead insertion issue and why it renders Omnia’s high-plus-low-frequency messaging disingenuous and “a lie.” We posed a question and note the reply, which stated that “you’re screwed” if you toggle frequencies. A second KOL provided additional detail to underscore the same concern.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24098401-2c8b-4cb2-8215-7b07d9713ff4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "quote",
          "text": "Nevro says that you should cover the 9/10 thoracic interspace. That’s their thing. Low-frequency stimulation can be anywhere from T8 to L1. If you want to stimulate the back, you’re probably doing T10. That whole science, the art of neuromodulation, was what Nevro said they mitigated. You don’t have to be a neuromodulator. Historically, when you look at [names redacted, the most prominent KOL’s in the field] we would look for different ways to get pain relief at different locations within the spinal cord versus what we called “plant and pray.” Nevro’s electrodes usually cover the top of T9 and the bottom of T10, which may stimulate a certain anatomic region. If you need foot coverage, that location doesn't have a hope. For below the knee, that array is not going to work. Unfortunately if the HF10 doesn't work, you might not be in the right spot with the leads to do tonic [low frequency stimulation].",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "080c6e11-7d90-488b-b507-20badc6a467c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "Q: How do you use other waveforms with Omnia like low frequency, if the leads are still in the same place as for high frequency? You hit the nail on the head. That’s part of the problem. Nevro is so locked in that their leads have to be at one spot. If there's any variation they get lost. Low frequency doesn't necessarily work at just that T9/10 junction. A lot of it works at T8/9. You’re bound by their restrictions. So if you use high frequency first and the leads have to be over the T9/10j unction, you’re screwed if that patient does better with low frequency because that’s not where the leads are implanted.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "242174e9-d50f-4d65-b093-2fa6a1ac5331",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“You hit the nail on the head. That’s part of the problem. Nevro is so locked in that their leads have to be at one spot. If there’s any variation they get lost. Low frequency doesn’t necessarily work at just that T9/10 junction. A lot of it works at T8/9. You’re bound by their restrictions. So if you use high frequency first and the leads have to be over the T9/10junction, you’re screwed if that patient does better with low frequency because that’s not where the leads are implanted.” — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:38+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b342-bf1744bb5b37",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "802f6c63-55ec-4108-b676-ee5ff69114c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb7d4dd4-ea3a-4a8c-94ff-793c775019fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2598d86-34ac-4f8a-884f-db163ab6d9db",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c4146ba2-3ff6-4975-8eeb-00f62b8f7802",
          "evidence": "The slide explicitly frames the company's marketing as 'a lie' and 'disingenuous' based on expert testimony.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:00.001+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 149,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 150,
      "type": "tension",
      "title": "Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 3872,
        "nDataPoints": 0,
        "notes": "Uses expert testimony (KOL and Medtronic regional manager) to undermine the company's core product value proposition.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:59.272+00",
          "seconds": 4.146,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/150",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-150",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "If Nevro continues to do sloppy lead placement and try to switch to classic low frequency stimulation, they're going to run into all sorts of problems and unintended consequences.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-7e0e00c8c1a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "A KOL explained why Omnia’s “all frequencies and waveforms” shtick is absurd and haphazard. Aside from differences in lead location by frequency, different waveforms which Omnia claims to offer, like burst, also require placement at different vertebrae than Nevro’s one-size-fits-all insertion at T8/9.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "010c07f9-e519-43b8-bc9c-e34bf7573cf7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "list",
          "text": "A regional manager in one of Medtronic’s largest territories stated that Nevro’s no-paresthesia method causes doctors to be sloppy with lead insertion, causing “all sorts of problems and unintended consequences” if trying to use Omnia for low-frequency stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0afecd94-41f4-414c-a3cc-0ce620fd5fcd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL’s explained why Omnia’s “One System, All Frequencies” positioning is clinically illogical and risky, as different frequencies and waveforms require different surgical lead placements. We believe this explains the CEO's admission that Omnia is used almost exclusively as a high frequency device, and it leads us to find alternate explanations for why Omnia is rarely used for lower frequencies as misleading.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2fe98785-2d3a-4de6-9bb0-bca38e4282c9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.16,
            "w": 0.83,
            "x": 0.11,
            "y": 0.63
          },
          "kind": "quote",
          "text": "I’ve seen some cases where Medtronic was implanted after a Nevro device was in there, I think their docs get a little sloppy with their lead placement because there is no paresthesia. They just kind of put the leads up, pretty much midline, and it’s good enough. That’s why docs early on were interested - I don’t have to wake up the patient during the procedure. If Nevro continues to do sloppy lead placement and try to switch to classic low frequency stimulation, they’re going to run into all sorts of problems and unintended consequences.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44583e9f-8c50-434a-8590-ecd417d867bd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.16,
            "w": 0.83,
            "x": 0.11,
            "y": 0.35
          },
          "kind": "quote",
          "text": "If you look at true burst, they want you to be about a level up T8/9 which is the sweet spot for burst. So if your electrodes aren’t covering that and you try to do burst, you’re not going to hit it. For different frequencies, you need to be at the right place on the spinal cord to get that stimulation. If you’re at T9/10 where you put your Nevro, you might get it depending on where the affected problem is. You might get the upper thigh but for lower leg, probably not. And you may get other paresthesias that you don’t want. You try to do a tonic, but you’re to get all rib simulation. The idea that you put it in at T9/10 and get the other frequencies to work is very 50/50.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a49f49d6-bddd-4053-a9e9-f4cbe21f71b5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"If you look at true burst, they want you to be about a level up T8/9 which is the sweet spot for burst. So if your electrodes aren't covering that and you try to do burst, you're not going to hit it. For different frequencies, you need to be at the right place on the spinal cord to get that stimulation. If you're at T9/10 where you put your Nevro, you might get it depending on where the affected problem is. You might get the upper thigh but for lower leg, probably not. And you may get other paresthesias that you don't want. You try to do a tonic, but you're to get all rib simulation. The idea that you put it in at T9/10 and get the other frequencies to work is very 50/50.\" — KOL and former high volume Nevro implanter; \"I've seen some cases where Medtronic was implanted after a Nevro device was in there, I think their docs get a little sloppy with their lead placement because there is no paresthesia. They just kind of put the leads up, pretty much midline, and it's good enough. That was why docs early on were interested - I don't have to wake up the patient during the procedure. If Nevro continues to do sloppy lead placement and try to switch to classic low frequency stimulation, they're going to run into all sorts of problems and unintended consequences.\" — Medtronic SCS regional manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-8008f43bbceb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.18,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0908828c-9cad-42bc-a5c3-23b4e65bd2a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c977638-8587-4406-904b-123797e58875",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fa33831f-3339-4f31-9f79-c188dadc6b3d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6e4118c6-bbb8-488a-aae7-8e3ec1eee9d3",
          "evidence": "Frames Nevro's product as a 'colossal flop' and 'clinically illogical' via expert testimony.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:59.272+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 150,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [
        {
          "to": 150,
          "arc": {
            "name": "Overcoming the Monster",
            "slug": "overcoming-monster",
            "status": "active",
            "bestFor": "Competitive positioning, rallying teams",
            "canonId": "019dd956-6339-76ac-9cbf-4b377c3aa89e",
            "version": 1,
            "bodyDocId": "019df22a-2356-73eb-8061-d8c81dc0aa49",
            "structure": "The Monster -> The Call -> The Struggle -> The Victory -> The New Order",
            "description": null,
            "familyLabel": null
          },
          "from": 51,
          "name": "The Victory",
          "beatId": "903c076a-f368-4ca1-844c-277874c1afb2",
          "matchId": "bbb0ffb0-61a4-4966-a282-941bc7d8e2eb",
          "beatType": {
            "name": "The Victory",
            "slug": "overcoming-monster-the-victory",
            "status": "active",
            "canonId": "019dd9b8-3dbe-71b9-b5a9-7191b5f8782b",
            "version": 1,
            "description": null
          },
          "evidence": "The deck presents a conclusion that Nevro's problems are insurmountable",
          "position": 2,
          "isPrimaryArc": true,
          "parentBeatType": {
            "name": "Turn",
            "slug": "turn",
            "status": "active",
            "canonId": "019dd9b8-0396-702b-ac2f-9901f8dd8b54",
            "version": 1,
            "description": "The pivot — solution proposed, catalyst introduced, decision made. Common (15/20 arcs) but not universal: Triple-take, AIDA, PAS, Voyage-return and Pixar substitute it with a strong reflection or development beat."
          },
          "alignedBlockIds": null,
          "matchConfidence": 0.8
        }
      ],
      "loops": [],
      "locked": true
    },
    {
      "page": 151,
      "type": "tension",
      "title": "Uses expert quotes to undermine the company's core product claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3536,
        "nDataPoints": 0,
        "notes": "Uses expert quotes to undermine the company's core product claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:15:59.802+00",
          "seconds": 4.267,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/151",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-151",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "It's impossible to capture both fields.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-6469a92c17d6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A KOL bluntly stated that “it’s impossible to capture” both low and high frequency fields and that “you can’t have it both ways,” saying it’s not a “real world” scenario and that Nevro’s claims make him “shake my head.” He detailed worrisome adverse effects from attempting to do so. A Medtronic regional sales manager provided another reason why Omnia is just Nevro’s old high device with different packaging: the handheld controller used by patients to adjust the stimulator is still tailored for high frequency and doesn’t allow the proper adjustments for lower frequency stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b617f27-de4e-4c84-ab6b-9655dadec046",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "quote",
          "text": "“Honestly, one of the biggest restrictions with Omnia is their handheld patient controller - if you want to turn the volume up on your television, you hit the button once, and it turns up one. You hit the button twice; it turns up two. From my understanding of how the patient programming works, if you do a left and a right, with the Nevro controller, you can’t just turn your left leg up, and have your right leg stay the same. You’re turning them both up. For high frequency, with their components and their design, they don’t need that. But when you have the inability to separate out their programming at low frequency, it will be a challenge for the patients, because it is for us. – Medtronic regional sales manager for one of their largest territories",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd170cde-7978-40f0-8a24-bdd59f8d9c94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "“Nevro puts their patients to sleep during the trial. They're the only company that does this. When I do a trial, I put the leads in at vertebrae six, seven, and eight, and ask the patient \"How does that feel?\" And they say \"You got it in the wrong spot. You're in my rib on the side.\" We use trial and error to get it right. But with Nevro, it’s always staggered leads at T9/T10. That’s fine for 10,000-Hz but you can’t have it both ways and insist the leads have to be in a certain spot and then say with Omnia they can do both high frequency and paresthesia. It just makes me shake my head. They’re trying to stay afloat with Omnia, but I don’t know how in the real world they can do this. I watched Nevro program one of my patients. They say, \"Turn on 10k. Now, turn on paresthesia-based.\" My patient was pissed-off. The soles of his feet were on fire. And the Nevro rep sitting in my office would hem and haw and go, \"Ah, well, let me try something else.\" It’s impossible to capture both fields.” - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce9a795e-01ec-41ea-ae9a-1821d41ab669",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"It's impossible to capture\" both low and high frequency fields and that \"you can't have it both ways,\" saying it's not a \"real world\" scenario and that Nevro's claims make him \"shake my head.\" — KOL; \"Honestly, one of the biggest restrictions with Omnia is their handheld patient controller - if you want to turn the volume up on your television, you hit the button once, and it turns up one. You hit the button twice; it turns up two. From my understanding of how the patient programming works, if you do a left and a right, with the Nevro controller, you can't just turn your left leg up, and have your right leg stay the same. You're turning them both up. For high frequency, with their components and their design, they don't need that. But when you have the inability to separate out their programming at low frequency, it will be a challenge for the patients, because it is for us.\" — Medtronic regional sales manager for one of their largest territories",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-68a1e93dade4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36fa1a02-2dc8-4b6f-831a-1f0af213636f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d3c3f67-852c-41c0-b854-505c2581d33d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe4570c0-f7ce-411a-8380-b5ef8b18717e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "89d498dc-554a-45c1-adb0-ef676a70d5a1",
          "evidence": "Uses expert testimony to frame the company's product as a failure.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:15:59.802+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 151,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 152,
      "type": "tension",
      "title": "Uses KOL testimonials to highlight a technical contradiction in the company's product claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3380,
        "nDataPoints": 0,
        "notes": "Uses KOL testimonials to highlight a technical contradiction in the company's product claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:00.755+00",
          "seconds": 4.243,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/152",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-152",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro’s PDN claims are so prima facie contradictory that we consider them fraudulent, as paresthesia mapping is mandatory to find which vertebrae stimulate the feet – “they’re lying,” to quote a KOL.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-e824a8cb40d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Although we address Nevro’s supposed market opportunity in painful diabetic neuropathy in a later section, we note KOL comments indicating that Nevro’s one-size-fits-all lead insertion at vertebrae T9/T10 renders Omnia clinically impossible for PDN patients specifically. Getting stimulation to reach an anatomical region as far from the spine as the feet is difficult and requires a complex trial-and-error process via paresthesia mapping along various vertebrae. However, Nevro’s entire reason for pushing high frequency is that it *avoids* paresthesia mapping, which its reps don’t even know how to do properly. We caution investors to understand the preposterous contradiction at the heard of Nevro’s PDN claims: that high frequency is clinically superior for PDN patients, and high frequency is also easier to implant because its leads are always at T9/10 to avoid paresthesia-mapping. Nevro’s PDN claims are so prima facie contradictory that we consider them fraudulent, as paresthesia mapping is mandatory to find which vertebrae stimulate the feet – “they’re lying,” to quote a KOL.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b21d385f-9ab8-4971-aa2e-cd8101e6a9c2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.52
          },
          "kind": "quote",
          "text": "“Nevro has always said you have no choice with lead placement, that everyone has to place the leads at T9/T10. The beauty of paresthesia-based [low-frequency] stimulation is that if you have foot pain as a diabetic with neuropathy, I would enter with the leads at L2, and I would put the leads at L1, T12 at what’s called the cronus. I’ll turn it on and say, \"How do you feel?\" and you say \"This sucks. You’re not getting to my feet.\" Then I push a lead to L5, at the root, at T12, L1 – right in that area of T12, T11. I turn it on there, and I put the leads wide, so we can capture the nerves on the left and the right as they’re descending past the lead. And you say, \"This is much better.\" Then the next patient comes in and goes. \"What are you trying to do? Kill me? This is all ribs and butt cheek.\" Then I go back to L1 and that person is happy as a clam. So, each person has a different spinal cord. That’s why you’ve got to do your job, you’ve got to do paresthesia fishing. You’ve got to throw your line out there with bait and fish because your spine is different than mine.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a1bb8f6-54d7-47e2-9422-3a6f7d3322c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.83
          },
          "kind": "quote",
          "text": "“I don’t know how they’re going to do both high frequency and paresthesia [low frequency] with Omnia. In fact, I think they’re lying. I think if you’re going to go for diabetic peripheral neuropathy, you can’t be in the T9/T10 spot. You’re going to have to be somewhere else, which means now you can’t do the high frequency.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fcdd8edb-01a9-45c1-b5fc-bec00d00d9f2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro has always said you have no choice with lead placement, that everyone has to place the leads at T9/T10... So, each person has a different spinal cord. That's why you've got to do your job, you've got to do paresthesia fishing.” — KOL and high volume implanter; “I don't know how they're going to do both high frequency and paresthesia [low frequency] with Omnia. In fact, I think they're lying.” — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-ef1ecb75ca2b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ac1446a-9614-4a15-91ac-3bed6d13844e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "10. The new Omnia stimulator, the centerpiece of Nevro’s turnaround hopes, is a Hail Mary and colossal flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9bdd6a0f-e721-4daf-8a3b-813e552080dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b2ea5af1-46ed-4c26-a58b-17a2f781bf51",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d72fcd89-30c3-4081-b4d2-a7c587a5b5b1",
          "evidence": "The slide explicitly frames the company's claims as a 'preposterous contradiction' and 'fraudulent' based on expert testimony.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:00.755+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 152,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 153,
      "type": "tension",
      "title": "Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 7,
        "textChars": 908,
        "nDataPoints": 4,
        "notes": "Uses a funnel diagram to visualize the market sizing, then juxtaposes it with CEO quotes to highlight the 'hype' narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "funnel_chart",
          "quote_block"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:00.984+00",
          "seconds": 4.236,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/153",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-153",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The number of times PDN was hyped by the CEO and sell-side on the recent Q3 earnings call - 19 mentions of PDN - is suggestive of its importance to the story.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-1e276a97640d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.45,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "diagram",
          "text": "PDN: A Significant Opportunity for HF10",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Diagram",
              "slug": "diagram",
              "status": "active",
              "canonId": "019de52c-f9f0-734a-81de-15382ff28c65",
              "version": 1,
              "description": "Schematic or relational diagram."
            },
            "tool": null,
            "subkind": {
              "name": "Pyramid",
              "slug": "pyramid",
              "status": "active",
              "canonId": "019de52d-043b-715a-b3a3-780976e14c5c",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pyramid",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "681a6b9c-5a2c-4e4d-8268-2cb7f92779bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "A key part of the Nevro bull case hinges on the company expanding its high frequency stimulation into other indications, notably painful diabetic neuropathy (PDN) of the lower limbs.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36bd1168-c7a1-48b3-88e8-14d674dbdc57",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.45,
            "w": 0.42,
            "x": 0.53,
            "y": 0.41
          },
          "kind": "quote",
          "text": "Keith Grossman, CEO, comments 11/5/20: ...a growing level of excitement among our team and our board about this [PDN] opportunity.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b1dbfb7b-a57f-4df3-804e-d2e7f2667219",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"...a growing level of excitement among our team and our board about this [PDN] opportunity. So, I would say we are, with each passing month, we get, the more psyched internally about the ability to enter this market and grow a meaningful and defensible business...\" — Keith Grossman, CEO, comments 11/5/20",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-213df2bb8b21",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: NVRO JPM presentation; earnings call transcript.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "90399469-e78c-4e2c-a36e-d085a79f86c7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d665915-df07-4207-9b82-1982c4c8f1cc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "1fbdd491-8893-461b-908d-70a36ba80dc7",
          "evidence": "Juxtaposition of company market sizing funnel with CEO hype quotes to suggest a mirage.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:00.984+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 153,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 154,
      "type": "tension",
      "title": "Uses direct quotes from KOLs to undermine company narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 11,
        "textChars": 3061,
        "nDataPoints": 0,
        "notes": "Uses direct quotes from KOLs to undermine company narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:01.191+00",
          "seconds": 4.379,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/154",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-154",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro calling PDN a new indication is \"so stupid\" and \"just dopey\" according to KOL's, given that it's widely coded today as neuropathy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-b3812607c821",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.05,
            "y": 0.39
          },
          "kind": "list",
          "text": "Stimulators have been extensively implanted for decades for PDN and the indication is already reimbursed by Medicare",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8237b947-c845-4fec-b1ac-b1417efc25fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.05,
            "y": 0.67
          },
          "kind": "list",
          "text": "Nevro calling PDN a new indication is \"so stupid\" and \"just dopey\" according to KOL's, given that it's widely coded today as neuropathy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "caeb7573-a420-49ac-a7e7-0426f8d398d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We investigated Nevro's PDN study and the claims that it expands the market for their high frequency device. Our research found widespread skepticism and outright ridicule among KOL's and Nevro's former executives and sales reps at the notion that PDN is a meaningful new commercial opportunity. One KOL after another – including some of Nevro's most loyal users – stated that spinal cord stimulation has already been used for decades for PDN and is already approved by Medicare, blasting the company's claims that it's a \"new indication\" as \"so stupid\" and \"just dopey.\" One stated that Nevro's PDN study has \"value to Wall Street and no one else.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dbf07607-45a6-43a7-aaa3-e4b53333ce55",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.08,
            "y": 0.46
          },
          "kind": "quote",
          "text": "\"So here's the deal with diabetic neuropathy. I used to lecture on this in the 90's. I've used stimulators for PDN for 25 years. Nevro's PDN study is not telling us anything new at all. The literature was always there. There were studies in the 90's. Bottom line is, you just call it neuropathic leg of the pain and Medicare pays for it. We were doing that, are doing that, and there's nothing new about it. The study has value to Wall Street and no one else. Any doctor who knows stimulators already uses them for diabetic neuropathy.\" – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14ab51bb-b153-44b6-a115-8c1ef7d153a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.08,
            "y": 0.62
          },
          "kind": "quote",
          "text": "\"In the 1980's, half of the patients we implanted with stimulators were for PDN.\" – High volume Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f6f1e11-9511-4f34-9bfe-ca44f266181e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.08,
            "y": 0.74
          },
          "kind": "quote",
          "text": "\"Nevro saying they have this diabetic peripheral neuropathy indication is so stupid. We've been doing PDN treatment with stimulators forever. All they did was say, it's off-label. We're going to get it so that it's on-label. But if I have a diabetic that has neuropathy, we just code it as neuropathy, lower extremity. We don't call it PDN So what Nevro is doing is just dopey. Here's the thing: everybody is treating diabetics with spinal cord stimulation already yet Nevro's saying \"Look what we invented!\" We've been using stim forever for diabetics with neuropathy. This has been around forever.\" – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c481ff66-f660-411d-a426-a4b392d47f9f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"So here's the deal with diabetic neuropathy. I used to lecture on this in the 90's. I've used stimulators for PDN for 25 years. Nevro's PDN study is not telling us anything new at all... The study has value to Wall Street and no one else.\" — KOL and high volume implanter; \"In the 1980's, half of the patients we implanted with stimulators were for PDN.\" — High volume Nevro user; \"Nevro saying they have this diabetic peripheral neuropathy indication is so stupid. We've been doing PDN treatment with stimulators forever... This has been around forever.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-b7b7e802b131",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b83a8e17-678e-4821-bdc5-970227935712",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a94fe3ca-dd16-4739-b3bb-32a62f8a4675",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c635702-28e2-42c4-aebf-4cf39799e171",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c3a53a0f-aaed-48ff-8c44-d7fd4ae9e871",
          "evidence": "The slide explicitly frames the company's claims as a 'mirage' and 'stupid' based on expert testimony to expose a contradiction in the company's growth narrative.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:01.191+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 154,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 155,
      "type": "tension",
      "title": "The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 13,
        "textChars": 3409,
        "nDataPoints": 0,
        "notes": "The slide uses a 'quote-heavy' structure to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:01.621+00",
          "seconds": 4.329,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/155",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-155",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's PDN study and claims of a new indication elicited a striking level of derision among KOL's: that it's \"putting lipstick on a pig\" and won't change anyone's use of stimulators \"in any way\" and that competitors began pushing stimulators for PDN in 2004.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-308212e87745",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.24
          },
          "kind": "list",
          "text": "One KOL called it \"putting lipstick on a pig\" and stated hat \"it won't change my use or anyone else's\" use of stimulators \"in any way.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "631f7fd7-e7bf-420f-88bf-bea3480879d6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "list",
          "text": "Two of Nevro's highest volume implanters, one in the US and one in Europe, disputed that PDN is a new indication and stated that they've been implanting stimulators for it \"for a long time.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6031e2b-d6a9-443a-aee4-f3dc57f8fed1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "list",
          "text": "A KOL stated that Nevro's competitors have been offering stimulators for PDN for a decade or more",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7ded464-926f-4427-9d73-dc3a6eb50b50",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro's PDN study and claims of a new indication elicited a striking level of derision among KOL's: that it's \"putting lipstick on a pig\" and won't change anyone's use of stimulators \"in any way\" and that competitors began pushing stimulators for PDN in 2004. One of Nevro's most loyal and highest volume implanters confirmed he's been using stimulators for diabetic neuropathy \"for a long time.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca5feeb1-8310-4cdb-a6e7-48eeb455469a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.59
          },
          "kind": "quote",
          "text": "\"Boston Scientific has been doing stimulators for neuropathy in diabetics for close to 10 years, even with Precision-Plus back in 2004. Now all of a sudden, Nevro has some amazing thing? They're trying to hoodwink. I wish they would have gone after something innovative, something new.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b9d1c2c-c350-41b8-b65b-341a83dccce7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.49
          },
          "kind": "quote",
          "text": "\"We're the biggest stimulator implant unit in Europe. Our experience with Nevro started in 2009 with their EU study. We use it mainly for back pain, back surgery syndrome, and upper/lower neuropathic pain.\" - High volume Nevro implanter and consultant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f30f289-42e4-462d-810a-9d40f64c471a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.43
          },
          "kind": "quote",
          "text": "\"I have been treating idiopathic peripheral neuropathies, diabetic peripheral neuropathies, complex regional pain syndrome, and other types of painful neuropathies with spinal cord stimulation for a long time.\" - High volume Nevro implanter and loyalist",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "90714b2b-41f6-40a1-a368-f82c3fa608f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.83,
            "x": 0.11,
            "y": 0.29
          },
          "kind": "quote",
          "text": "\"The diabetic neuropathy study is an example of putting lipstick on a pig. It really is. They're saying, wow we have a study that shows us what we already know. I mean, please. It won't change my use or anyone else's of stimulators in any way.\" - KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e74ef584-7ef5-451e-b3f1-b95bd9835c34",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The diabetic neuropathy study is an example of putting lipstick on a pig. It really is. They're saying, wow we have a study that shows us what we already know. I mean, please. It won't change my use or anyone else's of stimulators in any way.\" — KOL and high volume implanter; \"I have been treating idiopathic peripheral neuropathies, diabetic peripheral neuropathies, complex regional pain syndrome, and other types of painful neuropathies with spinal cord stimulation for a long time.\" — High volume Nevro implanter and loyalist; \"We're the biggest stimulator implant unit in Europe. Our experience with Nevro started in 2009 with their EU study. We use it mainly for back pain, back surgery syndrome, and upper/lower neuropathic pain.\" — High volume Nevro implanter and consultant; \"Boston Scientific has been doing stimulators for neuropathy in diabetics for close to 10 years, even with Precision-Plus back in 2004. Now all of a sudden, Nevro has some amazing thing? They're trying to hoodwink. I wish they would have gone after something innovative, something new.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-37b34f6055cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ed36a9a-5f3d-4f4d-8ca3-11e2547c81da",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "73f1caae-ce5f-4884-86a4-afd30a0908af",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.621+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f003fe5d-9301-4b26-83f1-e658d2f76809",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 156,
      "type": "tension",
      "title": "The slide uses historical data to undermine the company's 'innovation' narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 66,
        "componentCount": 7,
        "textChars": 1121,
        "nDataPoints": 12,
        "notes": "The slide uses historical data to undermine the company's 'innovation' narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "data_table"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview",
          "runId": null,
          "at": "2026-07-17 03:28:36.725+00",
          "seconds": 3.107,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/156",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-156",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A simple literature search shows why KOL’s broadly ridicule Nevro’s PDN hype as stock promotion and Wall Street naivete.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-4aa2cb2b56b2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "A simple literature search shows why KOL's broadly ridicule Nevro's PDN hype as stock promotion and Wall Street naivete. Far from being a new indication that Nevro pioneered, one can find scores of publications going back over 25 years on the use of stimulators for PDN...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "16dc4eeb-aa94-426e-8639-6748d7a3f036",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy — Solomon Tesfaye, Jonathan Watt, Susan J Benbow, Kiang A Pang, John Miles, Ian A MacFarlane",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-4e44b1cf96fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.92
          },
          "kind": "source-note",
          "text": "Source: https://stjudepaincenters.com/wp-content/uploads/2018/12/Spinal-cord-stimulation-painful-diabetic-neuropathy-Tesfaye.pdf; https://stjudepaincenters.com/wp-content/uploads/2018/12/Safety-efficacy-spinal-cord-stimulation-chronic-pain-20-year-review-Cameron-1.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "41718cf9-3dff-4d44-b341-d22a7a37b9f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.45,
            "x": 0.05,
            "y": 0.65
          },
          "kind": "table",
          "text": "Study published in 1996 claimed a 70% reduction in VAS pain score and 86% narcotics reduction",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aa8fbe08-b1c9-4f46-bd98-48efd49ceb18",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.4,
            "x": 0.55,
            "y": 0.65
          },
          "kind": "table",
          "text": "20 year literature review of SCS published in 2004 lists 4 PDN studies with 67% success rate",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad186d42-35dc-4c42-9b57-ab888a8a3cba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.05
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e78f1865-a95f-4be0-8b5a-1b2b47889d78",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Data Story Arc",
            "slug": "data-story-arc",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd956-9c30-728e-b974-d3fb123dcf5a",
            "version": 1,
            "bodyDocId": null,
            "description": "Context → Conflict → Insight → Implication structure for data narratives",
            "familyLabel": null,
            "categoryName": "Loop",
            "categorySlug": "loop"
          },
          "agent": "Storyteller",
          "layer": "slide",
          "agents": [
            "Storyteller"
          ],
          "matchId": "fe3796a0-af79-4fa3-ad13-84d8fd5ee29d",
          "evidence": "The use of data and literature to support the allegations about Nevro's practices.",
          "pageRefs": null,
          "priority": "Core",
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:46.392709+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 156,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "cbe47396-2a4a-4755-903f-fc897efb358b",
          "evidence": "Contrasts current company claims with historical academic literature.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-07-17 03:28:36.725+00",
            "model": "google/gemini-3.1-flash-lite-preview",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 156,
          "frameworkName": "expose_contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 157,
      "type": "tension",
      "title": "Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 44,
        "componentCount": 6,
        "textChars": 855,
        "nDataPoints": 0,
        "notes": "Uses red boxes to highlight 'diabetic neuropathy' or 'peripheral neuropathy' in various insurance policy documents.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:01.29+00",
          "seconds": 3.139,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/157",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-157",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One can easily search online for insurance authorization forms, which already include PDN as a typical indication and reimbursement category for spinal cord stimulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:39+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-369eb6d9b4a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.6,
            "w": 0.8,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "other",
          "text": "Aetna, Health Partners, One of many state BCBS plans, PEHP",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": {
              "name": "Unclassified",
              "slug": "unclassified",
              "status": "active",
              "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "unclassified",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b5bd742-f2fd-41ad-9762-f73661337925",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One can easily search online for insurance authorization forms, which already include PDN as a typical indication and reimbursement category for spinal cord stimulation. Examples -",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "822727fb-1323-43a2-942c-d387fcb4eee8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: http://www.aetna.com/cpb/medical/data/100_199/0194.html; https://www.pehp.org/mango/pdf/pehp/pdc/spinalcordstim_fe3203a6.pdf; https://www.healthpartners.com/ucm/groups/public/@hp/@public/@cc/documents/dev_058770.pdf; https://www.bcbst.com/mpmanual/spinal_cord_stimulation_for_treatment_of_pain.htm",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09f77f57-b3d3-4a2a-b3ce-9d3e8c1a1503",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c2a03b58-de11-4d9a-b966-1715123b938f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0fbb61a2-0b09-49c7-886e-e18fd75ec517",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "865fcdb4-b794-4853-a60b-19b6e6e951c8",
          "evidence": "Exposing company claims as a 'mirage' using primary source documentation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:01.29+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 157,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 158,
      "type": "tension",
      "title": "Uses a series of quotes to undermine the company's growth narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2493,
        "nDataPoints": 0,
        "notes": "Uses a series of quotes to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:36.608+00",
          "seconds": 4.255,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/158",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-158",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's claims are commercially irrelevant and \"smoke and mirrors.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-cc82ce5aa94d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "A former Nevro regional sales director, also now at a key competitor confirmed that stimulators have been used for PDN \"for forever\" and that it's not \"going to be a game changer.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03f5a83e-4c70-4a28-9837-d1f8e09276ca",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "list",
          "text": "Stimulation \"has always been approved or used\" for PDN and Nevro's claims are \"smoke and mirrors\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "392fbf85-1e6e-4313-ac16-84b763198fef",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "list",
          "text": "Former Nevro sales executive now at a key competitor states doctors can freely \"use stimulators for PDN today.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8f5dfbf3-f269-496a-b69d-472084d77f6b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Comments by KOL's that PDN is an established, longstanding indication for spinal cord stimulators were also repeated by Nevro's former executives, sales reps, as well as its main competitors. Nevro may argue that PDN is an off-label indication and that getting it on-label is meaningful, but doctors and former employees forcefully stated that PDN is so widely coded and accepted as regular neuropathy that Nevro's claims are commercially irrelevant and \"smoke and mirrors.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b484eab-8302-46b2-9e87-252c44baac03",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.51
          },
          "kind": "quote",
          "text": "\"Doctors can use stimulators for PDN today. What you're hearing from the Medtronic rep is completely true. The doctor can just say something is neuropathy.\" – Former Nevro sales executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0414e313-df46-4727-949f-40e106653d36",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.36
          },
          "kind": "quote",
          "text": "\"Spinal cord stim has always been approved or used for neuropathy. PDN is just another smoke and mirrors way for Nevro to position their device.\" – Medtronic regional manager in charge of a large multi-state territory",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4ceedb23-a1cf-415c-8999-0e9198cb723a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.83,
            "x": 0.11,
            "y": 0.66
          },
          "kind": "quote",
          "text": "\"We've been stimulating for diabetic neuropathy for forever, and no, I don't think it's going to be a game changer. I think you will have guys that live by the indication law and they're going to use Nevro because they have an indication for it, but I don't think it's a game changer [...] And then, you have to look at the data and ask if it's really skewed like their Senza data was. Like, is this really real-world data? So, I think there's going to be some skepticism, with the clinical side.\" – Former regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd76056e-313d-4090-a476-826684ce5209",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Spinal cord stim has always been approved or used for neuropathy. PDN is just another smoke and mirrors way for Nevro to position their device.\" — Medtronic regional manager in charge of a large multi-state territory; \"Doctors can just say something is neuropathy.\" — Former Nevro sales executive; \"We've been stimulating for diabetic neuropathy for forever, and no, I don't think it's going to be a game changer.\" — Former regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b343-d33f248f7e98",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e697dbd6-7060-4696-bb8e-2e7f3084aeb7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "834c33f1-8594-4f59-8111-9f9079c75005",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fadbf07-447f-4c5c-9e49-dbb414016cbf",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "713851d1-9db9-4998-9ad1-f323d9cf9dfc",
          "evidence": "The slide uses expert testimonials to expose the company's growth narrative as deceptive.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:36.608+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 158,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 159,
      "type": "tension",
      "title": "Uses expert quotes to undermine the company's growth narrative.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 3339,
        "nDataPoints": 0,
        "notes": "Uses expert quotes to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:36.935+00",
          "seconds": 3.925,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/159",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-159",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "It's a bit of a quagmire because they announced a PDN study with the potential for a new indication. Well, the physician community is using it for that anyhow. Okay, maybe if the physician community is reimbursed for it, but they're coding funky anyhow. I don't know how much of an uptick it's going to give them in revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-368217c2face",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "A territory manager for a key Nevro SCS competitor said he does plenty of PDN cases today, and provided granular reimbursement color to explain why he doesn't \"see how a PDN indication changes the market\" and why PDN is \"nothing new or different.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "504ed3e4-4932-4c54-88e9-14613df8e536",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.2
          },
          "kind": "list",
          "text": "A longtime C-level executive in the SCS space echoed the widespread skepticism regarding PDN's potential revenue contribution for Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ea5e8b5d-8390-45e6-a1fd-2c6d754274bf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.82,
            "x": 0.09,
            "y": 0.26
          },
          "kind": "quote",
          "text": "It's a bit of a quagmire because they announced a PDN study with the potential for a new indication. Well, the physician community is using it for that anyhow. Okay, maybe if the physician community is reimbursed for it, but they're coding funky anyhow. I don't know how much of an uptick it's going to give them in revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5e2e0830-a194-4598-a839-e3f6e70b6dd4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.82,
            "x": 0.09,
            "y": 0.55
          },
          "kind": "quote",
          "text": "I did twenty PDN cases in my territory in 2019. Stimulation is already approved for PDN. With Medicare, you need a primary and secondary pain indication. You just put in foot and the second as PDN and it will get approved. You can say today that the secondary indication is neuropathic pain. I don't see how a PDN indication changes the market. I've been walling to podiatrists and endocrinologists for years on PDN. It's the same indication as regular stimulation. Foot pain is the same codes, same delivery system, same placement of leads. It's nothing new or different. Doctors who want to use stimulation for PDN are already using it. If you have tingling in your hands and feet, they already use it. Off label, on label, they use it. A new PDN indication just allows you to have more of a conversation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ab4e925-985d-4f5e-9261-a444d66ea8ca",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"It’s a bit of a quagmire because they announced a PDN study with the potential for a new indication. Well, the physician community is using it for that anyhow. Okay, maybe if the physician community is reimbursed for it, but they’re coding funky anyhow. I don’t know how much of an uptick it’s going to give them in revenue.\" — C-level executive in the SCS space; \"I did twenty PDN cases in my territory in 2019. Stimulation is already approved for PDN. With Medicare, you need a primary and secondary pain indication. You just put in foot and the second as PDN and it will get approved. You can say today that the secondary indication is neuropathic pain. I don’t see how a PDN indication changes the market. I’ve been walling to podiatrists and endocrinologists for years on PDN. It’s the same indication as regular stimulation. Foot pain is the same codes, same delivery system, same placement of leads. It’s nothing new or different. Doctors who want to use stimulation for PDN are already using it. If you have tingling in your hands and feet, they already use it. Off label, on label, they use it. A new PDN indication just allows you to have more of a conversation.\" — Territory manager at one of Nevro’s 3 key SCS competitors",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-3b2c57a40d1c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7396d6df-411c-4b38-8ebe-82410ab4091d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5af278ed-7094-4e7d-bde5-7a575c2fb439",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d349eaf3-9a56-4784-9a67-bb60aa5112ac",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "title",
          "text": "Skepticism of PDN opportunity by Nevro's former executives and competitors (continued)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:36.935+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "85b7ac7d-aaa2-45b3-a97d-b9a107c100cb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 160,
      "type": "tension",
      "title": "Uses expert testimony (KOLs) to undermine the company's growth thesis.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 8,
        "textChars": 2857,
        "nDataPoints": 1,
        "notes": "Uses expert testimony (KOLs) to undermine the company's growth thesis.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:02.79+00",
          "seconds": 3.981,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/160",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-160",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A PDN label won't help Nevro's market share with me.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-1917e0040a56",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "While many KOL's indicate that they already use stimulators for PDN today, others stated that diabetics who have deteriorated to the point of neuropathy are too risky as stimulator patients and suffer far higher complications when implanted. Our research suggests that the PDN opportunity is already played out with doctors firmly entrenched in two camps: those who already code it and it implant it today, and those who are wary because of higher complication rates and are unlikely to be swayed by label and reimbursement tweaking. A KOL who occasionally uses stimulators for PDN explained the conundrum: “the ones with the worst pain are the ones with worst diabetes” and therefore the riskiest, adding that “a PDN label won’t help Nevro’s market share” and that most doctors he knows “feel similarly.” A second KOL, a moderate Nevro user, expressed skepticism of Nevro’s PDN study and corroborated why a PDN label won’t be “a gamechanger”: a small, suspect market of high-risk patients whose comorbidities make it less likely they’ll even be referred.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77a730da-a888-43a0-9c9b-38e220658740",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "“I wasn't so impressed with the PDN study. I'm a little bit leery because it's a market of primarily elderly sick people with a lot of comorbidities, and I am not sure that it is such a big market for them, number one. The patient population is a suspect category for referral to a pain doctor or surgeon. A lot of them are more elderly, sick with other comorbidities, risks of infection, so it's less common that they'll be referred. I think the patient population is suspect in terms of surgical candidates. I don't think it's going to be a gamechanger.” – KOL, high volume implanter with moderate use of Nevro",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4fce152-557c-4378-a01a-7d7afe235b45",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“PDN would give Nevro an opportunity to have an extra condition on their label but it doesn't move the needle. I'm already using stimulators for PDN but in general diabetic patients are very sick and I don't like to use a stimulator. They're much more likely to get a side effect. They have four times the infection rate with an implant. When one of these devices gets infected it ruins my month and makes me miserable. I really try to avoid diabetic patients. If their diabetes is under decent control I'll do them. But the ones with the worst pain are the ones with the worst diabetes. A PDN label won't help Nevro's market share with me. When I talk to other implanters at my hospital, most feel similarly to me.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e2cb4322-ed20-468c-b79b-9b1c0666d7bc",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"the ones with the worst pain are the ones with the worst diabetes\" and therefore the riskiest, adding that \"a PDN label won't help Nevro's market share\" and that most doctors he knows \"feel similarly.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-1f0626fe882a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "630e3c7a-5f6d-4211-bfbf-3c2b5288be20",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f420336-5ed3-4aa6-ae2f-c5496cf5f759",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c3cd715-fded-496b-bf1a-60ba7c7f0db0",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f7fce66a-1a0b-4043-9d87-d255b3f0d0fe",
          "evidence": "Uses expert testimony to contradict company growth claims",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:02.79+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 160,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 161,
      "type": "tension",
      "title": "The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2291,
        "nDataPoints": 0,
        "notes": "The slide uses testimonial quotes from KOLs to undermine the credibility of the company's clinical data.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.581+00",
          "seconds": 7.692,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/161",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-161",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's and former executives blasted the study for using the same tricks and gimmicks as the SENZA trial: an open-label design (i.e., no blinding), a loosy-goosy comparator arm guaranteed to produce a \"successful\" trial, cherry-picked patients, and patient manipulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-9735042bb20f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "list",
          "text": "Nevro has a history of playing “games” with trials, is “just a lot of smoke and mirrors,” and now “no one buys their data.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0ec7e61d-2ae5-449e-ae4f-0f16d4990a92",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "list",
          "text": "A KOL states “I don't believe anything they say” and doubts “their PDN claims”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a152e512-1aaa-4360-b71f-0eb80a910510",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "In chapter 3 we detailed widespread skepticism of Nevro's pivotal SENZA-RCT study... KOL's indicated that the PDN study was the latest example of Nevro's suspect pattern of clinical trial conduct and making up new indications:",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59927a51-2cb7-43b3-960c-fe3cb3fc3609",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.52
          },
          "kind": "quote",
          "text": "Nevro's always played a lot of games... They put this data out that people don't even read anymore. It always shows these ridiculous numbers. They'll come up with numbers to show that high frequency treats cancer. No one buys their data.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b7ee67d-5058-457a-8a0d-2829f7df9f88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.1,
            "y": 0.76
          },
          "kind": "quote",
          "text": "Nevro has one size fits all. I don't believe anything they say and I doubt that their PDN claims are going to be any better. Every Nevro study is the same. It's a bunch of shit and you might get some initial improvement and then the same problems a year later.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4b3b401-674f-4c84-9ba3-2b68b48ec8db",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro's always played a lot of games. Rami, their previous CEO, was a notorious [redacted]. He just wasn't very on the up-and-up....It's just a lot of smoke and mirrors. There's not a lot there. There's a joke going around that we're one annual NANS meeting away from proving that Nevro's high frequency cures Covid. No matter what it is, Nevro says their device treats that, They put this data out that people don't even read anymore. It always shows these ridiculous numbers. They'll come up with numbers to show that high frequency treats cancer. No one buys their data.\" — KOL and high volume implanter; \"Nevro has one size fits all. I don't believe anything they say and I doubt that their PDN claims are going to be any better. Every Nevro study is the same. It's a bunch of shit and you might get some initial improvement and then the same problems a year later.\" — KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-9997433466f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "31ea0097-540c-4f55-b5c9-abc26da7f666",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b0ebfe4-fdfe-4f32-8081-e0275243a181",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ed42254-bb2e-4853-bf93-ea47a98c4b05",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "fdf25b14-36ed-4906-984e-709069cfde3d",
          "evidence": "The slide frames the company as a deceptive actor using 'smoke and mirrors' and 'tricks'.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:06.581+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 161,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 162,
      "type": "tension",
      "title": "The slide uses expert testimony to undermine the credibility of the company's clinical research and growth narrative.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 12,
        "textChars": 3023,
        "nDataPoints": 0,
        "notes": "The slide uses expert testimony to undermine the credibility of the company's clinical research and growth narrative.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:09.594+00",
          "seconds": 9.808,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/162",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-162",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro studies are not blinded and are skewed by well-known placebo effects",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-b3e7f88e04a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "list",
          "text": "Another KOL states that Nevro is defined by “the flawed design of their studies” and reflects a desperation to survive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1a7b280c-2d31-4fdb-8d22-ef3a3d987914",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "list",
          "text": "Nevro studies are not blinded and are skewed by well-known placebo effects",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "88c848ad-8da8-4561-b0d7-bf03bf65e97c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "list",
          "text": "The PDN study is the latest example of Nevro claiming that high frequency cures everything",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92691824-a337-49a9-b6fe-9b0fdaba040f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "PDN study as the latest example of Nevro's suspect pattern of clinical trial conduct and making up new indications (continued)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "895a4df0-fa2d-4bcf-b7e4-d0d785cad62d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.1,
            "y": 0.77
          },
          "kind": "quote",
          "text": "“The Hawthorne effect is well documented in science. If a person knows they're getting the experimental product or treatment they tend to have more of a placebo effect. Every patient in Nevro's study knew which device they got. Doctors believe the Hawthorne effect completely skewed Nevro's results. It happens in all their studies. Everybody knows which device they're getting. Nevro's always played a lot of games.” – KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0dd4ac06-92d8-42cf-a1d5-c0b1d51cb443",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.1,
            "y": 0.48
          },
          "kind": "quote",
          "text": "“There's no Rosetta Stone in medicine. There's no one thing that can treat everything but Nevro will have you believe that one therapy can treat every type of pain and all you have to do is put it in the same spot. They would have you believe that the same spot treats phantom limb pain and pelvic pain, that they can treat everything known to man, even though no one can replicate these studies with results in real life. Nevro's publications say you can use the same treatment for back and leg pain, the same spot for diabetic foot pain, for pelvic pain, for CRPS. Every single thing is the same thing for them and it's just it doesn't make sense. It goes against everything in science and medicine.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "10466a9a-71ae-45de-a359-a606cd950088",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.29
          },
          "kind": "quote",
          "text": "“Nevro tried to innovate, and I give them credit for that, but they're struggling and trying to survive. So they're trying to come up with these studies demonstrating superiority. The flawed design of their studies defines them as a company and they're failing.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1019a2d-a59e-41e3-96c5-55f9a0255940",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro tried to innovate, and I give them credit for that, but they're struggling and trying to survive. So they're trying to come up with these studies demonstrating superiority. The flawed design of their studies defines them as a company and they're failing.\" — KOL and high volume implanter; \"There's no Rosetta Stone in medicine. There's no one thing that can treat everything but Nevro will have you believe that one therapy can treat every type of pain and all you have to do is put it in the same spot... It goes against everything in science and medicine.\" — KOL and high volume implanter; \"The Hawthorne effect is well documented in science... Every patient in Nevro's study knew which device they got. Doctors believe the Hawthorne effect completely skewed Nevro's results. It happens in all their studies. Everybody knows which device they're getting. Nevro's always played a lot of games.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-b6448396d3a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0194c8fc-0fc9-4462-a6b5-4181af7c08a0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c6b3ea3b-56fd-4a46-a330-ca13cb8f6c25",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.594+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0e86c1d5-26c8-4242-a83c-bb025cbef83a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 163,
      "type": "tension",
      "title": "Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 94,
        "componentCount": 12,
        "textChars": 3533,
        "nDataPoints": 2,
        "notes": "Uses multiple pull-quotes from KOLs to build a case against the company's clinical trial integrity.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:03.996+00",
          "seconds": 4.185,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/163",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-163",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Everyone again feels that Nevro just cherry-picked their PDN study because diabetics are notoriously not compliant. That's why they have diabetes to begin with. And Nevro cherry-picks picture-perfect diabetic patients that always take the medication, their A1C was always below 7 and that's not realistic. That's not the average American that eats hoagies in Philadelphia.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-cfe0ddee70dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "list",
          "text": "A KOL stated that the ethics of the study design and exclusion criteria were \"questionable\" and thar the study \"lacks robustness.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1d42aa56-9c35-452b-9f7e-3c19a8dbbed4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "list",
          "text": "Another KOL stated that Nevro's exclusion criteria would cause him to reject 85-90% of diabetic stimulator candidates he sees",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "50b6e6cf-ba13-434e-a57f-ed9d28fe236b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "list",
          "text": "A KOL and speaker who teaches/meets with scores of implanters states that \"everyone again\" thinks Nevro cherry-picked study patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d508ad18-c901-434b-b2c2-3098de8c338f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Specifically, KOL's slammed the PDN study's cherry-picking of diabetic patients, implying the exclusion criteria reflected an unethical study design. The criticism was identical to that of the SENZA pivotal trial: enrolling patients that are not representative of the real world. One indicated the PDN study \"is just as bad as their original SENZA\" trial and \"lacks robustness.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6dbfb405-d7a1-4f8f-8d95-1cea3726c09b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.83,
            "x": 0.11,
            "y": 0.28
          },
          "kind": "quote",
          "text": "\"Everyone again feels that Nevro just cherry-picked their PDN study because diabetics are notoriously not compliant. That's why they have diabetes to begin with. And Nevro cherry-picks picture-perfect diabetic patients that always take the medication, their A1C was always below 7 and that's not realistic. That's not the average American that eats hoagies in Philadelphia.\" – KOL and speaker",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "031152ef-0c46-4b3b-9f2b-dc646b46fcb4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.83,
            "x": 0.11,
            "y": 0.61
          },
          "kind": "quote",
          "text": "\"Nevro's trying to put a sexy spin on a therapy that we've already been using forever. The ethics of their study design is questionable, like their exclusion criteria. They're going to have a lot of explants. They don't have the waveform capabilities that other companies have. The diabetic peripheral neuropathy study is just as bad as their original Senza study. It lacks robustness. It's not a level-one study.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "239af0ab-7219-463f-8378-7b3fd0494afa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.46
          },
          "kind": "quote",
          "text": "\"If I used these exclusion criteria in my own population of diabetic patients, I could maybe enroll 10% or 15% of them. It was a vast list of exclusion criteria. That study doesn't reflect real-world outcomes. It used the best of the best of the best patients.\" – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e5165f32-19fa-4f2c-99d2-4285092724e2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Everyone again feels that Nevro just cherry-picked their PDN study because diabetics are notoriously not compliant. That's why they have diabetes to begin with. And Nevro cherry-picks picture-perfect diabetic patients that always take the medication, their A1C was always below 7 and that's not realistic. That's not the average American that eats hoagies in Philadelphia.” — KOL and speaker; “If I used these exclusion criteria in my own population of diabetic patients, I could maybe enroll 10% or 15% of them. It was a vast list of exclusion criteria. That study doesn't reflect real-world outcomes. It used the best of the best of the best patients.” — KOL and high volume implanter; “Nevro's trying to put a sexy spin on a therapy that we've already been using forever. The ethics of their study design is questionable, like their exclusion criteria. They're going to have a lot of explants. They don't have the waveform capabilities that other companies have. The diabetic peripheral neuropathy study is just as bad as their original Senza study. It lacks robustness. It's not a level-one study.” — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-d15766fc34f1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c0c1531-9142-4496-9e75-781080cb76ab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ed06b47d-9529-4ab8-94ae-65105937148f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5b8049de-2fdc-430d-9b2a-7ee2e66d8086",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f1af12d2-dc6b-4e81-91cd-ecb3d7027775",
          "evidence": "Uses KOL quotes to validate claims",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:03.996+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 163,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 164,
      "type": "tension",
      "title": "Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 10,
        "textChars": 2081,
        "nDataPoints": 2,
        "notes": "Includes two direct quotes from KOLs and a screenshot of a ClinicalTrials.gov study design page.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:04.908+00",
          "seconds": 5.021,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/164",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-164",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.1,
            "w": 0.33,
            "x": 0.61,
            "y": 0.8
          },
          "kind": "callout",
          "text": "SENZA-PDN study began enrollment in July 2017 per ClinicalTrials.gov, but didn't complete enrollment until Aug 2019 per Nevro press release on 8/28/19.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "938bcce8-772d-4ff6-b86b-c26393bdbdb4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL’s indicated that it took Nevro years to complete enrollment for the PDN study, which should have been instantaneous given the vast number of diabetics in the US.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-656d34e9c722",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.45,
            "x": 0.06,
            "y": 0.77
          },
          "kind": "image",
          "text": "ClinicalTrials.gov study design snippet",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dc7f5b7e-4c11-48a0-96e3-d34fbe9837f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's indicated that it took Nevro years to complete enrollment for the PDN study, which should have been instantaneous given the vast number of diabetics in the US. Indeed, Nevro's own PDN addressable market slide indicates 2-5MM target patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57fbc996-7b6f-402c-8435-df2fed2ce76e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "quote",
          "text": "\"The biggest problem with their study was the exclusion criteria. They committed the cardinal sin, which is to cherry-pick... There's something like 24 points that would exclude diabetics from participating.\" - KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b687c94b-c2d8-4376-abe7-82f40df0b5cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "quote",
          "text": "\"Nevro's diabetic foot study should have taken them four months to fully recruit... They used rigid inclusion/exclusion criteria and basically have a medical monitor to pluck patients out...\" - KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ca23da91-a570-4c15-a41a-f51d9205feb0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Nevro’s diabetic foot study should have taken them four months to fully recruit. ... They used rigid inclusion/exclusion criteria and basically have a medical monitor to pluck patients out saying, 'Well, that’s not outside the study but I just don’t have a good feeling about [this patient]' Doctors have called out Nevro a bunch of times for cherry-picking. — KOL and high volume implanter; The biggest problem with their study was the exclusion criteria. They committed the cardinal sin, which is to cherry-pick. — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-68f6fe6b5a32",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://clinicaltrials.gov/ct2/show/NCT03228420; https://www.nevro.com/English/us/investors/investor-news/investor-news-details/2019/Nevro-Announces-Completion-of-Patient-Enrollment-in-Largest-Multicenter-Randomized-Controlled-Trial-of-High-Frequency-Spinal-Cord-Stimulation-for-Painful-Diabetic-Neuropathy/default.aspx",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "94f9decc-73ca-47f2-8bc8-d23896221eba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b2b2809-b98c-4617-b25e-3bf77b6a0d41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "46ece23f-b65f-44ce-a482-e9541e083d8e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "0e6a65c2-5c8e-4d34-860c-0e927b6b6436",
          "evidence": "The slide explicitly accuses the company of 'cherry-picking' and committing a 'cardinal sin' in study design to mislead investors.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:04.908+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 164,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 165,
      "type": "tension",
      "title": "Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 60,
        "componentCount": 7,
        "textChars": 1186,
        "nDataPoints": 0,
        "notes": "Highlights specific exclusion criteria (BMI, pain location, SSDI, worker's comp) using red boxes to support the 'cherry-picking' argument.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "numbered_list",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:03.59+00",
          "seconds": 3.628,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/165",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-165",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The SENZA-PDN study's exclusion criteria are sweeping and aggressive, illustrating the cherry-picking and absurdity KOL's pointed out.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:40+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-7c7d18bf8334",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.55,
            "w": 0.9,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "list",
          "text": "1. Have a diagnosis of a lower limb mononeuropathy... 2. Have a BMI >= 40. 3. Currently prescribed a daily opioid dosage > 120 mg morphine equivalents. 4. Have a medical condition or pain in other area(s)... 5-19... 20. Be a recipient of Social Security Disability Insurance (SSDI). 21. Have a pending or approved worker's compensation claim. 22. Have evidence of an active disruptive psychological...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Numbered list",
              "slug": "numbered",
              "status": "active",
              "canonId": "019de52c-fcc0-7718-a284-a4250c805df2",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "numbered",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d9ef055a-14f7-4c33-8462-631cf2f629d1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The SENZA-PDN study’s exclusion criteria are sweeping and aggressive, illustrating the cherry-picking and absurdity KOL’s pointed out. The criteria bend over backward to exclude bread-and-butter diabetics, such as those with pain anywhere but the lower limbs, severe obesity, recipients of Social Security disability, anyone with a worker’s comp claim, and various restrictions on opioid use or ulcers.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "824dc875-aa86-4e8a-87dd-0250ec35ba77",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.3,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://clinicaltrials.gov/ct2/show/NCT03228420",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "41948f88-81fc-4c0a-9623-4116fbbeab0b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a0d76d5-3ae9-4c28-b27d-59959a32d48c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bd6ba853-00e2-4994-8d5b-e7d0c1f999c9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "title",
          "text": "SENZA-PDN exclusion criteria per ClinicalTrials.gov",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c51845e7-f52e-40c9-8a89-150ee9112e15",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "a51e399b-9142-48fd-96ad-4cf61d0ebe07",
          "evidence": "Uses clinical trial data to argue that the company's growth narrative is based on manipulated/cherry-picked data.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:03.59+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 165,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 166,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 11,
        "textChars": 3383,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs and former executives to undermine the credibility of Nevro's clinical trials.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:10.099+00",
          "seconds": 9.751,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/166",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-166",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One KOL called it \"the dumbest study design\" and \"greaseball,\" lamenting why Nevro doesn't \"just come out with a normal study?\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-fea70049e1b4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "list",
          "text": "The former executive described patient manipulation and \"interaction bias\" as typical Nevro conduct curing trials",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c20ff71-1e94-4063-8dd5-c3784c68afd8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "list",
          "text": "A former executive as well a KOL strongly criticized the use of CMM as a comparator arm",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e708d853-246a-463b-9048-199a32e5ed15",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's – as well as Nevro's former executives – expressed disdain at other flaws in the PDN study beyond cherry-picked patients. One KOL called it \"the dumbest study design\" and \"greaseball,\" lamenting why Nevro doesn't \"just come out with a normal study?\" The concerns include the use of CMM (\"Conservative Medical Management\") as a low-bar comparator arm that ensures \"a layup\" study; interaction bias and patient manipulation during the trial; and placebo effect from lack of blinding.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d26373c8-0f42-44e8-a36d-2beabf521a51",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.71
          },
          "kind": "quote",
          "text": "\"What assisted Nevro with the Kapural study was interaction bias. It's all about how the study was designed and how the study team interacted with patients in the Boston Scientific arm versus the Nevro arm. The Boston patients' stimulators were programmed the same as always. But the Nevro arm had a team come in. The patient knows it's a new stimulator. The study team is excited to see you. You have 5 to 6 people at your programming session. They were methodical with patients in between sessions as well. Patients were managed differently. Nevro's PDN study would have managed patients exactly the same way, I'm sure. They compared Nevro to CMM [conservative medical management], and CMM is a very low bar.\" – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38259eba-3562-47e6-96b9-a7e28c09b104",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.39
          },
          "kind": "quote",
          "text": "\"One thing that concerns me is the huge amount of Nevro's valuation associated with PDN. It seem like half the valuation is linked to their PDN study. That study shows amazing results, but if you look at their control it's always CMM [conservative medical management] so these studies are always a layup.\" – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48d747ac-c4a1-4015-9287-e0819f6d6a7c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.48
          },
          "kind": "quote",
          "text": "\"And then the study also doesn't compare a Lamborghini to a Ferrari. They compared a stimulator to not another stimulator, but against just medication management. It is the dumbest study design. It's greaseball. And as doctors we just shake our heads and say, \"Why doesn't Nevro just come out with a normal study?\" – KOL and speaker",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7117eed9-7a65-45f6-b1e9-f2997b576d65",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"One thing that concerns me is the huge amount of Nevro's valuation associated with PDN. It seem like half the valuation is linked to their PDN study. That study shows amazing results, but if you look at their control it's always CMM [conservative medical management] so these studies are always a layup.\" — Former Nevro executive; \"And then the study also doesn't compare a Lamborghini to a Ferrari. They compared a stimulator to not another stimulator, but against just medication management. It is the dumbest study design. It's greaseball. And as doctors we just shake our heads and say, \"Why doesn't Nevro just come out with a normal study?\" — KOL and speaker; \"What assisted Nevro with the Kapural study was interaction bias. It's all about how the study was designed and how the study team interacted with patients in the Boston Scientific arm versus the Nevro arm... They compared Nevro to CMM [conservative medical management], and CMM is a very low bar.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-005609ce92bf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "68b22c7b-c86b-44f6-97fd-4726ba53c72f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "34cda998-e35d-450d-997f-2cdd0c61da3c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.099+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9efdb11f-8bf6-4b78-b534-1c9028569b50",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 167,
      "type": "tension",
      "title": "Uses multiple KOL quotes to undermine the company's growth narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 3800,
        "nDataPoints": 0,
        "notes": "Uses multiple KOL quotes to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:05.56+00",
          "seconds": 5.042,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/167",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-167",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Doctors more amenable to using stimulators for PDN – including Nevro loyalists - were vocal in stating that Abbott's DRG is the best waveform for PDN versus high frequency: “without question”; “it’s not even a question”; “100 times better than any other neuromodulation system.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-df9c5546f3ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's stated that although spinal cord stimulation has long been used for PDN, it doesn't work well given difficulties in reaching the extremities and is in fact \"notoriously very bad for the foot,\", reinforcing doctors' concern that PDN patients are already vulnerable with other comorbidities. Doctors explained why Nevro's high frequency mechanism will backfire if used for the foot. We note that doctors more amenable to using stimulators for PDN – including Nevro loyalists - were vocal in stating that Abbott's DRG is the best waveform for PDN versus high frequency: \"without question\"; \"it's not even a question\"; \"100 times better than any other neuromodulation system.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b1007f58-b39b-417b-b86d-b1e4fc691f82",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "quote",
          "text": "\"The other thing is that a lot of patients with diabetic neuropathy have pain in their feet, the actual feet themselves, and I personally don't believe Nevro is the best for the feet as the Abbott DRG is better.\" – KOL and high volume implanter, who still uses Nevro moderately",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1219c922-8277-4fa3-b9fb-6ec33efcc1e8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "\"Doctors have been using spinal cord stimulation for PDN for a while, but notoriously it's very bad for the foot. It doesn't get to the foot. You can't get spinal stimulation into the foot without having to stimulate everything along the way, Stimulation doesn't change the plumbing. Diabetic neuropathy causes pain because there's shitty blood flow which affects the nerves, which get rewired and interpret it as pain. What's going to happen with Nevro is what happens with every other spinal cord stimulator for the foot. You can't get to the foot, so you have to jack up the current, and then you get tolerance and [any pain relief] goes away.\" – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6f38f0e-fef6-4f68-9e8a-22d428a6a556",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "\"For diabetic neuropathy, DRG is 100 times better than any other neuromodulation system. Without question. Nevro has one size fits all. It's not even a question – DRG is the answer, at least anything neuromodulation-related for neuropathy. At least with DRG you are going to have increased blood flow because it's a real system.– KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f27f7650-6a08-4e38-9b55-f59bc5951bac",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Doctors have been using spinal cord stimulation for PDN for a while, but notoriously it’s very bad for the foot. It doesn’t get to the foot. You can’t get spinal stimulation into the foot without having to stimulate everything along the way, Stimulation doesn’t change the plumbing. Diabetic neuropathy causes pain because there’s shitty blood flow which affects the nerves, which get rewired and interpret it as pain. What’s going to happen with Nevro is what happens with every other spinal cord stimulator for the foot. You can’t get to the foot, so you have to jack up the current, and then you get tolerance and [any pain relief] goes away.” — KOL and high volume implanter; “For diabetic neuropathy, DRG is 100 times better than any other neuromodulation system. Without question. Nevro has one size fits all. It’s not even a question – DRG is the answer, at least anything neuromodulation-related for neuropathy. At least with DRG you are going to have increased blood flow because it’s a real system.” — KOL and former high volume Nevro implanter; “The other thing is that a lot of patients with diabetic neuropathy have pain in their feet, the actual feet themselves, and I personally don’t believe Nevro is the best for the feet as the Abbott DRG is better.” — KOL and high volume implanter, who still uses Nevro moderately",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-e2a646c3c91d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "497aa44b-f857-437c-a025-e007d115bd71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb35acc9-8665-4454-bd16-b5e0382eb9ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad936092-a1c1-4f5a-8499-b2d65f9085dd",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "9d8b2379-4bf6-44f1-8a4a-1f5646fcfeb2",
          "evidence": "Frames Nevro as the 'villain' or ineffective solution compared to Abbott's DRG.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:05.56+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 167,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 168,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs to undermine the company's technical claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 72,
        "componentCount": 8,
        "textChars": 1625,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs to undermine the company's technical claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:05.146+00",
          "seconds": 4.126,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/168",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-168",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "For Nevro to say its doing both high frequency and PDN is so contradictory that one KOL bluntly stated: \"I think they're lying.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-e4c7e4c1148f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "On p.148-151 we detailed a fatal flaw that renders Nevro's new Omnia device essentially unusable for low frequency stimulation: leads for high frequency and low frequency are surgically implanted at different vertebrae...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe297ed6-119e-47b1-9779-7bbc4a873a54",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "In some PDN patients, the leads need to be at T11, T12, L1. If that doesn't work, you can go up to T9, T10, T11. And it's not just where the leads are - it's also laterality... With Nevro, you can't do that.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6638e93c-f7b1-4c06-8627-16b58dd9c9a8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "quote",
          "text": "So I don't know how they're going to do both high frequency and paresthesia [low frequency] with Omnia. In fact, I think they're lying. I think if you're going to go for diabetic peripheral neuropathy, you can't be in the T9/T10 spot.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc3a14fa-385a-4bf4-af81-9b2ee1276a1f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"So I don't know how they're going to do both high frequency and paresthesia [low frequency] with Omnia. In fact, I think they're lying. I think if you're going to go for diabetic peripheral neuropathy, you can't be in the T9/T10 spot. You're going to have to be somewhere else, which means now you can't do the high frequency.\" — KOL; \"In some PDN patients, the leads need to be at T11, T12, L1. If that doesn't work, you can go up to T9, T10, T11. And it's not just where the leads are - it's also laterality... With Nevro, you can't do that. There are 32 contacts, say with a Boston Scientific lead. With Nevro, they only activate two of them.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:41+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b344-ea58f91abb43",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4e5816d-43f4-4b1d-a2b8-4ce9a5184a34",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ba1d699a-7ae7-4799-85d8-7da47c039968",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af0a76a6-6602-4cc8-9701-f0c831c71767",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "3a7a59ff-7e85-44fb-bd36-7c7b4a8f37a8",
          "evidence": "The slide explicitly labels the company's claims as 'fraudulent' and 'a mirage' based on technical contradictions.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:05.146+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 168,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 169,
      "type": "tension",
      "title": "Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2820,
        "nDataPoints": 0,
        "notes": "Uses expert testimony (KOLs and former executives) to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:05.193+00",
          "seconds": 3.885,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/169",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-169",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The PDN opportunity is commercially dead-on-arrival due to referral patterns with PDN patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-1bff667be979",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "A KOL and moderate Nevro implanter described the importance of referral patterns and why PDN won't \"move the needle\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1d2497d2-45e5-4370-9700-3275265c2848",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "A KOL who tries to implant stimulators for PDN today says their doctors view them as inappropriate candidates and refuse to refer",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "285e4bd2-b61f-4433-973a-a23a464bf8f5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "list",
          "text": "A former Nevro sales executive states that the company \"has no plan or understanding\" about accessing the PDN market, and that endocrinologists will not hand off these patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fcf17ff9-8858-4068-9f98-5c0369b2b754",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "In addition to stimulators already being used today for PDN, skepticism of Nevro's study, a small market of high-risk patients, and high frequency lead placement being incompatible with PDN, the opportunity is commercially dead-on-arrival due to referral patterns with PDN patients. Nevro's former executives and KOL's emphatically repeated that the primary care doctors and endocrinologists who manage PDN patients are gatekeepers who simply will not refer them to doctors who implant stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5e56b1f1-b7e6-4723-9791-18875a7ef517",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.66
          },
          "kind": "quote",
          "text": "\"Even if they get FDA approval, the issue is getting referrals. Their doctors do not view PDN patients as ones that you should install a stimulator in.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c9ae414-f364-4e4f-9f42-fd91bb120e95",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.83,
            "x": 0.11,
            "y": 0.32
          },
          "kind": "quote",
          "text": "\"I have trouble getting PDN patients away from vascular surgeons. They hold on to these patients. Those are the ones that would have benefit. The PDN opportunity is not going to move the needle. The thing to realize is that referral patterns are really important. Vascular surgeons hold on to these patients. That's the realty. You don't get the diabetologist referring patient to the pain doctor.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84a2c80a-359f-486f-bf54-9a1f21e6fe71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.51
          },
          "kind": "quote",
          "text": "\"The issue is accessing the PDN market. Nevro has no plan or understanding of how to access that market. I spent 12 years in the market. I don't know many endocrinologists that will hand off diabetic patients to pain docs.\" - Former sales executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b5ef7ac9-6830-473d-8450-9f397f8aae05",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I have trouble getting PDN patients away from vascular surgeons. They hold on to these patients. Those are the ones that would have benefit. The PDN opportunity is not going to move the needle. The thing to realize is that referral patterns are really important. Vascular surgeons hold on to these patients. That's the realty. You don't get the diabetologist referring patient to the pain doctor.\" — KOL; \"The issue is accessing the PDN market. Nevro has no plan or understanding of how to access that market. I spent 12 years in the market. I don't know many endocrinologists that will hand off diabetic patients to pain docs.\" — Former sales executive; \"Even if they get FDA approval, the issue is getting referrals. Their doctors do not view PDN patients as ones that you should install a stimulator in.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-1f18c3c962e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3a91e4ef-62b3-4f6a-9b10-4d1a23239ab4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "487add7e-9380-4e6b-b321-722ac1c00e33",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:05.193+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56882bb3-0f6d-4b4d-8307-434a03d1a0e6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 170,
      "type": "tension",
      "title": "The slide uses a 'quote-sandwich' structure to validate the thesis headline.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3905,
        "nDataPoints": 0,
        "notes": "The slide uses a 'quote-sandwich' structure to validate the thesis headline.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.61+00",
          "seconds": 5.095,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/170",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-170",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One of Nevro’s highest volume implanters – a consultant and speaker for the company – threw cold water on the PDN opportunity.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-e1685d7d78d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One of Nevro’s highest volume implanters – a consultant and speaker for the company – threw cold water on the PDN opportunity. He questioned Nevro’s TAM claims and explained how referral patterns make it unrealistic to get PDN patients. He described his personal attempts to market stimulators for PDN and why they failed: the only place to find these patients is in Medicare/Medicaid clinics with a low-income population, where PDN patients have extensive comorbidities like infections, amputation risk, and other issues that preclude them as viable stimulator candidates. A former Nevro executive added that primary care doctors have “a huge amount of skepticism” about stimulators and that “a genuine financial disincentive” prevents them from referring their PDN patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86c87b92-035e-4659-953e-e0ed54e21b94",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.77
          },
          "kind": "quote",
          "text": "“The issue that everyone going into PDN has are the primary care physicians responsible for the patient group. They are not interventional pain physicians. It's convincing that primary care doctor to refer that patient off to another physician to manage that condition. There’s a huge amount of skepticism from the actual physicians managing these PDN patients. There is a genuine financial disincentive for them to send a patient to another person to manage something that they feel they can manage themselves.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2b6441e3-f121-425f-94b1-9aca6cf90fbd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.41
          },
          "kind": "quote",
          "text": "“Nevro throws around this number of 2 million diabetics a year, but not all of those are painful diabetics seeking out treatment beyond other therapies. Gabapentin and Lyrica are failures. They don't really do much. The problem is the referral patterns aren't quite there yet. One, it takes the insurance coding and approval and two, finding these patients, because these patients do not exist in typical pain practices, the ones that treat back and leg pain all day. These practices don't necessarily see PDN. I decided that I was going to start marketing SCS for PDN treatment and ultimately endocrinologists don't have PDN patients, neurologists don't have them. The sick population Medicare, Medicaid practices have them. So you go into Harlem, you go into the Bronx or any hospital that has a sort of Medicaid clinic, they have them. But then the challenge is, they have cardiac disease that keeps them on blood thinners or they have recurrent infections or they are likely to amputate and so it just becomes challenging as to what are we going to do with those patients.” – KOL and one of Nevro’s highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "37f94513-0fc8-40ec-956f-fa8f65a8af67",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro throws around this number of 2 million diabetics a year, but not all of those are painful diabetics seeking out treatment beyond other therapies... The sick population Medicare, Medicaid practices have them. So you go into Harlem, you go into the Bronx or any hospital that has a sort of Medicaid clinic, they have them. But then the challenge is, they have cardiac disease that keeps them on blood thinners or they have recurrent infections or they are likely to amputate and so it just becomes challenging as to what are we going to do with those patients.” — KOL and one of Nevro’s highest volume implanters; “The issue that everyone going into PDN has are the primary care physicians responsible for the patient group. They are not interventional pain physicians. It's convincing that primary care doctor to refer that patient off to another physician to manage that condition. There's a huge amount of skepticism from the actual physicians managing these PDN patients. There is a genuine financial disincentive for them to send a patient to another person to manage something that they feel they can manage themselves.” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-e71533991294",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c18e0c51-7149-4f71-81c5-0ca29a6d1bb3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4018422c-09f0-427d-8fe1-31db3adfd798",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aab633ac-aead-4e5a-a30d-ff3d22effb8b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "1a15ceef-1fcc-4be8-a61d-7301dcfaf4cb",
          "evidence": "The slide frames Nevro's management claims as a 'mirage' and uses expert testimony to discredit them.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:06.61+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 170,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 171,
      "type": "tension",
      "title": "Uses expert testimony to contradict company growth narratives.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3756,
        "nDataPoints": 0,
        "notes": "Uses expert testimony to contradict company growth narratives.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:37.029+00",
          "seconds": 3.782,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/171",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-171",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The other aspect is how much do these PDN patients really want to have an implant?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-cb7fdc3e94d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The Nevro consultant/speaker and KOL who failed in his attempts to broaden his practice to PDN patients mentioned two other barriers to commercialization. First, PDN patients do not want implants, and because they’re not recurring monthly patients like those on opioids, pain practices don’t have the opportunity to “constantly bombard” them with a stimulator sell (we detail patients being pressured into stimulators in a later section). Second, he reinforced the point made by other doctors that Medicare already covers stimulations for PDN today, and that PDN is therefore not a new market for Nevro. Because the PDN population is almost all Medicare/Medicaid, the patients are not an attractive commercial pay opportunity: they’re typically unable to work and therefore lack employer healthcare, which is essentially the definition of commercial insurance. He added that Nevro may not even get label exclusivity from commercial insurers if approved for PDN, as Medicare covers any stimulator for it today. meaning that any commercial payors would cover all stimulators not just Nevro’s.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b70e07b-4cb1-4d34-b6a2-c6ca62399f3b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "quote",
          "text": "For PDN it will have to be determined how they do in terms of negotiating with the payers. Are they going to get a label exclusivity on it? Because yes, you can code it today as neuropathic pain of the leg. The commercial payers are not interested in engaging with diabetic neuropathy right now. The trouble is that the diabetic population that has significant enough pain tends to be the Medicare, Medicaid population. You can use any device for Medicare. With the bulk of the population being Medicare, doctors can use the device for PDN today. And commercial-insured patients don't mean much, because commercial insurance usually means an employed person that generally is not the one that's usually a severe diabetic.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "794e768e-2578-491c-b779-c143e861d859",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "The other aspect is how much do these PDN patients really want to have an implant? The back and leg pain patients are constantly getting bombarded with the idea of simulation. Here it's like a one-time consult, maybe a referral from a from a primary care doc and then the patient says \"Well that's not really what I expected to hear\" and they walk out. The back and leg patient keeps coming back to you and you can keep talking about stim as an option.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3ba35c6-f8fd-488c-8014-fea301bdf435",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“The other aspect is how much do these PDN patients really want to have an implant? The back and leg pain patients are constantly getting bombarded with the idea of simulation. Here it's like a one-time consult, maybe a referral from a from a primary care doc and then the patient says \"Well that's not really what I expected to hear\" and they walk out. The back and leg patient keeps coming back to you and you can keep talking about stim as an option.” “For PDN it will have to be determined how they do in terms of negotiating with the payers. Are they going to get a label exclusivity on it? Because yes, you can code it today as neuropathic pain of the leg. The commercial payers are not interested in engaging with diabetic neuropathy right now. The trouble is that the diabetic population that has significant enough pain tends to be the Medicare, Medicaid population. You can use any device for Medicare. With the bulk of the population being Medicare, doctors can use the device for PDN today. And commercial-insured patients don't mean much, because commercial insurance usually means an employed person that generally is not the one that's usually a severe diabetic.” — KOL and one of Nevro’s highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-cd623e7515b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "223f0966-f5bf-4fd4-aeae-cd8632dadc7b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c9060a34-015a-47fb-989d-6bf5278a4d10",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fb90d5c-2e95-4fee-ae90-d5aed8c003b8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "a4a08ea7-6c25-48af-9dc1-b8aa5686090f",
          "evidence": "Contradicting company TAM claims with expert testimony",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 21:26:37.029+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 171,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 172,
      "type": "tension",
      "title": "Uses a direct quote from a KOL to undermine the company's growth thesis.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 7,
        "textChars": 2339,
        "nDataPoints": 0,
        "notes": "Uses a direct quote from a KOL to undermine the company's growth thesis.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:08.677+00",
          "seconds": 6.964,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/172",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-172",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "PDN wouldn't be a Nevro-driven market. If the numbers increase, you will probably see a distribution relatively equally over all the manufacturers and perhaps down the road, perhaps a little bit more for Abbott.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-662790edcff0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The Nevro consultant’s/speaker’s point on PDN label exclusivity – that even if Nevro were to get “approval” for PDN, Medicare and others would apply it to all other stimulators – was reinforced by another KOL who remains a moderate Nevro user. He stated that “PDN wouldn’t be a Nevro-driven market” and that it wouldn’t alter Nevro’s sales much, adding that insurers simply do not monitor or care which stimulator doctors use for which indication. He stated that insurers only care “once in a 100” times.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ffa21f5-c97b-4fbb-a0a0-bb9373810235",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "quote",
          "text": "“PDN wouldn’t be a Nevro-driven market. If the numbers increase, you will probably see a distribution relatively equally over all the manufacturers and perhaps down the road, perhaps a little bit more for Abbott. It's not necessarily a uniquely Nevro type of thing. I don't think all of a sudden it's going to dramatically change Nevro's numbers. The way the game works is that if company A gets FDA approval for indication X, the insurance companies do not really ask which device you're using, so you can technically use another device for an indication approved by Nevro. Very rarely will an insurer ask which device you're using. I've only seen that once in a 100.” - KOL and high volume implanter, moderate Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44875f89-38f0-43c1-8937-7dff303ddf46",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "PDN wouldn't be a Nevro-driven market. If the numbers increase, you will probably see a distribution relatively equally over all the manufacturers and perhaps down the road, perhaps a little bit more for Abbott. It's not necessarily a uniquely Nevro type of thing. I don't think all of a sudden it's going to dramatically change Nevro's numbers. The way the game works is that if company A gets FDA approval for indication X, the insurance companies do not really ask which device you're using, so you can technically use another device for an indication approved by Nevro. Very rarely will an insurer ask which device you're using. I've only seen that once in a 100. — KOL and high volume implanter, moderate Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-69098318651d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "23a1a116-75d4-4827-8326-d76b8eaf029b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b9106390-a065-4b08-a29e-b27d24461a0d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "977f8b7f-8828-45bd-94f7-3ce43c1c3321",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e38e3f7a-5ef4-43ad-bd19-80953daccb55",
          "evidence": "Uses expert testimony to contradict company growth claims.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:08.677+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 172,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 173,
      "type": "tension",
      "title": "Uses expert testimonials to debunk company growth narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 9,
        "textChars": 3696,
        "nDataPoints": 1,
        "notes": "Uses expert testimonials to debunk company growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.036+00",
          "seconds": 4.131,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/173",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-173",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The notion that insurers would allow such an aggressive first line treatment is preposterous.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-509c85563621",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "In addition to PDN, Nevro has begun to dangle a second indication expansion as part of its turnaround plan: non-surgical refractory back pain (NSRBP), for which it will present 3 month data in January. Stimulators are generally only reimbursable after a patient has already exhausted other options like back surgery. In plain English, NSRBP – also called “virgin back” or “first line back” - means implanting a $25,000 stimulator right away - without prior authorization - when a patient walks in with back pain. The notion that insurers would allow such an aggressive first line treatment is preposterous. We commend the Street for their morsel of accuracy in at least indirectly trashing the opportunity, e.g., a 10/22/20 report by Guggenheim – otherwise frothing with a $190 TP – which stated that 30% of Nevro’s sales are already for NSRBP (after prior auth); that the indication is already on-label; and that reimbursement is the obstacle. Not surprisingly, one KOL after another – including Nevro loyalists – ripped the NSRBP “indication expansion” as a delusion and outside the standard of care.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a348352-bc1a-4e2f-9d7e-17d72632d560",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.8
          },
          "kind": "quote",
          "text": "“Insurers are making it even harder. Getting approval for stimulators is the hardest it has been. In some local code determinations, they’re making doctors send the patient to a neurosurgeon who writes a letter stating the patient is not a candidate. In an age like this, stimulators for first-line back....there’s no way that’s going to happen. You can’t go right to a $50,000 treatment. I mean, that’s way outside of the standard care.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "09190109-9523-4543-bce9-b7d2da075a7b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.51
          },
          "kind": "quote",
          "text": "“Spinal cord stimulation as a first-line treatment is, no...it’s absolutely not a realistic opportunity.. The insurance companies will never cover that. If Nevro’s saying they’ll make stimulators the first line of treatment when a back pain patient comes in, I have never heard of that.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7190b27a-ff46-4102-831f-322a37247950",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.63
          },
          "kind": "quote",
          "text": "“As far as stimulators being used for first-line back, this is question that’s been asked for 15-25 years. Whenever a company comes out and says, we are using it for back pain, it causes problems. Back pain is a huge diagnosis category. The industry has gotten in trouble by claiming it works better for back pain than another device. Upfront back pain is so multi-factorial. I don’t see that market being appropriate for spinal cord stimulation. There are a lot of psychological issues as well, so I don’t see non-surgical back as a big market for them or any company.” – KOL and Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a65158d6-c1eb-4875-b61b-017ee190fd04",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Spinal cord stimulation as a first-line treatment is, no...it’s absolutely not a realistic opportunity.. The insurance companies will never cover that. If Nevro’s saying they’ll make stimulators the first line of treatment when a back pain patient comes in, I have never heard of that. — KOL and high volume implanter; As far as stimulators being used for first-line back, this is question that’s been asked for 15-25 years... I don’t see that market being appropriate for spinal cord stimulation. There are a lot of psychological issues as well, so I don’t see non-surgical back as a big market for them or any company. — KOL and Nevro user; Insurers are making it even harder. Getting approval for stimulators is the hardest it has been... stimulators for first-line back....there’s no way that’s going to happen. You can’t go right to a $50,000 treatment. I mean, that’s way outside of the standard care. — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:42+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-54a166452eb9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "635e01f5-9c6c-4093-8e26-6f952b10c94f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "11. TAM expansion and growth from painful diabetic neuropathy (PDN) and other new indications are a mirage",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35f472f2-bf8d-4681-a95d-f14640b84402",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.036+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77b4a48a-a81b-4ed9-be31-1e43e1013c02",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 174,
      "type": "tension",
      "title": "Features highlighted text blocks in yellow to emphasize critical quotes from former executives.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 92,
        "componentCount": 10,
        "textChars": 2638,
        "nDataPoints": 7,
        "notes": "Features highlighted text blocks in yellow to emphasize critical quotes from former executives.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.5-flash",
          "runId": null,
          "at": "2026-07-17 03:50:48.549+00",
          "seconds": 22.247,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/174",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-174",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "They move some people in, move some people out, but at the end of the day, they really control cost. They don't really add true value and that's kind of how I see Grossman.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-436f509c182d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.77
          },
          "kind": "list",
          "text": "He believes that there’s “no long term plan there” and that Grossman was looking for a quick flip",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "03b27f2b-9a3f-4cea-ad9c-8e0bd79a7386",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "list",
          "text": "The former executive believes that Grossman doesn't understand the SCS market; that the lack of growth under his tenure is underwhelming and \"crazy\" given the massive salesforce expansion; and that Grossman has a superficial playbook focused on cutting costs",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1531adc4-2f25-4b15-8202-559c103cbfa7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.21,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Nevro’s stock was at $45 and jumped 35% the day Keith Grossman was announced as CEO. A herd of sell-side analysts tripped over each other to upgrade and double-upgrade the stock in hours. Given the stock is 4X higher since his hiring while sales are still stuck at the same level as 2018, Nevro is little more than a bet on Keith Grossman’s God-like turnaround and quick-flip powers.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b2c0d04-52fa-49b4-9f8b-adc45782cae1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.23,
            "w": 0.82,
            "x": 0.1,
            "y": 0.51
          },
          "kind": "quote",
          "text": "“Grossman has a history of working with Bess Weatherman of Warburg Pincus who’s on the board, and I think they look for companies that are really ground down. They move some people in, move some people out, but at the end of the day, they really control cost. They don’t really add true value and that’s kind of how I see Grossman... I’m very underwhelmed because when I look at sales capacity, there’s 150 more field team now, for about the same amount of revenue. It’s crazy.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05ba1b85-3b3a-4885-94ed-647c7df9512b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.82,
            "x": 0.1,
            "y": 0.82
          },
          "kind": "quote",
          "text": "“The other side of Grossman is that when that stock hit $90, you saw 3X acceleration according to the public record to his stock, so he’s all about flipping the company and making as much money as possible in the shortest amount of time. I don’t think there’s a long-term plan there.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4dacc75d-1fe6-41ae-99d9-956d014acd09",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Grossman has a history of working with Bess Weatherman of Warburg Pincus who's on the board, and I think they look for companies that are really ground down. They move some people in, move some people out, but at the end of the day, they really control cost. They don't really add true value and that's kind of how I see Grossman. I don't see Grossman adding value to spinal cord stimulation. I don't think he really understands the market. He'll reformat all those guarantees that the reps have. From a revenue point of view, the company should be a lot bigger than it is, but I'm very underwhelmed because when I look at sales capacity, there's 150 more field team now, for about the same amount of revenue. It's crazy. — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-46e6996e740e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": "source-note",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3f58c302-914c-4713-9ef9-ed39065f01ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.68,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec29b1dd-8e0d-41e2-a9ff-e16dcedbf7b1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a20e26f-770a-4134-8a88-466f679cc6a7",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Authority citation",
            "slug": "authority-citation",
            "status": "active",
            "bestFor": null,
            "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
            "version": 1,
            "bodyDocId": null,
            "description": "Quoting an authority figure, study, or precedent to lend weight.",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "feacb666-db5d-4860-a5b5-69bd2e20ddd6",
          "evidence": "The use of quotes from experts and KOLs to support the allegations about Nevro's practices.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-07-17 03:55:46.478324+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 174,
          "whyItWorks": null,
          "antipattern": null,
          "cardinality": "common",
          "narrativePurpose": null
        }
      ],
      "frameworks": [
        {
          "matchId": "726ecacc-fe3a-42a9-aabb-bed22bdc9e1a",
          "evidence": "Focuses heavily on criticizing the newly appointed CEO Keith Grossman using ex-executive quotes.",
          "framework": null,
          "confidence": 0.85,
          "extraction": {
            "at": "2026-07-17 03:50:48.549+00",
            "model": "google/gemini-3.5-flash",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 174,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 175,
      "type": "evidence",
      "title": "Uses expert testimony to frame the company's situation as dire.",
      "function": "illustrate_case",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "illustrate_case",
        "functionCanon": {
          "name": "Illustrate case",
          "slug": "illustrate_case",
          "status": "active",
          "canonId": "019de52d-13b4-772c-bb73-1873612a7463",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2748,
        "nDataPoints": 0,
        "notes": "Uses expert testimony to frame the company's situation as dire.",
        "elementsJson": [
          "headline_text",
          "subtitle_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.254+00",
          "seconds": 3.956,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/175",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-175",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The only reason why Grossman stabilized the salesforce was because the stock price went up and those reps had options.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-ace019741318",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.06,
            "y": 0.19
          },
          "kind": "list",
          "text": "The ex-executive stated Nevro will now “die of a thousand cuts” and provided a damning assessment: no growth from Omnia; losing doctors; no market share gains; and being forced to pay doctors to use the product.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d7c2e37b-2100-4469-980a-a6b6987f70f3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "He stated that there will be an exodus of sales reps at the end of this year – “a bloodletting” - when options expire, and that reps are ready to flee to new competitors such as Saluda",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dff016af-4ebe-46cf-9103-2db42fab7e2a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The former executive described a dire situation at Nevro with an impending exodus of talent.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5cce0572-5f00-46de-9b8a-bb45bd6f2e41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.1,
            "y": 0.52
          },
          "kind": "quote",
          "text": "“The only reason why Grossman stabilized the salesforce was because the stock price went up and those reps had options... Interesting enough, most all those options are going to expire at the end of this year and its going to be a bloodletting. All those reps are going to leave... It’s kind of a rinse and wash type philosophy.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "40be16d7-35aa-48a0-aac8-d057f751ba6d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.26
          },
          "kind": "quote",
          "text": "“Nevro has boxed themselves into a corner and now they’ll die of a thousand cuts. because unless they start seeing some increased sales, which they’re not going to at the price point that they’re at... Who are they converting from Boston, from Medtronic, from Abbott? Where are those customers? And you don’t see it.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f2a19056-132b-47a8-a386-cfc4f1beaeb2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro has boxed themselves into a corner and now they’ll die of a thousand cuts. because unless they start seeing some increased sales, which they’re not going to at the price point that they’re at, because the high-volume doctors are not going to overpay for Omnia. Maybe the diehard Nevro guys hold on, but how many of those diehard guys are also consultants for the company? How many new customers are they getting? Who are they converting from Boston, from Medtronic, from Abbott? Where are those customers? And you don’t see it.\" — Former Nevro executive; \"The only reason why Grossman stabilized the salesforce was because the stock price went up and those reps had options. Those options were in general in the high 60’s...that’s $200,000-$300,000 to those reps, so they’re going to stay. Interesting enough, most all those options are going to expire at the end of this year and its going to be a bloodletting. All those reps are going to leave, because they want to get out of their non-competes and then in a year they go back into the Saluda’s, the Nalu’s and everything else. It’s kind of a rinse and wash type philosophy. If the price of the stock goes down, you’ll see a major amount of reps leave the company, and they’ll go elsewhere.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-b24025a4f11d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f88cf74b-bce0-411f-bd3f-947e2eac6eff",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "86430757-5421-4b2e-979c-0262cb7f21c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2eb6deb9-cb3c-42e4-9293-a6dafef1867d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "5473a988-0fa6-4b25-ad86-ff7d54e9caf8",
          "evidence": "The slide uses a clear, thesis-driven headline to frame the argument.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:06.254+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 175,
          "frameworkName": "action-titles"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 176,
      "type": "tension",
      "title": "Uses expert testimony to undermine management credibility and highlight operational failures.",
      "function": "expose_contradiction",
      "rawType": "ceo_quote",
      "block": null,
      "metadata": {
        "slideType": "ceo_quote",
        "slideTypeCanon": {
          "name": "CEO quote",
          "slug": "ceo_quote",
          "status": "active",
          "canonId": "019de52d-09b6-71c8-93a5-f90a9772a8fa",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 2836,
        "nDataPoints": 0,
        "notes": "Uses expert testimony to undermine management credibility and highlight operational failures.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.319+00",
          "seconds": 3.889,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/176",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-176",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The purported momentum the CEO hypes on earnings calls is a mirage: massive market share losses, impending defections, and other signs of a sinking ship with the CEO backed “in a corner.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-11d98e851117",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.5,
            "x": 0.06,
            "y": 0.2
          },
          "kind": "list",
          "text": "He described Grossman as engaged in “window dressing” and Omnia as a flop",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2444dd75-85e0-4957-9455-095932d41248",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "list",
          "text": "The purported momentum the CEO hypes on earnings calls is a mirage: massive market share losses, impending defections, and other signs of a sinking ship with the CEO backed “in a corner.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fba7e55-7e7a-439d-92dc-bdb93e8ad18a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "He concluded by implying that Grossman is more engaged in optics than substance, backed “in a corner,” and that his key initiatives like Omnia are failures.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "78cd93bd-048a-4a48-a9a7-a26eea8d8fdc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.85,
            "x": 0.11,
            "y": 0.46
          },
          "kind": "quote",
          "text": "“When I listen to earnings calls, it’s “the business has stabilized... but at the end of the day, I just don’t see it. I really don’t see it. You’ve seen massive losses in Australia... In Europe, high percentages of business are just going away... They’re going to lose a lot of their high-quality reps... They’re going to sell those and get out of there and then you’re back to pretty average people with pretty average performance.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "488748fb-f666-4377-a710-ec1726c31450",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.11,
            "y": 0.24
          },
          "kind": "quote",
          "text": "“I think there’s a lot of window-dressing with Grossman and that’s why you’re not seeing this big uptake in revenue. If Omnia is so good... why is it not going up? They’ve eroded their price.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df38adb0-be66-41f4-8e13-48790dce2632",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I think there’s a lot of window-dressing with Grossman and that’s why you’re not seeing this big uptake in revenue. If Omnia is so good and you’re got a hundred more reps out on the field and you’re doing all this great selling and all these customers are happy, why is it not going up? They’ve eroded their price. Nobody’s going to buy Omnia, unless you’re getting paid a couple thousand bucks to be put in a study to use it. — Former Nevro executive; When I listen to earnings calls, it’s “the business has stabilized, we’re excited about all these new platforms and new disease states, we’re going to do more of this” but at the end of the day, I just don’t see it. I really don’t see it. You’ve seen massive losses in Australia where that business used to be number one and now they’re number three or four. In Europe, high percentages of business are just going away because they don’t have the core competency in leadership. Here in the US, they’re going to have to start making changes in leadership and when that happens and stock options expire, then Keith is back in a corner. They’re going to lose a lot of their high-quality reps that have been on guarantees. For their management team, the stock options have already hit. They’re going to sell those and get out of there and then you’re back to pretty average people with pretty average performance. — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-15c20acfcd09",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4de8a6f-92cf-47cb-b52a-2b6321be348b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.75,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3e66476a-c725-4c21-ae35-7c936d05606c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4edf4ea-c67d-403e-867a-5857e9bef1f3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "4bfe7788-6aa4-4db7-a142-5c1725b8ae66",
          "evidence": "Uses expert quotes to directly contradict CEO earnings call narratives.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:06.319+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 176,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 177,
      "type": "tension",
      "title": "The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2803,
        "nDataPoints": 0,
        "notes": "The slide uses expert testimony to undermine the credibility of the CEO and the company's strategic direction.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.433+00",
          "seconds": 3.87,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/177",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-177",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We note that one executive after another we spoke with described Grossman as a quick-flip artist who now finds himself in an uncomfortable position.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-fad883d83ccc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "A second former executive, in touch with the management team and now in a senior role at a key competitor, provided a similarly damning view of Grossman’s turnaround, describing his understanding of the SCS space as “naïve.” He shared his sense from members of the management team that Grossman is “busy on a lot of others things” and questioned who’s running Nevro day to day, given that he failed to deliver a quick flip and now finds himself in a role he didn’t expect. We note that one executive after another we spoke with described Grossman as a quick-flip artist who now finds himself in an uncomfortable position. The former executive also described an ongoing collapse of Nevro’s international business.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2940e84e-ad3d-4cf8-93e1-a6387eb99b65",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.59
          },
          "kind": "quote",
          "text": "“I also got a sense this wasn’t a role that he was expecting and that he’s very busy on a lot of other things he’s doing. A lot of other things, and I don’t know how much attention - I mean obviously he’s spending a lot of time on Nevro - but I think there are other people who are running the ship largely and that’s sort of the sense I got from these people on the leadership team” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a687201-26db-4748-b501-442b17218df4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.05,
            "y": 0.38
          },
          "kind": "quote",
          "text": "“Keith is definitely a more polished individual but his understanding of the technology that he’s speaking to, and the way that’s going to be received by physicians, is naïve. Grossman describes Omnia as really just the marketing, like the same marketing spin that was being presented at NANS. I don’t think he understands the way that these physicians work and their desire to have new and innovative products. Omnia is not a new or innovative product. It’s basically just a repackaging of an old product.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "968a340a-d28f-40c0-a59f-da2728f83068",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.77
          },
          "kind": "quote",
          "text": "“Three key people, including the person responsible for all of global, have been taken out of the organization and about four weeks later two key people in the European area left the organization. So now there’s a fairly junior leadership team within the European organization.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ddb0d8bc-35e6-4660-9d94-fee468adabd3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Keith is definitely a more polished individual but his understanding of the technology that he’s speaking to, and the way that’s going to be received by physicians, is naïve. Grossman describes Omnia as really just the marketing, like the same marketing spin that was being presented at NANS. I don’t think he understands the way that these physicians work and their desire to have new and innovative products. Omnia is not a new or innovative product. It’s basically just a repackaging of an old product. — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-fec1c2d91fae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "55082d09-6b1a-4148-aa99-579774dd713f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3f82896-5f02-417d-9fd7-d01387c47190",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.433+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81fac205-e859-45ab-aa61-491b1495bf33",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 178,
      "type": "tension",
      "title": "Uses expert testimony to undermine the investment thesis of a turnaround.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 90,
        "componentCount": 10,
        "textChars": 2965,
        "nDataPoints": 1,
        "notes": "Uses expert testimony to undermine the investment thesis of a turnaround.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.462+00",
          "seconds": 3.742,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/178",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-178",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I would not invest in Nevro today.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-7f6833a6497e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.49
          },
          "kind": "list",
          "text": "The executive is skeptical of Nevro’s value and wouldn’t invest, and explained why the business model will never be profitable",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1986861c-1223-4e57-b709-50eb426f5679",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.85,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "list",
          "text": "The company’s market share remains stagnant at 15-17% and won’t grow given competitor’s structural advantages and scale",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "359b4bae-d3d7-460f-b12e-bf47d4e3fbab",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A third former executive was equally skeptical and described Nevro’s predicament as structural and not operational, doubted the possibility of any turnaround, and stated the business model is unfixable: “I would not invest in Nevro today.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fd17e1c8-b8ba-48a3-bfa5-28c2f845d602",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.85,
            "x": 0.09,
            "y": 0.56
          },
          "kind": "quote",
          "text": "I would not invest in Nevro today. The outlook is so unclear. I don’t know that I see the long-term value. It’s just a question of what’s the long term business model for a company in the SCS space - the heavy ongoing cost associated with support and retention of physicians and patients. You’ve got sales being made by experienced, very high-cost sales representatives, so that’s going to be your upfront cost and then, in order to retain physician business, their expectation is for continued support of their implanted patient, so you can’t ever disentangle yourself from the burden and that base only increases over time. A big reason the company is unprofitable is the cost of sales. You’ve got a high touch business where they’re having to follow up all the time and put in face time with their physicians and you’ve got the patients needing ongoing support and optimization. Once you factor all of that in, the profit margin is very slim.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "339719cf-7976-442b-b0af-39d91340499e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.31
          },
          "kind": "quote",
          "text": "If they’re tracking at 15-17% share right now, I think the question is, is there anything else that can significantly move the needle? And I don’t know that there is with the landscape of the SCS market being what it is. The other big companies, especially Boston and Abbott, have spent enormous time and resources on very strong KOL and relationship development and have very, very strong marketing and sales organizations and that’s going to be hard to crack.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aedf11ef-8f58-46fb-9060-5080c911ff5d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"If they're tracking at 15-17% share right now, I think the question is, is there anything else that can significantly move the needle? And I don't know that there is with the landscape of the SCS market being what it is. The other big companies, especially Boston and Abbott, have spent enormous time and resources on very strong KOL and relationship development and have very, very strong marketing and sales organizations and that's going to be hard to crack.\" — Former Nevro executive; \"I would not invest in Nevro today. The outlook is so unclear. I don't know that I see the long-term value. It's just a question of what's the long term business model for a company in the SCS space - the heavy ongoing cost associated with support and retention of physicians and patients... Once you factor all of that in, the profit margin is very slim.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-826c84509c72",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce711100-a802-46b2-9c03-111b310ba2c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2e0ae99-5d22-4b1f-bdc3-92ebfdbf023b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "807cd017-d398-4060-8b2d-025f7dee55f3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ed9d1f82-6c48-4519-862a-b28f1e3c7c63",
          "evidence": "Uses former executive quotes to validate the bearish thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:06.462+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 178,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 179,
      "type": "tension",
      "title": "The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2481,
        "nDataPoints": 0,
        "notes": "The slide uses expert testimony to undermine the credibility of the CEO and the company's growth prospects.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:06.798+00",
          "seconds": 3.717,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/179",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-179",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "I know for a fact, on the inside, Grossman has said he's scratching his head over why the stock has done what it's done.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-9529faa7c91d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "list",
          "text": "Grossman doesn’t understand the SCS market and his previous Thoratec experience is irrelevant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "04411af3-0ea6-49f6-a081-0fd16be1a1bc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.68
          },
          "kind": "list",
          "text": "Grossman may be skeptical of the sharp rise in Nevro’s stock, with the >2x overvaluation making it difficult to sell the company",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7b2f2fd-8f5c-4518-8e82-c0b1ef845d5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.25
          },
          "kind": "list",
          "text": "Nevro’s market share is not changing and company’s future is questionable",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fa8a6c9a-7499-4156-8c21-39e9865a51a6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A longtime C-level executive in the spinal cord stimulation space offered extensive insights into Nevro’s plight. Much like Nevro’s ex-executives, he described Grossman’s “turnaround” as an ongoing failure and current staff as skeptical of “the substance” and confused by the stock.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "af5cbfcd-e49c-42af-b3df-2214dd40ee61",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.1,
            "y": 0.47
          },
          "kind": "quote",
          "text": "I study a leader's history, and I want to know what adversity they've dealt with. Did they pull a company out of the hole against all odds? Grossman's product sold itself at Thoratec. I don't think he has an appreciation for what motivates the spinal cord stimulator customer. When I say customer, I mean the physician, the patient, the nurse, the payer, and the administrator. There are five different customers in this space, and you have to products and services for all five, and if you don't, you are going to not be differentiated.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0fe0a2fd-82d9-40f2-beaa-df5ce6ccf3c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.3
          },
          "kind": "quote",
          "text": "I question what their future looks like because if they don't have a strategic initiative that is going to gain them market share, it's going to be just hand-to-hand combat in the spinal cord stimulation space. I don't see the market share shifting a lot.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6252cf73-b5c8-4e67-959c-ea448abc42c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.1,
            "y": 0.75
          },
          "kind": "quote",
          "text": "I know for a fact, on the inside, Grossman has said he's scratching his head over why the stock has done what it's done. Grossman may have bitten off more than he can chew because at a much lower stock price, let's say at $70, he'd have an easier time selling this thing.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc276ed6-0142-4e88-b14b-0c217d577acc",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I question what their future looks like because if they don't have a strategic initiative that is going to gain them market share, it's going to be just hand-to-hand combat in the spinal cord stimulation space. I don't see the market share shifting a lot.\" — Longtime SCS executive; \"I don't think he has an appreciation for what motivates the spinal cord stimulator customer.\" — Longtime SCS executive; \"I know for a fact, on the inside, Grossman has said he's scratching his head over why the stock has done what it's done.\" — Longtime SCS executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b345-9a04a94861f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1c4f7cc0-7f59-406d-9e5f-447225e1365a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fceba6c-fc17-4fbd-af83-e95d85eb875e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:06.798+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e329472d-6b22-4afb-9da0-5603a8125cf3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 180,
      "type": "tension",
      "title": "Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 75,
        "componentCount": 8,
        "textChars": 2435,
        "nDataPoints": 0,
        "notes": "Uses expert consultation quotes to undermine the credibility of the CEO's turnaround narrative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:07.377+00",
          "seconds": 4.086,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/180",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-180",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Internally at Nevro, I don't think they see the substance, based on what I've been told, and they're scratching their heads and saying, \"Hey, whatever. I'll take it. I hope the stock keeps going.\" There aren't fundamentals behind it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-c4c4263c0b61",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "He added that Nevro’s staff are equally mystified by the stock and underwhelmed at the supposed turnaround, and that Grossman’s various excuses – the former CEO, COVID, a declining market – will soon run out and expose his lack of performance.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a7e89b47-e54e-46d0-b543-b7be8a2108c2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.33
          },
          "kind": "quote",
          "text": "A bunch of the guys that are [titles redacted] at Nevro used to work for me... Internally at Nevro, I don't think they see the substance... There aren't fundamentals behind it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a78ae4c-fd34-44ac-9824-09ebc6c1e2d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.85,
            "x": 0.09,
            "y": 0.61
          },
          "kind": "quote",
          "text": "On his first two quarterly calls he basically said, 'I'm too new to give you numbers... His timing is pretty damn good because I know the people on the street at Nevro who are selling product... It's that they were losing market share.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "43a9d8e4-2e95-47fa-83c5-5fd7ab9dce38",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"A bunch of the guys that are [titles redacted] at Nevro used to work for me. I hired them into the neuromodulation space. Grossman's chief commercial officer doesn't know this space. I don't know that she understands the war that she's in for [...] Internally at Nevro, I don't think they see the substance, based on what I've been told, and they're scratching their heads and saying, \"Hey, whatever. I'll take it. I hope the stock keeps going.\" There aren't fundamentals behind it.\" — Longtime SCS executive; \"On his first two quarterly calls he basically said, 'I'm too new to give you numbers. I'm not going to commit to anything.' I've said all along; eventually, this guy is going to have to perform. His timing [in getting a pass from COVID] is pretty damn good because I know the people on the street at Nevro who are selling product, and I know the roadblocks they're up against. They haven't out-performed from a revenue standpoint. They've been given a 24-month pass. Rami was the scapegoat, and then it was, \"Okay, let's give Grossman a year to get his feet under him,\" and now it's COVID. So, when does Nevro actually have to perform in Wall Street's eyes? They were the first company to say that that SCS market was shrinking and that just wasn't true. It's that they were losing market share, and they didn't know how to explain it away.\" — Longtime SCS executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-c857630b6932",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a59b9e92-7aaa-43cc-a982-7541b7e32d4d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f50a57fd-4d6c-4c6d-bec6-c3e4ac3f3b2b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28d49159-07aa-4657-a491-ff83da708238",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "fff6fdc9-4284-4cd6-a697-57f6304ff4d1",
          "evidence": "Frames the CEO as the antagonist whose excuses are running out.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:07.377+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 180,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 181,
      "type": "tension",
      "title": "The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 68,
        "componentCount": 7,
        "textChars": 2511,
        "nDataPoints": 0,
        "notes": "The slide uses a direct quote from a 'Longtime C-level executive' to undermine investor confidence in the CEO.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:07.211+00",
          "seconds": 3.424,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/181",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-181",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The longtime SCS executive stated his belief that Grossman “doesn’t have a strategy” beyond initially wanting to “flip it in six months,” did little diligence before taking the CEO role, and is in now in over his head.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-2a0cd46751b3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The longtime SCS executive stated his belief that Grossman “doesn't have a strategy” beyond initially wanting to “flip it in six months,” did little diligence before taking the CEO role, and is in now in over his head. He stated this is “why I don't own a penny of Nevro.” We view his opinion as credible given his relationships with Nevro's staff.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d486af43-3a56-4dee-a338-e912152ab88b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.29
          },
          "kind": "quote",
          "text": "“Grossman doesn't have a strategy. This is what concerns me. This is why I don't own a penny of Nevro. Keith Grossman may have wanted to flip it in six months. If you do not know the neuromodulation space and you're listening to the Board tell you that Rami [prior CEO] screwed this up. You think, I've talked to Kasra Amirdelfan [implanter who is the #1 recipient of Nevro payments*] and David Caraway, their Chief Medical Officer, these guys are high on it. I can come in here and look like a rock star and just not be an [redacted] like Rami, and I can flip this thing in no time because I know the investment community because of my history. I would bet that that's about the due diligence that Keith Grossman did, and he was sold hook, line, and sinker. Now he's going to have to roll up his sleeves and say, ‘What do I do with this thing?’” –Longtime C-level executive in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7388947c-a940-4ef1-a4fd-43fba6bbcec3",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Grossman doesn’t have a strategy. This is what concerns me. This is why I don’t own a penny of Nevro. Keith Grossman may have wanted to flip it in six months. If you do not know the neuromodulation space and you’re listening to the Board tell you that Rami [prior CEO] screwed this up. You think, I’ve talked to Kasra Amirdelfan [implanter who is the #1 recipient of Nevro payments*] and David Caraway, their Chief Medical Officer, these guys are high on it. I can come in here and look like a rock star and just not be an [redacted] like Rami, and I can flip this thing in no time because I know the investment community because of my history. I would bet that that’s about the due diligence that Keith Grossman did, and he was sold hook, line, and sinker. Now he’s going to have to roll up his sleeves and say, ‘What do I do with this thing?’” — Longtime C-level executive in the space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-2cc80e543f45",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef249ac1-b99b-4020-ad6e-ca48b3ae66df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "12. Investors betting on a Keith Grossman-driven turnaround will shortly face a rude awakening",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6028f417-2edd-402a-89a7-ea6f61c39168",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "604fc9f9-ca49-41af-9990-c709bbb6e356",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "47ec7f2e-9184-44f1-8af1-5afaedba795a",
          "evidence": "Uses expert testimony to validate the thesis",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:07.211+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 181,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 182,
      "type": "setup",
      "title": "The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.",
      "function": "preempt_rebuttal",
      "rawType": "preempt_rebuttal",
      "block": null,
      "metadata": {
        "slideType": "preempt_rebuttal",
        "slideTypeCanon": {
          "name": "Preempt rebuttal",
          "slug": "preempt_rebuttal",
          "status": "active",
          "canonId": "019de52d-1225-7368-af32-6381fddabdb3",
          "version": 1,
          "description": null
        },
        "function": "preempt_rebuttal",
        "functionCanon": {
          "name": "Preempt rebuttal",
          "slug": "preempt_rebuttal",
          "status": "active",
          "canonId": "019de52d-18ab-7479-9a7e-820a2f03586a",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 8,
        "textChars": 3679,
        "nDataPoints": 2,
        "notes": "The slide uses a testimonial to debunk the 'take-out' thesis, framing the company as a 'one-trick pony' in a 'price war'.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:13.243+00",
          "seconds": 9.266,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/182",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-182",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro is now boxed \"into a corner\" and will \"die of a thousand cuts.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-ee1ca1181c40",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A substantial part of Nevro’s stock rise has been fueled by investor hopes of a take-out, with the sell-side sainting Grossman as a quick-flip magician. We asked longtime executives in the space for their opinions of potential acquirers, and contrast investor fantasy with realism from a former Nevro executive who bluntly dismissed the company’s appeal to potential buyers. We note his dismissive opinion of Stryker, speculated upon as the most logical savior, even at a $2B valuation (~$58/share or 1/3 the current stock price). He stated that Nevro’s value as a “one-trick pony” is now diminished because it’s a “commodity business” in a “price war”; that any acquirers would rather buy new, smaller stimulator entrants; that J&J was a major investor in Nevro yet never bought them; and that large acquirers with an interest in the stimulator space, such as Medtronic and Abbott, are instead paying “absolute pennies on the dollar” for emerging, inexpensive stimulator companies. He added that Nevro is now boxed “into a corner” and will “die of a thousand cuts.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bfd3fabc-fe86-44c9-a800-d5760104a196",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.5
          },
          "kind": "quote",
          "text": "Stryker is fantastic at buying really inexpensive crummy companies, so for them to think about buying a $2, $3, or $4 billion dollar company like Nevro, I don’t see it. I just don’t. I don’t think it’s in the culture. I don’t think it’s who they are. When Nevro stock was down in the $30’s and low $40’s, that would have been a great m&a target but now it’s an incredibly expensive platform. If another technology comes up and beats them, it’s really not worth much. All the other stim companies are scaling bigger and they have more options for doctors. Nevro is still pretty much a one-trick pony. They’re going to cut costs to shore up the bleeding, so they’re not going to pay reps $350,000. They’re going to pay $185,000 and you’ll see low-quality reps.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "511cabce-508d-46d0-902a-ee6e648c8fba",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "If this is going to be a price war, it’s going to be a commodity business. Medtronic just did an acquisition of Stimgenics for pennies. Absolute pennies on the dollar. Medtronic can buy anything they want, yet they chose to buy one of the low-cost new stimulator companies out there, because the clinical data looks good. Abbott bought DRG for pennies on the dollar and they’ve never made money off of it. So when you look at the dollars that it would take to acquire Nevro, who would it be? J&J was one of the original investors in Nevro and they never bought it. So I don’t see a Stryker acquisition for sure. And you’ve got a bunch of other companies that are trying to figure out how to get in the space, so I personally don’t see it. Nevro has boxed themselves into a corner and now they’ll die of a thousand cuts.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d663dba6-5625-4b87-b549-39b9af0bdcd4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Stryker is fantastic at buying really inexpensive crummy companies, so for them to think about buying a $2, $3, or $4 billion dollar company like Nevro, I don't see it. I just don't. I don't think it's in the culture. I don't think it's who they are. When Nevro stock was down in the $30's and low $40's, that would have been a great m&a target but now it's an incredibly expensive platform. If another technology comes up and beats them, it's really not worth much. All the other stim companies are scaling bigger and they have more options for doctors. Nevro is still pretty much a one-trick pony. They're going to have to cut costs to shore up the bleeding, so they're not going to pay reps $350,000. They're going to pay $185,000 and you'll see low-quality reps.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-f3a5044b83b7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d064cc5b-7a12-4e77-9c93-831f96114303",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "13. Investor hopes of a Nevro acquisition are delusional and misinformed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f83c3c7e-49c7-4103-9f55-efbcd919f575",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.243+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7fe6f8a4-af73-4e49-ab55-bf06458b8998",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 183,
      "type": "tension",
      "title": "Uses expert testimony to debunk market optimism regarding M&A.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 8,
        "textChars": 2177,
        "nDataPoints": 3,
        "notes": "Uses expert testimony to debunk market optimism regarding M&A.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:07.275+00",
          "seconds": 3.269,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/183",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-183",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The former executive provided a particularly damning data point that illustrates the depth of investor misunderstanding of Nevro’s m&a potential.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-5e78b892f3dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "The former executive provided a particularly damning data point that illustrates the depth of investor misunderstanding of Nevro’s m&a potential. Nevro disrupted the stimulator space when it launched in 2015 and took 15% of the market...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e1170952-6fc9-4139-b33a-44e7bd083e1b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "When you look at M&A, you have too many emerging spinal cord stimulation technologies out there. You’ve got Nalu that’s coming out. That came out of Stanford. You’ve got companies like Saluda. They’ve been trying to shop that thing for the last 18 months and they have no buyers and the reason is, how are you going to come in and compete when price erosion is happening all around you? – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5f4e3906-73b0-4b41-bc6e-4f0bc9016b18",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "quote",
          "text": "If Saluda could have sold for a couple hundred million bucks, they would have sold it. John Parker has said publicly that he wants a billion dollars for the company. Nobody’s going to spend a billion dollars for that company. Nobody. Nobody. Like $800 million is nuts. Had he positioned it at $500 to $700 million, it probably would have been sold, but John Parker is out of his mind.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8141a8d7-eeea-405b-8b8b-247031858291",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“When you look at M&A, you have too many emerging spinal cord stimulation technologies out there. You’ve got Nalu that’s coming out. That came out of Stanford. You’ve got companies like Saluda. They’ve been trying to shop that thing for the last 18 months and they have no buyers and the reason is, how are you going to come in and compete when price erosion is happening all around you?” — Former Nevro executive; “If Saluda could have sold for a couple hundred million bucks, they would have sold it. John Parker has said publicly that he wants a billion dollars for the company. Nobody’s going to spend a billion dollars for that company. Nobody. Nobody. Like $800 million is nuts. Had he positioned it at $500 to $700 million, it probably would have been sold, but John Parker is out of his mind.” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-634c2bce10f9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5e7eeaab-4246-4721-970e-c998f1ea7419",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.6,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "13. Investor hopes of a Nevro acquisition are delusional and misinformed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a0e788b-78bd-4402-ae74-2f70a1315158",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02c8b44c-a45f-4717-9009-65737fac00f5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "7649df24-a1c2-4a28-b3ea-29129629e797",
          "evidence": "Frames Saluda and other competitors as the 'next disruptor' and 'catastrophe' for Nevro.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:07.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 183,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 184,
      "type": "setup",
      "title": "The slide uses expert testimony to debunk the bull case of a potential acquisition.",
      "function": "preempt_rebuttal",
      "rawType": "preempt_rebuttal",
      "block": null,
      "metadata": {
        "slideType": "preempt_rebuttal",
        "slideTypeCanon": {
          "name": "Preempt rebuttal",
          "slug": "preempt_rebuttal",
          "status": "active",
          "canonId": "019de52d-1225-7368-af32-6381fddabdb3",
          "version": 1,
          "description": null
        },
        "function": "preempt_rebuttal",
        "functionCanon": {
          "name": "Preempt rebuttal",
          "slug": "preempt_rebuttal",
          "status": "active",
          "canonId": "019de52d-18ab-7479-9a7e-820a2f03586a",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 2777,
        "nDataPoints": 0,
        "notes": "The slide uses expert testimony to debunk the bull case of a potential acquisition.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:08.127+00",
          "seconds": 4.093,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/184",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-184",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "At these multiples, I can't see anybody digesting a business that isn't diversified.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-8cd5f59e81cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A longtime C-level executive in the spinal cord stimulator space provided an equally devastating assessment of Nevro’s m&a prospects. He echoed that Nevro is a one-trick company that companies like Stryker or J&J would have no interest in, and corroborated that the space “is becoming increasingly competitive” with a “line of” new entrants “behind Saluda” that are also looking to get bought. He added that Biotronik, a leading European medical device company – privately held with an estimated 9,000 employees – is also shortly entering the stimulator space but is building in-house versus acquiring.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ebac6f16-4df3-4b59-a423-e5911f09958f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.9,
            "x": 0.05,
            "y": 0.38
          },
          "kind": "quote",
          "text": "“At these multiples, I can’t see anybody digesting a business that isn’t diversified. With St. Jude, I understood the Abbott acquisition because all of your eggs aren’t in one basket, and they were a proven entity. But with Nevro, I don’t know that a Stryker or a J&J is going to want to bite off that much. I can’t see Stryker making an acquisition in the SCS space. I really can’t see it. If Boston Scientific wanted to spin off their neuromodulation business, I think their product portfolio is better than Nevro’s. But I can’t see it.” – Longtime C-level executive in the spinal cord stimulation space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "233e2aa2-83cf-45c3-b5b0-7854497033a0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "quote",
          "text": "“The market is becoming increasingly competitive. There are a line of people behind Saluda. Nalu Medical is probably next. All of these companies just want to get bought and I just don’t know that it’s going to happen with Nevro.” – Longtime C-level executive in the spinal cord stimulation space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cefb2b50-3afb-474f-b490-ebb183bd10d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "“Biotronik has a keen interest in the SCS space, but I don’t think they’re going to buy into it. I think they’re going to develop their own product. They’ve hired a chief technology officer to make sure that their product is shored up before they hire a commercialization expert. Biotronik is going to be, in my opinion, a competitor in that space in the next 24 months.” – Longtime C-level executive in the spinal cord stimulation space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e9dbc950-95d0-4eb0-a2ed-47d5f8d6ffad",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"At these multiples, I can't see anybody digesting a business that isn't diversified. With St. Jude, I understood the Abbott acquisition because all of your eggs aren't in one basket, and they were a proven entity. But with Nevro, I don't know that a Stryker or a J&J is going to want to bite off that much. I can't see Stryker making an acquisition in the SCS space. I really can't see it. If Boston Scientific wanted to spin off their neuromodulation business, I think their product portfolio is better than Nevro's. But I can't see it.\" — Longtime C-level executive in the spinal cord stimulation space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-924f695d0b3e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02e5b509-e46a-44dc-a941-1c1419942627",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "13. Investor hopes of a Nevro acquisition are delusional and misinformed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "eea7abc4-5954-4b87-919f-652d16204424",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ab96185d-1d69-4929-a289-db41c4b896cb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6bc6143c-e335-4747-935a-0f138abaed57",
          "evidence": "Uses expert C-level testimony to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:08.127+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 184,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 185,
      "type": "tension",
      "title": "The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3092,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from industry experts to undermine the investment thesis of Nevro, specifically targeting the idea of a potential acquisition.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:09.35+00",
          "seconds": 4.651,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/185",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-185",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "They can crush Nevro at a systems level if they want to. The big buys can crush them in hospitals.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-76555cfe6e5b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Not surprisingly, whenever we asked former Nevro executives and even KOL’s who still use the company’s device whether they would invest in the company, they said no. One KOL called it “like a pump in the dump [sic].” Another high volume implanter said he was thinking of shorting it. Others wondered whether the company could survive the “wave of new stimulator” entrants, stated the market is “over-saturated”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a3b4981-caea-4f78-a2a6-4603f1fe7c08",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.9,
            "x": 0.06,
            "y": 0.51
          },
          "kind": "quote",
          "text": "“I don’t see a whole lot of innovation. They’re stuck with one product which makes them very vulnerable unlike other companies. I’m a bit wary. I’m not sure they can survive the wave of new stimulator companies. A number are coming into the field. Spinal cord stimulation seems over-saturated. And a lot of doctors are not enthused about Nevro. That critical mass will turn the ride. They’ve plateaued. They won’t grow their market further. The competition is key to understand. There are ways to get around their patents.” – High volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f9f2f0a-501e-4ad6-aa35-70a353f1bf8f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "quote",
          "text": "“I wouldn’t invest in Nevro. I did at IPO. I was thinking of shorting Nevro. Their competitive advantage got eaten away as everyone caught up. You can never discount what Medtronic comes up with. They were forgotten about yet they were the first stimulator company. They’re the biggest device company in the world. Their pipeline across the board will have hits. There’s a reason they’re so well entrenched. Medtronic and Abbot can contract out stimulators with a broader product portfolio. They can bundle. They can crush Nevro at a systems level if they want to. The big buys can crush them in hospitals.” – KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "265a2d56-cec1-4c81-a652-73929a8214ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "quote",
          "text": "“My broker was really pushing Nevro stock because [prominent underwriting bank] was pushing them. They’re the ones that brought Nevro public and they were saying how great it was doing. I knew the opposite as a high volume implanter. But the bank was still pushing it. I don’t know if they didn’t know or they didn’t care, but I thought Nevro is like a pump in the dump [sic].” – KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42c29173-b308-4f68-9092-f8dceef140a5",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I wouldn't invest in Nevro. I did at IPO. I was thinking of shorting Nevro. Their competitive advantage got eaten away as everyone caught up... They can crush Nevro at a systems level if they want to. The big buys can crush them in hospitals.\" — KOL and high volume implanter; \"I don't see a whole lot of innovation. They're stuck with one product which makes them very vulnerable unlike other companies... Spinal cord stimulation seems over-saturated.\" — High volume Nevro implanter; \"My broker was really pushing Nevro stock because [prominent underwriting bank] was pushing them... I knew the opposite as a high volume implanter. But the bank was still pushing it. I don't know if they didn't know or they didn't care, but I thought Nevro is like a pump in the dump [sic].\" — KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:43+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-7b842307d639",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "96d706a0-a520-45bf-9c83-5377ba602fdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "13. Investor hopes of a Nevro acquisition are delusional and misinformed",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "abe66f7d-c30e-4d24-8f44-ee279fcc324f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0d84ed18-6083-46cf-8021-65b88cee4066",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b650ee79-85ab-4bdf-8184-f11edb4da37e",
          "evidence": "The slide frames Nevro as the 'villain' or failing entity through expert testimonials.",
          "framework": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-05-02 20:16:09.35+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 185,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 186,
      "type": "tension",
      "title": "The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinica",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 67,
        "componentCount": 8,
        "textChars": 904,
        "nDataPoints": 2,
        "notes": "The slide uses a 'villain' framing by characterizing Nevro's technology as 'gimmicky' and 'one-size fits all' while highlighting a competitor's superior clinical outcomes.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "big_number",
          "callout_box",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:08.389+00",
          "seconds": 2.874,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/186",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-186",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Saluda’s approach – personalize stimulation not only by patient but second by second – is the polar opposite of and a frontal challenge to Nevro’s entire reason for existence: a gimmicky one-size fits all approach based on a fixed 10kHz frequency.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-19fb5d916de3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.45,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "chart",
          "text": "89.1% at 12 months; 89.5% at 24 months",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Donut chart",
              "slug": "donut",
              "status": "active",
              "canonId": "019de52d-0006-752c-9528-0fef476b8004",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "donut",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "621487a2-1568-4d1a-853a-6bab480eb816",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.39,
            "x": 0.55,
            "y": 0.53
          },
          "kind": "list",
          "text": "Saluda's AVALON study: Sustained Long-Term Outcomes... Conclusion: The 12-mo results from the Avalon study show the highest degree of pain relief recorded for an SCS system to date.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1182b1bb-02ef-47a3-a413-a5e2a390927f",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "pain relief rate: 89.5%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-23338c0086b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9df805c2-e781-4b2d-9bbf-b60e3fd836f7",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Conclusion The 12-mo results from the Avalon study show the highest degree of pain relief recorded for an SCS system to date. — Avalon Study",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-1d842347dbae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://www.saludamedical.com; https://academic.oup.com/neurosurgery/article/87/4/E485/5727863; *per Crunchbase",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c23caac9-18d4-4a7c-8e1f-662223e918dd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c14af553-84a8-4340-b4b0-a83afe218384",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6eb97021-625f-4aa2-87c7-ee43a0a83983",
          "evidence": "Frames Nevro as a failing incumbent with a 'gimmicky' product facing a superior competitor.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:08.389+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 186,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 187,
      "type": "tension",
      "title": "Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 8,
        "textChars": 1929,
        "nDataPoints": 10,
        "notes": "Uses OpenPayments data to link Nevro's top paid KOLs to the Saluda clinical trial authorship.",
        "elementsJson": [
          "paragraph",
          "bar_chart_horizontal",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:09.199+00",
          "seconds": 3.542,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/187",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-187",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-a5125eeb4bd3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.35,
            "x": 0.6,
            "y": 0.6
          },
          "kind": "chart",
          "text": "Top Entities Receiving General Payments in All Years",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Horizontal bar chart",
              "slug": "bar-horizontal",
              "status": "active",
              "canonId": "019de52c-fec4-7221-986b-1cb5f5e84b1f",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bar-horizontal",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "11ea0965-1bef-4125-b2ec-417fc1a5cb00",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "General Payments",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-ad5a62812f0d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda. One research interview after another – whether KOL’s or Nevro’s ex-executives – indicated that the SCS space is driven by product cycles based on the shiny new thing. Nevro was the last such launch, in 2015, and rapidly went from zero to ~15-17% share in the US. With Nevro’s high frequency fad having come and gone, KOL’s – especially Nevro’s highest volume implanters – are eagerly awaiting Saluda. Whether Saluda’s efficacy is as spectacular as the data suggest or not, our research indicates that mass trialing of their device is imminent, followed by a market share disaster for Nevro. If we assume that Nevro’s share today is 17%, that Saluda quickly reaches 15% as Nevro did, and that share loss is weighted by current market share, then Nevro stands to lose ~2.6% of its share - yet another headwind after basically no growth in 2 years. As an ominous sign that share loss will be far worse than this simple estimate, we note that the authors of Saluda’s US study – published in 2020 – are the lead investigator for Nevro’s pivotal SENZA trial as well many of its highest volume implanters, including *all 3* of its highest compensated KOL’s per OpenPayments.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2661cb7e-4a87-413b-94a1-1d85dff96823",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.4,
            "x": 0.05,
            "y": 0.78
          },
          "kind": "quote",
          "text": "These objective measurements, collected in a double-blind randomised controlled trial, provide a level of evidence that is unmatched in this field.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "45e3450f-f7e4-4ad9-9202-3f3e2633f7ed",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "These objective measurements, collected in a double-blind randomised controlled trial, provide a level of evidence that is unmatched in this field. — Evoke Study Group (Lancet)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-a93d1cf8c4e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://pubmed.ncbi.nlm.nih.gov/31870766/; https://openpaymentsdata.cms.gov/company/100000136428",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e5bcc09f-32a0-4660-8963-c179c3f1ef15",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6534f4e2-c572-4770-a558-93132a8ebb94",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "0b37a4d0-bc2d-46e1-b20a-99ca41e31e18",
          "evidence": "Linking financial payments to clinical trial authorship to suggest bias.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:09.199+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 187,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 188,
      "type": "tension",
      "title": "The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 92,
        "componentCount": 10,
        "textChars": 3809,
        "nDataPoints": 4,
        "notes": "The slide uses expert quotes to build a narrative of competitive vulnerability for Nevro.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:09.761+00",
          "seconds": 4.089,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/188",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-188",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A senior executive in the space indicated that Saluda will launch shortly and take 3 to 5 points of Nevro's current 15-17% share – or ~18-33% of their revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-9782d1c54ccb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "list",
          "text": "A Nevro ex-executive states their customer base is the type that will switch to Saluda and that the impact “is going to be significant.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c14c1c2-b300-40e2-b8fc-46036a232e08",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "A senior executive in the space indicated that Saluda will launch shortly and take 3 to 5 points of Nevro’s current 15-17% share – or ~18-33% of their revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e32ab37b-9740-4657-a9c6-f6dc2a61478a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "market share: 18-33%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-9c42d335cbce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda Interviews with KOL’s, Nevro ex-executives and sales reps, and competitors indicate tremendous enthusiasm and anticipation for Saluda’s device, with an impending disruption that one executive estimated could eradicate 18-33% of Nevro’s business. We highlight comments by a former Nevro executive that the company is the most vulnerable among SCS players, given that it attracted a fickle implanter base that quickly bounces to the next hot launch. The strength of comments broadly across our 35+ interviews suggests a looming and disastrous competitive scenario.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "50559d3f-2c96-486a-9c2b-0bb9266e8020",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.23,
            "w": 0.83,
            "x": 0.11,
            "y": 0.67
          },
          "kind": "quote",
          "text": "The dynamic that's going to happen next is Saluda’s launch. I know things have been delayed for Saluda because of COVID. They wanted to initiate their commercialization now, but it's going to be a little while. They are going to gain an adoption rate, I think, similar to what Nevro did in their first 36 months, and people are going to want to try it. The reason is their key relationships in the physician community. I don't really view Nevro as the new kid on the block anymore. They've been around long enough for physicians to say, \"The results are bad and I'm going to explant this product.\" It's been through a life cycle. They have the share that they have and they're trying to compete with hand-to-hand combat. I see them losing three to five points of share, which is a lot.\" - Senior executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80fdc9ce-9525-439d-ae21-a22a67f11c84",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.83,
            "x": 0.11,
            "y": 0.44
          },
          "kind": "quote",
          "text": "Nevro’s customers want to try Saluda. They are the early adopters that like all the new technology. Nevro is being put in a box. New technology affects them more than anybody. The impact that Saluda has on Nevro is going to be significant, because their customers are the ones who say “Hey, I need something different. Saluda is going to recruit some good commercial leaders and now all of a sudden, Nevro is not the new technology anymore.” - Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c4909c39-106f-4469-a919-bc3d26664a42",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Nevro's customers want to try Saluda. They are the early adopters that like all the new technology. Nevro is being put in a box. New technology affects them more than anybody. The impact that Saluda has on Nevro is going to be significant, because their customers are the ones who say 'Hey, I need something different. Saluda is going to recruit some good commercial leaders and now all of a sudden, Nevro is not the new technology anymore.\" — Former Nevro executive; \"The dynamic that's going to happen next is Saluda's launch. I know things have been delayed for Saluda because of COVID. They wanted to initiate their commercialization now, but it's going to be a little while. They are going to gain an adoption rate, I think, similar to what Nevro did in their first 36 months, and people are going to want to try it. The reason is their key relationships in the physician community. I don't really view Nevro as the new kid on the block anymore. They've been around long enough for physicians to say, 'The results are bad and I'm going to explant this product.' It's been through a life cycle. They have the share that they have and they're trying to compete with hand-to-hand combat. I see them losing three to five points of share, which is a lot.\" — Senior executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-9a1ffb278cdd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fecef53b-adc2-4fcf-8a45-3086c119322f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.761+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4efbc459-6ac2-468f-87ef-260ad0886bb1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 189,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 9,
        "textChars": 2174,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key negative sentiment regarding Nevro's customer loyalty and future market position.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:13.174+00",
          "seconds": 7.051,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/189",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-189",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-f6e68a80bab1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda Interviews with competitors – at the executive, territory manager, and sales rep level – indicated that they expect Saluda to take “a lot of share.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f693fa6c-8004-41f6-ae54-2c202c35185b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.76
          },
          "kind": "quote",
          "text": "When Saluda comes into play, I think the market is going to shift and take a look at them.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "195e419c-724a-49ac-bcc3-fe780fd5ae71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "Saluda will absolutely take share. It’s totally different than anything out there. Doctors will absolutely want to go to it. It’ll be like having a Nevro launch all over again. They’ll take a lot of share.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "844f2def-d89a-4461-a0f9-39a10ea42b6f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "quote",
          "text": "I think Saluda will have an impact. I think there will be a splash.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "92b6bc05-6ea8-48cf-968f-8ce9d0a96ed1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "Omnia is a bump for a couple of quarters. Once Saluda is launched... you’re going to see the early Omnia doctors leave Nevro to try Saluda... Nevro’s customer base are people that are fickle.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db0c5b2e-1a85-4a20-9770-db7f09d403c0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Omnia is a bump for a couple of quarters. Once Saluda is launched, whenever that may be in 6 to 12 months,, you're going to see the early Omnia doctors leave Nevro to try Saluda. So, I think if anyone gets impacted by Saluda, it's going to be Nevro more than any of the other three big players. Nevro when it first came out got the early adopter types of doctors, and Saluda will make an impact with those doctors that try new technologies within the first 6-12 months. Correct, I'm saying that Nevro's customer base are people that are fickle. — Former Nevro district sales manager, now playing similar role at a key competitor; Saluda will absolutely take share. It's totally different than anything out there. Doctors will absolutely want to go to it. It'll be like having a Nevro launch all over again. They'll take a lot of share. It's a novel approach to pain. — Medtronic territory manager for a key multi-state region; I think Saluda will have an impact. I think there will be a splash. — Medtronic territory manager for one of their largest regions; When Saluda comes into play, I think the market is going to shift and take a look at them. — Longtime C-level executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b346-f83f29343f8e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d83e05d-da65-4a49-9c46-3ce1acb50873",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1f425bf-d4d9-46d2-8a5e-cd51b6992224",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e13818c2-e5e1-4452-807a-9e3793d01ada",
          "evidence": "Citing industry experts and competitors to validate the thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:13.174+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 189,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 190,
      "type": "tension",
      "title": "The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2652,
        "nDataPoints": 0,
        "notes": "The slide uses a 'villain critique' style by highlighting the defection of key opinion leaders (KOLs) from the subject company to a competitor.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:11.678+00",
          "seconds": 5.356,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/190",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-190",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "In a space driven by the trendy new device, the color suggests that Saluda is the \"new Nevro\" while Nevro is yesterday's fad.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-0e30dbb51590",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "list",
          "text": "A high volume implanter who uses some Nevro stated that Saluda has “the best data ever” and that it “beats Nevro’s data” while another called it “really cool.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "500e2336-5e69-438e-b96f-cc86be64d55c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.51
          },
          "kind": "list",
          "text": "One of Nevro’s highest volume implanters and speakers states he and his colleagues are “enthusiastically waiting” and that it “looks very exciting.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a3730c10-49a2-4806-baa8-11d03de63b78",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "list",
          "text": "A Saluda investigator, previously one of Nevro’s highest volume implanters, said he’s “never seen anything” as good as Saluda",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fc433f78-6b42-4b6b-bb9d-18a2d71dc911",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda Doctor excitement about Saluda reinforces the severity of the threat described by Nevro’s ex-executives and competitors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec7723c5-0338-43f6-b761-da1ed9ef0ca1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.83,
            "x": 0.11,
            "y": 0.72
          },
          "kind": "quote",
          "text": "“No one waveform is perfect for a patient. That’s what Saluda is trying to do. It’s very cool. It’s the best tonic device out there. It’s the best tonic data ever. Their data beats Nevro’s data. I hope Medtronic or someone buys them because it would give them a competitive advantage.” – High volume implanter and Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c64060e-d4e5-439c-adaa-0abc2a17b623",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.83,
            "x": 0.11,
            "y": 0.83
          },
          "kind": "quote",
          "text": "“Saluda is really cool. The device has an opportunity to be very efficient. I’m optimistic about it.” – High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "732f5905-edbe-4d79-8c2f-a746a6ab50a9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.57
          },
          "kind": "quote",
          "text": "“I guess we’re enthusiastically waiting for Saluda to come out and to see if that’s a game changer. Saluda overall looks very exciting and it makes sense.” – KOL and Nevro speaker",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b8f94417-ddf0-43fe-a309-b77c3ce0d337",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.41
          },
          "kind": "quote",
          "text": "“I was on Saluda’s trial and it’s published so the data is all out there. It was very good, like really good. I’d never seen anything like it. And these were normal patients. Real patients, not cherry-picked.” – KOL and previously a high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1ee230b-cff4-48f9-b090-ea82162c0e1a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I was on Saluda’s trial and it’s published so the data is all out there. It was very good, like really good. I’d never seen anything like it. And these were normal patients. Real patients, not cherry-picked.\" — KOL and previously a high volume Nevro implanter; \"I guess we’re enthusiastically waiting for Saluda to come out and to see if that’s a game changer. Saluda overall looks very exciting and it makes sense.\" — KOL and Nevro speaker; \"No one waveform is perfect for a patient. That’s what Saluda is trying to do. It’s very cool. It’s the best tonic device out there. It’s the best tonic data ever. Their data beats Nevro’s data. I hope Medtronic or someone buys them because it would give them a competitive advantage.\" — High volume implanter and Nevro user; \"Saluda is really cool. The device has an opportunity to be very efficient. I’m optimistic about it.\" — High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-123447971499",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0aeff59f-bbf8-4b25-a571-02816b9e7a59",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.678+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c8bd9d35-ddbb-4934-95cb-a98d24fb8eb1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 191,
      "type": "tension",
      "title": "The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 69,
        "componentCount": 7,
        "textChars": 1760,
        "nDataPoints": 1,
        "notes": "The slide uses quotes from industry experts to allege unethical behavior and kickbacks in the neuromodulation market.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:09.834+00",
          "seconds": 3.388,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/191",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-191",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "There are doctors in the landscape with a lot of influence who are completely corrupt who are on board with Saluda. And they will corrupt people with Saluda. They own stock and options in Saluda and have consulting contracts. Saluda is everywhere.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-60557ca42f0f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "paragraph",
          "text": "14. Unknown to most investors, Nevro faces an impending, disruptive competitive threat within 6 to 12 months: Saluda Industry executives and KOL’s stated that Saluda has locked up the most influential implanters...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.834+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1367b25f-8aac-4fff-906f-6ddb524eb078",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "quote",
          "text": "There are doctors in the landscape with a lot of influence who are completely corrupt who are on board with Saluda. And they will corrupt people with Saluda. They own stock and options in Saluda and have consulting contracts. Saluda is everywhere.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.834+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "df9d58fc-cfd1-46be-9034-3971a59b929a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.6
          },
          "kind": "quote",
          "text": "[Saluda executive] is as sharp as can be. [Name redacted] embraces the relationship that he has with [KOL name redacted]... He's the ex-president of [society name redacted]... He'll be a key reason Saluda takes share. because most of the market is doctors who are sheep.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.834+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe9c0106-2b2c-4a1c-9023-cd035dade8e2",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“There are doctors in the landscape with a lot of influence who are completely corrupt who are on board with Saluda. And they will corrupt people with Saluda. They own stock and options in Saluda and have consulting contracts. Saluda is everywhere.” — High volume KOL and Nevro implanter; “He's the ex-president of [society name redacted]. He's very well-published. He's also very feared by the physician community because if he wants you to succeed, he asks you to publish in a paper. If he doesn't want you to succeed, he ignores you. The physician community knows that. He'll be a key reason Saluda takes share. because most of the market is doctors who are sheep.” — Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-64e45773c60e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.834+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ab2d7eee-418c-4aef-b475-bd4ac7a064de",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:09.834+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "741861ca-6cae-4f62-8911-aef462f6d88f",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [
        {
          "tool": {
            "name": "Villain slide",
            "slug": "villain-slide",
            "status": "active",
            "bestFor": "In activist decks where the personality matters",
            "canonId": "019dd9e1-518c-7404-976a-5be5a517b659",
            "version": 1,
            "bodyDocId": null,
            "description": "A dedicated slide presenting the named villain visually",
            "familyLabel": null,
            "categoryName": null,
            "categorySlug": null
          },
          "agent": null,
          "layer": "slide",
          "agents": null,
          "matchId": "e849d845-778f-44fa-ada3-88e5c6a4ceb3",
          "evidence": "The slide features several quotes and testimonials that portray a negative view of Saluda and its influence on medical professionals, indicating a villain critique.",
          "pageRefs": null,
          "priority": null,
          "whenToUse": "In activist decks where the personality matters",
          "confidence": 0.9,
          "extraction": {
            "at": "2026-07-16 23:09:38.720273+00",
            "model": "or:meta-llama/llama-4-scout",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 191,
          "whyItWorks": "Makes the antagonist concrete",
          "antipattern": null,
          "cardinality": null,
          "narrativePurpose": null
        }
      ],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 192,
      "type": "tension",
      "title": "Includes a direct testimonial quote highlighted in yellow.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 8,
        "textChars": 3376,
        "nDataPoints": 1,
        "notes": "Includes a direct testimonial quote highlighted in yellow.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:15.712+00",
          "seconds": 8.848,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/192",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-192",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "we say it’s like a drug where you try it and then you’re hooked. Nevro began utilizing QP’s in Q2 2018 and by Q1 2019, within 3 quarters, they were completely hooked.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-79211e841bb0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "list",
          "text": "A former regional sales director described how Nevro became hooked on channel stuffing and discounting in 2018/2019, and described how it has now conditioned key accounts to expect annual price cuts. He stated he heard that channel stuffing still occurs but with “more scrutiny.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad872a5f-a7b4-4c59-b338-519f428f4d6f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A critical factor in Nevro’s sales growth collapse over the last two years is price discounting, a topic we have seen no sell-side or investor awareness of. Former Nevro executives, competitors, and KOL’s describe a “price war” as the major stimulator companies fight over a small group of price-sensitive ASC accounts that drive most of the industry’s volume. The pattern began as the previous CEO began using discounts in 2018 to stuff the channel as sales tanked, conditioning accounts to expect lower prices every year. Our interviews indicate the new CEO has also focused aggressively on price as a lever to drive volume, and that his actions kicked off a new round of industry discounting – “cutting off your nose to spite your face” according to a competitor. We first detail the magnitude of channel stuffing in recent years, which a former employees stated may still occur.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f1c2036e-8344-4d88-9560-2b7bccda6b47",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "“Nevro was categorically against what we called Quantity Purchases for the first 3 years the product was on the market. Then as they started to fall short and needed to meet quarterly numbers – we say it’s like a drug where you try it and then you’re hooked. Nevro began utilizing QP’s in Q2 2018 and by Q1 2019, within 3 quarters, they were completely hooked. Once you do one, you can’t hop off that ride. You’re now provided the account a new price point. You’re demonstrated you’ll sell at that price, and they’re shown willingness to buy at that volume. The company can’t say no because they know the volume they can move. As a director, I was the one negotiating those. I’d joke I’d write it as a one-time offer, every time I did it. For my region, on a quarterly basis, as much as 16-17% of my sales were driven by channel stuffing. I’ve heard it still takes place but more scrutiny of it.” – Former Nevro regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3fae6eb3-123d-4efd-b193-b7842cce937e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro was categorically against what we called Quantity Purchases for the first 3 years the product was on the market. Then as they started to fall short and needed to meet quarterly numbers – we say it’s like a drug where you try it and then you’re hooked. Nevro began utilizing QP’s in Q2 2018 and by Q1 2019, within 3 quarters, they were completely hooked. Once you do one, you can’t hop off that ride. You’ve now provided the account a new price point. You’re demonstrated you’ll sell at that price, and they’re shown willingness to buy at that volume. The company can’t say no because they know the volume they can move. As a director, I was the one negotiating those. I’d joke I’d write it as a one-time offer, every time I did it. For my region, on a quarterly basis, as much as 16-17% of my sales were driven by channel stuffing. I’ve heard it still takes place but more scrutiny of it.” — Former Nevro regional sales director",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-7e3ca887c439",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "da6a805c-fee2-4929-9b68-2d226946a622",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro’s collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d8b0fdb9-99d6-465b-8665-d1cfa6302435",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b6cbe23-e8e9-401e-bbfd-b68f80ab9213",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "3470dd34-ee2f-49b6-87eb-639d4270dcd9",
          "evidence": "The slide frames the company's pricing strategy as a 'drug' and 'collapse' mechanism, positioning the company's actions as the villain.",
          "framework": null,
          "confidence": 0.7,
          "extraction": {
            "at": "2026-05-02 20:16:15.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 192,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 193,
      "type": "tension",
      "title": "Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 12,
        "textChars": 2538,
        "nDataPoints": 3,
        "notes": "Uses quotes from industry participants to validate the thesis of unsustainable pricing pressure.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:10.859+00",
          "seconds": 3.965,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/193",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-193",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro started price reductions in the space after Grossman came in. Nevro drastically lowered pricing to get as much share as possible in 2019. It’s cutting your nose off to spite your face.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-45e0b876777b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.75,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "list",
          "text": "KOL’s confirmed the discounting dynamic which a former Nevro rep described as a price war",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "88f49933-c980-4a22-9053-a44c8a4b1d1f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.24
          },
          "kind": "list",
          "text": "A Medtronic territory manager, who runs one of their largest multi-state regions, stated that Nevro’s pricing was too high for ASC’s and that the company “drastically lowered pricing” in 2019 under the new CEO. A second territory manager reported price cuts under Grossman as well.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b380358f-3e8f-4757-bb33-af70aaa5ea4b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Competitor interviews suggest that the new CEO has “drastically” cut pricing in an attempt to gain market share, and that with Omnia pricing still too high, further discounts are occurring. KOL’s confirmed seeing price reductions. A former Nevro rep described a recent 20% price cut by Medtronic and then being undercut by Abbott – providing field-level color into the current price war in stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "171f4d55-8136-455c-977b-61bca1948f10",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.66
          },
          "kind": "quote",
          "text": "“Medtronic cut prices 20% last week in my territory. Abbot undercuts everyone on price and gave away the generators. There are different ways to get share.” – Former Nevro sales rep",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "045ca49c-55a4-4f65-b90a-1281a5be1a68",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“They’ve consistently kept their pricing relatively higher than most. But under their new leadership, they seem to be falling more in line with local contracts... Omnia it high to the point where some facilities have said, we’re not approving it.” – Second Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a4c420f-0003-4413-953d-2ee098d40dee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.59
          },
          "kind": "quote",
          "text": "“Nevro has cut prices. I’m not getting pushback on prices from my facility like I was. They started discounting.” – High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3ec11cc0-0c9b-4d8b-8e38-340f3aa2d30d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.83,
            "x": 0.11,
            "y": 0.32
          },
          "kind": "quote",
          "text": "“The market will be flat... Nevro started price reductions in the space after Grossman came in. Nevro drastically lowered pricing to get as much share as possible in 2019. It’s cutting your nose off to spite your face.” – Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d69307f3-077f-46b3-8bac-b6f2df75ebdf",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“The market will be flat. It should have been flat last year. There are just a lot of players in the market and pricing is eroding in the space. ASC’s couldn’t use Nevro because they kept the price really high. Grossman said screw that. We want as much market share as possible. Nevro started price reductions in the space after Grossman came in. Nevro drastically lowered pricing to get as much share as possible in 2019. It’s cutting your nose off to spite your face. Cutting prices will lower reimbursements over time.” — Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-4b0f7e99e2cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.75
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "33ff6c6b-f794-4e32-bb92-bd9c8ba80c89",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro’s collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d7f2edf-45b6-4d3e-9570-ef18384c70e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.859+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80f5ab57-ddd7-44ef-87cb-9d04a7eda6ec",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 194,
      "type": "tension",
      "title": "The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 11,
        "textChars": 1840,
        "nDataPoints": 4,
        "notes": "The slide uses expert testimony to contradict potential growth narratives, specifically highlighting a $5,000 price erosion per device.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:10.577+00",
          "seconds": 3.655,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/194",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-194",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "discounting is part of Nevro's approach now",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-29e920b91da1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.05,
            "y": 0.21
          },
          "kind": "list",
          "text": "The ex-executive stated that while Omnia is a flop and Grossman is over-rated. Nevro's biggest issue is that they've begun heavily discounting their stimulators and that it's a price war with Medtronic. Abbott, and Boston Scientific",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ea15e7e-9d23-4e91-b0d3-cd9128d7abd2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "list",
          "text": "The ex-executive indicated that stimulator prices dropped a stunning $5,000, or roughly -20%, and that \"discounting is part of Nevro's approach now\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a03bedb0-61e5-432a-8d37-fd4a9cb97b30",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "price erosion: -20%",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-30b8c22cf3fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A former Nevro executive corroborated the price war. He offered extensive insights into Nevro's pricing predicament and how it dooms any \"turnaround.\" He stated that \"discounting is part of Nevro's approach now.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c9d33af-cd60-4408-8bcd-5f01a453a45c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.08,
            "y": 0.28
          },
          "kind": "quote",
          "text": "\"I think it's highly over-valued... Omnia is an overpriced product... they never got any kind of pop on Omnia... it's a price war.\" - Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27bc6758-9bf4-44f1-aedb-f6b9ae36b34e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.85,
            "x": 0.08,
            "y": 0.47
          },
          "kind": "quote",
          "text": "\"A great question that you should always ask every physician... what are you paying for a battery this year over last year? And you see erosion in price... about $5k in price erosion annually... discounting is part of Nevro's approach now.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e4d383d-1e4a-4584-b83b-47f4bb73dd74",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I think it’s highly over-valued. And I would say, not only the stock but the company, Omnia, and also Grossman....an outsider looks at what he’s trying to do and says, wow that’s pretty impressive. However, Omnia is an overpriced product and I don’t see it saving the day. And the reason they’re not growing is that they never got an impact from Omnia. What really caught them was that they discounted their pricing heavily on their other product line, so they never got any kind of pop on Omnia. Abbott and their other key competitors are also not doing well, and so, it’s a price war. — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:44+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-2c6c541f8d60",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0eb8a09-8b29-4484-bc78-2601e1a31d3d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro's collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2c4d01ff-44fb-44b3-abd0-a55edd984a29",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3b835fb3-a15d-4a58-aa85-10dd088250d1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b1876c41-6d2b-461d-a49f-55c8ae5dc01e",
          "evidence": "Uses former executive quotes to directly contradict company growth claims.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:10.577+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 194,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 195,
      "type": "tension",
      "title": "Uses expert testimony to frame the company's pricing strategy as a terminal failure.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 2902,
        "nDataPoints": 4,
        "notes": "Uses expert testimony to frame the company's pricing strategy as a terminal failure.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:11.091+00",
          "seconds": 4.143,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/195",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-195",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "With 25% of the physicians driving 70% of the revenue, you see massive price erosion, so although Omnia might be their flagship, what percentage of sales is coming from it?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-ba61b3eb8c58",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.57
          },
          "kind": "list",
          "text": "He implied that Nevro has no way out and that ASC’s will crush pricing post-Covid",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "325ce3f8-3095-4526-896d-d572a7d4f326",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "He stated that price declines are about to accelerate, worsening the already “massive price erosion,” as ASC’s seek discounts to compensate for the impact from the pandemic. He added that a small percentage of high-volume physicians drive most of the volume and use their leverage to extract discounts.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c55533fa-4622-41e8-a744-ea0949e20c30",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "He stated that “the massive price erosion” is about to worsen as Covid-hit surgery centers seek to make up lost revenue by demanding even deeper discounts. He painted a grim picture of dependence on a small number of high-volume, price-seeking ASC’s with little loyalty, and large competitors slashing pricing to offer “deals.” He stated he’s “pessimistic” about the company’s future and can’t see how “Nevro really wins this.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "730554df-352d-4ace-959f-17b5a078a16f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.85,
            "x": 0.09,
            "y": 0.37
          },
          "kind": "quote",
          "text": "“As a perfect example. Dr. [redacted] does 240 cases a year. Nevro used to price him in the high to upper $20-thousands. He’s now is buying the same product in the upper teens. That’s a huge erosion of price and that’s where the market is. This year, I think it’s going to come down even more because so many of these ASC’s have been kind of done. With 25% of the physicians driving 70% of the revenue, you see massive price erosion, so although Omnia might be their flagship, what percentage of sales is coming from it? 5%? 10% Those are the questions, as an investor I would ask.” - Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f5ad22c-7678-43f8-a557-c58960b0c68c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.85,
            "x": 0.09,
            "y": 0.62
          },
          "kind": "quote",
          "text": "“The reason I’m pessimistic is, how does Nevro really win this? They don’t have any new technologies. They only have one real platform, and Omnia doesn’t really attract new customers. They have their existing customer base, which is in real trouble with Covid. When you look at the next 18 months, the high-usage implanters, who are where the value is, are going to be looking for deals. Medtronic, Boston Scientific, and Abbott give out those deals— a $5,000 discount on a stimulator is an immense amount of money if you’re doing 75-100 stims a year. So I think there’s going to be some real pricing pressure coming out of Covid. For sure. These guys that own ASC’have payrolls that are a couple of hundred thousand dollars for every couple of weeks because some of them have 20-30 nurses on board. The real importance after Covid s going to be on pricing. The loyalties go away almost immediately.” - Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e66004c6-6522-4825-93cc-34217275c3d1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The reason I’m pessimistic is, how does Nevro really win this? They don’t have any new technologies. They only have one real platform, and Omnia doesn’t really attract new customers.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-bef7d58c679c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dda49ac6-37e3-4630-b40b-44e7b6d5253b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro’s collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "52fe12fb-b8e4-46b3-8d3b-38a685a7072e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "255a837e-fc9f-4247-a0c8-ae0c3dd16f10",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f69457da-7713-4fea-b79e-492621c02f6d",
          "evidence": "Uses former executive testimony to validate claims",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:11.091+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 195,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 196,
      "type": "tension",
      "title": "Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 90,
        "componentCount": 10,
        "textChars": 2504,
        "nDataPoints": 3,
        "notes": "Uses expert testimony to frame the company's business model as structurally flawed due to customer leverage.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:11.045+00",
          "seconds": 3.85,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/196",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-196",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The ex-executive pointed to several factors that make it impossible to reverse price declines.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-d1de695f8391",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "list",
          "text": "He stated that Nevro’s dependence on ASC’s, which drive >70% of the company’s sales, drives price sensitivity as the discounts go straight to the doctors who owns the surgery centers.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "32ba3f11-55bf-47a8-b8d7-7f597370015a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.58
          },
          "kind": "list",
          "text": "The “whale customers” are ones that own their ASC’s, and given the small number of such accounts, stimulator companies fight over them by lowering prices.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e89c7258-14de-496f-9fcd-17ee894f55a2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "The ex-executive pointed to several factors that make it impossible to reverse price declines. First, the vast majority of Nevro’s revenue comes from ASC’s, which are personally owned by doctors who are therefore extremely price-sensitive.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee46853c-8ea4-4f43-be95-e20aef45518f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.09,
            "y": 0.66
          },
          "kind": "quote",
          "text": "And it’s a price war because none of the companies have created great customers... Every stimulator company is trying to fight over a couple of hundred customers a year that are up for play and they want a lower price.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "05223c17-cf1f-4a89-a087-3a2e055437f3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.86,
            "x": 0.09,
            "y": 0.38
          },
          "kind": "quote",
          "text": "The percentage of the business that comes from ASC’s is certainly over 70% on a national basis. The reason they’re so price-sensitive is that the physicians have ownership in that ASC or they own it outright... I pick up the extra $500,000.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1450f2e3-db70-45d0-b88e-a2824ffec970",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The percentage of the business that comes from ASC's is certainly over 70% on a national basis. The reason they're so price-sensitive is that the physicians have ownership in that ASC or they own it outright, so they're getting two fees. They're getting the facility fee. They get the physician fee and the equipment fee. As an example, if I can really knock you down on price, where I was paying $25,000 per stimulator before and now I'm paying $20,000 and I do a hundred cases a year, I pick up the extra $500,000. Then if I get reimbursed at $38,000, now I'm making $18,000 back on.\" — Nevro ex-executive; \"And it's a price war because none of the companies have created great customers. Those big whale customers that own their own ASC are making money off of the generator. Let's say as an example, Omnia is $5,000 more and you do a hundred cases a year. Are you really going to say it's a $500,000 better product than something else? Of course not. That money goes directly to the ASC owner who is the physician that does the cases. Every stimulator company is trying to fight over a couple of hundred customers a year that are up for play and they want a lower price.\" — Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-d6159120287a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee9b90a3-1029-4dc7-a0d7-b085a8fe5f89",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro’s collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bae5f999-bd8a-4bc8-a930-a07292d56ef7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "585aeef0-bf4b-4238-845e-3a7a603d54f5",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "d626d2d2-b8c9-41ec-8c21-3e6af58ebefb",
          "evidence": "Uses expert testimony to highlight the structural conflict between physician-owned ASCs and Nevro's pricing power.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:11.045+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 196,
          "frameworkName": "expose_contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 197,
      "type": "tension",
      "title": "The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 3087,
        "nDataPoints": 4,
        "notes": "The slide uses highlighted quotes from an ex-executive to frame the company's pricing strategy as a 'stupid move' that destroyed value.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:43.763+00",
          "seconds": 9.74,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/197",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-197",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The ex-executive described the price conditioning as ruinous: “a stupid move”; “one of the dumbest moves you could ever make.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-b4e66fe2a3db",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "list",
          "text": "Nevro then jumped off the cliff and now has an “ongoing problem” of a downward price spiral.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8a903491-df66-40b3-9716-32c9e1d51ab3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.32
          },
          "kind": "list",
          "text": "Until 2018/2019, Nevro never engaged in channel stuffing – “bulk orders” – given its dependence on an extremely small number of large accounts and the risk of destroying its ASP.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9e4a3a46-9d02-48d4-a896-24276bad4a80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Second, the former executive stated that Nevro has an “ongoing problem” kicked off by channel stuffing in 2018/2019, which has conditioned accounts to expect ongoing concessions and led to a price-cutting spiral. Our research suggests the new CEO has reinforced the behavior by doubled-down on discounts. The ex-executive described the price conditioning as ruinous: “a stupid move”; “one of the dumbest moves you could ever make.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e277c755-18c1-4a23-86da-2a3dc2847b51",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.83,
            "x": 0.11,
            "y": 0.39
          },
          "kind": "quote",
          "text": "“We would never allow bulk orders, ever, under any circumstance, given the sensitivity of the pricing. The one thing that I really want you to take away from this conversation are the high-volume implanters. That’s really the nuts and bolts of the spinal cord stimulation business. For example, the highest volume doctor in Wisconsin is [name redacted] and he does over 200 stims a year. The closest guy next to him probably does 30. You can put a similar state-by-state tapestry together. These high-volume stim users own their ASC’s. I can say, “I’m closing out the quarter and my average sale price to you is $27,000, but if you order 25 for next quarter, I’ll knock it down to $22,000-$23,000.” Rami was trying to save his job. And everybody looks like they win off for one or two quarters. But the problem is that now you eroded your ASP and you’re not making it up with new customers, and your existing customers are at capacity at 100 stim’s a year.” – Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "449ed698-7e9f-41e8-9526-cea5e3290dc6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.83,
            "x": 0.11,
            "y": 0.76
          },
          "kind": "quote",
          "text": "“The ongoing problem that Nevro has is that once doctors start paying $2,3,4 thousand dollars less per device they say “Well, I don’t want to go back to the high price” and of course an Abbott will match that price because it’s new business for them. It was a stupid move. Fundamentally, it was one of the dumbest moves you could ever make. The reps were dumb enough to go along with it and ultimately, all it does is it drives pricing down.” – Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6f37f8de-d6a2-40c7-ad86-b39f7c734883",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“We would never allow bulk orders, ever, under any circumstance, given the sensitivity of the pricing... I’m closing out the quarter and my average sale price to you is $27,000, but if you order 25 for next quarter, I’ll knock it down to $22,000-$23,000.” — Nevro ex-executive; “The ongoing problem that Nevro has is that once doctors start paying $2,3,4 thousand dollars less per device they say ‘Well, I don’t want to go back to the high price’ and of course an Abbott will match that price because it’s new business for them. It was a stupid move. Fundamentally, it was one of the dumbest moves you could ever make.” — Nevro ex-executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:45+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b347-b999d0067148",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "477a2034-ca8c-4ca9-8283-7d22629155b3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "15. Pricing pressure and discounting are a key driver of Nevro’s collapse and doom any return to growth",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "289cdd71-6994-4368-b9fb-ee91346227bb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e32b3a09-6610-4420-8d8c-30f066609956",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "eb123428-7f62-4cb7-a723-2a6f2693b4f6",
          "evidence": "The slide frames the company's management and pricing strategy as the 'villain' causing its own collapse.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 21:26:43.763+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 197,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 198,
      "type": "tension",
      "title": "The slide uses a 'villain critique' approach by framing the company's growth story as 'false' and 'misguided' while citing external regulatory bodies to validat",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 9,
        "textChars": 2312,
        "nDataPoints": 8,
        "notes": "The slide uses a 'villain critique' approach by framing the company's growth story as 'false' and 'misguided' while citing external regulatory bodies to validate the bearish thesis.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "footnote"
        ],
        "confidence": 0.95,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:11.769+00",
          "seconds": 4.211,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/198",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-198",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Washington state terminated coverage after a lengthy 2018 evidence review by 11 clinicians, slamming stimulators as unsafe with sky-high complication rates of 42-60%, and concluding that they fail to provide pain relief or reduce the need for pain medication like opioids.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-00272c073f6c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "The committee agreed that safety was a significant factor: the number of trial reported complications ranged from 8 to 100%. Device related complication requiring revision ranged from 25% to 38% of patients in short term and 42% to 60% in up to 5 years (not including 54% of patients undergoing pulse generator replacements due to battery life).",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fe05011-3acd-484c-aa91-ef7119999ce1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.75
          },
          "kind": "list",
          "text": "Given the serious limitations of the studies, the committee agreed that, at best, weak evidence exists that SCS may provide temporary improvement of pain in some patients, but there is no evidence of mid or long term pain improvement.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56c346af-2c67-47fb-9e4e-472bf3ca89b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "The committee found that evidence overall on important patient outcomes was limited. For all outcomes, there is no evidence of longer term improvement, particularly important when there are significant risks (including 1/3 revision and high removal rate) and the device is intended for permanent implant.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91cadd93-c811-4918-aaed-dbf6851c3ab8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Interviews with KOL's, ex-employees, and competitors indicate that the reimbursement environment for spinal cord stimulators is becoming increasingly difficult as insurers crack down. Both government and commercial payors increasingly view stimulators as ineffective and lacking in evidence and high-quality studies; expensive with no ROI; and as driving additional costs given their widespread adverse effects. A key part of the Nevro bull case is based on misguided notions of market growth, which our research indicates faces substantial headwinds as reimbursement rapidly deteriorates. Washington state terminated coverage after a lengthy 2018 evidence review by 11 clinicians, slamming stimulators as unsafe with sky-high complication rates of 42-60%, and concluding that they fail to provide pain relief or reduce the need for pain medication like opioids.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cd7ecffb-c7ba-4214-a49f-c941f2186bec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://www.hca.wa.gov/assets/program/spinal-cord-stimulation-signal-update-20180807.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1a1acce6-4b58-4db8-99bc-392591db0692",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a308321e-d579-4ea4-a59d-a632324cb9fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84a9cf5c-8f62-4dca-99bc-50f280ea6763",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.45,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "title",
          "text": "Washington State Health Care Authority review - excerpts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Subtitle",
              "slug": "subtitle",
              "status": "active",
              "canonId": "019de52c-fb09-739d-900c-815b0d9ac526",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "subtitle",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e5449b37-854d-4122-bbd3-eeb15a53a323",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6aa6cf75-1927-443f-b4a4-2647b2d34bc6",
          "evidence": "The slide uses a strong, thesis-driven headline that summarizes the argument.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:16:11.769+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 198,
          "frameworkName": "action-titles"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 199,
      "type": "tension",
      "title": "The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2717,
        "nDataPoints": 0,
        "notes": "The slide uses a series of quotes and summaries from medical and state-level reviews to undermine the company's value proposition.",
        "elementsJson": [
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:12.253+00",
          "seconds": 4.589,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/199",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-199",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Thus, it remains unclear whether SCS provides meaningful long-term benefits to all patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-51b704d67e69",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "paragraph",
          "text": "Yale/Hopkins paper notes lack of patient benefit and low quality of SCS studies purporting efficacy",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7dd5379c-925e-4f32-8507-f05d81d7f79a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Our interviews indicate that other states such as California are following Washington’s lead. We note that CMS recently proposed a prior authorization requirement, indicating pressure at the national level as well. The findings in the WA study are echoed by numerous independent reviews, in particular the recent Public Citizen review of stimulators (p.31) and a 2018 Yale and Johns Hopkins paper that came to a similar conclusion, expressing “an additional major concern with the SCS efficacy studies”: “they tend to be industry funded with numerous financial conflicts of interest.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8b32e6db-3f1f-4664-95ae-c031643cd9d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "paragraph",
          "text": "Oregon state review of 6 years of SCS outcomes indicated little impact in reducing pain or opioid use, and found that half of patients needed revision surgery or device removal, within about a year",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93898e67-90a5-40d7-9ba4-db018dba37ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "paragraph",
          "text": "Study concluding that SCS fails to provide pain relief for workers comp patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98c54ca5-7c46-41cb-bbc4-fe40c5330f60",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.5
          },
          "kind": "quote",
          "text": "The spinal cord stimulator is considered a permanent device to reduce the injured worker's pain and decrease the utilization of pain medications. We are not seeing significant positive impact in either of these areas.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "285271d2-08c5-47ad-ad60-48309e8c5df2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.35
          },
          "kind": "quote",
          "text": "In sum, we found no evidence for greater effectiveness of SCS versus alternative treatments in this patient population after 6 months.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8f2f50a8-671b-410a-9af1-bf2ac0e0409a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "quote",
          "text": "It is important to note that efficacy studies often rely on patient-based outcome measures to quantify pain relief, such as the pain visual analog scale (VAS) and patient satisfaction. Such measures are subjective, and patients may report high satisfaction via placebo effects, clinician influences, or secondary gain reasons. The long-term effects and/or benefits of SCS for back pain are also unclear. Most trials had relatively short follow-ups of six to 12 months or even less, and only three trials had follow-ups of up to 24 months (Table 1). Indeed, one study has suggested that while pain relief can be observed after six months, these benefits from SCS dissipated after 12 months [48]. Thus, it remains unclear whether SCS provides meaningful long-term benefits to all patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93c52c89-f999-40dd-9c56-59612525f288",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "an additional major concern with the SCS efficacy studies: they tend to be industry funded with numerous financial conflicts of interest. — Yale and Johns Hopkins paper",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-5442288fea91",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.75,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: https://pubmed.ncbi.nlm.nih.gov/19875232/; https://wcd.oregon.gov/medical/mac/Documents/meetings/2016/7-8-16/SCS-data-from-SAIF.pdf;; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6153614/pdf/yjbm_91_3_323.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "23d5e637-61b1-4800-b77d-734c9a2d5b54",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9a3a957c-fa00-4e27-a694-e8486d9de8b6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:12.253+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "659dafdd-9281-4f38-a896-27915bb2cbdf",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 200,
      "type": "tension",
      "title": "Uses highlighted text to emphasize key negative sentiment from KOLs.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 13,
        "textChars": 2006,
        "nDataPoints": 0,
        "notes": "Uses highlighted text to emphasize key negative sentiment from KOLs.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:11.601+00",
          "seconds": 3.866,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/200",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-200",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "It is therefore no surprise that one KOL after another indicated that reimbursement is now \"the hardest it has ever been\" and that payors are escalating denials and making it \"impossible.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-7efe4deb2a37",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.8,
            "x": 0.05,
            "y": 0.56
          },
          "kind": "list",
          "text": "Insurers are balking at the high up-front cost of stimulators, making it \"impossible to get stimulators approved\" in many cases",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6a73d7be-19d8-441b-bfbf-bf6182ab00e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.05,
            "y": 0.34
          },
          "kind": "list",
          "text": "The reimbursement environment for stimulators is deteriorating and states are cracking down",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "767e3d7b-9699-4295-a405-fc0677b3ba32",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.05,
            "y": 0.2
          },
          "kind": "list",
          "text": "A KOL indicated that getting stimulators approved is now \"the hardest it has been\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3e10371-06b4-4c4b-b499-ce3c12692d46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "It is therefore no surprise that one KOL after another indicated that reimbursement is now \"the hardest it has ever been\" and that payors are escalating denials and making it \"impossible.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aee663f0-79fb-4fa8-8ee0-4d565513940f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.08,
            "y": 0.72
          },
          "kind": "quote",
          "text": "\"I'll explain why the average insurer doesn't pay. It takes 5 years to recoup the up-front cost of a stimulator...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1116b761-01d6-428a-8397-1f0420d6fd61",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.08,
            "y": 0.38
          },
          "kind": "quote",
          "text": "\"The reimbursement environment has gotten progressively worse. I mean authorizations. Insurance company guidelines are being very ridiculous...\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "419e1fbc-3e45-418f-9d58-0a457ae6e9ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.62
          },
          "kind": "quote",
          "text": "\"The reimbursement environment has gotten tougher over the years, definitely. Spinal cord stimulators are a hard-to-get item. They're a big upfront cost, so it's difficult. You have to fight based on diagnosis code and so on.\" –High volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ae52e3d-230a-44e9-acee-71b2d72289a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.08,
            "y": 0.24
          },
          "kind": "quote",
          "text": "\"Insurers are making it even harder. Getting approval for spinal cord stimulation is the hardest it has been. In some local code determinations, they're making doctors send the patient to a neurosurgeon who writes a letter stating the patient is not a candidate for spinal cord stimulation.\" – KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6b94aec-39f6-4f5a-a751-bb49a18ede62",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Insurers are making it even harder. Getting approval for spinal cord stimulation is the hardest it has been. In some local code determinations, they're making doctors send the patient to a neurosurgeon who writes a letter stating the patient is not a candidate for spinal cord stimulation.\" — KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-8179ad87e24e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "672a5687-6307-4a3c-83dc-b1a050cd474e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3327b57b-f440-407f-985a-8f4083a027ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:11.601+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ec0dca5a-1fbc-4f44-9946-3e100668b543",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 201,
      "type": "tension",
      "title": "Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 94,
        "componentCount": 12,
        "textChars": 3620,
        "nDataPoints": 2,
        "notes": "Uses direct quotes from 'high volume implanters' to build credibility for the bearish thesis.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:19.942+00",
          "seconds": 12.154,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/201",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-201",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's indicated that payor pressure has become so onerous that many doctors have stopped implanting stimulators altogether.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-e93cf5acb3e2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "Reimbursement hassles – such as 50% of stimulators being denied and needing appeals – are so severe that some doctors have stopped implanting stimulations",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5577e973-99a3-4d2f-b3bb-001619449b46",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "list",
          "text": "A high volume KOL indicated that reimbursement is \"getting worse year after year\" and bemoaned the amount of his time it sucks up",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "99cfc463-62f6-4bef-8b40-e3c5ed8d61e8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "list",
          "text": "A leading KOL stated reimbursement is \"horrible\" and \"it's financially not worth it,\" adding that he doesn't blame insurers for cracking down, given the abuse",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e43bae4a-1720-43ad-8705-4c3d2cf26807",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "KOL's indicated that payor pressure has become so onerous that many doctors have stopped implanting stimulators altogether. One stated that he sees 50% of implants denied. Another stated that implanting is now \"financially not worth it.\" A third, speaking of insurers, said there's so much abuse that \"I don't blame them. I really don't blame them.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "10037940-9326-4cbc-8a79-bca76df0d5a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.84,
            "x": 0.1,
            "y": 0.72
          },
          "kind": "quote",
          "text": "\"The reimbursement sucks. Insurer rejections are the bane of my existence. Every year I spend more and more time on peer and peers. As we do more expensive stuff like stim, the insurers are raising the ante. Yes, I'm spending more energy on it. It's getting worse year over year. It's an expensive technology. Reimbursement pressure has gradually increased and slowly trailed the proliferation of stimulators. Right around the time that Nevro appeared. The stim market grew and insurers pushed back. Blue Cross, any of the blues, are all bad. They're the worst.\" –KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0375c2a9-7c9e-4cf1-85c1-49acb96de7ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.84,
            "x": 0.1,
            "y": 0.32
          },
          "kind": "quote",
          "text": "\"I have one full time person who dots the i's and crosses the t's. They handle denials, then the appeals, then the independent medical review denies it again. Most doctors don't take the time and don't bother. Some have stopped implanting stimulators because it's such a pain in the ass. 50% are initially denied and I get 70% covered. It's a lot of hassle to go through.\" –KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15834bf5-ed54-411a-a43a-6c627a18954c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.84,
            "x": 0.1,
            "y": 0.52
          },
          "kind": "quote",
          "text": "\"Reimbursement is horrible. It's financially not worth it. There's not much money in it. There's not much at all. And the equipment now has to be bought by a surgery center and there's hardly any profit in that. There's just no profit anymore. They took it all away, which is fine, I don't blame them. I really don't blame them. People abuse it\". –KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dab5bae8-ad04-471f-9862-148b4ce1a589",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Some have stopped implanting stimulators because it's such a pain in the ass. 50% are initially denied and I get 70% covered. It's a lot of hassle to go through.\" — KOL, high volume implanter; \"Reimbursement is horrible. It's financially not worth it. There's not much money in it. There's not much at all. And the equipment now has to be bought by a surgery center and there's hardly any profit in that. There's just no profit anymore. They took it all away, which is fine, I don't blame them. I really don't blame them. People abuse it\" — KOL, high volume implanter; \"The reimbursement sucks. Insurer rejections are the bane of my existence. Every year I spend more and more time on peer and peers. As we do more expensive stuff like stim, the insurers are raising the ante. Yes, I'm spending more energy on it. It's getting worse year over year. It's an expensive technology. Reimbursement pressure has gradually increased and slowly trailed the proliferation of stimulators. Right around the time that Nevro appeared. The stim market grew and insurers pushed back. Blue Cross, any of the blues, are all bad. They're the worst.\" — KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-edf5b1a4c93b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.97
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fa3756ed-f097-49e3-a1ef-4652af4060ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4a61094-5db3-4a6f-bd28-afa23c425d7b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f534e37c-25ba-4a74-acad-4e5a73b7b101",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "acda4e4a-5978-4acc-90ce-36acbd53744f",
          "evidence": "Uses KOL quotes to validate the bearish thesis",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:19.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 201,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 202,
      "type": "tension",
      "title": "Uses direct quotes from high-volume implanters to contradict the market growth narrative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2445,
        "nDataPoints": 0,
        "notes": "Uses direct quotes from high-volume implanters to contradict the market growth narrative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:16.848+00",
          "seconds": 8.275,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/202",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-202",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Both the increasing rate of insurer denials and doctors therefore \"not wanting to do spinal cord stimulators as much\" were recurring themes of KOL interviews. Implanters indicated it's only a matter of time before reimbursement gets \"hammered again.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-0271d3a3825a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.22
          },
          "kind": "list",
          "text": "Insurers are putting up more “roadblocks” and “more hoops,” creating denials and delays that extend for months",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f73937c-d97f-4def-94be-de658e301887",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "list",
          "text": "Insurers are taking “a lot of shots” at stimulators and reimbursement will get “hammered again,” leading doctors to “kind of not wanting to do SCS as much.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd337736-3597-4552-b7bf-4946897e16dc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Both the increasing rate of insurer denials and doctors therefore “not wanting to do spinal cord stimulators as much” were recurring themes of KOL interviews. Implanters indicated it’s only a matter of time before reimbursement gets “hammered again.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aad43db9-4f3a-436e-8eee-2fffdcc76acb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.84,
            "x": 0.1,
            "y": 0.51
          },
          "kind": "quote",
          "text": "“Insurers have taken a lot of shots at spinal cord stimulation. In 2015 they tried to split up the coding. We’re just kicking the can down the road until the reimbursement gets hammered again. It’s just harder to get approved. Doctors are kind of not wanting to do spinal cord stimulation as much.” –KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59e99178-a230-4602-9cb8-78a9ceb8180e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.84,
            "x": 0.1,
            "y": 0.28
          },
          "kind": "quote",
          "text": "“The Aetna’s, United Health’s of the world have put up more roadblocks. They make docs call, justify it, deny it. The denials have gone up. Also the delays. I have a couple of doctors who took four months to get patients through a stim trial. The insurers kept delaying it for extra info. Reimbursement was piece of cake five years ago. Now it’s getting more difficult. There are more hoops.” – KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e187eec6-c4ac-4c62-a6c1-cd45359fddcf",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The Aetna's, United Health's of the world have put up more roadblocks. They make docs call, justify it, deny it. The denials have gone up. Also the delays. I have a couple of doctors who took four months to get patients through a stim trial. The insurers kept delaying it for extra info. Reimbursement was piece of cake five years ago. Now it's getting more difficult. There are more hoops.\" — KOL, high volume implanter; \"Insurers have taken a lot of shots at spinal cord stimulation. In 2015 they tried to split up the coding. We're just kicking the can down the road until the reimbursement gets hammered again. It's just harder to get approved. Doctors are kind of not wanting to do spinal cord stimulation as much.\" — KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-0774e69ae4b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f23c841a-401f-424e-8b5b-4d267bcee1a4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f4a6273-57d3-4cc7-9687-4fdcb126907e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.848+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "57dee4e9-6862-4a4d-a076-168f0a2dc810",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 203,
      "type": "tension",
      "title": "The slide uses a series of testimonials to undermine the company's growth narrative.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 87,
        "componentCount": 11,
        "textChars": 2479,
        "nDataPoints": 0,
        "notes": "The slide uses a series of testimonials to undermine the company's growth narrative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:17.2+00",
          "seconds": 8.386,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/203",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-203",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-6b40ef9e0f5f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "Former Nevro employees as well as key competitors like Medtronic corroborated the reimbursement pressure highlighted by KOL's: payors are getting smart and pushing back; denials accelerated in 2019/2020; and CMS is poised to cut reimbursement yet again.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ebd39f6-daf4-4637-8758-d01959ac7787",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.69
          },
          "kind": "quote",
          "text": "The payors say keep the prices down... The payors don't care about the bells and whistles. They care about low infection rates. They care about low explant rates... According to the MAUDE database, Nevro is actually pretty high in complications.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "24d45e5e-1c93-4456-85f9-fb6c68c9d516",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "quote",
          "text": "I agree with doctors who are saying the reimbursement environment is getting more difficult... The payers are getting more educated in this market and pushing back more... we've been noticing a lot more... people not getting through the insurance process.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5a118dbe-2e34-4c0b-bbb7-86418226d145",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "There are insurance companies now that are getting much more stringent with the way they approve these. One of the insurance companies hired a third party company to actually deny cases and they're getting a lot more strict...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a2bfa809-0232-4245-ab0b-e508d66cd4ae",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "quote",
          "text": "CMS is watching. They will cut reimbursement like they did with the stimulator leads.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc2e7d55-1141-4d9c-8be6-be2cf437612e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.59
          },
          "kind": "quote",
          "text": "There's huge amounts of pressure from a worker's comp perspective in California. The key doctor who worked on eliminating workers comp reimbursement in Washington is same person who is leading the charge within California.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d3cf753f-93b7-4382-b4bd-6245f168be35",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I agree with doctors who are saying the reimbursement environment is getting more difficult... The payers are getting more educated in this market and pushing back more... we've been noticing a lot more, I felt like this year, more than ever, people not getting through the insurance process.\" — Medtronic territory manager; \"There are insurance companies now that are getting much more stringent with the way they approve these...\" — Former Nevro territory manager, now at Abbott; \"CMS is watching. They will cut reimbursement like they did with the stimulator leads.\" — Medtronic territory manager; \"There's huge amounts of pressure from a worker's comp perspective in California...\" — Former Nevro executive; \"The payors say keep the prices down... The payors don't care about the bells and whistles. They care about low infection rates. They care about low explant rates...\" — Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-6e5d6488b76b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "69cc4b1b-0fee-481c-96e4-a6f8ecf4885b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3915b38-1316-46e3-bf40-7cdf581fb536",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e0dd2bfa-47e5-4923-ac0c-f4e3353a4b46",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "59cbc03b-3bd8-4f93-a78d-857f3d816e69",
          "evidence": "Uses expert testimonials to validate claims",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:17.2+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 203,
          "frameworkName": "authority-citation"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 204,
      "type": "tension",
      "title": "The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 3885,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from former employees to support the thesis of fraudulent market growth reporting.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:13.884+00",
          "seconds": 4.832,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/204",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-204",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A second Nevro ex-employee, who was involved in the market growth calculations the company represented to investors and the sell-side, basically admitted to us that it was a fraudulent exercise.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-a36efcd18a0d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Reimbursement pressure undermines the SCS market growth narrative that has been a key part of the bull case ever since Nevro went public in 2015. A former Nevro territory manager implied that the narrative was fabricated to get the stock up. A second Nevro ex-employee, who was involved in the market growth calculations the company represented to investors and the sell-side, basically admitted to us that it was a fraudulent exercise. We show the ex-employee's explanation below and note its incoherence and absurdity, in response to our bluntly asking if the company was fabricating a growth number for investors and Wall Street.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5d3c136a-9a5d-4f09-b191-399df0e3113b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.51
          },
          "kind": "paragraph",
          "text": "Question: Were data sources being cherry-picked to reinforce a narrative, a market growth number that the stock required, just to be blunt?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65125eba-5b99-437d-9981-27d209c1af1f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "Market analysts look at the spinal cord stimulation market as a bigger growing market than it actually is. I believe it has been inflated. In order to get a stock up, you need to show that a market is at a certain growth level. That's my belief. It's my solid, firm belief, and it's because I've been dealing with these same patients and doctors for 25 years. The market for the number of new implants is not growing as fast as what investors are being told. That's my belief.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "aaaef250-f160-436f-a411-b3647de961fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "quote",
          "text": "Umm...probably to a degree, right? I don't...you know... I think some of the data sources weren't always the full picture that they needed to be. I wouldn't say picking and choosing perhaps but there was, which I'm sure happens in all kinds of angles sort of leaning more heavily on data that maybe people thought supported a narrative and then, to some degree, sure. So, I think, again, it was a triangulation of different data sources, right? The payer data. I mean, I would say the payer data, Wall Street and analysts and other physician market research, and you know, I think...I don't know how would I characterize it. I think it was—I don't know. I think at a specific point that you were referring to, I think—I don't know. I think there were different times where different data sources were weighed more heavily and I think that weighing of different data sources was at times skewed.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5f886f9-a6ce-43b8-a6d8-e61052cc5aa6",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I believe it has been inflated. In order to get a stock up, you need to show that a market is at a certain growth level. That's my belief. It's my solid, firm belief, and it's because I've been dealing with these same patients and doctors for 25 years. The market for the number of new implants is not growing as fast as what investors are being told. That's my belief. — Former Nevro territory manager; Umm...probably to a degree, right? I don't...you know... I think some of the data sources weren't always the full picture that they needed to be. I wouldn't say picking and choosing perhaps but there was, which I'm sure happens in all kinds of angles sort of leaning more heavily on data that maybe people thought supported a narrative and then, to some degree, sure. So, I think, again, it was a triangulation of different data sources, right? The payer data. I mean, I would say the payer data, Wall Street and analysts and other physician market research, and you know, I think...I don't know how would I characterize it. I think it was—I don't know. I think at a specific point that you were referring to, I think—I don't know. I think there were different times where different data sources were weighed more heavily and I think that weighing of different data sources was at times skewed. — Former Nevro employee involved in calculating market growth figures",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-a5eab430c254",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3930fe40-f0a3-4eed-94c5-447a514d1d45",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2da90748-574c-4331-b231-dd56d6af49b0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "deb43a4a-c501-4ad7-95b9-da413709dd8a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "87267cde-ac51-44ec-9eaa-245a59b48a86",
          "evidence": "The slide explicitly frames the narrative as a 'fraudulent exercise' and uses expert testimony to expose the contradiction between public growth claims and internal reality.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:13.884+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 204,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 205,
      "type": "tension",
      "title": "The slide uses expert testimony to debunk the company's growth claims.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 91,
        "componentCount": 10,
        "textChars": 3562,
        "nDataPoints": 3,
        "notes": "The slide uses expert testimony to debunk the company's growth claims.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.083+00",
          "seconds": 4.486,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/205",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-205",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We queried KOL's and Nevro competitors on the normalized market growth rate excluding a pandemic. A Medtronic SCS product manager stated it's low single digits at best and cast those who claim it's higher as \"liars,\" adding that they simply make up neuromodulation growth rates for earnings calls.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-2ae7d6150c3c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We queried KOL's and Nevro competitors on the normalized market growth rate excluding a pandemic. A Medtronic SCS product manager stated it's low single digits at best and cast those who claim it's higher as \"liars,\" adding that they simply make up neuromodulation growth rates for earnings calls. KOL's and territory managers at Nevro's 3 key competitors indicated that market growth already hit a wall pre-Covid, due to reimbursement, cannibalization from a flood of smaller entrants, pricing pressure, and cannabis legalization.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a75ccc0e-6ca2-4ebf-b955-3a6fc50632ad",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.84
          },
          "kind": "quote",
          "text": "\"My December 2019 wasn't as busy as before. In December 2018 I was scrambling to fit in procedures. Last year there no scrambling. It was slower at the end of 2019.\" - KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80b7105d-b4bc-4546-a0b3-6ad95cbe3e8f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.76
          },
          "kind": "quote",
          "text": "\"Stimulator implant volumes have decreased. Boston Scientific has decreased. I speak to Medtronic and it's true for them as well. The Abbot rep doesn't complain quite as much in my area but said 2019 was down about 20% and other areas are down more.\" - KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "84149bf5-5f6c-41d3-9a51-ae762ad33916",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.32,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "\"The market will be flat. It should have been flat in 2019. There are just a lot of players in the market and pricing is eroding in the space. In my territory my numbers have dropped. We've come back fighting by lowering our pricing. My territory is back to $5.5mm, down from $7mm. Loyal docs are being slower than in previous years. It's partly the cannabis situation. Primary care doctors have gotten cannabis licenses. A lot of patients are on cannabis and doing fairly well without interventional procedures. We're seeing very loyal Medtronic doctors where their stim implants are down 30-40% after getting a cannabis license. I see market growth being flat. I don't see it growing. A lot of new players are cannibalizing everyone. The market's not like you hope it would be with four legacy players. The market has changed completely. What hurt Medtronic wasn't the larger players. It's the smaller companies earlier in the pain continuum. Smaller players are having an impact. Boston was smart to buy Vertiflex. Stim placement is an hour, and you can do four Vertiflex in an hour.\" - Medtronic territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6f1e217-2fa6-4e0c-8fd2-b386c653a81d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.3
          },
          "kind": "quote",
          "text": "\"We think the spinal cord stimulator market grows at 3-5%, I don't want to call people liars on these calls [who are saying it's high single digit or teens growth]. An honest number is 3-5%. I get emails from senior management saying we need a growth rate number for our earnings call. It's an echo chamber. You touch your finger to the wind. There's no database.\" - Medtronic product manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f8d1b21a-95cb-4760-88c8-60debcd680fe",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I get emails from senior management saying we need a growth rate number for our earnings call. It's an echo chamber. You touch your finger to the wind. There's no database.\" — Medtronic product manager; \"There are just a lot of players in the market and pricing is eroding in the space. In my territory my numbers have dropped. We've come back fighting by lowering our pricing.\" — Medtronic territory manager; \"Stimulator implant volumes have decreased. Boston Scientific has decreased. I speak to Medtronic and it's true for them as well.\" — KOL, high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-2f1aef833a5b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "64849cc6-367c-49f2-bcf1-a2947b18b972",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "91e7fe81-6775-4c4c-aa7f-b11ab553dd47",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.083+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "70f26578-da39-491b-a532-1a381695a9bb",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 206,
      "type": "tension",
      "title": "Includes a direct testimonial from a high-volume implanter to support the thesis.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 3328,
        "nDataPoints": 0,
        "notes": "Includes a direct testimonial from a high-volume implanter to support the thesis.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.78+00",
          "seconds": 4.904,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/206",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-206",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "As states crack down on opioids, the stimulator market gets hammered as well.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-18da8ae199ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.28,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We note a key, misunderstood dynamic regarding the market growth narrative pushed by Nevro and Wall Street. Nevro is portrayed as a beneficiary of the opioid crisis, with stimulators pitched as a savior. Over the past five years, the opioid crisis has been the primary explanation used to lend legitimacy to fabricated double-digit growth rates. Our research indicates that Nevro is in fact a beneficiary of the opioid epidemic, not because it’s a safer alternative, but because opioids are the “bait” – to quote a Nevro implanter - that drive stimulator volumes at the same sketchy pain clinics. As opioid users flooded clinics, doctors had more patients to push stimulators onto, by threatening to withhold monthly refills, among other pressure tactics. In states like Florida that have cracked down on pain doctors, stimulator volumes have collapsed. One of Nevro’s highest volume implanters, in Florida, explained how an opioid crackdown has led to his stimulator volumes dropping by half. As states crack down on opioids, the stimulator market gets hammered as well.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "74c2b39a-5592-4188-a511-a570fb645cf1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.69
          },
          "kind": "paragraph",
          "text": "The number of stimulator patients entering clinics declined in Florida. Unfortunately, there are a lot of bad actors and a lot of people on pain medication who shouldn’t have been and a lot of the patients that funneled into stimulators were those. There are doctors here in Florida, which I don’t consider part of my colleagues or community, but you see these things happening. Their bait is to offer everything, including the pain medication, so once the patients were engaged with these drugs, they would do whatever was financially appropriate, for themselves or for the practice, so those are the bad doctors, the bad actors.” – One of Nevro’s highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "85e87081-9b64-4a45-b0f7-7755ea1e3642",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "quote",
          "text": "“I’ve implanted a hundred stimulators in some years but last year it dropped to 50 or 60. The rules for pain clinics in opiate management in Florida changed. Although I had been a low-opiate prescriber, a large number of the patients that came into the practice were already on pain medication or looking to get started or continuing on them. I never wanted to dedicate myself to that or contribute to the opiate crisis. Regardless, I think that the end result of us being more stringent with patients that we allowed to enter the practice was a decrease in the overall numbers of stimulator implants. I want to be careful with what I say. The motivation for patients to come in to see the right doctor to manage their pain was sometimes the wrong motivation. They just wanted to continue their pain medications or the status quo. But within those huge number of patients, we could find the appropriate candidates for this type of therapy.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "851674f9-79d0-4c4c-8d35-24c7d0698d3c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“I’ve implanted a hundred stimulators in some years but last year it dropped to 50 or 60. The rules for pain clinics in opiate management in Florida changed... Regardless, I think that the end result of us being more stringent with patients that we allowed to enter the practice was a decrease in the overall numbers of stimulator implants.” — One of Nevro’s highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-1dcf05d3f7e2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee897503-faa6-4080-bd93-8fa8f7edf77c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "16. The SCS market growth story fueled by Wall Street is false and undermined by escalating payor backlash",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7c4d2bd9-6552-4196-8f67-8617b848fc79",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d94168dd-0a0d-4767-b174-e7d39b1d4edc",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "e7806ceb-f154-40d6-86ec-1531628f2303",
          "evidence": "Frames the company as a beneficiary of the opioid crisis and 'bad actors'.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:14.78+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 206,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 207,
      "type": "tension",
      "title": "The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 1491,
        "nDataPoints": 2,
        "notes": "The slide uses a direct quote and a news headline to substantiate the claim of unethical business practices.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.125+00",
          "seconds": 4.05,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/207",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-207",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-d289f7d88957",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.15,
            "x": 0.06,
            "y": 0.44
          },
          "kind": "image",
          "text": "SWI swissinfo.ch",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Logo",
              "slug": "logo",
              "status": "active",
              "canonId": "019de52c-fdaf-743d-94c4-d7c6a0e55302",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "logo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1e4626ce-7fd2-48d5-946a-31666269ce34",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.45,
            "x": 0.28,
            "y": 0.49
          },
          "kind": "paragraph",
          "text": "US company provided kickbacks to doctors in Switzerland",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "02bbbdd6-f922-4697-8433-14cbeef2992e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "KOL's and Nevro's former executives described the spinal cord stimulator space as driven by a small number of high volume implanters who will only use your device if you pay them to do so. Some used the word kickbacks to describe how companies like Nevro attract and retain their top accounts, while others described the same dynamic without directly labeling it as such. We begin with Nevro's practices in Europe, which we believe are more accurately described as simply bribery. An article by the Swiss Broadcasting Corporation in February 2020 alleged that Nevro paid doctors ~$10,000 per device implanted. Journalists obtained a 2019 Nevro contract and stated that \"the kickback scheme\" began in 2017.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4af0fa1d-6527-4d61-bc1d-3e9e3cc3e0a3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.78,
            "x": 0.06,
            "y": 0.7
          },
          "kind": "paragraph",
          "text": "According to a 2019 contract obtained by the German language paper, California-based Nevro, which specialises in the treatment of chronic pain in the trunk and limbs, offered Swiss doctors CHF10,000 ($10,181) for each Nevro spinal cord stimulator implanted in a patient.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5dd45511-bb1c-402b-9d4b-949d65a2da4d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "US company provided kickbacks to doctors in Switzerland — Swiss Broadcasting Corporation (via swissinfo.ch)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-d4ca6b1fc41d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.55,
            "x": 0.06,
            "y": 0.91
          },
          "kind": "source-note",
          "text": "Source: https://www.swissinfo.ch/eng/us-company-provided-kickbacks-to-doctors-in-switzerland/45562136",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f6ba1704-86ea-4b30-9e3e-773faafed03d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1b7bf312-e367-4771-a323-da089d97d2e5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4bc1ae6e-e9dc-4faf-a7e9-1d496bb01248",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "df968256-1d1f-4025-a5ef-46b1473405c8",
          "evidence": "The slide presents evidence of alleged bribery and kickbacks to support a short thesis.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:14.125+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 207,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 208,
      "type": "tension",
      "title": "Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 9,
        "textChars": 1792,
        "nDataPoints": 4,
        "notes": "Includes source links to a German-language publication (SonntagsBlick) and Google Translate versions.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.275+00",
          "seconds": 4.108,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/208",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-208",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The company rewards doctors with 10,000 francs per procedure",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-36c348ba219c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.59,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "image",
          "text": "Bonuses encourage more operations. The company rewards doctors with 10,000 francs per procedure",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9981cfc0-61be-4200-aec8-e30806d45d8e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We translated the source article in the German-language publication, using Google Translate. We interpret the article to imply that Nevro terminated the program \"with immediate effect\" when asked and did not dispute its existence. We note the translation below may be incorrect. If the scheme wasn't terminated until the paper asked about it in early 2020, that would imply that it continued under the current CEO for about a year.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4622a58a-f708-4bcf-9ea3-ad024a2f13d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.56,
            "x": 0.06,
            "y": 0.53
          },
          "kind": "paragraph",
          "text": "The industry is silent on this subject as if it were a state secret. But SonntagsBlick is now the contract that Nevro had signed for 2019 with Swiss doctors and clinics. For the first time, outsiders get a detailed insight into how the system works.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "653bd94b-352d-4aba-933c-391bd6db0b64",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.56,
            "x": 0.06,
            "y": 0.63
          },
          "kind": "paragraph",
          "text": "If a doctor brings implants for 400,000 francs to the public, he receives 80,000 francs in cash back. That's enough for a Patek Philippe watch. Those who put Nevro stimulators in the back of their patients for CHF 800,000 will be rewarded with CHF 160,000. With that you can already buy a Maserati - so it pays off for pain medicine specialists if they opt for the expensive procedure.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "754aee96-394e-40ef-8f03-75ee34164ca4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Bonuses encourage more operations — SonntagsBlick",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-39defb16850e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.9,
            "x": 0.06,
            "y": 0.85
          },
          "kind": "source-note",
          "text": "Source: Original https://www.blick.ch/schweiz/boni-verleiten-zu-mehr-operationen-firma-belohnt-aerzte-mit-10000-franken-pro-eingriff-id15750793.html; Google Translate version https://translate.google.com/translate?sl=auto&tl=en&u=https://www.blick.ch/schweiz/boni-verleiten-zu-mehr-operationen-firma-belohnt-aerzte-mit-10000-franken-pro-eingriff-id15750793.html; red ours for emphasis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "724352f5-a1ca-458e-ba3a-fad3abd3c989",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "81cc1ba3-828b-4666-890a-84c84904d4e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77b1bc00-61a5-442e-8b30-262dfb331fed",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "b7df404c-5ded-463c-862a-2096f72e6b09",
          "evidence": "The slide explicitly frames the company's business model as a kickback scheme.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:14.275+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 208,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 209,
      "type": "tension",
      "title": "The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 84,
        "componentCount": 10,
        "textChars": 2086,
        "nDataPoints": 0,
        "notes": "The slide uses external legal commentary to frame the company's business model as a 'textbook case' for potential FCPA violations.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:19.101+00",
          "seconds": 8.876,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/209",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-209",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "callout",
          "text": "“Medical device companies are particularly at risk with respect to FCPA violations. [...] More directly, practices that are common in the medical device industry, such as product discounts tied to purchase volume and incentive programs to encourage increased purchasing, may violate both the letter and the spirit of the FCPA.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2fd63406-1109-4643-8655-6ca56724187a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "callout",
          "text": "“In recent years, the medical device industry has been in the spotlight and subject to increased scrutiny by government regulators. The U.S. Department of Justice (DOJ) and Securities and Exchange Commission (SEC) have pursued several companies in the medical device industry for a number of Foreign Corrupt Practices Act (FCPA) violations, including kickbacks with foreign health departments, payments to consultants in hospitals, unjustified fees and using excessive means to influence healthcare professionals.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e76cbd3a-0112-4d23-afc2-2382ad7f3e82",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-a0f092cea778",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.35,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "paragraph",
          "text": "Emerging Risk Trends in the Medical Device Industry: Whistleblowing, Anti-Bribery, Corruption Law and Enforcement",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "19d90d66-3857-4a16-8f82-e381659d0311",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A review of enforcement actions brought against medical device companies under the Foreign Corrupt Practices Act leads us to believe that Nevro and its executives may be one internal whistleblower and/or inquisitive DOJ attorney away from a major FCPA problem.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e7824976-f943-4b69-bbc5-32028494d85d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Medical device companies are particularly at risk with respect to FCPA violations. [...] More directly, practices that are common in the medical device industry, such as product discounts tied to purchase volume and incentive programs to encourage increased purchasing, may violate both the letter and the spirit of the FCPA.” — MD+DI Online",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-a437d8d42f4f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.94
          },
          "kind": "source-note",
          "text": "Source: https://www.mddionline.com/news/foreign-corrupt-practices-act-high-risks-medical-device-industry; https://www.kroll.com/en/insights/publications/compliance-risk/emerging-risk-trends-in-the-medical-device-industry",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "119e8269-c10c-4904-baaa-a02c19ead1ee",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4c15abe9-9ade-4234-b4ef-aa42616d51d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.5,
            "x": 0.06,
            "y": 0.34
          },
          "kind": "title",
          "text": "Foreign Corrupt Practices Act: High Risks for the Medical Device Industry",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "44fb0198-de5f-4f11-92ad-d1d8720683ce",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b0b24b7-5532-4a67-afaf-3aad62fc81d6",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "08183c94-15ee-4539-afb3-d72060723fdd",
          "evidence": "The slide explicitly links the company's business model to potential legal violations (FCPA) and regulatory scrutiny.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:19.101+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 209,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 210,
      "type": "tension",
      "title": "Uses yellow highlighting to emphasize key incriminating phrases in the quotes.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 8,
        "textChars": 2066,
        "nDataPoints": 1,
        "notes": "Uses yellow highlighting to emphasize key incriminating phrases in the quotes.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:15.316+00",
          "seconds": 4.766,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/210",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-210",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We asked two former Nevro executives to comment on the alleged kickbacks program in Europe. One stated his belief that it couldn’t have had happened without participation by the US headquarters (\"everyone knows\"); and that the staff Nevro terminated in the aftermath were \"sacrificial lambs.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-4f130976e11a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We asked two former Nevro executives to comment on the alleged kickbacks program in Europe. One stated his belief that it couldn’t have had happened without participation by the US headquarters (“everyone knows”); and that the staff Nevro terminated in the aftermath were “sacrificial lambs.” He called the program “crazy.” Another described underpaid government doctors who “make five times” their salary from device companies and described kickbacks as something “easy to happen in that environment.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b37c43dc-098e-4b66-88bc-e40bc90d17c8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.65
          },
          "kind": "quote",
          "text": "Usually the physicians, like in Germany, 85% of them are all university doctors... You could probably get a rogue distributor... I could see something like that happening. That would be pretty easy to happen in that environment.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "33c8d7ec-800b-465d-a4cb-020c58165292",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "quote",
          "text": "There aren't any other companies operating the way that Nevro was. There were enough people that would have known that it couldn't have happened without the head office knowing. ... Obviously, they were used as sacrificial lambs. ... [The Switzerland program] is totally crazy. I've never heard of that being a ethical practice in any countries in Europe.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9f66c148-6146-414b-b7e0-04f45ddb8df4",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"There aren't any other companies operating the way that Nevro was. There were enough people that would have known that it couldn't have happened without the head office knowing... Obviously, they were used as sacrificial lambs... [The Switzerland program] is totally crazy.\" — Former Nevro executive; \"Usually the physicians, like in Germany, 85% of them are all university doctors... I could see something like that happening. That would be pretty easy to happen in that environment.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-50d3328ce5c4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ab44d201-a206-4f12-b569-3eec7f76a707",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6b986430-4925-4f1c-b3db-f5d0b9397e7f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "97f52841-0f3e-498c-85e6-da88c9dd278b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "a9a84657-068f-48f4-a71f-5b22fc251de1",
          "evidence": "The slide uses expert testimony to allege corporate misconduct and kickback schemes.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:15.316+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 210,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 211,
      "type": "tension",
      "title": "The slide uses a combination of a trend line chart, a summary table of payment types, and a detailed table of specific recipient payments to build a case of fin",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 70,
        "componentCount": 9,
        "textChars": 694,
        "nDataPoints": 15,
        "notes": "The slide uses a combination of a trend line chart, a summary table of payment types, and a detailed table of specific recipient payments to build a case of financial impropriety.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "line_chart",
          "data_table",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.501+00",
          "seconds": 3.444,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/211",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-211",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The breakdown – combined with comments from Nevro’s own consultants and ex-employees - suggests to us that the speakers program is a kickback scheme in disguise.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-8310108b3d9c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.35,
            "x": 0.06,
            "y": 0.4
          },
          "kind": "chart",
          "text": "General Payments across All Years",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Chart",
              "slug": "chart",
              "status": "active",
              "canonId": "019de52c-f9a0-76ef-adc6-0b859109d1f8",
              "version": 1,
              "description": "Quantitative chart."
            },
            "tool": null,
            "subkind": {
              "name": "Line chart",
              "slug": "line",
              "status": "active",
              "canonId": "019de52c-ff62-778f-8f6c-a952ceae8677",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "line",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3fe28af-1ee7-48fc-a0fb-c8978c4cbfde",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "metric",
          "text": "General Payments: $3.5MM",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Metric",
              "slug": "metric",
              "status": "active",
              "canonId": "019de52c-f923-73bf-8081-d0b1a8c5264d",
              "version": 1,
              "description": "Big-number or KPI value."
            },
            "tool": {
              "name": "Quantification",
              "slug": "quantification",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-47ab-72ce-a079-aab1f5299e88",
              "version": 1,
              "bodyDocId": null,
              "description": "Translating a claim into numbers, charts, or tables.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:46+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b348-844e56859569",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.12
          },
          "kind": "paragraph",
          "text": "In the US specifically, the OpenPayments database paints a troubling picture of Nevro's “general payments” to doctors – about $3.5MM/year - which are separate from any alleged inducements via “research payments.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a9b2a934-1f3f-482f-85fc-55458f703c98",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.35,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://openpaymentsdata.cms.gov/company/100000136428",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ebc57481-8bc9-4020-ad82-5d108a16d598",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.4,
            "x": 0.06,
            "y": 0.74
          },
          "kind": "table",
          "text": "Nature of Payment breakdown table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e82e13b-4718-4412-a286-b0cbeaef44ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.48,
            "w": 0.48,
            "x": 0.46,
            "y": 0.4
          },
          "kind": "table",
          "text": "Recipient payment details table",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Table",
              "slug": "table",
              "status": "active",
              "canonId": "019de52c-f9c8-7148-8119-eaac9594cd28",
              "version": 1,
              "description": "Tabular data layout."
            },
            "tool": null,
            "subkind": {
              "name": "Data table",
              "slug": "data",
              "status": "active",
              "canonId": "019de52d-02d5-75b8-8abf-88e92bf63569",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "data",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e4792c58-941a-42e5-a76b-68d579271e00",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.08
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2dfc5c64-762f-4f7b-bafc-9b24d7a5c2a7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cf050945-5c68-402f-b8b9-716d9a099138",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "226c8461-3a71-454c-ae9e-8d8af3398100",
          "evidence": "The slide explicitly frames financial data to expose a 'kickback scheme'.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:14.501+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 211,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 212,
      "type": "tension",
      "title": "Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 9,
        "textChars": 3608,
        "nDataPoints": 0,
        "notes": "Includes a pull-quote from an ex-Nevro consultant and a snippet from a DOJ press release.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:15.641+00",
          "seconds": 4.196,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/212",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-212",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We note that speakers programs which are essentially kickback schemes are illegal, e.g., the recent criminal convictions of Insys Therapeutics executives and some of their high volume KOL's, in connection with the \"Insys Speakers Bureau.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-33bd4427c205",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.4,
            "x": 0.05,
            "y": 0.42
          },
          "kind": "other",
          "text": "Manhattan Doctor Sentenced To Nearly Five Years In Prison For Accepting Bribes And Kickbacks In Exchange For Prescribing Fentanyl Drug",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Other",
              "slug": "other",
              "status": "active",
              "canonId": "019de52c-fa90-743c-8bf6-20d1fbe82b6d",
              "version": 1,
              "description": "Fallback when no canonical kind applies."
            },
            "tool": null,
            "subkind": {
              "name": "Unclassified",
              "slug": "unclassified",
              "status": "active",
              "canonId": "019de52d-05ca-77db-81fb-db7d4234bbc0",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "unclassified",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ad0c06ce-681e-4696-a665-7268ef0c8c7a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "We note that speakers programs which are essentially kickback schemes are illegal, e.g., the recent criminal convictions of Insys Therapeutics executives and some of their high volume KOL's, in connection with the \"Insys Speakers Bureau.\" In a DOJ press release announcing the 5 year imprisonment of one such KOL, the US attorney described how the speakers program was used as cover. We leave it to readers to ascertain the existence or absence of any parallels, while noting that a Nevro ex-consultant and previously one of their highest volume KOL's used Insys as an analogy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "59eb46b6-bdf3-4887-b963-6794b9dbe68a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.45,
            "x": 0.05,
            "y": 0.6
          },
          "kind": "paragraph",
          "text": "In or about August 2012, Insys launched a “Speakers Bureau,” a roster of doctors who would conduct programs (“Speaker Programs”) purportedly aimed at educating other practitioners about Subsys. In reality, Insys used its Speakers Bureau to induce the doctors who served as speakers to prescribe large volumes of Subsys by paying them Speaker Program fees. Speakers were supposed to conduct an educational slide presentation for other health care practitioners at each Speaker Program. In reality, many of the Speaker Programs were predominantly social affairs where no educational presentation about Subsys occurred. Attendance sign-in sheets for the Speaker Programs were frequently forged by adding the names and signatures of health care practitioners who had not actually been present.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bd797e98-7c5f-473a-9597-562922867254",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.5,
            "w": 0.4,
            "x": 0.55,
            "y": 0.38
          },
          "kind": "quote",
          "text": "Doctors that implanted a lot of devices, they hated Nevro. I don't know doctors who were high volume Nevro implanters that liked it and continued with their device. The high volume Nevro implanters today who are involved with Nevro's studies – I saw the guys who went to jail for prescribing the Insys fentanyl drug. An Insys VP was saying how he hired hookers and strippers. You have to remember the doctor runs the show. And the only way I know to change that doctor's practice paradigm is bribing. It works. You give a doctor some money and they will say whatever you want. I would imagine Nevro probably doesn't give them money. They just hire them as consultants, pay them to give lectures and to teach classes. Doctors are whores – Ex-Nevro consultant and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f3faeb91-dee0-498c-af56-87b92f89a3cb",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Doctors that implanted a lot of devices, they hated Nevro. I don't know doctors who were high volume Nevro implanters that liked it and continued with their device. The high volume Nevro implanters today who are involved with Nevro's studies – I saw the guys who went to jail for prescribing the Insys fentanyl drug. An Insys VP was saying how he hired hookers and strippers. You have to remember the doctor runs the show. And the only way I know to change that doctor's practice paradigm is bribing. It works. You give a doctor some money and they will say whatever you want. I would imagine Nevro probably doesn't give them money. They just hire them as consultants, pay them to give lectures and to teach classes. Doctors are whores\" — Ex-Nevro consultant and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:47+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-35389635acfb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: https://www.justice.gov/usao-sdny/pr/manhattan-doctor-sentenced-nearly-five-years-in-prison-accepting-bribes-and-kickbacks; consultation calls with experts",
          "attrs": {
            "numbered": true
          },
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c896a7f0-5fd3-47d4-833c-81f96d7eaf79",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cde4c354-31de-45c6-8971-4aa590008d1a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9eee79a4-49e8-4bfb-8a41-1357830a2214",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "91638105-b82a-42c7-8364-6bb2bb2a7fcd",
          "evidence": "The slide frames Nevro's business practices as analogous to the criminal activities of Insys Therapeutics.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:15.641+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 212,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 213,
      "type": "tension",
      "title": "Uses a screenshot of an official government document to frame the company's business model as fraudulent.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "balanced",
        "densityScore": 28,
        "componentCount": 5,
        "textChars": 573,
        "nDataPoints": 0,
        "notes": "Uses a screenshot of an official government document to frame the company's business model as fraudulent.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:14.263+00",
          "seconds": 2.69,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/213",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-213",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.65,
            "w": 0.88,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "image",
          "text": "OIG Special Fraud Alert document header and introduction text",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "adcfdfca-7bba-460c-99ca-113ad3aa6c60",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "On November 16, 2020 the OIG issued a Special Fraud Alert on speaker programs – an arrow pointed straight at the heard of Nevro's business model. Our reading of the alert leads us to believe that Nevro's program is a textbook case of what regulators are seeking to reign in.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5855947f-7006-4144-a595-0f6247b72252",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.55,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://oig.hhs.gov/fraud/docs/alertsandbulletins/2020/SpecialFraudAlertSpeakerPrograms.pdf",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bc8d0e61-06c8-442f-817b-a7209523cfa5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b3015f60-b271-41eb-939d-d090ff67b705",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a0e547fd-b122-44a2-b79e-43cde46bfb1b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "5e6a5232-5096-4d6f-87b9-3eb79eef248f",
          "evidence": "Uses regulatory alert to frame company business model as illegal",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:14.263+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 213,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 214,
      "type": "tension",
      "title": "Uses yellow highlighting to emphasize key incriminating phrases in quotes.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 12,
        "textChars": 3833,
        "nDataPoints": 1,
        "notes": "Uses yellow highlighting to emphasize key incriminating phrases in quotes.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:15.942+00",
          "seconds": 4.337,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/214",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-214",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-94047f32fe0f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "list",
          "text": "A high volume implanter and Nevro user states doctors only use devices like Nevro's if they're \"on the dole\" and that you have to \"grease\" them with consulting, teaching, and other fees to get the business.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "10e568fd-f280-411c-9149-bdde3da9dc5a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "list",
          "text": "A second KOL described Nevro's various programs as financial inducements and \"rewards\" to do more Nevro volume, which we believe violates anti-kickback laws.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80e27edf-54da-4dfb-9ac4-c8c1f8966be7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "list",
          "text": "A third, a current Nevro consultant and one of their highest volume implanters, described the wink-wink",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "93f09aee-9579-48e2-b229-19fae6acc450",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's and former Nevro executives describe practices identical to what the OIG Fraud Alert targets, detailing what we interpret as blatant kickbacks and indicating that the SCS space is driven by a small number of high volume implanters who are seeking to be essentially bribed for their device volume. Some doctors used the word kickbacks directly, while others preferred phrases like \"they'll throw a lot of money your way\" or \"it's basically like a reward system.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "048ce0b1-3200-456b-86c3-6fd40aaa34d4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.83,
            "x": 0.11,
            "y": 0.32
          },
          "kind": "quote",
          "text": "\"I know a doctor down the block who was doing a lot of Nevro. He only does procedures when he gets the dole. He's now doing Abbot. You have to grease him to get his business. I don't operate that way and everyone knows it. Consulting is one way, teaching is another. You can get a ridiculous amount for teaching. Then they have these round tables that are junkets.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3060686a-0d00-4f85-bd66-8aa1bcaec09b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.16,
            "w": 0.83,
            "x": 0.11,
            "y": 0.48
          },
          "kind": "quote",
          "text": "\"Nevro will put doctors on studies because it's a way to boost income in their practices. They'll throw a lot of money your way. They'll put you on these consulting contracts and give you a bunch of speaking things and everything else and it's basically like a reward system. If you're doing a lot more Nevro, you get more speaking engagements. [Name redacted] gets a ton of seeking opportunities because they know he's very influential in the field. Nevro was giving [name redacted] easily a hundred fifty thousand dollars a year and they gave him stock, so you can look that up. He openly has stock, to keep him implanting [Nevro's device].\" - High volume KOL and former Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "41b682fc-a444-4da5-bf67-47dbf9709fc0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.83,
            "x": 0.11,
            "y": 0.7
          },
          "kind": "quote",
          "text": "\"They figure out from their rep \"What does he [the doctor] like?\" Companies use those levers to engage with you and say \"Yeah, we got these opportunities, would love to get you on board\" and talk about those things.\" - KOL and one of Nevro's highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4f64f06b-ee43-4b34-a8d8-b7f22504204a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I know a doctor down the block who was doing a lot of Nevro. He only does procedures when he gets the dole. You have to grease him to get his business. I don't operate that way and everyone knows it. Consulting is one way, teaching is another. You can get a ridiculous amount for teaching. Then they have these round tables that are junkets.\" — KOL; \"Nevro will put doctors on studies because it's a way to boost income in their practices. They'll throw a lot of money your way. They'll put you on these consulting contracts and give you a bunch of speaking things and everything else and it's basically like a reward system. If you're doing a lot more Nevro, you get more speaking engagements. [Name redacted] gets a ton of seeking opportunities because they know he's very influential in the field. Nevro was giving [name redacted] easily a hundred fifty thousand dollars a year and they gave him stock, so you can look that up. He openly has stock, to keep him implanting [Nevro's device].\" — High volume KOL and former Nevro user; \"They figure out from their rep 'What does he [the doctor] like?' Companies use those levers to engage with you and say 'Yeah, we got these opportunities, would love to get you on board' and talk about those things.\" — KOL and one of Nevro's highest volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-9a08ff1ab32e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.8
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d9175744-4c15-4e62-b704-f99d7c666d55",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28ed0d23-7fbe-4be9-8a13-6eb1a63fd006",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "286be678-a6b7-48d9-abe1-a9ddd7ebec58",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "064b8a17-9252-44f2-9a26-a3daefc45d8f",
          "evidence": "The slide explicitly frames the business model as violating anti-kickback laws and references OIG Fraud Alerts.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:15.942+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 214,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 215,
      "type": "tension",
      "title": "Uses yellow highlighting to emphasize key incriminating phrases in the quotes.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 10,
        "textChars": 2580,
        "nDataPoints": 1,
        "notes": "Uses yellow highlighting to emphasize key incriminating phrases in the quotes.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:17.177+00",
          "seconds": 5.062,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/215",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-215",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-ae5f2120ee6d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.1,
            "x": 0.06,
            "y": 0.58
          },
          "kind": "list",
          "text": "KOL #2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1a478c68-3c60-4f08-a9dd-92b3e04b70c8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.1,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "list",
          "text": "KOL #1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db462ecc-f0b6-4a73-a2c2-1c630da0fbfd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A former Nevro consultant and previously one of their highest volume implanters described their payments to doctors as aggressive and replied “100%” when asked if they were kickbacks. A second high volume implanter said the speakers program was tied to volume and that he observed reps engage in improper or illegal behavior “all the time.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "20a38219-7546-4ce5-9a38-265352eed4f8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.83,
            "x": 0.11,
            "y": 0.63
          },
          "kind": "quote",
          "text": "Question: Have Nevro reps ever said \"If you do a certain amount of volume, we'll put you in the speakers program? “Yeah, because they're just trying to feed their kids. They're saying, \"If you do this, we'll take care of you.\" I look beyond that because I don't want to be that greaseball doc. At NANS every January in Vegas or the INS meeting – it really depends on the doctor. Nevro can hoodwink a doctor that's just interested in revenue [..] The Nevro reps spend a lot of money on honoraria. They'll pay you to do a dinner with 20 doctors at a steakhouse. Doctors like me can smell right through that. Question: Have you ever observed the Nevro reps do anything illegal or what you thought may cross the line, or is it just kind of gray? “All the time”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3602f010-b0af-4ba9-a395-1edc0e3fcfaf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.2,
            "w": 0.83,
            "x": 0.11,
            "y": 0.3
          },
          "kind": "quote",
          "text": "“I know a lot of doctors who usually get $350-$400 an hour for being speakers or whatever. But I know that Nevro was paying a lot for consultants. I mean, a lot. I might guess that their top dogs are making a lot more. I’ve heard a couple of people say what they are getting from Nevro is pretty ridiculous, but I don’t know if that’s the norm or that they were just special. I heard anecdotally that Nevro was paying $1,000 an hour.” Question: Do you think what they are doing is essentially a kickback or an inducement? “Well, I’m not an ethicist but that certainly seems to be the case. [laughs] I mean, a hundred percent. Hundred percent.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb764968-b859-42bd-8e37-ca3b17d56777",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I heard anecdotally that Nevro was paying $1,000 an hour. Question: Do you think what they're doing is essentially a kickback or an inducement? \"Well, I'm not an ethicist but that certainly seems to be the case. [laughs] I mean, a hundred percent. Hundred percent.\" — KOL #1; \"Yeah, because they're just trying to feed their kids. They're saying, \"If you do this, we'll take care of you.\" ... Question: Have you ever observed the Nevro reps do anything illegal or what you thought may cross the line, or is it just kind of gray? \"All the time\"\" — KOL #2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-b38e564715d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "026df576-56be-4ae6-aba2-45c80aa7d2cd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "00663a75-3855-4252-8b29-ec1c6d690894",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.177+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b919541d-9a5e-4fbd-9362-fe3955a97b6c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 216,
      "type": "tension",
      "title": "The slide uses a series of quotes to build a narrative of corruption and unethical business practices.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3298,
        "nDataPoints": 0,
        "notes": "The slide uses a series of quotes to build a narrative of corruption and unethical business practices.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:17.092+00",
          "seconds": 4.886,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/216",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-216",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's and executives in the SCS space listed various high volume Nevro implanters by name and described them as \"their whore for California,\" \"a guy who takes money,\" \"borderline unethical what they do,\" doctors you could \"blow the whistle on,\" or as \"coin-operated.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-f9a8ac4fb72c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's and executives in the SCS space listed various high volume Nevro implanters by name and described them as \"their whore for California,\" \"a guy who takes money,\" \"borderline unethical what they do,\" doctors you could \"blow the whistle on,\" or as \"coin-operated.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce950e84-cc23-47a0-8c08-cf0ef32ec195",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.26
          },
          "kind": "quote",
          "text": "\"People know I don't take money and other doctors aren't so much like that. If you look up [name redacted] in my area on doctors for dollars he gets paid for talks. He tells reps to their face wont that he won't prescribe unless they put him on as a speaker. He goes 3 talks a day at $3,000 each. [Doctor name redacted] is Nevro's whore for California. He does lots of studies for them. They promote him. He gets on their papers. He's not part of the KOL crowd. [Prominent Nevro implanter] is a guy who takes money.\" - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15864832-cd84-43ce-ada6-6d8fee7f5eed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.46
          },
          "kind": "quote",
          "text": "\"It's borderline unethical what they do with [name redacted]. They pay him all kinds of stock options. He runs a lot of meetings and programs. He was the head of [redacted]. He makes a lot of decisions on papers and conference presentations. You could blow the whistle on these guys. NANS finally beat on these guys but they're still doing same stuff. He's now doing that with [company name redacted]\" - Key Nevro pivotal trial investigator",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1a9206af-0ec3-46e5-9c1a-3033878017a2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.66
          },
          "kind": "quote",
          "text": "\"The physician that's on stage at a society meeting is usually a consultant for the company. [Name redacted] as an example out of San Francisco, during Nevro's rise, was one of their strongest consultants. He's coin-operated, and he will say what he benefits from, as do most of these guys.\" - Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d2502851-2e91-4b2c-841d-cdddc3051974",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"People know I don't take money and other doctors aren't so much like that. If you look up [name redacted] in my area on doctors for dollars he gets paid for talks. He tells reps to their face wont that he won't prescribe unless they put him on as a speaker. He goes 3 talks a day at $3,000 each. [Doctor name redacted] is Nevro's whore for California. He does lots of studies for them. They promote him. He gets on their papers. He's not part of the KOL crowd. [Prominent Nevro implanter] is a guy who takes money.\" — KOL; \"It's borderline unethical what they do with [name redacted]. They pay him all kinds of stock options. He runs a lot of meetings and programs. He was the head of [redacted]. He makes a lot of decisions on papers and conference presentations. You could blow the whistle on these guys. NANS finally beat on these guys but they're still doing same stuff. He's now doing that with [company name redacted]\" — Key Nevro pivotal trial investigator; \"The physician that's on stage at a society meeting is usually a consultant for the company. [Name redacted] as an example out of San Francisco, during Nevro's rise, was one of their strongest consultants. He's coin-operated, and he will say what he benefits from, as do most of these guys.\" — Longtime executive in the SCS space",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-fd394519ceec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "406ee94e-73ae-4d85-a460-2974bd082853",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e29d9290-2c95-48e8-905a-9d36a98b2b95",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c06c303b-834d-46e9-bd5c-75665b37c16b",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "44587dc2-4151-4b20-b22b-98c6e7b25a56",
          "evidence": "The slide explicitly frames the business model as relying on unethical kickbacks and uses quotes to expose alleged corruption.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:17.092+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 216,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 217,
      "type": "tension",
      "title": "The slide uses highlighted text to emphasize key allegations of illegal payments and the prioritization of financial incentives over clinical evidence.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2745,
        "nDataPoints": 0,
        "notes": "The slide uses highlighted text to emphasize key allegations of illegal payments and the prioritization of financial incentives over clinical evidence.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:16.096+00",
          "seconds": 3.736,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/217",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-217",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We believe that Nevro’s business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-e254183c1ac9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A former Nevro district sales manager... described the pervasiveness and centrality of kickbacks... He detailed internal conversations at Nevro about tying payments to volumes - which we believe to be flagrantly illegal under anti-kickback laws.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "047bb3dc-167e-458d-9aba-63378d846db7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.55
          },
          "kind": "quote",
          "text": "I was privy to conversations like, you've got to make sure he does X volume over this period of time or we can't have him as a KOL... If the doc didn't ante up over that period of time, they would have cut him off.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6d2ad3c5-c414-4c20-93e0-c515153ca41d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.28
          },
          "kind": "quote",
          "text": "The guys that you would consider key opinion leaders in the field like [3 names redacted] - if they weren't going to get paid, you're not working with them. A KOL is a marketer in disguise as a physician...",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7639a4db-2781-4111-baa9-46b75050fec6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.45
          },
          "kind": "quote",
          "text": "If they don't get paid, they're not in the game. That's almost what it has become like with the big KOLs, not just with the number of implants that they do, but the clout that they have in the pain management community.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9cb80181-01e4-495c-ac91-6775fd087553",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.72
          },
          "kind": "quote",
          "text": "I hoped that all of this was going to go away with clinical evidence. That's what my stupid belief was. I truly believe money trumps the evidence every day of the week, unfortunately. - Former Nevro district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce67215e-d9d9-4b88-8076-ce37088bdcf8",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "The guys that you would consider key opinion leaders in the field like [3 names redacted] - if they weren't going to get paid, you're not working with them. A KOL is a marketer in disguise as a physician, They pit companies against each other to get more out of each. They'll say, “I don't need to meet with your regional manager or VP. I want to meet with your CEO because to get me working with you, I need to have high-level communications on how much I’m getting paid.” ... If they don't get paid, they're not in the game. That's almost what it has become like with the big KOLs, not just with the number of implants that they do, but the clout that they have in the pain management community. ... I was privy to conversations like, you've got to make sure he does X volume over this period of time or we can't have him as a KOL. But I don't believe it would have ever been anything in writing. If the doc didn't ante up over that period of time, they would have cut him off. The verbal conversations would never have been with the territory managers. It would have been the area vice president's, with a couple of people in the room. ... I hoped that all of this was going to go away with clinical evidence. That's what my stupid belief was. I truly believe money trumps the evidence every day of the week, unfortunately. — Former Nevro district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-e7b6ef76600b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "41d877f2-bee3-432d-a92a-9554fcc928f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "17. We believe that Nevro's business model hinges on unsustainable kickbacks to high-volume implanters",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db93c424-9429-4a45-bf94-ead754c194f7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5ef2befe-f6e1-482e-b93a-4f8dc76bec89",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "008c0329-83f3-4559-9e56-c9b427b1c9ea",
          "evidence": "The slide explicitly frames the business model as illegal and relies on whistleblower testimony to expose a contradiction between public claims and private practices.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:16.096+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 217,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 218,
      "type": "tension",
      "title": "The slide uses inflammatory language ('cesspool', 'exploitation') to frame the company as a villain.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 54,
        "componentCount": 6,
        "textChars": 1522,
        "nDataPoints": 0,
        "notes": "The slide uses inflammatory language ('cesspool', 'exploitation') to frame the company as a villain.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "photo",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:16.826+00",
          "seconds": 3.994,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/218",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-218",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": {
            "h": 0.15,
            "w": 0.24,
            "x": 0.71,
            "y": 0.52
          },
          "kind": "callout",
          "text": "Trial stimulator is externally secured and the procedure is not as invasive as a permanent surgical implant",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": null,
            "subkind": {
              "name": "Primary callout",
              "slug": "primary",
              "status": "active",
              "canonId": "019de52c-fbd1-70eb-a9ce-8997f8674c1d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "primary",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fff1d902-00fc-4e4a-806d-c497ade401d9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.42,
            "w": 0.65,
            "x": 0.05,
            "y": 0.52
          },
          "kind": "image",
          "text": null,
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Photo",
              "slug": "photo",
              "status": "active",
              "canonId": "019de52c-fd37-757f-b4a8-ca26d4888875",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "photo",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fd488f15-968b-4a83-ae95-1c8f4d4d2fcc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A number of Nevro’s former executives, sales reps, and KOL’s described the exploitation of patients – particularly the psychiatrically vulnerable - as a key driver of the spinal cord stimulation business and of Nevro’s sales in particular, portraying it as a cesspool of unethical and illegal practices with troubling incentives driving corporate, sales rep, and doctor behavior. We detail five practices: 1) pushing unnecessary trial implants; 2) pushing permanent implants even if the trial implant indicated no pain relief; 3) gaming mandatory psychiatric evaluations; 4) “flipping” implants and pushing unnecessary “upgrades”; and 5) implanters pressuring patients into simulators by withholding pain medication and other widespread, disturbing tactics. We begin by explaining what “stimulator trials” are: insurers require patients to begin with a trial period of a few days to a week, where temporary leads are attached to an external battery/generator. If the trial stimulator indicates at least 50% pain relief, the patients undergoes a permanent implant that is placed inside their body.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "19062c15-9385-428d-84c1-daa4f7f47700",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: https://www.reddit.com/r/ChronicPain/comments/78yt1a/started_the_spinal_cord_stimulator_trialfeeling_a/; https://nickfener.wordpress.com/2013/02/18/spinal-cord-stimulator-trial/",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8c90ca40-3eab-41ef-b0e3-25371f0fba42",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9c459619-952e-49f9-ab48-5b777bb4fa02",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2e7ee908-2c35-4e17-beeb-255572d4440c",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "454424f3-688a-44ae-a8e6-57682be1977b",
          "evidence": "The slide explicitly frames the company as a villain by detailing unethical practices and patient exploitation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:16.826+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 218,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 219,
      "type": "tension",
      "title": "The slide uses the 'ceo-quote-contradiction' framework to frame the CEO's own words as evidence of unethical business practices.",
      "function": "expose_contradiction",
      "rawType": "ceo_quote",
      "block": null,
      "metadata": {
        "slideType": "ceo_quote",
        "slideTypeCanon": {
          "name": "CEO quote",
          "slug": "ceo_quote",
          "status": "active",
          "canonId": "019de52d-09b6-71c8-93a5-f90a9772a8fa",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 76,
        "componentCount": 8,
        "textChars": 3113,
        "nDataPoints": 0,
        "notes": "The slide uses the 'ceo-quote-contradiction' framework to frame the CEO's own words as evidence of unethical business practices.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:17.624+00",
          "seconds": 3.965,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/219",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-219",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-c8901e562f96",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.11,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "On his first earnings call as CEO, in May 2019, Keith Grossman singled out trial implants as a key lever of his strategy, declaring his intentions around “directing and incentivizing” the sales force to “grow trials” “very intensely.” On earnings calls since, amorphous operating metrics about trial implant growth are used to emphasize how well the turnaround is succeeding.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "14c40a4b-dade-4c2f-b6c5-1b5f1faff5b3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.36
          },
          "kind": "quote",
          "text": "Another area where we may have lost focus is around patient trials. As most of you know, I think patients enter our treatment pathway via a trial, the success of which leads to payor approval for the implantation of our device which is the principal driver of our revenues. Our trials begin to flatten out in the middle of 2018 and this activity is obviously an important one to two quarter predictor of future implant revenues...we have focused and reengaged our field team very intensely on patient trial growth.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6dd0f9f7-3920-44aa-a513-fd0d5a044a38",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.21,
            "w": 0.88,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "quote",
          "text": "And I think trials got kind of lost in the noise, and we simply weren't focused on it. And I think what is encouraging is that -- is that as we have focus on it in very short order, we've seen very rapid and I think very important responsiveness to trial volume based on our results. I think that's an encouraging sign. It's also very early. And so that's something that we've been focusing on for the better part of the last two months and we've seen a very quick response but we need to we need to better understand that. But I really think it was just for lack of focus. We weren't directing and incentivizing our sales force to do what they should have been doing in my view, which was to grow trials.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7ab8e4e6-8a79-4b24-96cf-4c36c9c5ee38",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Another area where we may have lost focus is around patient trials. As most of you know, I think patients enter our treatment pathway via a trial, the success of which leads to payor approval for the implantation of our device which is the principal driver of our revenues. Our trials begin to flatten out in the middle of 2018 and this activity is obviously an important one to two quarter predictor of future implant revenues...we have focused and reengaged our field team very intensely on patient trial growth. And I think trials got kind of lost in the noise, and we simply weren't focused on it. And I think what is encouraging is that -- is that as we have focus on it in very short order, we've seen very rapid and I think very important responsiveness to trial volume based on our results. I think that's an encouraging sign. It's also very early. And so that's something that we've been focusing on for the better part of the last two months and we've seen a very quick response but we need to we need to better understand that. But I really think it was just for lack of focus. We weren't directing and incentivizing our sales force to do what they should have been doing in my view, which was to grow trials. — Keith Grossman, CEO",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:48+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b349-cdcdb3621b3f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.18,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Nevro earnings call transcript",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "984b1b60-a5f1-4ec5-9d9d-022dd659f41f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "afbd5b64-a18e-45c3-b533-437355f2d18c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4fd19b26-39f1-4dce-8e4b-45e70b7d9ce1",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "6ac82638-7794-4c7b-abde-be7426ef9432",
          "evidence": "The slide presents CEO quotes to frame his strategy as evidence of exploitation.",
          "framework": null,
          "confidence": 1,
          "extraction": {
            "at": "2026-05-02 20:16:17.624+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 219,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 220,
      "type": "tension",
      "title": "Uses testimonial-style quotes to frame the company as corrupt and exploitative.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 3849,
        "nDataPoints": 0,
        "notes": "Uses testimonial-style quotes to frame the company as corrupt and exploitative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:18.828+00",
          "seconds": 5.134,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/220",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-220",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A former Nevro sales rep stated the company is “not on the up and up,” and will “invariably be audited by Medicare,” describing how patients are pressured, manipulated, or lied into implants.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:52+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3e-76f7-b9d6-0099b853d658",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "list",
          "text": "A former Nevro sales rep stated the company is “not on the up and up,” and will “invariably be audited by Medicare,” describing how patients are pressured, manipulated, or lied into implants.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "22e09c48-6574-4088-b663-44bd9af12223",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.67
          },
          "kind": "list",
          "text": "A former high volume Nevro implanter states that clinics are “bamboozling patients” into permanent implants despite a lack of pain relief during the trial and implied Nevro was “corrupt.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b7f69fc1-2465-4ccd-ab4c-63bc8f4696ea",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "We find Grossman’s incentivizing of trial implants as troubling, given that former employees and KOL’s describe trials as the gateway for misuse, over-utilization, and patient manipulation. First, doctors push as many patients into trials as possible, whether medically indicated or not, given lucrative reimbursement for trials versus permanent implants. Second, sales reps then manipulate patients during the trial to push them into a permanent implant, given the conversion ratio drives their compensation. A former rep stated that Nevro is abusing the system and his opinion that a Medicare audit is inevitable, with a KOL implying the company is “corrupt” and clinics are “bamboozling patients.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8c91156b-0a41-4750-8aa3-f283e6f3e08a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.83,
            "x": 0.11,
            "y": 0.49
          },
          "kind": "quote",
          "text": "There were definitely practices at Nevro that pushed patients into implants. They will invariably be audited by Medicare. They’re doing other things that are not on the up and up. In the past I worked with a couple of practices where doctors would tell patients they wouldn’t get medication if they didn’t do a stimulator trial. I had patients show up for a visit and not know they were there for a stimulator trial. In every town there are one to two bad eggs. They’re in it for the wrong reasons.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2cd138a7-252f-4e9d-8d98-826c3faf80cc",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.75
          },
          "kind": "quote",
          "text": "Clinics are bamboozling patients into implanting the device when, in fact, the device during trial did not provide them adequate pain relief. This caters only to the physician cohort that doesn't really care about outcomes. It's about how many you can implant. And if they have to be explanted, even better. It's another surgery you can charge for. Nevro's also paying probably great honoraria for the Kapural's of the world to publish this kind of bullshit data that hurts us all. They did it with Senza and now they're doing it again with diabetic neuropathy. They're shooting everybody in the foot with their practices. That's the kind of corrupt stuff that we're seeing.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "90f3c61b-b1af-4ec8-8c07-92a95ea89a02",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“There were definitely practices at Nevro that pushed patients into implants. They will invariably be audited by Medicare. They’re doing other things that are not on the up and up. In the past I worked with a couple of practices where doctors would tell patients they wouldn’t get medication if they didn’t do a stimulator trial. I had patients show up for a visit and not know they were there for a stimulator trial. In every town there are one to two bad eggs. They’re in it for the wrong reasons.” — Former Nevro sales rep; “Clinics are bamboozling patients into implanting the device when, in fact, the device during trial did not provide them adequate pain relief. This caters only to the physician cohort that doesn't really care about outcomes. It's about how many you can implant. And if they have to be explanted, even better. It's another surgery you can charge for. Nevro's also paying probably great honoraria for the Kapural's of the world to publish this kind of bullshit data that hurts us all. They did it with Senza and now they're doing it again with diabetic neuropathy. They're shooting everybody in the foot with their practices. That's the kind of corrupt stuff that we're seeing.” — KOL and high volume implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:52+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3e-76f7-b9d6-0519dec762c1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "13c03a9d-3682-40e7-ac19-987ccc32dfde",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ec737c0-000f-44f0-8f91-dfc8813d5fda",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.828+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98f82d85-bff2-47eb-a243-3bd778cf27e2",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 221,
      "type": "tension",
      "title": "The slide uses a 'villain critique' approach by framing the company's business model as exploitative and unsustainable.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 78,
        "componentCount": 9,
        "textChars": 1592,
        "nDataPoints": 0,
        "notes": "The slide uses a 'villain critique' approach by framing the company's business model as exploitative and unsustainable.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:17.524+00",
          "seconds": 3.116,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/221",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-221",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "This kind of aggressive rep behavior goes on a lot. That's a big part of the business and I think it's incentivized as a big part of the business. Wink-wink, not verbally. The companies say it's all about the patient. It has nothing to do with the patient.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-428d42f8f798",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A former Nevro district manager, one of the longest tenured reps in the stimulator space, detailed toxic incentives and a company culture of “over-aggressive” reps pushing trials and stimulators when not indicated.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "882bad46-e32c-4ef9-82c3-fcf4d60674f5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.9,
            "x": 0.05,
            "y": 0.41
          },
          "kind": "quote",
          "text": "I would say a third of Nevro’s business is driven by these patients that are being pushed into a stimulator by an over-aggressive rep. One-third of patients are the perfect candidate, one-third are 50/50, and one-third aren't good candidates.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1994686b-f2b4-49e9-b0d9-2e8b6821b7ec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.53
          },
          "kind": "quote",
          "text": "You have the new pharma rep who drinks the Kool-Aid... This kind of aggressive rep behavior goes on a lot. That's a big part of the business and I think it's incentivized as a big part of the business. Wink-wink, not verbally.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "acbd1441-37d5-4c06-92ac-9427dccbc36e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.7
          },
          "kind": "quote",
          "text": "How reps get paid is trial to perm... They don't measure based upon patient satisfaction. They measure the way you close your sales. I get it. I'm not arguing with that. That's just the way that it is.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bd9a23a0-74bf-41b9-a940-cbc607f61174",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I would say a third of Nevro’s business is driven by these patients that are being pushed into a stimulator by an over-aggressive rep. One-third of patients are the perfect candidate, one-third are 50/50, and one-third aren't good candidates. — Former Nevro district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-46bede0a1c0b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "007184ca-e1dd-4804-a485-41d8859d69f8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "616e3708-5d4c-4fea-81ca-7bf9afc9e9a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d5c0027d-0e6b-4aaa-958d-883cf3456b58",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "f9aeb620-779d-4f00-83e7-ede58602b25a",
          "evidence": "The slide frames the company's sales practices as exploitative and unethical.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:17.524+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 221,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 222,
      "type": "tension",
      "title": "Uses testimonial evidence to frame the company's sales practices as unethical and exploitative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 82,
        "componentCount": 9,
        "textChars": 3435,
        "nDataPoints": 0,
        "notes": "Uses testimonial evidence to frame the company's sales practices as unethical and exploitative.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:18.962+00",
          "seconds": 4.392,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/222",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-222",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Former Nevro executives and reps suggested that employees game the evaluation to ensure a virtually 100% pass rate.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-13cd8041dfe1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Insurers recognize that stimulator patients comprise a vulnerable population at high risk of being exploited into a device. Stimulators are typically a last resort for long-time chronic pain patients, often with multiple failed surgeries, opioid dependence, and the associated psychiatric toll and vulnerabilities. As a result, prior to a stimulator trial, patients are required to undergo a psychiatric evaluation. Former Nevro executives and reps suggested that employees game the evaluation to ensure a virtually 100% pass rate. They painted a disturbing picture of implant recipients who are “not the best stimulator candidates” and would “never pass the psychiatric evaluation”; suicidal patients calling the central support line; and patients complaining that the Nevro rep lied to them about 100% pain relief and a cure.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "61ca7929-b136-46a4-920e-281776f185fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "quote",
          "text": "The chronic pain patient population has a psychiatric toll. It affects 100% of patients. If a patient failed a psychiatric evaluation, the sales rep would send them to another psychiatrist. It’s fair to say they get shopped around. You don’t even need to get shopped around because the psychiatric evaluation is not in depth. It’s a bottleneck for time but not for volumes in the sales funnel.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1358e411-2205-4a66-b0d3-994b69721feb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "quote",
          "text": "We’d get calls from patients, hear their demeanor on the phone, and wonder how they ever got the device. These were not the best stimulator candidates. Our conversations in the call center were with device recipients who were suicidal, folks with really really high and unrealistic expectations. They told me I’d get 100% pain relief, it would cure me, it would go away. The call center would say it’s not true, it’s not a cure. I don’t know if they were oversold by the doctor or rep. Patients had unrealistic expectations of the device and therapy.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9101b82d-270c-47a4-977d-3e7fa1710d6e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "quote",
          "text": "When Nevro’s call center would deal with patients, we’d realize they’d never pass the psychiatric evaluation yet here we are and they have the device.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce352900-c08d-4ca6-8263-2f05793ac3c0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"The chronic pain patient population has a psychiatric toll. It affects 100% of patients. If a patient failed a psychiatric evaluation, the sales rep would send them to another psychiatrist. It’s fair to say they get shopped around. You don’t even need to get shopped around because the psychiatric evaluation is not in depth. It’s a bottleneck for time but not for volumes in the sales funnel.\" — Former Nevro regional sales director for one of its largest territories; \"When Nevro’s call center would deal with patients, we’d realize they’d never pass the psychiatric evaluation yet here we are and they have the device.\" — Former Nevro executive; \"We’d get calls from patients, hear their demeanor on the phone, and wonder how they ever got the device. These were not the best stimulator candidates. Our conversations in the call center were with device recipients who were suicidal, folks with really really high and unrealistic expectations. They told me I’d get 100% pain relief, it would cure me, it would go away. The call center would say it’s not true, it’s not a cure. I don’t know if they were oversold by the doctor or rep. Patients had unrealistic expectations of the device and therapy.\" — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-148b013388e2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a98b8924-8591-4d9e-9587-20f16a961736",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3368eaf4-bce1-44cd-b9ba-49d566bb066a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e407602a-9cea-48ad-a31e-5b6c346a2208",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "ff93305b-fa97-4f4e-8451-9a920955bfce",
          "evidence": "The slide systematically presents evidence of unethical and potentially fraudulent sales practices.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:18.962+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 222,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 223,
      "type": "tension",
      "title": "The slide uses testimonial quotes to frame the company's business model as exploitative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 88,
        "componentCount": 12,
        "textChars": 2724,
        "nDataPoints": 0,
        "notes": "The slide uses testimonial quotes to frame the company's business model as exploitative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:43.833+00",
          "seconds": 9.32,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/223",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-223",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's elaborated on the dynamic described by former employees, calling the pushing of stimulator trials as \"straight up fraud\" and \"a big problem,\" saying that doctors \"pump bodies\" through stimulator clinics, particularly in high-abuse states with \"giant billboards\" for stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-8b59f2b8ce9c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.56
          },
          "kind": "list",
          "text": "A KOL and Nevro user characterized the SCS space as pumping bodies through clinics",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "403f03a0-665a-4eb9-9d3f-62fb442a18f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "list",
          "text": "Doctors doing trials “to make money” with no intent of doing a permanent implant is a “big problem”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ed4cabf-2175-4fbf-b99d-16c274c997d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.8,
            "x": 0.06,
            "y": 0.24
          },
          "kind": "list",
          "text": "A Nevro user described “straight up fraud” around trial implants and implanters who “belong in jail”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb5b0fd3-a6b5-4287-9755-ff0e864476a4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL’s elaborated on the dynamic described by former employees, calling the pushing of stimulator trials as “straight up fraud” and “a big problem,” saying that doctors “pump bodies” through stimulator clinics, particularly in high-abuse states with “giant billboards” for stimulators.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "42609d3c-c11c-4861-a72b-8d5d8fa40c0b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.1,
            "w": 0.85,
            "x": 0.09,
            "y": 0.6
          },
          "kind": "quote",
          "text": "“There are doctors looking to pump bodies through the clinic and install stimulators. There absolutely are. The trial should speak for itself. I never push the permanent implant. Florida is the big abuse state not only for stimulators but opioids. There are giant billboards on highways for cataract surgery and stimulators too.” - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "35e5643d-4554-4d21-b970-5f061c6890fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.09,
            "y": 0.28
          },
          "kind": "quote",
          "text": "“Trials – that’s where the misuse is. A guy in Brooklyn had a test to permanent implant ratio of 10%. He was just taping the lead to patients’ backs and not even implanting the leads. That’s just straight up fraud and he belongs in jail. That’s one opportunity for abuse.” - KOL and moderate Nevro user",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9ebb49e3-055e-4fd5-9da3-1a502e46f713",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.85,
            "x": 0.09,
            "y": 0.45
          },
          "kind": "quote",
          "text": "“Doctors doing trials to make money was a big problem. Companies were charging $1,000 to $2,000 per lead and having doctor putting in 4 leads with no intent to do a permanent implant.” - KOL and Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dd42c9fd-ac9d-450d-abd2-5a90da874dc0",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Trials – that’s where the misuse is. A guy in Brooklyn had a test to permanent implant ratio of 10%. He was just taping the lead to patients’ backs and not even implanting the leads. That’s just straight up fraud and he belongs in jail. That’s one opportunity for abuse.\" — KOL and moderate Nevro user; \"Doctors doing trials to make money was a big problem. Companies were charging $1,000 to $2,000 per lead and having doctor putting in 4 leads with no intent to do a permanent implant.\" — KOL and Nevro implanter; \"There are doctors looking to pump bodies through the clinic and install stimulators. There absolutely are. The trial should speak for itself. I never push the permanent implant. Florida is the big abuse state not only for stimulators but opioids. There are giant billboards on highways for cataract surgery and stimulators too.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-8f6aa3b85576",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f52e0bb8-052c-46cb-9484-e61ec5b7bd23",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "206d68c0-0a53-4945-88c2-ade1177d8351",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c1ce82a9-6313-4ae0-910f-149d599c3549",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "0e8763af-f1d0-4f9d-9c3f-99a75c77c13c",
          "evidence": "The slide frames doctors and the company as the antagonist in a narrative of patient exploitation.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 21:26:43.833+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 223,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 224,
      "type": "tension",
      "title": "Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 8,
        "textChars": 3082,
        "nDataPoints": 2,
        "notes": "Uses direct quotes from KOLs to substantiate claims of unethical billing and procedure practices.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:18.318+00",
          "seconds": 3.639,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/224",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-224",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We find this troubling as high volume implanters drive 90% of the SCS industry's revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-55c6366c7dc5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One KOL candidly admitted that he was “aggressive” in pushing trials and pointed to colleagues lining up “10 or 12 of them” one day a week with no intention of doing a permanent implant. Another KOL says he sees widespread abuse in his role working with an insurer, and that he just assumes that any high volume implanter is suspicious. We find this troubling as high volume implanters drive 90% of the SCS industry’s revenue.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "baa8ef47-ad17-4fb4-bebb-fa2ce23c9fbd",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.41
          },
          "kind": "quote",
          "text": "I work with an insurance company so I see lots of requests for stuff. When I see high stimulator volumes I’m suspicious. I deny a lot from some high volume implanters They do 5X more surgeries. You can make money on the trial, but you usually don’t make money on the implant. And there have been a lot of patients who are just trialed for no reason by shitty doctors just wanting to making money on the trial knowing full-well they’re not going to proceed with the implant. There’s a lot of crap going on in that regard. That’s been ripe for abuse.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "49502563-bc1b-4135-babb-c559b1735e0c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.67
          },
          "kind": "quote",
          "text": "We used to do a lot of trials and they were quite lucrative. Especially for a guy like me who did a lot and I’m kind of aggressive, like with my billing. They used to pay us per lead. So if you put in four leads, you’d make a lot of money. I would buy the equipment myself so that’s where all the money was instead of the hospital buying the equipment. There were a bunch of guys that were just putting in all these trials on Medicare patients, where you don’t have to get authorization. One day a week, they’d line up 10 or 12 of them. Put the trials in and I don’t know if they even cared about implanting a device after the trials.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "db81c8da-d63d-4621-9f79-ffcc60d1d06b",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"I work with an insurance company so I see lots of requests for stuff. When I see high stimulator volumes I'm suspicious. I deny a lot from some high volume implanters They do 5X more surgeries. You can make money on the trial, but you usually don't make money on the implant. And there have been a lot of patients who are just trialed for no reason by shitty doctors just wanting to making money on the trial knowing full-well they're not going to proceed with the implant. There's a lot of crap going on in that regard. That's been ripe for abuse.\" — KOL; \"We used to do a lot of trials and they were quite lucrative. Especially for a guy like me who did a lot and I'm kind of aggressive, like with my billing. They used to pay us per lead. So if you put in four leads, you'd make a lot of money. I would buy the equipment myself so that's where all the money was instead of the hospital buying the equipment. There were a bunch of guys that were just putting in all these trials on Medicare patients, where you don't have to get authorization. One day a week, they'd line up 10 or 12 of them. Put the trials in and I don't know if they even cared about implanting a device after the trials.\" — High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-59553ca159aa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9e44dd5c-c486-440d-9c2f-bebb9ddefc98",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c053200-d356-4ece-994c-21689cbf8abf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b232cd96-acb7-4e76-ba52-c7deb87b390a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "cf1b39af-0f7d-4738-b5b9-dc8ad88166ce",
          "evidence": "Uses expert testimony to allege systemic abuse and financial exploitation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:18.318+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 224,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 225,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs to frame the sales representatives as unethical actors.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 89,
        "componentCount": 13,
        "textChars": 3185,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs to frame the sales representatives as unethical actors.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "callout_box",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 21:26:45.32+00",
          "seconds": 10.322,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/225",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-225",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A KOL stated that reps are incentivized to manipulate patients during the trial phase with leading questions and coach them to provide false answers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-717f4ad4e7b9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "A KOL stated that reps are incentivized to manipulate patients during the trial phase with leading questions and coach them to provide false answers",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3de9dd43-118e-42a3-890b-bb0015d7a02c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.71
          },
          "kind": "list",
          "text": "A high volume KOL described stimulator reps as “all the same scum.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fad65fad-7cd2-4f9c-a705-fface952261a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.49
          },
          "kind": "list",
          "text": "KOL’s describe catching Nevro reps who are manipulating patients and banning them from the room",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fee2f141-9e55-4a04-b9f6-5341ab1fcaf4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.13,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Once patients are implanted with a trial, sales reps are then singularly focused on converting the patient into a permanent implant. The fact that reps interact directly with patients during this phase is troubling enough, but KOL’s described far worse dynamics: Nevro reps manipulating and pressuring patients and their families, and coaching patients to lie about the degree of pain relief. One KOL went so far as to describe reps as “scum,” although we caveat that we spoke with several who we found to be troubled by these abuses.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0f306930-39dd-41d8-a8ae-ed59616b811c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.83,
            "x": 0.11,
            "y": 0.33
          },
          "kind": "quote",
          "text": "Leading questions are one area of patient manipulation. I’ve caught reps specifically telling patients what they have to say. It’s an incentive-based thing for reps. Reps are very very incentivized to want the permanent implant and they’ll tell patients what to say. The rep will ask, what's your pain relief? A patient comes in and their pain is an eight, and after the trial implant the patients says well now it's a five. The rep says, if you want this device you'll have to say you have 50% pain relief, and you want the device right? And the patients says, \"Well I guess so, I mean, it helped me a little bit.\" - High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4b8ff7be-f70d-48b5-a18f-ba66e1054bc5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.83,
            "x": 0.11,
            "y": 0.75
          },
          "kind": "quote",
          "text": "Neuromodulation reps are all the same scum. Maybe that’s an overstatement. I just look at the reps that I interface with.” - KOL and former high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "85f4c0d7-d95b-4d3d-a4eb-94a3814696c3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.62
          },
          "kind": "quote",
          "text": "I’ve caught Nevro reps steering patients with leading questions a number of times. That’s why I don’t let them in the room anymore when I talk to patients. I want to ask what the patient’s pain level is. I want to talk to the patient before the rep goes in.’ - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef9076b1-ddb5-4820-adde-a3d4ed12c50b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.53
          },
          "kind": "quote",
          "text": "I’ve caught reps telling patients to say they have over 50% pain relief. I’ve asked reps to step out of the room while I ask patients whether the rep told them what to say. I’ve asked if the rep told them to use the phrase “my pain is 50%” because that’s an odd thing to say. So, the reps do lead them.” - High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f775ec09-8687-4af5-9ebb-a868cfd60e47",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Leading questions are one area of patient manipulation. I’ve caught reps specifically telling patients what they have to say. It’s an incentive-based thing for reps. Reps are very very incentivized to want the permanent implant and they’ll tell patients what to say. The rep will ask, what's your pain relief? A patient comes in and their pain is an eight, and after the trial implant the patients says well now it's a five. The rep says, if you want this device you'll have to say you have 50% pain relief, and you want the device right? And the patients says, \"Well I guess so, I mean, it helped me a little bit.\"” — High volume KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-7458b4b323d7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.87
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "77199434-3456-4623-99de-edcf6f8ef106",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2d29ebf4-a31b-4d40-a5b2-eb8da9a1d79b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dca16d48-f65d-4984-8f24-e709b7aa8c11",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "17c63637-8e0b-4554-b086-96639321bac5",
          "evidence": "The slide explicitly frames sales representatives as unethical manipulators to build a case against the company.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 21:26:45.32+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 225,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 226,
      "type": "tension",
      "title": "Uses direct quotes from KOLs (Key Opinion Leaders) to build a case of unethical business practices.",
      "function": "name_villain",
      "rawType": "villain_critique",
      "block": null,
      "metadata": {
        "slideType": "villain_critique",
        "slideTypeCanon": {
          "name": "Villain critique",
          "slug": "villain_critique",
          "status": "active",
          "canonId": "019de52d-10bc-7136-bf20-09de59d17447",
          "version": 1,
          "description": null
        },
        "function": "name_villain",
        "functionCanon": {
          "name": "Name villain",
          "slug": "name_villain",
          "status": "active",
          "canonId": "019de52d-1746-70d6-bc58-5eeaf5865526",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 1667,
        "nDataPoints": 1,
        "notes": "Uses direct quotes from KOLs (Key Opinion Leaders) to build a case of unethical business practices.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:23.489+00",
          "seconds": 8.468,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/226",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-226",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-582b5b6fcba6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.31
          },
          "kind": "list",
          "text": "A KOL stated that Nevro reps bombard patients during the trial phase",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "12d3e39b-4fcf-43a4-9220-7e62ff6d3430",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.61
          },
          "kind": "list",
          "text": "A KOL and Nevro implanter indicated that the company, more recently began pressuring reps to allow implants when not medically warranted and bemoaned the lack of regulation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "76d6bd76-9802-4f32-88db-5042734d8e18",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One KOL stated that Nevro reps were the worst offenders in badgering and manipulating patients during the trial. Another opined that Nevro began pressuring reps more so in the last 18 months to push implants when not medically warranted, which we note coincided with about when Grossman came on as CEO and began to push trials. He added that the industry is “not well regulated.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3de7d7c9-46f1-42ca-9ee4-d106cd141dc4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.82,
            "x": 0.12,
            "y": 0.69
          },
          "kind": "quote",
          "text": "Nevro was strict on patient selection early on then they started recommending their device for everything... There's pressure on them. They have to generate X number of patients. The industry is not well regulated.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4feafdda-a7e1-4152-b167-66b85a36e485",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.82,
            "x": 0.12,
            "y": 0.36
          },
          "kind": "quote",
          "text": "Reps will hammer patients with questions... According to my patients that have a Nevro trial, they'll get on average of ten calls over the course of two days.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "835bfef1-1eaf-4d7d-ad8e-8bb3e986ac3c",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Reps will hammer patients with questions... According to my patients that have a Nevro trial, they'll get on average of ten calls over the course of two days.\" — KOL; \"Nevro was strict on patient selection early on then they started recommending their device for everything. They overshot... There's pressure on them. They have to generate X number of patients. The industry is not well regulated.\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:49+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-5f98ab3d26e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ad4aa60-5906-4307-8e25-d24b1524b4f0",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80cc346f-5614-4fb4-b6e6-dfa78135582b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8625fb39-ea4f-49ce-85c3-5a4d37962c88",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c848cfb2-893b-4976-9283-4ca801e04894",
          "evidence": "The slide explicitly frames Nevro's management and sales practices as the 'villain' causing patient harm.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:23.489+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 226,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 227,
      "type": "tension",
      "title": "Uses testimonials from former executives and KOLs to support the thesis of financial abuse.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 85,
        "componentCount": 10,
        "textChars": 2708,
        "nDataPoints": 0,
        "notes": "Uses testimonials from former executives and KOLs to support the thesis of financial abuse.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:19.664+00",
          "seconds": 4.431,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/227",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-227",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-d10f067b0a34",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.43
          },
          "kind": "list",
          "text": "Nevro’s stimulators are mostly implanted at doctor-owned ambulatory surgery centers (ASC’s) which greatly magnifies the incentivize to push and overutilize trials and stimulators versus hospitals.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b02f04dc-da08-4eb0-96a5-ea8644e03f40",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.04,
            "w": 0.88,
            "x": 0.06,
            "y": 0.23
          },
          "kind": "list",
          "text": "A former Nevro executive stated that doctors make far money for a trial than a permanent implant, leading them to proliferate trial volumes.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bb349808-4207-4da7-a726-6967f9071b70",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL’s and former executives outlined the distorted financial incentives that lead to abuse around trials. Trials are extremely lucrative, while permanent implants may lose money. Doctors therefore push patients into trials with no intention of doing a permanent implant. The problem is exacerbated by doctor-owned ASC’s which drive the vast majority of stimulator volume.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c88652c8-bc7e-401c-9582-65b249a9f37f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.85,
            "x": 0.09,
            "y": 0.28
          },
          "kind": "quote",
          "text": "Pain doctors don’t make a lot of money implanting stimulators. They make more money trialing. You can make thousands of dollars trialing a procedure. In the past you used to be paid per electrode, so Boston Scientific created a 16 electrode lead and the government figured out what was happening and then they reimbursed by lead not electrode. You can make $5,000 to $8,000 for a trial and a couple of hundred to a couple of thousand for implantation. It’s not very lucrative to implant. It’s always been that way.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "999517e2-e024-43e6-92f7-5c83a68eb5f6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.85,
            "x": 0.09,
            "y": 0.48
          },
          "kind": "quote",
          "text": "I'd say the majority of stim is done in ASC's, in the pain world. If you own your own ASC you're more likely to push stim therapy and stim trials and implants on your patients. If you are a hospital employee, you're likely to not care as much and your utilization is going to be far less for a given hundred patients.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ce507979-32c3-43bf-9782-12f3b63b2dd1",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "Pain doctors don't make a lot of money implanting stimulators. They make more money trialing. You can make thousands of dollars trialing a procedure. In the past you used to be paid per electrode, so Boston Scientific created a 16 electrode lead and the government figured out what was happening and then they reimbursed by lead not electrode. You can make $5,000 to $8,000 for a trial and a couple of hundred to a couple of thousand for implantation. It's not very lucrative to implant. It's always been that way. — Former Nevro executive; I'd say the majority of stim is done in ASC's, in the pain world. If you own your own ASC you're more likely to push stim therapy and stim trials and implants on your patients. If you are a hospital employee, you're likely to not care as much and your utilization is going to be far less for a given hundred patients. — One of Nevro's highest volume KOL's",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-d516a2dd037f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38b19df2-710a-4854-a42f-d42c4ed4ca41",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f419e234-acc5-4c07-90e2-53fa8fa912e9",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "48465a37-74d9-4ff1-be7f-fc4720608eff",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "7aed3e31-159c-4969-9828-e470acffadc2",
          "evidence": "The slide explicitly frames the business model as a mechanism for financial abuse and over-utilization.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:19.664+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 227,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 228,
      "type": "tension",
      "title": "Uses KOL (Key Opinion Leader) quotes to frame the company's business model as exploitative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 83,
        "componentCount": 10,
        "textChars": 1776,
        "nDataPoints": 0,
        "notes": "Uses KOL (Key Opinion Leader) quotes to frame the company's business model as exploitative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:19.169+00",
          "seconds": 3.403,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/228",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-228",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "KOL's indicated that the problem is so pervasive that patients are then stranded and dumped as the doctor who did the trial has no desire to do a permanent implant.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-b9f9975bf6fe",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.52
          },
          "kind": "list",
          "text": "Another outlined a pervasive pattern of doctors pushing trials onto patients who “shouldn’t be implanted,” fueled by sales reps, and then stranding them.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ae24bf7-3e41-4e54-9b35-16f3de504912",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.25
          },
          "kind": "list",
          "text": "A KOL indicated that while doctors always make money on trials, it's hit or miss for permanent implants by payor, creating incentives to dump the patient after the trial.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c09eec4c-0fd3-4e17-a33c-108cd6f33ce4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "KOL's indicated that the problem is so pervasive that patients are then stranded and dumped as the doctor who did the trial has no desire to do a permanent implant.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "38e18aac-1daa-46d0-85c6-6c6cb19947a5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.83,
            "x": 0.11,
            "y": 0.33
          },
          "kind": "quote",
          "text": "With the trials, you always make money. For the implanted device, it really depends on which payor... If a trial is done somewhere else and we do the implanting, the hospital will lose money, so there are a lot of situations like that.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "c7369610-ec33-405b-aa87-2836532466a4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.6
          },
          "kind": "quote",
          "text": "I get patients for implants that, quite frankly, shouldn't be implanted... They're all out there. They're all the reps. They all get paid on commission. What they're doing is, \"I'll do the trial and make money in my surgery center.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Pull quote",
              "slug": "pull-quote",
              "status": "active",
              "canonId": "019de52c-fbf9-76fe-97e1-a0b7540445c9",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "pull-quote",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cf72ca3d-4bf1-4bfc-8249-94c735889a3d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"With the trials, you always make money. For the implanted device, it really depends on which payer... If a trial is done somewhere else and we do the implanting, the hospital will lose money, so there are a lot of situations like that.\" — KOL; \"I get patients for implants that, quite frankly, shouldn't be implanted... What they're doing is, 'I'll do the trial and make money in my surgery center. I don't want to do the implant because I'm not going to make money on it.'\" — KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-becb196e88b5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "dccde88c-19e2-450b-98a2-54dafa76fac4",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "63e4fdbc-c5a6-404f-a42c-343452e7d17b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5c34d38d-95a3-49ce-a695-3d30fb3c651e",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "66cd8ac5-c092-4a46-93df-1f657b9d2a9d",
          "evidence": "Frames doctors and sales reps as the antagonists exploiting patients for profit.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:19.169+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 228,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 229,
      "type": "tension",
      "title": "Uses direct quotes from former employees to build a case of unethical business practices.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 92,
        "componentCount": 10,
        "textChars": 2817,
        "nDataPoints": 5,
        "notes": "Uses direct quotes from former employees to build a case of unethical business practices.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.117+00",
          "seconds": 4.95,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/229",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-229",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The wild west dynamic is far from a bug: it is a feature specifically engineered, in our opinion, to promote over-utilization and the abuses that KOL’s describe.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-0b21c5f9b3df",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.6,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "A former Nevro executive stated that trial leads are basically given away",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0880312e-f91d-4859-b541-9d3df99e84e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.48
          },
          "kind": "list",
          "text": "A former Nevro district manager explained that low-cost leads enable doctors to make almost $10,000 on a trial, creating a powerful motivation to implant patients who are questionable candidates",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bf0b8417-5362-413b-a78c-ff023f8d71a1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Former executives and reps revealed a key lever by which Nevro fans these flames. On top of aggressively incentivizing reps to convert patients from trial to permanent implant, doctors are given free or low-cost trial leads, creating a powerful financial motivation to jam patients into trial stimulators. The wild west dynamic is far from a bug: it is a feature specifically engineered, in our opinion, to promote over-utilization and the abuses that KOL’s describe.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ae7ae3ae-7dda-4ec3-ba03-608404e4e688",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.85,
            "x": 0.09,
            "y": 0.55
          },
          "kind": "quote",
          "text": "A lot of doctors own a surgical center and Medicare reimbursement at ASC’s for doing a trial is $4686 per lead, and how much are the companies selling the leads to the surgical centers for? Say $500. So, you do two leads, you can buy it for a thousand, now you've gotten back 100% of $4686 times two or let's just say $9000, but since it's Medicare, Medicare pays 80% of that, and then hopefully they have a co-insurance, and the co-insurance picks up the 20% that the Medicare does not. So, now I'm an ASC owner, and I'm a doctor. What do I do when I see questionable patients and injection pays $30?",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0a3d6167-3506-49c2-b658-f2f0b17fb4cf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.85,
            "x": 0.09,
            "y": 0.31
          },
          "kind": "quote",
          "text": "Trial leads are often given to a facility for like $100, sometimes even less. They're trying to incent physicians to do trial leads. The idea from a company's perspective is that if we get the trial we're going to sell a stimulator for $25,000. There are those sorts of things that are happening. Centers negotiate very low prices on the actual trial leads themselves. They're just trying to maximize their margin and some physicians leverage the number of trials they do to get the lowest price, so if they don't get $100 from Boston Scientific they will go to Nevro or Medtronic might give them free trial leads.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6dbf4924-bd8c-4c62-8928-7f01dddff69a",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Trial leads are often given to a facility for like $100, sometimes even less. They're trying to incent physicians to do trial leads. The idea from a company's perspective is that if we get the trial we're going to sell a stimulator for $25,000.\" — Former Nevro executive; \"A lot of doctors own a surgical center and Medicare reimbursement at ASC's for doing a trial is $4686 per lead... so, now I'm an ASC owner, and I'm a doctor. What do I do when I see questionable patients and injection pays $30?\" — Former Nevro district manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-0ffb4308bcec",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "66dae770-a5e1-49c5-a17f-840f9d9823e3",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f51a9745-430d-44ee-b29b-e4141a39059d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.117+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "456135f2-9c90-4260-9868-22863585acd3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 230,
      "type": "tension",
      "title": "Uses testimonial evidence to frame the company's business model as unethical.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 90,
        "componentCount": 10,
        "textChars": 2709,
        "nDataPoints": 2,
        "notes": "Uses testimonial evidence to frame the company's business model as unethical.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.166+00",
          "seconds": 4.918,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/230",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-230",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One estimated that 25-50% of Nevro’s revenue comes from surgery centers pushing patients into \"one stimulator and then another and then another.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-ec48df47c86e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "A former Nevro territory manager, part of the original launch team and one of the most experienced reps in the SCS industry, estimated that 25-50% of the company's revenue comes from pushing replacement devices via ASC's seeking to profit.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9a0a8404-330f-470f-a23d-2f60bd61fd53",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.05,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "list",
          "text": "A former Nevro sales rep \"didn't like the ethics\" of the company's push to sell upgrades, subjecting patients to infection risk from repeated implants in the same location",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ee7b61c5-6fae-477d-95f5-944ae628ea3a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Aside from pushing trials and permanent implants onto patients who don't need them, former Nevro sales reps described another troubling revenue driver: pushing unnecessary implant upgrades. Reps questioned the ethics of the company's push, stating that repeated implants and removals at the same site led to infection risk. One estimated that 25-50% of Nevro's revenue comes from surgery centers pushing patients into \"one stimulator and then another and then another.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4c00bfdf-8375-46d0-9ed5-71600b77e773",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.83,
            "x": 0.11,
            "y": 0.34
          },
          "kind": "quote",
          "text": "\"Yes, yes, yes - some of the growth is that patients are getting one stimulator and then another and then another as the new ones come out. I don't think Nevro, coming out of the gates in 2015, thought a lot of the market was repeat business. I think they didn't learn that until they started down the road of being in the business of it. I'll be conservative and say 25% of the market is repeat business and the more aggressive number is 50%. Why? Because if you're an ASC owner, by changing the battery, there's revenue involved. If you don't change the battery, there's only the professional fee and a small fee for doing the movement of the battery.\" - Former Nevro territory manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "a594c300-1e27-4ff3-a8e2-46511933bd47",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.83,
            "x": 0.11,
            "y": 0.6
          },
          "kind": "quote",
          "text": "\"We were pushing replacements of old devices. A number of things can go wrong when you open up the pocket where the device is implant. You're automatically not MRI-compatible and these patients need MRI's. There was a push to sell upgrades when I was there. I didn't like the ethics. There's infection risk when you do the surgery.\" - Former Nevro sales rep",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e783580d-4bc6-49ff-bf67-8c8cbd93fa62",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Yes, yes, yes - some of the growth is that patients are getting one stimulator and then another as the new ones come out... I'll be conservative and say 25% of the market is repeat business and the more aggressive number is 50%.\" — Former Nevro territory manager; \"We were pushing replacements of old devices... There was a push to sell upgrades when I was there. I didn't like the ethics. There's infection risk when you do the surgery.\" — Former Nevro sales rep",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34a-f294ee6a5120",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "9fb26c89-f393-46f3-aaf8-6c55fc126278",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro's sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5496b041-b110-4482-a05a-26da3c9c6287",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.166+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f22ee3b-311f-4af1-9c32-3cf92bb5ecde",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 231,
      "type": "tension",
      "title": "The slide uses quotes from KOLs and executives to frame the company's revenue model as exploitative.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 93,
        "componentCount": 13,
        "textChars": 3290,
        "nDataPoints": 1,
        "notes": "The slide uses quotes from KOLs and executives to frame the company's revenue model as exploitative.",
        "elementsJson": [
          "headline_text",
          "bullet_list",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.19+00",
          "seconds": 4.599,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/231",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-231",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Exploiting individual patients are sources of recurring implant revenue is so prevalent that one KOL described stimulators as simply “a lease that you trade in.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-3e3d2f0991f5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.42
          },
          "kind": "list",
          "text": "A longtime C-level executive described it as “flipping implants” whether patients need a new one or not",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "678558d2-dc58-4a75-b8f3-58b7053be68c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.54
          },
          "kind": "list",
          "text": "KOL’s and territory managers described pain practices seeking to make money on repeated device removals in the same patient, on top of reimbursement for the repeated new implants",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bda970b9-f9ef-4a02-a797-ae9e6484db5c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.27
          },
          "kind": "list",
          "text": "Repeated implants are so prevalent that one KOL described stimulators as just “lease that you trade in,” implying the industry is run by the same questionable doctors who fomented the opioid crisis",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "List",
              "slug": "list",
              "status": "active",
              "canonId": "019de52c-f94b-779b-a53b-fd4904a5f4d2",
              "version": 1,
              "description": "Bullet or numbered list."
            },
            "tool": null,
            "subkind": {
              "name": "Bullet list",
              "slug": "bullet",
              "status": "active",
              "canonId": "019de52c-fc98-7169-a083-5cab805076ca",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "bullet",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "ef938efb-ac29-45e0-8ee3-e07920c78ad2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Exploiting individual patients are sources of recurring implant revenue is so prevalent that one KOL described stimulators as simply “a lease that you trade in.” An executive in the space described the practice as “flipping implants.” Disturbingly, reps describe pain practices seeking to profit from both multiple implants as well as multiple removals in the same patient, which one said is “like going long and short.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "51ae84b5-1852-430e-82b1-0ee297b7caaa",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.7
          },
          "kind": "quote",
          "text": "“There’s a whole group of doctors down the street. They suck patients in. They implant the device at their surgery centers because they can make a fat amount of cash. They put it in and if they explant it, who cares? An explant is just another surgery they can bill for, so let’s take it out.” - High volume KOL and former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "36dbc23b-93de-4e83-a995-e36323495791",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.08,
            "w": 0.83,
            "x": 0.11,
            "y": 0.61
          },
          "kind": "quote",
          "text": "“Medicare pays them to do the explant. If Medicare doesn’t pay, I guarantee they won’t explant. They get paid on both sides. It’s like going long and short. Premier Pain will put them in, take them out, put them in, take them out.” - Territory manager at a large Nevro competitor",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "4d05f8d6-e1a3-4ab1-bbb4-55d84b1ccf19",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.46
          },
          "kind": "quote",
          "text": "“One of their top reps is in [city redacted], Whether a patient needed it or not, he had his doctors flip those implants. He did $6-7 million in revenue in one year just because of those flips.” - SCS executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "766e059b-42cc-460d-8922-93d5cff11bdb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.83,
            "x": 0.11,
            "y": 0.34
          },
          "kind": "quote",
          "text": "“Stimulators have a reputation as a lease that you trade in. It’s probably the same guys who were selling opioids. They’re not the academics, not the ones coming to conferences and meetings.” - KOL",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bed75ebd-3795-4e8c-b295-9d9ca6544383",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Stimulators have a reputation as a lease that you trade in. It’s probably the same guys who were selling opioids. They’re not the academics, not the ones coming to conferences and meetings.” — KOL; “One of their top reps is in [city redacted], Whether a patient needed it or not, he had his doctors flip those implants. He did $6-7 million in revenue in one year just because of those flips.” — SCS executive; “Medicare pays them to do the explant. If Medicare doesn’t pay, I guarantee they won’t explant. They get paid on both sides. It’s like going long and short. Premier Pain will put them in, take them out, put them in, take them out.” — Territory manager at a large Nevro competitor; “There’s a whole group of doctors down the street. They suck patients in. They implant the device at their surgery centers because they can make a fat amount of cash. They put it in and if they explant it, who cares? An explant is just another surgery they can bill for, so let’s take it out.” — High volume KOL and former Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-400964579ed5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "752aa7ea-abab-4b0e-8185-5bd58733f89f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.85,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2f5362f4-30ec-40b1-ac25-b293c940344f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e6dc5561-ed30-46ec-9151-7ba34024daf3",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "37d9b4a0-d974-4467-a30e-6ba0bf5e38c7",
          "evidence": "The slide frames the company and its associated doctors as the 'villain' exploiting patients for profit.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:21.19+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 231,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 232,
      "type": "tension",
      "title": "The slide uses testimonials to frame the company's business model as predatory.",
      "function": "expose_contradiction",
      "rawType": "quote_slide",
      "block": null,
      "metadata": {
        "slideType": "quote_slide",
        "slideTypeCanon": {
          "name": "Quote slide",
          "slug": "quote_slide",
          "status": "active",
          "canonId": "019de52d-098e-7555-a9fd-4f0af7e80bc2",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 80,
        "componentCount": 9,
        "textChars": 1956,
        "nDataPoints": 0,
        "notes": "The slide uses testimonials to frame the company's business model as predatory.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.167+00",
          "seconds": 4.472,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/232",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-232",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "A former Nevro executive shared his dismay at patients being “flipped” and painted a sordid picture of “bad actors” hustling patients into the company’s stimulators and threatening to cut off their opioid refills as leverage to force them into the device.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-8a662498a21c",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A former Nevro executive shared his dismay at patients being “flipped” and painted a sordid picture of “bad actors” hustling patients into the company’s stimulators and threatening to cut off their opioid refills as leverage to force them into the device.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2a859701-f203-42a8-bc1d-e6df687fe061",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "There are definitely some doctors —they're business spend first—that's probably the easiest way to describe it, and they really know how to maximize every patient that walks through that door. So, they switch them to Nevro.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "2190ca14-3213-4e33-bc8d-d4b26c9f1717",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.77
          },
          "kind": "quote",
          "text": "At both [key Nevro competitor] and Nevro, I saw doctors that only did trial implants because they could bill for it and wanted no responsibility for the patient after. The doctor doesn’t care what happens after the implant.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27212d22-5e88-46ab-a327-d0aca3953d71",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.59
          },
          "kind": "quote",
          "text": "Doctors ditching responsibility – we saw quite a bit of this. We’d get pushback when we’d go back to the doctor who did implant. The doctor didn’t want responsibility when Nevro’s group opened an investigation.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "e3da3311-22f9-4247-9f0f-01b7240524fc",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“There are definitely some doctors —they're business spend first—that's probably the easiest way to describe it, and they really know how to maximize every patient that walks through that door. So, they switch them to Nevro. Bad actors are putting in implants over and over and switching brands. Selling that patient on there's something better, always keeping that carrot out there, that there's something new, there's something different that might be the magic pill. And then he also says, if you don't do what I recommend, I'm going to cut you off from your opioids, so there's that.” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-8e6f2c7daa53",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8bd981a2-dde7-49c0-ad24-73e9a9271a88",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "10b49379-649a-41b7-88ac-0f8396193c6e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3954b466-b427-4740-8566-2bad7ca86d01",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "06bb6b28-2f45-4be6-ae07-8d3ee76ca684",
          "evidence": "The slide uses expert testimony to allege systemic unethical behavior and patient exploitation.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:21.167+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 232,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 233,
      "type": "tension",
      "title": "Uses direct quotes from high-volume implanters to substantiate claims of systemic abuse in specific US regions.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 81,
        "componentCount": 8,
        "textChars": 4045,
        "nDataPoints": 1,
        "notes": "Uses direct quotes from high-volume implanters to substantiate claims of systemic abuse in specific US regions.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.712+00",
          "seconds": 4.91,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/233",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-233",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "18, Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-71869e6f94fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One of Nevro’s highest volume implanters elaborated on pain practices threatening to cut off monthly opioid refills to pressure patients into stimulators, and estimated that a stunning 30% or more of implanters in his region – one of the largest metro’s in Florida – are bad actors. He stated that main source for stimulator patients are pain clinics that also traffic in opioids, which doctors use to “bait” patients into stimulators. He noted that as the state cracked down on opioid abuse, stimulator volumes declined. Another of Nevro’s highest volume implanters, in New York, described New Jersey, Texas, Florida, and Louisiana as notable pockets of abuse, and stated that companies like Nevro are happy to engage with “those docs if they see some legitimacy of usage.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "69f24f9c-8a85-41a9-979d-1865d378f2fb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "The number of stimulator patients declined because in Florida, unfortunately, there are a lot of bad actors and there were a lot of people on pain medication that shouldn’t have been and a lot of the patients that funneled into stimulators were those. Their bait is to offer medication, and once patients were engaged with these drugs, they would do whatever was financially appropriate for themselves, so those are the bad actors. When a patient is on opioids, they have to come in monthly which gives the doctor the chance to convince them to do anything or otherwise their opioids will get discontinued. We saw that occur for years. That’s really bad. Yeah, it is a complicated situation. If we’re talking about my region [large metro redacted] I would say that at least 30% of the doctors implanting stimulators are bad actors.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "06e1302d-2726-494a-9bdd-00cf0237c2e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.68
          },
          "kind": "quote",
          "text": "New Jersey is probably a pocket of abuse. They have a high rate of usage in the workers comp and Medicare population and then you see it a lot in Texas and Florida and Louisiana. They’re doing a high rate of trials, a high rate of implants. They have surgery centers and have a very high rate of usage of any interventional therapy, stim included. You do a lot of injections, then you do your stim and then you continue your injection and then maybe revise the stim or you swap it out or put something else and that kind of stuff. Stimulator companies are happy to engage with those docs if they see some legitimacy of usage.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "598e0a92-c1f2-4255-ac7d-6dc8ccaa3118",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "The number of stimulator patients declined because in Florida, unfortunately, there are a lot of bad actors and there were a lot of people on pain medication that shouldn't have been and a lot of the patients that funneled into stimulators were those. Their bait is to offer medication, and once patients were engaged with these drugs, they would do whatever was financially appropriate for themselves, so those are the bad actors. When a patient is on opioids, they have to come in monthly which gives the doctor the chance to convince them to do anything or otherwise their opioids will get discontinued. We saw that occur for years. That’s really bad. Yeah, it is a complicated situation. If we’re talking about my region [large metro redacted] I would say that at least 30% of the doctors implanting stimulators are bad actors. — High volume Nevro implanter in Florida; New Jersey is probably a pocket of abuse. They have a high rate of usage in the workers comp and Medicare population and then you see it a lot in Texas and Florida and Louisiana. They’re doing a high rate of trials, a high rate of implants. They have surgery centers and have a very high rate of usage of any interventional therapy, stim included. You do a lot of injections, then you do your stim and then you continue your injection and then maybe revise the stim or you swap it out or put something else and that kind of stuff. Stimulator companies are happy to engage with those docs if they see some legitimacy of usage. — High volume Nevro implanter in New York",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-760195e8100b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "27c1e7c3-8f1e-490d-af39-beab93006953",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "Over-utilization, unnecessary implants, and patient exploitation are key drivers of Nevro’s sales",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fae217dc-3474-4845-a38d-4028708ac31b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "8ff2a3f3-1e69-4926-95ec-3a6518c846ae",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "01f61783-abf7-434e-b85e-81afc89c9697",
          "evidence": "The slide uses expert testimony to expose alleged unethical and fraudulent business practices.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:21.712+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 233,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 234,
      "type": "tension",
      "title": "The slide uses a 'villain critique' approach by framing the company's core operational model as a criminal liability.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 79,
        "componentCount": 8,
        "textChars": 1744,
        "nDataPoints": 4,
        "notes": "The slide uses a 'villain critique' approach by framing the company's core operational model as a criminal liability.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.215+00",
          "seconds": 3.911,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/234",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-234",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "If his description of reps' role before, during, and after the implant is even half accurate, we believe Nevro is one internal whistleblower or inquisitive DOJ attorney away from its business model imploding.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-b5c635440745",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Investors are oblivious to one of Nevro's greatest risks: its business model, far more than any other stimulator company, is predicated – in our opinion – on reps and other employees engaging in the unauthorized practice of medicine.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "80c4a32f-1296-461e-ae97-3e46e9099de2",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.48
          },
          "kind": "quote",
          "text": "In an average territory with an average team, they're spending 40% of their time in the OR. They're spending 40% of their time reprograming and patients visits and 20% of the time on sales.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "232910e7-d7e4-4acc-9ef8-932325add359",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.72
          },
          "kind": "quote",
          "text": "Inter-operatively, most doctors will say [to the rep]: \"How does that look?\" \"Do you think that the lead placement is fine looking at the X-ray?\" \"Looking at your testing that you're doing right now, do you think we're good?\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "5e25de96-9ef1-4edb-a616-6965b5e88b17",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“In an average territory with an average team, they’re spending 40% of their time in the OR. They’re spending 40% of their time reprograming and patients visits and 20% of the time on sales... We take images of X-rays. We do inter-op tests to make sure that the leads are in the right area.” — Former district sales manager; “Inter-operatively, most doctors will say [to the rep]: ‘How does that look?’ ‘Do you think that the lead placement is fine looking at the X-ray?’ ‘Looking at your testing that you’re doing right now, do you think we’re good?’ And then the rep and the doctor will make that decision on if the lead should be moved up or down or if they think it’s good.” — Former district sales manager",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-b8315dae1d63",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b4b0be1e-5c66-433f-a73f-326b59575b3d",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "15a701a6-5a10-46c7-893d-f8667983f127",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "56f31dce-7d26-454a-97a9-ae28fc00fe0a",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "68bb9f51-989e-4ceb-a2d8-f0303c970735",
          "evidence": "The slide explicitly frames the company's business model as a criminal liability to expose potential fraud or regulatory risk.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:21.215+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 234,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 235,
      "type": "tension",
      "title": "The slide uses direct quotes from KOLs and high-volume implanters to build a case for regulatory/legal risk regarding the unauthorized practice of medicine.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 4279,
        "nDataPoints": 0,
        "notes": "The slide uses direct quotes from KOLs and high-volume implanters to build a case for regulatory/legal risk regarding the unauthorized practice of medicine.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.788+00",
          "seconds": 4.472,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/235",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-235",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:52+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3e-76f7-b9d5-b80adf251284",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "A KOL took the rep's characterization of his role even further, and stated that stimulator reps have a “very unique” role versus typical reps because “You have clinic hours” and “You actually have patients.” He stated what reps are “legally, ethically, appropriately” supposed to do versus their actual conduct. A second implanter, one of Nevro's highest volume users, stated that he simply outsources patient care to reps if they still have pain after implant. He stated that reps use x-rays to diagnose the patient and to re-program the device, and that if the rep fails, that a central call center – the “Therapy Optimization Team” – takes over.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98a0e62e-64d4-412b-8def-17594e2e8d2b",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.45
          },
          "kind": "paragraph",
          "text": "Question: “Isn't that kind of a risk? A rep isn't licensed to practice medicine.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d4fd986b-0d6a-4e36-b648-857722a1849e",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.9,
            "x": 0.05,
            "y": 0.49
          },
          "kind": "quote",
          "text": "Who has more experience programming the device - me or somebody who spends their entire life programming stimulators? Being a stimulator rep is not like being a pharma rep selling Viagra. You have clinic hours. It's a very unique sales position. You actually have patients. You actually come into clinic. I'll walk by a room and go, oh, Mike the rep is in room three and he's programming somebody. Cool, I didn't even know. I can make recommendations to reps but they're really the experts in programming.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "1fa59731-0e82-40e0-b7cb-ed12d4e52db1",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.9,
            "x": 0.05,
            "y": 0.66
          },
          "kind": "quote",
          "text": "If a patient is not responding or the pain comes back, I have the rep come talk to them. They can check in a rough way whether the leads have moved so in most cases, they get an X-ray of the leads before they come in so they have a better idea of how to program it. If it's just that the therapy has diminished, then Nevro has a special group of clinical specialists that manage those cases remotely and guide the representatives on what to do if they cannot solve the problem themselves. Now, if everything is in place and everything is functioning as expected, but a patient is not getting pain relief, that's when they start trying other programs and they start engaging the Therapy Optimization Team as Nevro calls it.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "427c777c-4f08-4eba-8455-1d93e022afe7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.9,
            "x": 0.05,
            "y": 0.31
          },
          "kind": "quote",
          "text": "Programming is usually done by the rep. I have a programming computer, but the reps do it all day long. Legally, ethically, appropriately, the rep is supposed to meet the patient in my office. The reality is that some of them meet at the patient's house. They're not supposed to do that. They'll go to their house and they'll hook up their programmer and they'll program right there.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7248016e-d7f7-4378-b71f-c205ea19327e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Programming is usually done by the rep. I have a programming computer, but the reps do it all day long. Legally, ethically, appropriately, the rep is supposed to meet the patient in my office. The reality is that some of them meet at the patient's house. They're not supposed to do that. They'll go to their house and they'll hook up their programmer and they'll program right there.\" — KOL; \"Who has more experience programming the device - me or somebody who spends their entire life programming stimulators? Being a stimulator rep is not like being a pharma rep selling Viagra. You have clinic hours. It's a very unique sales position. You actually have patients. You actually come into clinic. I'll walk by a room and go, oh, Mike the rep is in room three and he's programming somebody. Cool, I didn't even know. I can make recommendations to reps but they're really the experts in programming.\" — KOL; \"If a patient is not responding or the pain comes back, I have the rep come talk to them. They can check in a rough way whether the leads have moved so in most cases, they get an X-ray of the leads before they come in so they have a better idea of how to program it. If it's just that the therapy has diminished, then Nevro has a special group of clinical specialists that manage those cases remotely and guide the representatives on what to do if they cannot solve the problem themselves. Now, if everything is in place and everything is functioning as expected, but a patient is not getting pain relief, that's when they start trying other programs and they start engaging the Therapy Optimization Team as Nevro calls it.\" — High volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:52+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3e-76f7-b9d5-bdcb54f06649",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.05,
            "y": 0.95
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "cbb99c1b-8700-4072-8ca8-aa97c00825d8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.9,
            "x": 0.05,
            "y": 0.09
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b8429e11-da74-4e28-bc34-c5333bfb03ed",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.05,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "943dc3ce-b0b8-4e3a-9ffd-7d2e76159bc8",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "09bdd715-ad2d-48cf-ba08-65c5d323d713",
          "evidence": "The slide explicitly frames the business model as an illegal practice of medicine, a common tactic in activist short-selling reports to expose regulatory/legal risk.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:21.788+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 235,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 236,
      "type": "tension",
      "title": "Uses a quote from a former executive to support the claim of unauthorized medical practice.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 77,
        "componentCount": 8,
        "textChars": 4040,
        "nDataPoints": 0,
        "notes": "Uses a quote from a former executive to support the claim of unauthorized medical practice.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:21.823+00",
          "seconds": 4.156,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/236",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-236",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "We particularly note the role of reps and the central team in managing side effects such as “over-stimulation” - given the complex and multi-factorial nature of pain management, we question how reps are making clinical diagnoses of “over-stimulation” and determining its cause and treatment.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34c-2e8a2afb8fbf",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.25,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "A former Nevro executive described the role of the central patient support and programming team – and that of reps generally – in a manner we believe to be identical to the practice of medicine: having “a list of patients they were in charge of”; “high patient contact”; using trial and error to direct the correct dosage of stimulation. Determining dosage goes to the heart of practicing medicine. He stated that this central team was unique to Nevro’s business model and driven by the programming-intensive nature of high frequency. We particularly note the role of reps and the central team in managing side effects such as “over-stimulation” – given the complex and multi-factorial nature of pain management, we question how reps are making clinical diagnoses of “over-stimulation” and determining its cause and treatment.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "191ef7b7-cf3f-41a4-bce5-9c85fd623071",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.18,
            "w": 0.88,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "quote",
          "text": "“Nevro had high patient contact. They had to develop a structure to support patients because high frequency stimulation didn’t result in immediate feedback to the patient. With low frequencies, the patient gets immediate feedback. With HF, there’s no paresthesia and feedback. You have to change the program, then wait 24 to 48 hours. Overstimulation exceeds the patient’s problem threshold. The patient then says I’m in worse pain now than before the surgery. We’d need to turn off the device for 24 to 48 hours and shut the patient down to wash the stimulation out of their system.” – Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "bef05883-44fa-4e99-ac57-f095bfbf946f",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.3,
            "w": 0.88,
            "x": 0.06,
            "y": 0.41
          },
          "kind": "quote",
          "text": "“Nevro put together a brand new patient support and programming team. It’s role was to work with patients, call the patient on a daily basis, and advise the patient to turn the stimulator on or off. It was a big organization. They would have a list of patients they were in charge of. They would call them daily during the trial, right after, after the procedure, to make sure the stim is set correctly. No other neuromodulation company had that. It was unique to HF10. A lot of times the patient had to be patient. We’d lower or increase the stimulation. We’d start at a low frequency, would wait 24 to 48 hours, would increase it by 1, then wait, then increase it again. For one algorithm, you’d spend a week and a half just on that algorithm. The reps would ask on the phone if you’re getting pain coverage, take notes, then add 3 milliamps. They’d have to go through this over the next 3 to 4 weeks to get correct coverage. If they didn’t get correct pain coverage, they’d have to bring the patient back in for reprogramming to see which programs work or don’t work.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "f21eb780-2b5d-4004-bbb2-26e92e40302e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "“Nevro put together a brand new patient support and programming team. It’s role was to work with patients, call the patient on a daily basis, and advise the patient to turn the stimulator on or off. They would have a list of patients they were in charge of. They would call them daily during the trial, right after, after the procedure, to make sure the stim is set correctly. No other neuromodulation company had that. It was unique to HF10. A lot of times the patient had to be patient. We’d lower or increase the stimulation. We’d start at a low frequency, would wait 24 to 48 hours, would increase it by 1, then wait, then increase it again. For one algorithm, you’d spend a week and a half just on that algorithm. The reps would ask on the phone if you’re getting pain coverage, take notes, then add 3 milliamps. They’d have to go through this over the next 3 to 4 weeks to get correct coverage. If they didn’t get correct coverage, they’d have to bring the patient back in for reprogramming to see which programs work or don’t work.” — Former Nevro executive",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34c-302a79b4eacb",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "921524c7-51fb-45b3-9678-7278b1a0991a",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b407030e-2b72-4c91-83ae-0ec5807022a6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.4,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:21.823+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "3d4d1d92-2af4-46ac-8cae-c2df682c5f63",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 237,
      "type": "tension",
      "title": "The slide uses a screenshot of a social media post as primary evidence to support the claim of unauthorized practice of medicine.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 55,
        "componentCount": 7,
        "textChars": 921,
        "nDataPoints": 0,
        "notes": "The slide uses a screenshot of a social media post as primary evidence to support the claim of unauthorized practice of medicine.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "screenshot"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:24.517+00",
          "seconds": 6.842,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/237",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-237",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "One Nevro patient, in a Facebook support group, described what her surgeon told her: that \"the surgeon in his own words is 'merely the technician'\" and the \"rep from NEVRO [patient's emphasis] will instruct him where to place the leads.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-277c9e5123f5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.68,
            "w": 0.31,
            "x": 0.12,
            "y": 0.26
          },
          "kind": "image",
          "text": "Facebook post screenshot",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Image",
              "slug": "image",
              "status": "active",
              "canonId": "019de52c-f978-701f-a720-51d029d769e7",
              "version": 1,
              "description": "Photo, illustration, screenshot or icon."
            },
            "tool": null,
            "subkind": {
              "name": "Screenshot",
              "slug": "screenshot",
              "status": "active",
              "canonId": "019de52c-fd87-7509-8391-3d79fb339379",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "screenshot",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "90a0869f-1801-4ec0-8d18-51b314b99787",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.06,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "One Nevro patient, in a Facebook support group, described what her surgeon told her: that \"the surgeon in his own words is 'merely the technician'\" and the \"rep from NEVRO [patient's emphasis] will instruct him where to place the leads.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "959e6d33-5352-4731-b199-5d0aa821e24d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "the surgeon, in his own words is 'merely the technician'. The rep from NEVRO will instruct him where to place the leads (in my case, paddles). — Facebook support group for Nevro patients",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:50+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-29bf4018e739",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.5,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Facebook support group for Nevro patients https://www.facebook.com/groups/213633049377315",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6e9dd8ae-1dfd-439f-a3a8-8b8c1cb82bb8",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fe62dfbc-f9a5-4b15-a9e7-7a937b05eb25",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.45,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7e408c9b-8c5d-4be0-b7eb-f2292cad5c74",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "c34ef42c-2ff2-47ca-96d8-2ce8c21fd276",
          "evidence": "The slide attempts to expose potential illegal activity (unauthorized practice of medicine) to undermine the company's business model.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:24.517+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 237,
          "frameworkName": "fraud-exposure"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 238,
      "type": "tension",
      "title": "Uses direct quotes from former executives to build a case of regulatory and ethical risk.",
      "function": "expose_contradiction",
      "rawType": "expose_contradiction",
      "block": null,
      "metadata": {
        "slideType": "expose_contradiction",
        "slideTypeCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-124c-75aa-984a-0a3d0d8fc8df",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "overcrowded",
        "densityScore": 86,
        "componentCount": 10,
        "textChars": 3629,
        "nDataPoints": 0,
        "notes": "Uses direct quotes from former executives to build a case of regulatory and ethical risk.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:22.795+00",
          "seconds": 5.11,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/238",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-238",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-a2ac232cb5e7",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.22,
            "w": 0.88,
            "x": 0.06,
            "y": 0.13
          },
          "kind": "paragraph",
          "text": "Two former Nevro executives elaborated on why “reps engaging in the practice of medicine has always been the concern,” suggesting that the risk is known inside the company. One stated that programming their device is so time intensive that the company’s entire value proposition and business model are predicated on doctors outsourcing patient care to Nevro. A second stated that Nevro’s reps and clinical specialists are “not health care providers in any way, shape, or form” but are “responsible for the care of patients.” He added that patients would be “pretty concerned” if they knew the credentials of these employees. He added that it’s illegal in Europe for reps to program stimulators, and that Nevro’s US model is “weird” and requires “huge overhead.”",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "fb082e9a-5d3b-4f1c-956e-03ba7cf80573",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.09,
            "w": 0.88,
            "x": 0.06,
            "y": 0.62
          },
          "kind": "quote",
          "text": "“They’re not health care providers in any way, shape, or form. Some of them are not educated in medicine or science at all, and they’re responsible for the care of patients. You can say that’s definitely not a great thing. If the patients knew what the credentials of some of the caregivers are they would probably be pretty concerned.” – Former Nevro executive #2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "12550677-8a86-4ee8-8816-91c8bc3036e6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.37
          },
          "kind": "quote",
          "text": "“Reps engaging in the practice of medicine has always been the concern. It’s very time consuming to schedule the patient with a doctor to reprogram them. A majority of the doctors don’t know how stimulators work or how to program them. The rep is in the operating room doing the programming. The doctors are not involved in the programming. They understand at a high level that they’re driving a current through the spine. From a technical standpoint to use the programmer or remote control, not so much.” – Former Nevro executive #1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "28e2ba35-e81b-4ee1-aa75-5c3785b2a519",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.07,
            "w": 0.88,
            "x": 0.06,
            "y": 0.53
          },
          "kind": "quote",
          "text": "“Doctors don’t want to give up office space to have patients to come in. They might have a portfolio of several hundred patients that need reprogramming, who they’d have schedule and reschedule, which would tie up a lot of office space.” – Former Nevro executive #1",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "65bca161-adba-457a-b09d-b608df0b54db",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.12,
            "w": 0.88,
            "x": 0.06,
            "y": 0.73
          },
          "kind": "quote",
          "text": "“In Europe because of regulations, reps aren’t allowed to interact with the patient. Programming has to be done by a physician, so healthcare professionals there have learned how to program the patient. In the US having manufacturers on the hook for support is not realistic. It requires a huge overhead to maintain and support a neuromodulation business. It’s a weird model. Whenever you send a rep to program the device, the manufacturer is not getting paid. The rep spends two hours programming.” – Former Nevro executive #2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "98bdfac4-693a-43ed-b60f-15137af44c2e",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "\"Reps engaging in the practice of medicine has always been the concern. It’s very time consuming to schedule the patient with a doctor to reprogram them. The majority of the doctors don’t know how stimulators work or how to program them. The rep is in the operating room doing the programming. The doctors are not involved in the programming. They understand at a high level that they’re driving a current through the spine. From a technical standpoint to use the programmer or remote control, not so much.\" — Former Nevro executive #1; \"They’re not health care providers in any way, shape, or form. Some of them are not educated in medicine or science at all, and they’re responsible for the care of patients. You can say that’s definitely not a great thing. If the patients knew what the credentials of some of the caregivers are they would probably be pretty concerned.\" — Former Nevro executive #2",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-a5b6acab0150",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.15,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "7b046c8f-9428-4874-bf90-bf2f804d7730",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.09
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6c4de848-c7e2-4dbd-a0c3-9f9cf266bb80",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6be06229-7ae4-4ed4-87f3-67d8580f658d",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "71f09ef7-70ee-4b27-9edb-59dfea340718",
          "evidence": "Frames the company's business model as inherently unethical/illegal through executive testimony.",
          "framework": null,
          "confidence": 0.8,
          "extraction": {
            "at": "2026-05-02 20:16:22.795+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 238,
          "frameworkName": "antagonist-introduction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    },
    {
      "page": 239,
      "type": "tension",
      "title": "The slide uses a direct quote from a KOL to support the thesis that Nevro reps are overstepping their professional boundaries.",
      "function": "expose_contradiction",
      "rawType": "testimonial",
      "block": null,
      "metadata": {
        "slideType": "testimonial",
        "slideTypeCanon": {
          "name": "Testimonial",
          "slug": "testimonial",
          "status": "active",
          "canonId": "019de52d-0a2d-7782-8a48-7e84df92cc97",
          "version": 1,
          "description": null
        },
        "function": "expose_contradiction",
        "functionCanon": {
          "name": "Expose contradiction",
          "slug": "expose_contradiction",
          "status": "active",
          "canonId": "019de52d-171f-776f-887c-73edaff4cf9c",
          "version": 1,
          "description": null
        },
        "density": "dense",
        "densityScore": 68,
        "componentCount": 7,
        "textChars": 2833,
        "nDataPoints": 0,
        "notes": "The slide uses a direct quote from a KOL to support the thesis that Nevro reps are overstepping their professional boundaries.",
        "elementsJson": [
          "headline_text",
          "paragraph",
          "quote_block",
          "footnote"
        ],
        "confidence": 1,
        "extraction": {
          "model": "google/gemini-3.1-flash-lite-preview-20260303",
          "runId": null,
          "at": "2026-05-02 20:16:25.245+00",
          "seconds": 7.511,
          "promptVersion": "v2-canon-conditioned"
        }
      },
      "links": {
        "slide": "/slides/019dd923-622c-750b-8b9a-2a2468219173/239",
        "deck": "/decks/019dd923-622c-750b-8b9a-2a2468219173",
        "deckAnchor": "/decks/019dd923-622c-750b-8b9a-2a2468219173#slide-239",
        "deckJson": "/decks/019dd923-622c-750b-8b9a-2a2468219173.json"
      },
      "components": [
        {
          "bbox": null,
          "kind": "callout",
          "text": "The rep is kind of an extension of your practice.",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Callout",
              "slug": "callout",
              "status": "active",
              "canonId": "019de52c-f8d3-761a-8953-7d37080de5e2",
              "version": 1,
              "description": "Highlighted callout box."
            },
            "tool": {
              "name": "Visual emphasis",
              "slug": "visual-emphasis",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-474b-736b-a8eb-a794dd88241c",
              "version": 1,
              "bodyDocId": null,
              "description": "Drawing the eye to one element above the rest of the slide.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-f5468c6180a6",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.15,
            "w": 0.88,
            "x": 0.06,
            "y": 0.14
          },
          "kind": "paragraph",
          "text": "We conclude this section with comments by another KOL, one of Nevro's highest volume accounts, who also expressed his discomfort with reps engaging in the practice of medicine, stating that \"the rep is kind of an extension of your practice.\" Aside from the obvious reasons why handing off patient care to reps without medical qualifications is indicative of a questionable business model, he outlined the dangers from reps caring more about their commissions than their patients, such as lying to doctors about how patients are actually doing and feeding \"misinformation.\"",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "5f2affc0-941d-4d07-959d-4bfc1930cea4",
              "version": 1,
              "description": "Single prose block in the body of a slide."
            },
            "tool": null,
            "subkind": {
              "name": "Paragraph",
              "slug": "paragraph",
              "status": "active",
              "canonId": "019de52c-fb80-75af-aa5c-a7a4bfac2433",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "paragraph",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d6460431-4200-4301-ab4f-b64ba6d7aa07",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.35,
            "w": 0.88,
            "x": 0.06,
            "y": 0.38
          },
          "kind": "quote",
          "text": "Question: \"Do you have any concern about reps engaging in the practice of medicine?\" \"I do and I always debate with myself about whether I should even have the rep in the room when a patient discussion is going on. It is a valid concern. The rep is kind of an extension of your practice. I've seen some really egregious things where the feedback is really negative about what the rep did in terms of steering a patient that was unsure and pushing them towards implant. The reps will certainly try to be there every time because that's their opportunity to steer the conversation. My concern is that they're potentially doing things that I don't like, on the phone with he patient. Sometimes practices don't have a bandwidth to engage with their patient every day for a week. The rep gives text message updates saying \"Hey Mr. Jones is going great\" and then you call Mr. Jones and he's like \"Oh no I am doing terrible. I don't like this\". Sometimes the doc is not really paying attention. They start to get misinformation.\" – KOL and high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": null,
            "subkind": {
              "name": "Testimonial",
              "slug": "testimonial",
              "status": "active",
              "canonId": "019de52c-fc21-71b6-9ac3-8266a64945e8",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "testimonial",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "d863518d-0c4d-4fd5-9c9f-3713d3ecc33d",
          "parentComponentId": null
        },
        {
          "bbox": null,
          "kind": "quote",
          "text": "I do and I always debate with myself about whether I should even have the rep in the room when a patient discussion is going on. It is a valid concern. The rep is kind of an extension of your practice. I've seen some really egregious things where the feedback is really negative about what the rep did in terms of steering a patient that was unsure and pushing them towards implant. The reps will certainly try to be there every time because that's their opportunity to steer the conversation. My concern is that they're potentially doing things that I don't like, on the phone with he patient. Sometimes practices don't have a bandwidth to engage with their patient every day for a week. The rep gives text message updates saying \"Hey Mr. Jones is going great\" and then you call Mr. Jones and he's like \"Oh no I am doing terrible. I don't like this\". Sometimes the doc is not really paying attention. They start to get misinformation. — KOL and high volume Nevro implanter",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Quote",
              "slug": "quote",
              "status": "active",
              "canonId": "019de52c-f8fb-751e-8bc6-d58e2d59562a",
              "version": 1,
              "description": "Pull quote or testimonial."
            },
            "tool": {
              "name": "Authority citation",
              "slug": "authority-citation",
              "status": "active",
              "bestFor": null,
              "canonId": "019dd9e1-49ae-7557-89ad-3fca70469b45",
              "version": 1,
              "bodyDocId": null,
              "description": "Quoting an authority figure, study, or precedent to lend weight.",
              "familyLabel": null
            },
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-04-22 23:39:51+00",
            "model": "unknown-legacy",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "019dd953-3f3d-76db-b34b-f83b512dc865",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.02,
            "w": 0.2,
            "x": 0.06,
            "y": 0.96
          },
          "kind": "source-note",
          "text": "Source: Consultation calls with experts",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Source note",
              "slug": "source-note",
              "status": "active",
              "canonId": "23484952-494b-4a5e-b1ad-550d0d70e948",
              "version": 1,
              "description": "Attribution / source / caveat placed at the slide footer. Numbered footnotes use attrs.numbered."
            },
            "tool": null,
            "subkind": null,
            "framework": null
          },
          "subkind": null,
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "0c81e6a8-a134-4171-9baa-89b750d30709",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.88,
            "x": 0.06,
            "y": 0.1
          },
          "kind": "title",
          "text": "19. Nevro's business model is predicated on employees engaging in the unauthorized practice of medicine",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Action title",
              "slug": "action-title",
              "status": "active",
              "canonId": "019de52c-fb31-734c-a0f5-a3935b73135d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "action-title",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "b0d5c8b1-54fa-436a-a1a0-c5e7f54e08d5",
          "parentComponentId": null
        },
        {
          "bbox": {
            "h": 0.03,
            "w": 0.35,
            "x": 0.06,
            "y": 0.04
          },
          "kind": "title",
          "text": "Scorpion Capital | Nevro (NYSE: NVRO)",
          "attrs": null,
          "canon": {
            "kind": {
              "name": "Title",
              "slug": "title",
              "status": "active",
              "canonId": "019de52c-f7dd-76d9-b848-b1f12bd85cf4",
              "version": 1,
              "description": "Slide title or headline."
            },
            "tool": null,
            "subkind": {
              "name": "Headline",
              "slug": "headline",
              "status": "active",
              "canonId": "019de52c-fae1-7463-9a7c-d60668eced0d",
              "version": 1,
              "description": null
            },
            "framework": null
          },
          "subkind": "headline",
          "groupRole": null,
          "confidence": null,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "componentId": "6ce2485b-64ab-4319-bcc8-d2926b1cab79",
          "parentComponentId": null
        }
      ],
      "metrics": [],
      "tools": [],
      "frameworks": [
        {
          "matchId": "83e1afb7-083a-4045-8f91-4601143c383b",
          "evidence": "Uses a KOL quote to contradict the company's business model legitimacy.",
          "framework": null,
          "confidence": 0.9,
          "extraction": {
            "at": "2026-05-02 20:16:25.245+00",
            "model": "google/gemini-3.1-flash-lite-preview-20260303",
            "runId": null,
            "seconds": null,
            "promptVersion": null
          },
          "pageNumber": 239,
          "frameworkName": "ceo-quote-contradiction"
        }
      ],
      "arcBeats": [],
      "loops": [],
      "locked": true
    }
  ],
  "arcBeats": [
    {
      "from": 9,
      "to": 20,
      "label": "The Monster",
      "description": "The deck presents a series of criticisms and contradictions against Nevro"
    },
    {
      "from": 21,
      "to": 50,
      "label": "The Struggle",
      "description": "The deck details the struggles faced by Nevro's patients and the company's response"
    },
    {
      "from": 51,
      "to": 150,
      "label": "The Victory",
      "description": "The deck presents a conclusion that Nevro's problems are insurmountable"
    }
  ],
  "loops": [
    {
      "from": 10,
      "to": 20,
      "label": "The Reveal",
      "description": "Reveal Nevro's flaws"
    },
    {
      "from": 50,
      "to": 60,
      "label": "Cost Of Inaction",
      "description": "Highlight the cost of inaction"
    }
  ]
}